1 00:00:22,771 --> 00:00:24,540 SECOND DAY, I WOULD LIKE TO 2 00:00:24,540 --> 00:00:26,041 INTRODUCE DR. CHANG FOR OUR KEY 3 00:00:26,041 --> 00:00:36,585 NOTE SPEAKER FOR THIS MORNING. 4 00:00:40,122 --> 00:00:41,557 THANK YOU. 5 00:00:41,557 --> 00:00:43,225 >> I'M DR. HUANG AND CAN I GET 6 00:00:43,225 --> 00:00:44,560 THE SLIDES PLEASE. 7 00:00:44,560 --> 00:00:47,162 THIS IS A PRIVILEGE FOR ME TO 8 00:00:47,162 --> 00:00:50,032 BRUCE OUR SECOND KEY NOTE WHO IS 9 00:00:50,032 --> 00:00:51,333 DAVID HUANG, OKAY, AND I WILL 10 00:00:51,333 --> 00:00:56,438 LET YOU DRIVE THIS. 11 00:00:56,438 --> 00:00:56,672 THANKS. 12 00:00:56,672 --> 00:00:59,108 SO, DAVID--YOU KNOW ALL OF--YOU 13 00:00:59,108 --> 00:01:00,542 KNOW THE BASICS ABOUT DAVID BUT 14 00:01:00,542 --> 00:01:03,312 LET ME JUST GO THROUGH SOME OF 15 00:01:03,312 --> 00:01:05,047 THIS BIOGRAPHY, DAVID WAS BORN 16 00:01:05,047 --> 00:01:06,648 IN TAIWAN, CAME TO THE U.S. AT 17 00:01:06,648 --> 00:01:10,152 AGE 13 WHERE HIS FAMILY MOVED TO 18 00:01:10,152 --> 00:01:11,954 UP STATE NEW YORK THAT'S WHERE 19 00:01:11,954 --> 00:01:14,156 HE WENT TO HIGH SCHOOL, JOINED 20 00:01:14,156 --> 00:01:22,698 THE WRESTLING TEAM, YOU KNOW 21 00:01:22,698 --> 00:01:24,533 JUST GRADUATED AND END ENDED UP 22 00:01:24,533 --> 00:01:26,835 GOING TO M. I.T. AND GOT A 23 00:01:26,835 --> 00:01:28,237 BACHELORS AND A MASTERS THERE 24 00:01:28,237 --> 00:01:31,774 AND THEN WENT TO HARVARD MEDICAL 25 00:01:31,774 --> 00:01:33,609 SCHOOL THAT WAS AFFILIATED WITH 26 00:01:33,609 --> 00:01:35,711 M. I.T. CALLED DIVISION OF 27 00:01:35,711 --> 00:01:37,012 HEALTH SCIENCES AND TECHNOLOGY. 28 00:01:37,012 --> 00:01:38,514 KNOWS THIS ABOUT DAVID, I 29 00:01:38,514 --> 00:01:40,616 THOUGHT WE HAD SOME SIMILARITIES 30 00:01:40,616 --> 00:01:41,984 BECAUSE LIKE DAVID MY FAMILY 31 00:01:41,984 --> 00:01:45,154 CAME TO THE U.S. IN TAIWAN, I 32 00:01:45,154 --> 00:01:45,788 STUDIED ELECTRICAL ENGINEERING 33 00:01:45,788 --> 00:01:47,256 IN COLLEGE AND I GRADUATED FROM 34 00:01:47,256 --> 00:01:50,726 THE SAME PROGRAM, OKAY, BUT QUH 35 00:01:50,726 --> 00:01:52,461 WE STARTED TO LOOK DEEPER, I 36 00:01:52,461 --> 00:01:53,762 STARTED TO FEEL LIKE MAYBE 37 00:01:53,762 --> 00:01:55,297 THAT'S WHERE THE SIMILARITIES, 38 00:01:55,297 --> 00:01:56,365 WE STARTED TO DIVERGE A LITTLE 39 00:01:56,365 --> 00:02:00,202 BIT SO I TRIED TO FIND SOME 40 00:02:00,202 --> 00:02:01,570 PICTURE JUST TO ILLUSTRATE 41 00:02:01,570 --> 00:02:03,906 MEDICAL SCHOOL, FROM MYSELF, AND 42 00:02:03,906 --> 00:02:06,408 ALL I COULD FIND WAS THINGS LIKE 43 00:02:06,408 --> 00:02:07,876 THIS, YOU KNOW WHERE APPARENTLY 44 00:02:07,876 --> 00:02:12,114 I WAS LEARNING TO PLAY BEACH 45 00:02:12,114 --> 00:02:14,083 VOLLEYBALL AND YOU KNOW GO TO 46 00:02:14,083 --> 00:02:17,519 AMUSEMENT PARKS IN WEST 47 00:02:17,519 --> 00:02:17,853 MASSACHUSETTS. 48 00:02:17,853 --> 00:02:20,422 WHEREAS DAVID ON THE OTHER HAND 49 00:02:20,422 --> 00:02:22,291 WAS GETTING HIS Ph.D. AT 50 00:02:22,291 --> 00:02:23,559 MEDICAL PHYSICS AT M. I.T. AND 51 00:02:23,559 --> 00:02:25,994 WORKING ON THIS SEMINOLE PAPER 52 00:02:25,994 --> 00:02:28,197 WITH YOU KNOW, THIS PAPER'S BEEN 53 00:02:28,197 --> 00:02:30,866 SHOWN HERE, SO MANY TIMES, YOU 54 00:02:30,866 --> 00:02:33,936 KNOW ERIC, JOEL, YOU KNOW CARMEN 55 00:02:33,936 --> 00:02:34,970 [INDISCERNIBLE] AND OBVIOUSLY 56 00:02:34,970 --> 00:02:37,573 JIM AND YOU KNOW TO STATE THE 57 00:02:37,573 --> 00:02:38,974 OBVIOUS, THIS PAPER HAS BECOME 58 00:02:38,974 --> 00:02:41,043 SUCH A CLASSIC THAT EVEN THOUGH 59 00:02:41,043 --> 00:02:42,578 IT'S GOT 18,000 CITATIONS, 60 00:02:42,578 --> 00:02:45,781 PEOPLE DON'T NEED TO CITE IT 61 00:02:45,781 --> 00:02:46,014 ANYMORE. 62 00:02:46,014 --> 00:02:47,850 IT'S JUST BECOME PART OF EVERY 63 00:02:47,850 --> 00:02:49,451 DAY KNOWLEDGE, THAT TRANSCENDS 64 00:02:49,451 --> 00:02:50,886 CITATION, EVEN AND AFTER THAT 65 00:02:50,886 --> 00:02:54,189 DAVID BECAME A RESIDENT IN 66 00:02:54,189 --> 00:02:55,224 OPHTHALMOLOGY AT THE EYE 67 00:02:55,224 --> 00:02:58,293 INSTITUTE AND DID A FELLOWSHIP 68 00:02:58,293 --> 00:02:59,995 IN CORNEA AT EMORY AND THAT WAS 69 00:02:59,995 --> 00:03:02,498 JUST THE BEGENERATEDDING FOR 70 00:03:02,498 --> 00:03:02,698 HIM. 71 00:03:02,698 --> 00:03:04,566 HE STARTED HIS CLEAR AT 72 00:03:04,566 --> 00:03:06,935 CLEVELAND CLINIC IN REFRACTIVE 73 00:03:06,935 --> 00:03:07,669 SURGERY AND BIOMEDICAL 74 00:03:07,669 --> 00:03:10,806 EMERGENCYING AND MOVED TO USC. 75 00:03:10,806 --> 00:03:13,408 AND THEN MOVED TO OREGON HEALTH 76 00:03:13,408 --> 00:03:16,011 AND SCIENCE UNIVERSITY IN 2010 77 00:03:16,011 --> 00:03:19,047 WHERE HE BECAME PROFESSOR AND 78 00:03:19,047 --> 00:03:21,216 BIOMEDICAL ENGINEERING, BECAME 79 00:03:21,216 --> 00:03:23,719 DIRECTOR OF THE CENTER FOR 80 00:03:23,719 --> 00:03:27,789 OPHTHALMIC, OPTICS AND LASERS, 81 00:03:27,789 --> 00:03:30,359 THE COOL LAB WHICH HAS OVER 30 82 00:03:30,359 --> 00:03:31,660 FACULTY, STAFF AND TRAINEES AND 83 00:03:31,660 --> 00:03:38,467 IT WAS DURING THAT TIME THAT HE 84 00:03:38,467 --> 00:03:40,402 RECEIVED MAJOR AWARDS, WITH A 85 00:03:40,402 --> 00:03:42,037 NUMBER OF THE PEOPLE IN THE 86 00:03:42,037 --> 00:03:44,406 AUDIENCE HERE, HE WAS ELECTED TO 87 00:03:44,406 --> 00:03:46,308 THE NATIONAL ARK CAD ME OF 88 00:03:46,308 --> 00:03:48,243 ENGINEERING AND RECEIVED THE 89 00:03:48,243 --> 00:03:50,312 STANFORD AND GREEN BERG PRIZE TO 90 00:03:50,312 --> 00:03:51,280 END PLIENDNESS VISIONARY AWARD 91 00:03:51,280 --> 00:03:53,115 AND YOU KNOW NUMBER OF YEARS 92 00:03:53,115 --> 00:03:54,416 AGO, HE BECAME ASSOCIATE 93 00:03:54,416 --> 00:03:58,153 DIRECTOR AT THE OHHSU EYE 94 00:03:58,153 --> 00:03:59,588 INSTITUTE AND IT WAS DURING THIS 95 00:03:59,588 --> 00:04:03,959 PERIOD WHERE HE RECEIVED ALL 96 00:04:03,959 --> 00:04:05,427 THE--THE LASKER AWARD, NATIONAL 97 00:04:05,427 --> 00:04:08,230 MEDAL OF TECHNOLOGY AND 98 00:04:08,230 --> 00:04:09,431 INNOVATION, NOW IN EMERGING ITS 99 00:04:09,431 --> 00:04:10,966 OF THESE PARALLEL ANDS HOW I GOT 100 00:04:10,966 --> 00:04:12,768 TO KNOW DAVID, I TARTED WORKING 101 00:04:12,768 --> 00:04:14,469 AT HEALTH AND OREGON SCIENCE 102 00:04:14,469 --> 00:04:15,837 UNIVERSITY ABOUT 6 MONTHS AFTER 103 00:04:15,837 --> 00:04:17,172 DAVID DID AND THAT'S WHERE I 104 00:04:17,172 --> 00:04:20,175 FELT LIKE I GOT TO KNOW HIM AS A 105 00:04:20,175 --> 00:04:23,045 COLLEAGUE AND AS A FRIEND. 106 00:04:23,045 --> 00:04:26,782 AND SO THAT'S MY LAST SLIDE OF 107 00:04:26,782 --> 00:04:27,249 THE INTRODUCTION. 108 00:04:27,249 --> 00:04:28,784 THAT ON A PERSONAL NOTE JUST 109 00:04:28,784 --> 00:04:30,752 FROM WORKING WITH HIM ON A 110 00:04:30,752 --> 00:04:31,753 COUPLE PROJECTS, AND I'VE GOTTEN 111 00:04:31,753 --> 00:04:33,255 TO UNDERSTAND THE WAY THAT HIS 112 00:04:33,255 --> 00:04:36,058 MIND WORKS. 113 00:04:36,058 --> 00:04:38,360 DAVID IS SO CREATIVE, HE HAS 114 00:04:38,360 --> 00:04:39,461 THIS UNUSUAL ABILITY TO ELECTRIC 115 00:04:39,461 --> 00:04:41,964 AT A PROJECT ON A VERY, VERY 116 00:04:41,964 --> 00:04:42,698 BROAD NOTE. 117 00:04:42,698 --> 00:04:43,632 LIKE WHAT'S THE IMPACT OF HIS 118 00:04:43,632 --> 00:04:47,970 WORK GOING TO BE IN OTHER AREAS. 119 00:04:47,970 --> 00:04:49,938 AND ALSO DELVE REALLY DEEPLY AND 120 00:04:49,938 --> 00:04:51,974 KIND OF UNDERSTAND EVERY NUANCE 121 00:04:51,974 --> 00:04:57,412 OF A PROBLEM AND IF YOU COULD 122 00:04:57,412 --> 00:05:02,517 POST THAT UP AND SO, DAVE I ALSO 123 00:05:02,517 --> 00:05:04,186 HAS 1 DAUGHTER, [INDISCERNIBLE] 124 00:05:04,186 --> 00:05:05,654 WHO WE GOT TO KNOW A LITTLE BIT 125 00:05:05,654 --> 00:05:06,855 BECAUSE I HAPPEN TO HAVE 2 126 00:05:06,855 --> 00:05:08,257 DAUGHTERS AND THEY'VE DONE A FEW 127 00:05:08,257 --> 00:05:12,694 THINGS TOGETHER OVER THE YEARS 128 00:05:12,694 --> 00:05:15,464 AND JUST MEETING HIS CHILD, SHE 129 00:05:15,464 --> 00:05:16,531 WAS SMART, SPUNKY, CREATIVE AND 130 00:05:16,531 --> 00:05:19,401 YOU KNOW THESE KIDS ARE ALL IN 131 00:05:19,401 --> 00:05:19,835 COLLEGE RIGHT NOW. 132 00:05:19,835 --> 00:05:21,803 AND YOU KNOW WHEN I LOOK AT 133 00:05:21,803 --> 00:05:24,940 PICTURES OF MY KIDS IN COLLEGE 134 00:05:24,940 --> 00:05:26,908 WHICH THEY SEND FROM TIME TO 135 00:05:26,908 --> 00:05:28,076 TIME, THEY'RE DOING THINGS LIKE 136 00:05:28,076 --> 00:05:29,611 HANGING OUT IN THE DORM WHEREAS 137 00:05:29,611 --> 00:05:32,614 WHEN I LOOK AT PICTURES OF HER, 138 00:05:32,614 --> 00:05:37,919 SHE'S HINGING OUT IN THE 139 00:05:37,919 --> 00:05:39,087 WHITE HOUSE, AND SO BUT THE 140 00:05:39,087 --> 00:05:40,689 REASON I PUT THIS UP ISN'T TO 141 00:05:40,689 --> 00:05:42,357 TALK ABOUT THE WHITE HOUSE OR 142 00:05:42,357 --> 00:05:43,992 SKIING, BUT TO SAY THAT, YOU 143 00:05:43,992 --> 00:05:46,094 KNOW THIS IS REALLY GIIVE ME A 144 00:05:46,094 --> 00:05:48,263 CHANCE TO SEE DAVID ON A MORE 145 00:05:48,263 --> 00:05:50,766 PERSONAL LEVEL AS A FATHER AND 146 00:05:50,766 --> 00:05:52,567 TO SEE HOW HE'S RAISED A 147 00:05:52,567 --> 00:05:54,069 DAUGHTER YOU KNOW WHO'S BECOME 148 00:05:54,069 --> 00:05:57,272 REALLY, REALLY SMART AND SHE 149 00:05:57,272 --> 00:06:00,742 TRIED TO--SHE CAME TO ATTEND THE 150 00:06:00,742 --> 00:06:01,910 LASKER AWARDS SYMPOSIUM BUT YOU 151 00:06:01,910 --> 00:06:05,247 KNOW THEY DIDN'T LET HER OUT OF 152 00:06:05,247 --> 00:06:06,515 ORGANIC CHEMISTRY EXAM EVEN 153 00:06:06,515 --> 00:06:09,184 THOUGH HER FATHER WAS WINNING 154 00:06:09,184 --> 00:06:10,485 THE LASKER AWARD AND A RECEPTION 155 00:06:10,485 --> 00:06:12,454 SO IT WAS A RUSH FOR HER HAD GET 156 00:06:12,454 --> 00:06:14,222 THERE BUT THIS HAS BEEN A REAL 157 00:06:14,222 --> 00:06:16,391 PRIVILEGE FOR ME TO WATCH DAVID 158 00:06:16,391 --> 00:06:17,859 BOTH AS AN ACADEMIC AND AS A 159 00:06:17,859 --> 00:06:19,628 PERSON AND WITH THAT, DAVID 160 00:06:19,628 --> 00:06:21,463 WE'RE REALLY EXCITED TO HAVE YOU 161 00:06:21,463 --> 00:06:23,432 HERE, CONGRATULATIONS FOR ALL 162 00:06:23,432 --> 00:06:24,266 YOUR ACCOMPLISHMENTS AND LOOK 163 00:06:24,266 --> 00:06:34,743 FORWARD TO YOUR TALK TODAY. 164 00:06:49,424 --> 00:06:50,425 [ APPLAUSE ] 165 00:06:50,425 --> 00:06:58,834 >> WOW, THANK YOU MIKE, THAT WAS 166 00:06:58,834 --> 00:07:00,602 A WONDERFUL INTRODUCTION I LOVE 167 00:07:00,602 --> 00:07:01,570 ALL YOUR PERSONAL TOUCHES, I 168 00:07:01,570 --> 00:07:04,573 DIDN'T KNOW YOU SAVED ALL THOSE 169 00:07:04,573 --> 00:07:06,174 PICTURES WITH OUR DAUGHTERS 170 00:07:06,174 --> 00:07:07,909 TOGETHER FROM THE HAWAII AND THE 171 00:07:07,909 --> 00:07:09,378 SKI TRIP. 172 00:07:09,378 --> 00:07:09,878 THAT'S REALLY WONDERFUL. 173 00:07:09,878 --> 00:07:13,048 SO I WANT TO THANK NATIONAL EYE 174 00:07:13,048 --> 00:07:19,121 INSTITUTE, DR. MIKE CHANG AND 175 00:07:19,121 --> 00:07:21,556 DR. [INDISCERNIBLE] TO ORGANIZE 176 00:07:21,556 --> 00:07:22,524 THIS SYMPOSIUM. 177 00:07:22,524 --> 00:07:30,866 I'VE BEEN SAVING UP LITTLE 178 00:07:30,866 --> 00:07:32,067 STORIES AND SNIPITS FOR THIS 179 00:07:32,067 --> 00:07:33,402 PRESENTATION AND I HOPE YOU WILL 180 00:07:33,402 --> 00:07:34,536 FIND IT AMAZING ALSO. 181 00:07:34,536 --> 00:07:36,538 SO I WILL TALK ABOUT SEEING 182 00:07:36,538 --> 00:07:38,974 SMALL AND AIMING BIG AT TWEPMENT 183 00:07:38,974 --> 00:07:42,077 AND CLINICAL IMPACT OF OCT AND I 184 00:07:42,077 --> 00:07:44,413 DO HAVE A FINANCIAL INTEREST IN 185 00:07:44,413 --> 00:07:52,254 SOME ASPECTS OF OCT, IT'S LISTED 186 00:07:52,254 --> 00:07:52,487 HERE. 187 00:07:52,487 --> 00:07:54,523 SO 2023 OF COURSE FERS A BANNER 188 00:07:54,523 --> 00:07:56,491 YEAR FOR OCT AND I FOUND 189 00:07:56,491 --> 00:07:57,759 ESPECIALLY GOING TO THE 190 00:07:57,759 --> 00:08:02,631 WHITE HOUSE TO BE QUITE 191 00:08:02,631 --> 00:08:03,165 THRILLING. 192 00:08:03,165 --> 00:08:05,033 PRESIDENT BIDEN WAS VERY QUICK 193 00:08:05,033 --> 00:08:08,470 WITTED AND OBVIOUSLY ENJOYED 194 00:08:08,470 --> 00:08:09,971 BOSSING EVERYONE AROUND, SO I 195 00:08:09,971 --> 00:08:11,840 THINK RUMORS THAT HE'S SLOWING 196 00:08:11,840 --> 00:08:15,277 DOWN IS GREATLY EXAGGERATED AND 197 00:08:15,277 --> 00:08:18,313 I REALLY CREDIT HIM FOR REVIVING 198 00:08:18,313 --> 00:08:21,049 THE NATIONAL MEDALS, AFTER A 6 199 00:08:21,049 --> 00:08:22,851 YEAR HIATUS, I THINK IT SHOWED A 200 00:08:22,851 --> 00:08:29,357 LOT OF RESPECT FOR SCIENCE AND 201 00:08:29,357 --> 00:08:29,658 TECHNOLOGY. 202 00:08:29,658 --> 00:08:32,527 WE CAN THINK OF OCT AS THE 203 00:08:32,527 --> 00:08:34,129 CULMINATION OF MORE THAN A 204 00:08:34,129 --> 00:08:36,731 HUNDRED YEARS OF RESEARCH INTO 205 00:08:36,731 --> 00:08:38,366 USING LIGHT TO MEASURE THE TIME 206 00:08:38,366 --> 00:08:43,338 OF FLIGHT OF LIGHT. 207 00:08:43,338 --> 00:08:50,545 I THINK JIM IN HIS TALK TALKED 208 00:08:50,545 --> 00:08:51,246 ABOUT [INDISCERNIBLE]. 209 00:08:51,246 --> 00:08:54,583 BUT MORE RECENTLY WE CAN TRACE 210 00:08:54,583 --> 00:09:02,123 IT TO THE MICHELSON MORALLY 211 00:09:02,123 --> 00:09:03,558 WHERE HE DEVELOPED THIS SPEED OF 212 00:09:03,558 --> 00:09:04,593 LIGHT RELATIVE TO THE MOTION OF 213 00:09:04,593 --> 00:09:05,660 EARTH AND OF COURSE HE FOUND 214 00:09:05,660 --> 00:09:07,596 THAT THE SPEED OF LIGHT DID NOT 215 00:09:07,596 --> 00:09:09,965 CHANGE RELATIVE TO EARTH MOTION 216 00:09:09,965 --> 00:09:12,868 AND THAT SET THE STAGE FOR THE 217 00:09:12,868 --> 00:09:17,973 THEORY OF RELATIVITY AND FOR HIS 218 00:09:17,973 --> 00:09:18,907 NOBEL PRIZE IN 1907. 219 00:09:18,907 --> 00:09:27,048 AND WE USED THE SAME MICHELSON 220 00:09:27,048 --> 00:09:29,351 INTERROMETER BUT NOW WITH SHORT 221 00:09:29,351 --> 00:09:30,619 COHERENCE LENGTH OF LIGHT AND 222 00:09:30,619 --> 00:09:31,953 THAT ALLOWS US TO MEASURE THE 223 00:09:31,953 --> 00:09:33,788 TIME OF LIGHT REFLECTED FROM 224 00:09:33,788 --> 00:09:37,092 TISSUE SAMPLES. 225 00:09:37,092 --> 00:09:42,030 THESE DAYS OFTEN DOWN TO LEVEL 226 00:09:42,030 --> 00:09:45,767 .03 MICROMETERS WHICH WAS EQUIV 227 00:09:45,767 --> 00:09:47,636 LEAPT TO 30 FS ROUND TRIP, AND 228 00:09:47,636 --> 00:09:49,604 OF COURSE TIME CANNOT BE WORTH A 229 00:09:49,604 --> 00:09:51,907 CLOCK OF ANY TYPE SO REALLY ONLY 230 00:09:51,907 --> 00:09:54,309 THE LIGHT IS THE ONLY THING THAT 231 00:09:54,309 --> 00:09:56,044 IS FAST ENOUGH TO MEASURE TIME 232 00:09:56,044 --> 00:10:03,285 OF FLIGHT AT THIS LEVEL. 233 00:10:03,285 --> 00:10:09,591 OCT TARTED IN PROFESSOR 234 00:10:09,591 --> 00:10:14,062 FUJI MOTO'S LAB IN 1990. 235 00:10:14,062 --> 00:10:17,465 SO PROFESSOR FUJIMOTO, GAVE ME 236 00:10:17,465 --> 00:10:19,868 THE INSTRUCTION OF MEASURING THE 237 00:10:19,868 --> 00:10:22,604 THICKNESS OF CORNEA AND RETINA 238 00:10:22,604 --> 00:10:25,273 AND THIS WAS A FS SECOND LASER 239 00:10:25,273 --> 00:10:29,911 LAB SO WE CLEARED A SMALL SPACE 240 00:10:29,911 --> 00:10:32,547 IN THE OPTICS TABLE AND THIS 241 00:10:32,547 --> 00:10:35,550 PHOTOGRAPH SHOWS MY FATHER 242 00:10:35,550 --> 00:10:38,720 VISITING BOSTON AND I WAS 243 00:10:38,720 --> 00:10:41,122 SHOWING HIM MY EXPERIMENTAL SET 244 00:10:41,122 --> 00:10:43,425 UP FOR OCT AND I'M NOT SURE HE 245 00:10:43,425 --> 00:10:46,861 UNDERSTOOD HOW IT WORKED BUT HE 246 00:10:46,861 --> 00:10:49,831 CANNED ME, YOU KNOW WHEN I'M 247 00:10:49,831 --> 00:10:50,865 GOING TO GRADUATE FROM MEDICAL 248 00:10:50,865 --> 00:10:54,202 SCHOOL BECAUSE I WAS TAKING A 249 00:10:54,202 --> 00:10:56,104 VERY LONG TIME. 250 00:10:56,104 --> 00:10:56,371 [LAUGHTER] 251 00:10:56,371 --> 00:10:59,874 AND YOU KNOW I DID NOT HAVE ANY 252 00:10:59,874 --> 00:11:00,875 GOOD ANSWERS. 253 00:11:00,875 --> 00:11:04,212 NEITHER OF US WERE SURE IT WAS 254 00:11:04,212 --> 00:11:13,722 WORTH TAKING EXTRA 4 RESEARCH 255 00:11:13,722 --> 00:11:14,189 YEARS. 256 00:11:14,189 --> 00:11:15,690 BEYOND THE ALREADY LONG SCHOOL 257 00:11:15,690 --> 00:11:16,124 MEDICAL CURRICULUM. 258 00:11:16,124 --> 00:11:18,193 BUT I KNEW I WAS ENJOYING MY 259 00:11:18,193 --> 00:11:20,228 TIME IN THE ULTRA FAST OPTICS 260 00:11:20,228 --> 00:11:22,664 GROUP BECAUSE I WAS LEARNING 261 00:11:22,664 --> 00:11:24,966 FROM VERY SMART PEOPLE AND THEY 262 00:11:24,966 --> 00:11:27,636 WERE TEACHING ME HOW TO NAVIGATE 263 00:11:27,636 --> 00:11:29,504 THIS UNEXPLORED TERRITORY THAT I 264 00:11:29,504 --> 00:11:33,775 WONDERED INTO AND I WAS HAVING A 265 00:11:33,775 --> 00:11:35,744 LOT OF IDEAS AND I WAS IMAGINING 266 00:11:35,744 --> 00:11:37,812 ALL KIND OF THINGS THAT THIS 267 00:11:37,812 --> 00:11:44,686 COULD LEAD TO AND WHAT 1 OF THE 268 00:11:44,686 --> 00:11:48,590 IDEAS WAS OPTIC O ADHERENCE 269 00:11:48,590 --> 00:11:48,890 TOMOGRAPHY. 270 00:11:48,890 --> 00:11:50,592 AND THE IDEA CAME TO ME WHEN I 271 00:11:50,592 --> 00:11:54,763 WAS LOOKING AT THE INTERFERA 272 00:11:54,763 --> 00:11:56,731 METRIC SIGNAL FROM A RETINAL 273 00:11:56,731 --> 00:12:00,168 SAMPLE AND BECAUSE WE HAD VERY 274 00:12:00,168 --> 00:12:02,570 HIGH SENSITIVITY, HUNDRED 275 00:12:02,570 --> 00:12:04,506 DECIBEL, AND RELATIVELY HIGH 276 00:12:04,506 --> 00:12:06,941 RESOLUTION COMPARED TO OTHER 277 00:12:06,941 --> 00:12:07,909 EFFORTS THEN, 10-MICRONS AND 278 00:12:07,909 --> 00:12:11,279 BECAUSE WE WERE PLOTTING THINGS 279 00:12:11,279 --> 00:12:14,582 ON LOGO RHYTHMIC SCALE, I SAW 280 00:12:14,582 --> 00:12:16,584 NOT JUST THE FRONT AND BACK 281 00:12:16,584 --> 00:12:17,752 RETINAL REFLECTIONS WHICH I WAS 282 00:12:17,752 --> 00:12:23,391 KIND OF EXPECTING IN THE 283 00:12:23,391 --> 00:12:24,726 BEGINNING BUT I WAS ALSO SEEING 284 00:12:24,726 --> 00:12:27,429 QUITE A NUMBER OF SIGNAL PEAKS 285 00:12:27,429 --> 00:12:29,164 FROM INSIDE THE RETINA AND OF 286 00:12:29,164 --> 00:12:35,937 COURSE UNDER THE RETINA AND IT 287 00:12:35,937 --> 00:12:38,573 BECOME AN ISSUE LIKE--AT 50 I 288 00:12:38,573 --> 00:12:40,875 THOUGHT OF IT AS A PROBLEM, LIKE 289 00:12:40,875 --> 00:12:42,744 WHICH 2 PEAKS WOULD I PICK TO 290 00:12:42,744 --> 00:12:44,779 MEASURE THE RETINAL THICKNESS 291 00:12:44,779 --> 00:12:47,082 AND THEN MY SECOND THOUGHT WAS, 292 00:12:47,082 --> 00:12:50,051 WELL, IF WE SCAN THE BEAM ACROSS 293 00:12:50,051 --> 00:12:52,721 THE RETINA, THEN I WOULD GET A 294 00:12:52,721 --> 00:12:56,057 PICTURE AND THAT WOULD REVEAL 295 00:12:56,057 --> 00:12:57,525 THAT LAYER STRUCTURE OF THE 296 00:12:57,525 --> 00:12:58,927 RETINA AND THEN MAYBE I COULD 297 00:12:58,927 --> 00:13:00,228 MEASURE THE RETINAL THICKNESS 298 00:13:00,228 --> 00:13:02,497 THAT WAY AND THEN THE THIRD 299 00:13:02,497 --> 00:13:05,166 THOUGHT WAS, IF I COULD GET A 300 00:13:05,166 --> 00:13:06,201 PICTURE OF THE INTERNAL 301 00:13:06,201 --> 00:13:07,535 STRUCTURE OF THE RETINA, THAT 302 00:13:07,535 --> 00:13:10,505 WOULD BE A FREIGHTER DISCOVERY 303 00:13:10,505 --> 00:13:12,674 THAN SIMPLY MEASURING THE 304 00:13:12,674 --> 00:13:12,941 THICKNESS. 305 00:13:12,941 --> 00:13:16,478 SO I WAS VERY EXCITED, I RENTED 306 00:13:16,478 --> 00:13:22,851 JIM'S OFFICE AND BEFORE I GOT 307 00:13:22,851 --> 00:13:26,521 DATA, ASKED FOR SOME 308 00:13:26,521 --> 00:13:29,724 PERMISSION TO BUY A DATA 309 00:13:29,724 --> 00:13:34,596 VISUALIZATION SOFTWARE, IMAGE 310 00:13:34,596 --> 00:13:36,097 RENDERING SOFTWARE SPYGLASS, AND 311 00:13:36,097 --> 00:13:37,298 JIM GRACIOUSLY AGREED TO DO THAT 312 00:13:37,298 --> 00:13:43,438 EVEN THOUGH I DIDN'T HAVE ANY 313 00:13:43,438 --> 00:13:44,072 DATA YET. 314 00:13:44,072 --> 00:13:46,741 AND THAT LED TO THE COLOR SCALE 315 00:13:46,741 --> 00:13:50,044 THAT GAVE OCT IMAGES MORE 316 00:13:50,044 --> 00:13:53,481 PIZAZZ, THAT WAS I STANDARD 317 00:13:53,481 --> 00:13:54,282 SPYDPLASES VISUALIZATION SCHEME 318 00:13:54,282 --> 00:13:58,820 AND OF COURSE IT WORKED OUT, YOU 319 00:13:58,820 --> 00:14:00,121 KNOW WE COULD SEE LAYER 320 00:14:00,121 --> 00:14:03,324 STRUCTURE IN THE RETINA AND THAT 321 00:14:03,324 --> 00:14:11,833 LED TO OUR EFFORT TO DEVELOP OCT 322 00:14:11,833 --> 00:14:12,534 SAY CLINICAL STRUMENT BUT THE 323 00:14:12,534 --> 00:14:15,136 IPT GREATER I SHALL RESULTS 324 00:14:15,136 --> 00:14:16,471 INVITRO WERE PUBLISHED IN 325 00:14:16,471 --> 00:14:19,674 SCIENCE AND DESPITE WHAT 326 00:14:19,674 --> 00:14:21,009 DR. CHANG SAID, I WOULD 327 00:14:21,009 --> 00:14:25,580 ENCOURAGE YOU TO CONTINUE CITING 328 00:14:25,580 --> 00:14:26,080 IT. 329 00:14:26,080 --> 00:14:26,347 [LAUGHTER] 330 00:14:26,347 --> 00:14:28,583 18,000 IS NOT ENOUGH, YOU KNOW, 331 00:14:28,583 --> 00:14:34,556 LET'S SHOOT FOR A BIGGER NUMBER. 332 00:14:34,556 --> 00:14:38,092 BUT I ALSO WANT TO MENTION THAT 333 00:14:38,092 --> 00:14:40,161 DR. JOE SHYOUMAN WERE THERE AT 334 00:14:40,161 --> 00:14:41,396 THE VERY BEGINNING, WHEN WE WERE 335 00:14:41,396 --> 00:14:42,897 DOING ALL THE RETINAL MEASURE 336 00:14:42,897 --> 00:14:46,634 AMS, HE WOULD BRING OVER CALF 337 00:14:46,634 --> 00:14:52,106 EYES AND THEN LATER ON HUMAN 338 00:14:52,106 --> 00:14:55,210 CATAVERRIC EYES AND HE SHOWED ME 339 00:14:55,210 --> 00:14:57,111 HOW TO CUT THE EYEBALL IN HALF 340 00:14:57,111 --> 00:14:59,080 SO WE BEING IMAGE THE RETINA 341 00:14:59,080 --> 00:15:01,916 WITHOUT THE INTERFERENCE OF THE 342 00:15:01,916 --> 00:15:04,219 CO CATARACTS THOO THESE EYES GET 343 00:15:04,219 --> 00:15:05,954 ANDS HE TOLL ME THAT THE RETINAL 344 00:15:05,954 --> 00:15:09,757 STRUCTURES AND HOW TO INTERPRET 345 00:15:09,757 --> 00:15:10,358 THIS INITIAL IMAGE. 346 00:15:10,358 --> 00:15:14,662 AS YOU KNOW, THERE ARE ARTIFACTS 347 00:15:14,662 --> 00:15:15,864 FROM CUTTING THE EYEBALL IN 348 00:15:15,864 --> 00:15:19,400 HALF, YOU GET A RETINAL 349 00:15:19,400 --> 00:15:23,338 DETACHMENT AND YOU KNOW WHAT ALL 350 00:15:23,338 --> 00:15:25,607 THESE STRUCTURES ARE, RETINA, 351 00:15:25,607 --> 00:15:29,844 OPTIC, ET CETERA, SO I OWE JOE A 352 00:15:29,844 --> 00:15:31,713 LOT IN TEACHING ME HOW TO DO THE 353 00:15:31,713 --> 00:15:32,680 EXPERIMENT AND THE EYE 354 00:15:32,680 --> 00:15:36,384 STRUCTURES AND OF COURSE, A LOT 355 00:15:36,384 --> 00:15:41,022 OF OTHER PEOPLE WERE ALSO 356 00:15:41,022 --> 00:15:41,522 INVOLVED. 357 00:15:41,522 --> 00:15:43,691 I DID NOT KNOW THEN, BUT I KNOW 358 00:15:43,691 --> 00:15:49,464 NOW THAT THERE WERE PARALLEL 359 00:15:49,464 --> 00:15:52,400 DEVELOPMENTS IN VIENNA AND THEY 360 00:15:52,400 --> 00:15:55,270 ALSO WERE USING AN INFRANCIS 361 00:15:55,270 --> 00:15:57,839 COLLINS TOM TERTO LOOK AT EYE 362 00:15:57,839 --> 00:15:59,941 STRUCTURES BUT THEIR INITIAL 363 00:15:59,941 --> 00:16:00,742 GOAL WERE DIFFERENT. 364 00:16:00,742 --> 00:16:02,243 THEY WERE MEASURING ACTUAL EYE 365 00:16:02,243 --> 00:16:11,185 LENGTH SO THEY USED A FABRY-PRO 366 00:16:11,185 --> 00:16:11,853 INTERPROMULGATE TERAND THE 367 00:16:11,853 --> 00:16:12,787 HETERODETECTION WHICH I WAS 368 00:16:12,787 --> 00:16:15,256 USING THEY WERE USING AN 369 00:16:15,256 --> 00:16:17,659 INFRARED SCOPE TO VISUALIZE 370 00:16:17,659 --> 00:16:19,060 INTERFERENCE PATTERN BETWEEN THE 371 00:16:19,060 --> 00:16:20,662 CORNEA AND RETINA AND I WOULD 372 00:16:20,662 --> 00:16:25,400 IMAGINE THEY WOULD JUST SEE THIS 373 00:16:25,400 --> 00:16:29,537 IRPT FER ENSEL PATTERN WHEN THE 374 00:16:29,537 --> 00:16:30,204 LIGHT--INTERFERENCE PATTERN WHEN 375 00:16:30,204 --> 00:16:32,106 THE LIGHT FROM THE CORN RAAND 376 00:16:32,106 --> 00:16:34,509 LET WITH THE RETINA INTERFERE. 377 00:16:34,509 --> 00:16:36,177 SO IT'S MORE DIFFICULT THAT YOU 378 00:16:36,177 --> 00:16:37,245 CAN SEE INTURNOVERRAL STRUCTURES 379 00:16:37,245 --> 00:16:39,547 THAT WAY, AND THAT'S WHY THEY 380 00:16:39,547 --> 00:16:43,418 DIDN'T GO TOWARD IMAGING UNTIL 381 00:16:43,418 --> 00:16:43,885 LATER. 382 00:16:43,885 --> 00:16:49,290 SO, YOUR IMPLEMENTATION OF THE 383 00:16:49,290 --> 00:16:51,225 INTERFROM TERDETECTION SYSTEM 384 00:16:51,225 --> 00:16:53,494 AND INITIAL GOAL DOES MATTER. 385 00:16:53,494 --> 00:16:56,130 AND OF YOU COURSE RCT WAS 386 00:16:56,130 --> 00:16:57,699 POSSIBLE ONLY BECAUSE OF 387 00:16:57,699 --> 00:16:59,867 ADVANCES IN OPTICAL TECHNOLOGIES 388 00:16:59,867 --> 00:17:01,602 THAT WERE DEVELOPED FOR OPTIMAL 389 00:17:01,602 --> 00:17:02,503 CHIEWNICATIONS WHICH WAS VERY 390 00:17:02,503 --> 00:17:07,976 HOT THEN IN THE 1980 ANDS THESE 391 00:17:07,976 --> 00:17:08,543 INCLUDED SEMICONDUCTOR 392 00:17:08,543 --> 00:17:09,644 DISCIPLINARIAL, LIGHT SOURCES 393 00:17:09,644 --> 00:17:10,912 AND OPTICAL FIBERS AND I LEARNED 394 00:17:10,912 --> 00:17:15,783 A LOT OF THESE TECHNOLOGIES FROM 395 00:17:15,783 --> 00:17:21,956 ERIC SWANSEN WHO WAS MY GURU IN 396 00:17:21,956 --> 00:17:22,824 THIS AREA. 397 00:17:22,824 --> 00:17:24,025 COME SO ERIC WAS RESPONSIBLE FOR 398 00:17:24,025 --> 00:17:28,896 A LOT OF THE DESIGN MUCH THE 399 00:17:28,896 --> 00:17:29,664 OCT. 400 00:17:29,664 --> 00:17:32,367 HE WAS THE FIRST INVENTOR LISTS 401 00:17:32,367 --> 00:17:36,404 IN OUR PATENT, THE FIRST PATENT 402 00:17:36,404 --> 00:17:41,542 ON OCT, THE 501 PEN WHICH 403 00:17:41,542 --> 00:17:44,178 DESCRIBED THE TIME DOMAIN OCT 404 00:17:44,178 --> 00:17:45,446 THAT BECAME THE BLUEPRINT FOR 405 00:17:45,446 --> 00:17:49,217 THE FIRST 10 YEARS OF OCT, AS 406 00:17:49,217 --> 00:17:51,719 WELL AS WEB-SOURCED OCT ACTUALLY 407 00:17:51,719 --> 00:17:53,721 WHICH WE REALIZED WHEN WE WERE 408 00:17:53,721 --> 00:17:55,957 LOOKING AT THE SPECTRAL PATTERNS 409 00:17:55,957 --> 00:17:59,260 OF THE FIBER OPTIC INIA 410 00:17:59,260 --> 00:18:00,094 FROM--INTEGRATION TOM TERAND 411 00:18:00,094 --> 00:18:02,797 ERIC OF COURSE WAS ALSO 412 00:18:02,797 --> 00:18:04,432 IMPORTANT IN STARTING A ON 413 00:18:04,432 --> 00:18:06,167 COUPLE OF THE IMPORTANT 414 00:18:06,167 --> 00:18:09,037 COMPANIES IN OCT, EVENTS 415 00:18:09,037 --> 00:18:11,873 OPHTHALMIC DEVICES THAT FIRST 416 00:18:11,873 --> 00:18:12,807 TWEPPED COMMERCIAL OPHTHALMIC 417 00:18:12,807 --> 00:18:16,544 OCT AND LIGHT LAB IMAGES THAT 418 00:18:16,544 --> 00:18:20,415 DEVELOPED CARDIOVASCULAR OCT, HE 419 00:18:20,415 --> 00:18:23,951 ALSO CONFOUNDED SYCAMORE AND 420 00:18:23,951 --> 00:18:26,521 ACACIA, WHICH WERE MAJOR PLAYERS 421 00:18:26,521 --> 00:18:30,391 IN HIGH CAPACITY FIBER OPTIC 422 00:18:30,391 --> 00:18:31,025 COMMUNICATIONS. 423 00:18:31,025 --> 00:18:33,628 SO ERIC WAS A VERY PROLIFIC 424 00:18:33,628 --> 00:18:39,167 ENGINEER OF THE FIRST ORDER. 425 00:18:39,167 --> 00:18:42,770 IN THE BEGINNING OCT, WAS A 426 00:18:42,770 --> 00:18:46,274 SOLUTION IN SEARCH OF A PROBLEM 427 00:18:46,274 --> 00:18:50,211 AND WE KNEW THAT IT HAD BETTER 428 00:18:50,211 --> 00:18:52,947 RESOLUTION, 10 TO A HUNDRED 429 00:18:52,947 --> 00:18:56,317 TIMES BETTER THAN EXISTING 430 00:18:56,317 --> 00:18:58,319 TOMOGRAPHIC IMAGING MODALITIES 431 00:18:58,319 --> 00:19:03,091 LIKE ULTRASOUND, MRI, AND CT. 432 00:19:03,091 --> 00:19:06,394 SO NATURALLY, WE THOUGHT THAT WE 433 00:19:06,394 --> 00:19:08,229 SHOULD FOCUS THE INITIAL 434 00:19:08,229 --> 00:19:11,732 RESEARCH AND ALSO 435 00:19:11,732 --> 00:19:12,967 COMMERCIALIZATION EFFORTS ON 436 00:19:12,967 --> 00:19:17,271 SMALL CRITICAL TISSUE STRUCTURES 437 00:19:17,271 --> 00:19:20,641 AND OUR BEST GUESSES WERE THE 438 00:19:20,641 --> 00:19:24,812 RETINA IN THE EYE, AND ALSO, 439 00:19:24,812 --> 00:19:26,114 CORONARY ARTERY PLAQUES, BOTH OF 440 00:19:26,114 --> 00:19:28,282 WHICH WERE PUBLISHED IN OUR 441 00:19:28,282 --> 00:19:29,717 INITIAL SCIENCE PAPER AND THAT 442 00:19:29,717 --> 00:19:31,552 TURNED OUT TO BE A VERY GOOD 443 00:19:31,552 --> 00:19:34,755 GUESS, WHEN WE WERE INVITED TO 444 00:19:34,755 --> 00:19:37,892 WRITE A REVIEW PAPER, 25 YEARS 445 00:19:37,892 --> 00:19:40,661 LATER IN 2016, WE LOOK AT THE 446 00:19:40,661 --> 00:19:42,930 UTILIZATION OF OCT AND INDEED 447 00:19:42,930 --> 00:19:49,403 THOSE WERE THE 2 BIGGEST 448 00:19:49,403 --> 00:19:51,038 APPLICATIONS OPHTHALMIC OCT WAS 449 00:19:51,038 --> 00:19:53,241 BEING PERFORMED THEN, ABOUT 450 00:19:53,241 --> 00:19:57,011 30 MILLION PROCEDURES WORLD WIDE 451 00:19:57,011 --> 00:19:58,179 AND CARDIOVASCULAR, INTRA 452 00:19:58,179 --> 00:19:59,847 VASCULAR OCT, ABOUT A HUNDRED 453 00:19:59,847 --> 00:20:04,519 THOUSAND PROCEDURES PER YEAR, I 454 00:20:04,519 --> 00:20:06,254 THINK EXTRAPOLATING FROM 455 00:20:06,254 --> 00:20:08,189 MEDICAID AND MEDICARE, I THINK 456 00:20:08,189 --> 00:20:09,223 IT'S ABOUT 40 MILLION PROCEDURES 457 00:20:09,223 --> 00:20:10,925 PER YEAR NOW IN THE EYE AND 458 00:20:10,925 --> 00:20:13,628 PROBABLY MUCH HIGHER IN 459 00:20:13,628 --> 00:20:16,030 CARDIOLOGY WHICH HAS SEEN A LOT 460 00:20:16,030 --> 00:20:18,065 OF RECENT GROWTH. 461 00:20:18,065 --> 00:20:24,372 I ALSO WANT TO MENTION JOE 462 00:20:24,372 --> 00:20:27,241 ISWROD AND MICHAEL HEE, WHO PLAY 463 00:20:27,241 --> 00:20:29,877 IMPORTANT ROADS IN DWTMENT OF 464 00:20:29,877 --> 00:20:34,849 THE FIRST OCT SYSTEMS FOR 465 00:20:34,849 --> 00:20:37,885 CLINICAL TODAYS AND AS WE WERE 466 00:20:37,885 --> 00:20:40,454 DISCUSSING YESTERDAY, IT WAS 467 00:20:40,454 --> 00:20:45,226 REALLY IMPORTANT FOR PEOPLE IN 468 00:20:45,226 --> 00:20:47,495 INDUSTRY TO BECOME INTERESTED 469 00:20:47,495 --> 00:20:50,231 AND ENGAGED AND INVEST IN A 470 00:20:50,231 --> 00:20:54,202 TECHNOLOGY FOR IT TO BECOME 471 00:20:54,202 --> 00:20:56,037 AVAILABLE TO CLINICIANS AND I 472 00:20:56,037 --> 00:20:59,307 ESPECIALLY WANT TO THANK JOHN 473 00:20:59,307 --> 00:21:03,744 MOORE, WHO WAS THE PRESIDENT OF 474 00:21:03,744 --> 00:21:06,347 HUMPHREY INSTRUMENT THEN AND 475 00:21:06,347 --> 00:21:16,724 WOULD LATER ON BOTTOM 476 00:21:19,327 --> 00:21:20,361 ZEISS HUMPRY WHEN IT COMBINED 477 00:21:20,361 --> 00:21:22,630 TOGETHER, AND I WANT TO REMEMBER 478 00:21:22,630 --> 00:21:24,532 JOHN CAME OVER AT THE 4 SEASONS 479 00:21:24,532 --> 00:21:26,100 HOTEL FOR A CELEBRATION AND 480 00:21:26,100 --> 00:21:29,303 SOMEHOW I ENDED UP AT A HOT TUB 481 00:21:29,303 --> 00:21:31,539 AT THE 4 SEASONS TALKS TO JOHN 482 00:21:31,539 --> 00:21:34,308 MOORE AND HE WAS EXPRESSING HIS 483 00:21:34,308 --> 00:21:35,710 ENTHUSIASM AND VISION, HE 484 00:21:35,710 --> 00:21:39,513 THOUGHT THAT OCT WAS GOING TO BE 485 00:21:39,513 --> 00:21:40,915 REALLY BIG IN OPHTHALMOLOGY AND 486 00:21:40,915 --> 00:21:43,851 OF COURSE HE WAS CORRECT 487 00:21:43,851 --> 00:21:45,786 ALTHOUGH IT TOOK 10 YEARS AND IT 488 00:21:45,786 --> 00:21:49,724 PROBABLY WASN'T VERY GOOD FOR 489 00:21:49,724 --> 00:21:50,625 HIM. 490 00:21:50,625 --> 00:21:54,495 BUT I THINK THAT HIS VISION 491 00:21:54,495 --> 00:21:56,797 REALLY PLAYED A KEY ROLE IN HOW 492 00:21:56,797 --> 00:22:03,638 FAST OCT WAS ABLE TO GAIN GROUND 493 00:22:03,638 --> 00:22:04,639 IN THE CLINIC. 494 00:22:04,639 --> 00:22:08,342 AND JAY WEI WAS THE FIRST 495 00:22:08,342 --> 00:22:14,315 ENGINEER TO LEAD COMMERCIAL 496 00:22:14,315 --> 00:22:16,050 DEVELOPMENT AND ZEISS HUMPHREY 497 00:22:16,050 --> 00:22:18,486 AND LATER ON HE BECAME THE VEO 498 00:22:18,486 --> 00:22:25,259 OF OPTAVIEW, HIS OWN COMPANY, E 499 00:22:25,259 --> 00:22:25,926 FOUNDED IT. 500 00:22:25,926 --> 00:22:31,966 I WORKED WITH HIM FOR MANY YEARS 501 00:22:31,966 --> 00:22:33,801 AND I ALSO REALLY APPRECIATED 502 00:22:33,801 --> 00:22:35,469 HIS ROLE AND ORIGINAL 503 00:22:35,469 --> 00:22:36,637 CONTRIBUTIONS TO THE 504 00:22:36,637 --> 00:22:37,838 COMMERCIALIZATION AND CLINICAL 505 00:22:37,838 --> 00:22:39,273 USE OF OCT. 506 00:22:39,273 --> 00:22:44,679 THE FIRST OCT SYSTEMS, OCT 1 AND 507 00:22:44,679 --> 00:22:48,449 OCT 2, WERE COME OUT OF HUMPHREY 508 00:22:48,449 --> 00:22:51,719 AND LATER KARL ZEISS METATECH 509 00:22:51,719 --> 00:22:53,587 AND THESE WERE ONLY USED IN 510 00:22:53,587 --> 00:22:55,890 MAJOR EYE CENTERS BECAUSE ONLY A 511 00:22:55,890 --> 00:23:02,063 FEW HUNDRED UNITS WERE SOLD AND 512 00:23:02,063 --> 00:23:07,435 IT--THERE WERE KIND OF PRODUCED 513 00:23:07,435 --> 00:23:10,538 GRAINY SMEARED OUT IMAGES AND I 514 00:23:10,538 --> 00:23:13,674 THINK IT WAS POLARIZING EVEN 515 00:23:13,674 --> 00:23:14,442 AMONG ACADEMIC MEDICINE. 516 00:23:14,442 --> 00:23:16,610 THERE WERE EARLY ADAPTORS WHO 517 00:23:16,610 --> 00:23:19,480 SAW GREAT POTENTIAL OF THIS 518 00:23:19,480 --> 00:23:21,716 TECHNOLOGY AND WORK TO USE IT 519 00:23:21,716 --> 00:23:23,718 AND WRITE ORIGINAL TRANSLATIONAL 520 00:23:23,718 --> 00:23:26,187 ARTICLES IN A NUMBER OF DISEASES 521 00:23:26,187 --> 00:23:36,664 THAT BECAME VERY IMPORTANT. 522 00:23:38,632 --> 00:23:41,235 THAT INCLUDED THE OCT, THAT CAME 523 00:23:41,235 --> 00:23:45,773 OUT IN 1999, AND I WANT TO 524 00:23:45,773 --> 00:23:47,575 MENTION COLLEAGUES HERE, THIS 525 00:23:47,575 --> 00:23:49,410 WAS IMPORTANT IN POPULARIZING 526 00:23:49,410 --> 00:23:53,848 THE KNOWLEDGE OF OCT, TO 527 00:23:53,848 --> 00:23:56,884 CLINICIANS AND THERE ARE OTHER 528 00:23:56,884 --> 00:23:58,986 CLINICIANS WHO SAW THESE IMAGES 529 00:23:58,986 --> 00:24:01,188 AND WERE NOT IMPRESSED BY THEIR 530 00:24:01,188 --> 00:24:03,824 QUALITY AND THOUGHT IT WAS PART 531 00:24:03,824 --> 00:24:08,829 OF AN EVIL SCHEME TO DEMOTOIVATE 532 00:24:08,829 --> 00:24:10,197 YOUNG RESIDENTS, CORRUPT THEM SO 533 00:24:10,197 --> 00:24:12,500 THEY DON'T LEARN THE FINE ART OF 534 00:24:12,500 --> 00:24:14,034 RETINAL EXAM NATION AND OF 535 00:24:14,034 --> 00:24:16,971 COURSE THEY WERE--THEY WERE 536 00:24:16,971 --> 00:24:23,377 RIGHT, ALSO, YOU KNOW, LIKE 537 00:24:23,377 --> 00:24:26,981 DR. MIKE CHANG MENTIONED, 538 00:24:26,981 --> 00:24:27,782 RESIDENTS PROBABLY DON'T DO 539 00:24:27,782 --> 00:24:30,785 NEARLY AS MUCH NOW TO LEARN 540 00:24:30,785 --> 00:24:32,052 DETAILED RETINAL EXAMINATION 541 00:24:32,052 --> 00:24:34,054 WITH A CONTACT LENS AND RELY ON 542 00:24:34,054 --> 00:24:35,856 OCT AND THEY'RE MAKING BETTER 543 00:24:35,856 --> 00:24:39,360 DIAGNOSIS THAN EVER WITH ALL 544 00:24:39,360 --> 00:24:40,594 THESE DIGITAL IMAGING 545 00:24:40,594 --> 00:24:45,132 TECHNOLOGIES BUT I WAS PRES 546 00:24:45,132 --> 00:24:46,667 ABTLY SURPRISED IN 1999 WHEN I 547 00:24:46,667 --> 00:24:47,735 WAS IN FELLOWSHIP TRAINING THERE 548 00:24:47,735 --> 00:24:50,938 WHEN I WENT TO SEE A MOVIE 549 00:24:50,938 --> 00:24:53,073 CALLED ENTRAPMENT WITH SEAN 550 00:24:53,073 --> 00:24:55,910 CONNERY AND KATHRYN ZETA-JONES, 551 00:24:55,910 --> 00:25:03,784 AND THE MOVIE WENT TONIGHT 552 00:25:03,784 --> 00:25:05,186 KUALA LIMPUR, WHERE THERE'S SOME 553 00:25:05,186 --> 00:25:06,887 TOP SECURITY INVOLVED AND 554 00:25:06,887 --> 00:25:11,125 THERE'S AN EYE SCANNER AND SEAN 555 00:25:11,125 --> 00:25:14,662 CONRY SCANS HIS EYE AND OUT POPS 556 00:25:14,662 --> 00:25:21,602 THIS IMAGE OF MACKULAR HOLE, AN 557 00:25:21,602 --> 00:25:24,371 OCT IMAGE WHY WOULD HE HAVE A 558 00:25:24,371 --> 00:25:25,539 MACULAR HOLE, IT DIDN'T MAKE ANY 559 00:25:25,539 --> 00:25:26,941 SENSE BUT I DON'T THINK ANYONE 560 00:25:26,941 --> 00:25:29,743 ELSE IN THE AUDIENCE HAD THE 561 00:25:29,743 --> 00:25:31,745 SAME THOUGHT. 562 00:25:31,745 --> 00:25:32,913 [ 563 00:25:32,913 --> 00:25:33,247 [LAUGHTER] 564 00:25:33,247 --> 00:25:36,016 SO WHAT I LEARNED FROM THAT IS 565 00:25:36,016 --> 00:25:36,884 THAT THE TRANSLATIONAL RESEARCH 566 00:25:36,884 --> 00:25:39,720 TAKES A LOT OF EFFORT AND 567 00:25:39,720 --> 00:25:41,655 PERSEVERANCE BUT IS NECESSARY 568 00:25:41,655 --> 00:25:45,759 AND CLINICAL ACCEPTANCE TAKES 569 00:25:45,759 --> 00:25:48,028 TIME AND YOU KNOW IN THE BIG 570 00:25:48,028 --> 00:25:50,231 SCHEME OF THINGS, PROBABLY 10 571 00:25:50,231 --> 00:25:51,699 YEARS WASN'T VERY LONG. 572 00:25:51,699 --> 00:25:54,568 AND NEVER MIND THE DOUBTERS. 573 00:25:54,568 --> 00:25:56,036 AND FOR THE NEXT PART OF THE 574 00:25:56,036 --> 00:25:58,839 STORY, I WANT TO TELL, I WANT TO 575 00:25:58,839 --> 00:26:07,281 GOVERN A HISTORICAL PARALLEL, 576 00:26:07,281 --> 00:26:09,717 120 MILLION YEARS AGO SOME 577 00:26:09,717 --> 00:26:13,087 KARNIVEEROUS WASPS LEARNED TO GO 578 00:26:13,087 --> 00:26:16,757 VEGETARIAN BY SIPPING NECTAR AND 579 00:26:16,757 --> 00:26:21,395 EATING POLLENS AND THESE 580 00:26:21,395 --> 00:26:22,463 PROTOBEES HAD COLOR VISION IN 581 00:26:22,463 --> 00:26:27,668 THE VISIBLE AND UV, AND BECAUSE 582 00:26:27,668 --> 00:26:30,004 OF THAT FLOWERS WHICH NEED BEES 583 00:26:30,004 --> 00:26:32,773 TO POLLENATE WILL BENEFIT FROM 584 00:26:32,773 --> 00:26:33,474 POLLENNATION, DEVELOP DISTINCT 585 00:26:33,474 --> 00:26:38,045 COLORS AND SHAPES TO, ATTRACT 586 00:26:38,045 --> 00:26:39,547 BEES AND THAT LED TO THE 587 00:26:39,547 --> 00:26:45,519 COLORFUL WORLD WE LIVE IN THAT 588 00:26:45,519 --> 00:26:47,955 WE ENJOY AND TOGETHER BEING AND 589 00:26:47,955 --> 00:26:49,356 FLOWERS, FLOWERING PLANTS WERE A 590 00:26:49,356 --> 00:26:51,592 BIG SUCCESS AND THEY SPREAD 591 00:26:51,592 --> 00:26:57,898 THROUGHOUT THE TERRESTRIAL 592 00:26:57,898 --> 00:26:59,199 WORLD. 593 00:26:59,199 --> 00:27:03,871 SO A PARALLEL. 594 00:27:03,871 --> 00:27:06,974 MORE RECENTLY CLEVER RETINA 595 00:27:06,974 --> 00:27:09,343 CLINICIANS, CLINICIAN SCIENTISTS 596 00:27:09,343 --> 00:27:10,778 LEARNED THAT IN NEOVASCULAR AMD 597 00:27:10,778 --> 00:27:15,950 WHEN YOU LOOK AT OCT IMAGING, 598 00:27:15,950 --> 00:27:18,252 YOU CAN SEE NEOVASCULAR MEMBRANE 599 00:27:18,252 --> 00:27:25,326 AND RETINAL FLUID AND THAT IF 600 00:27:25,326 --> 00:27:26,827 YOU INJECT ANTIVASCULAR 601 00:27:26,827 --> 00:27:30,030 ENDOTHELIAL GROWTH FACTOR OR 602 00:27:30,030 --> 00:27:34,768 ANTIVEGF YOU CAN MAKE THIS GO 603 00:27:34,768 --> 00:27:34,969 AWAY. 604 00:27:34,969 --> 00:27:37,805 AND THIS INSIGHT LED TO REALLY A 605 00:27:37,805 --> 00:27:40,307 REVOLUTION IN THE TREATMENT OF 606 00:27:40,307 --> 00:27:45,646 WET AMD WHICH USED TO BE A 1 WAY 607 00:27:45,646 --> 00:27:47,414 STREET TO BLINDNESS BUT NOW CAN 608 00:27:47,414 --> 00:27:49,917 BE MANAGED SUCCESSFULLY FOR A 609 00:27:49,917 --> 00:27:51,385 LONG TIME. 610 00:27:51,385 --> 00:27:54,688 AND THIS SYNERGY AND SUCCESS LED 611 00:27:54,688 --> 00:28:04,632 TO BOTH OCT AND ANTIVEG F 612 00:28:04,632 --> 00:28:06,400 INTROVITRAL TECHNOLOGY WITH 613 00:28:06,400 --> 00:28:08,736 ANTIVEIMRKS F INJECTIONS AND 614 00:28:08,736 --> 00:28:11,672 WITH ABOUT 2 AND HALF MILLION 615 00:28:11,672 --> 00:28:13,674 INYEKSES AND 40 MILLION OCT 616 00:28:13,674 --> 00:28:15,743 PROCEDURES PERFORMED EVERY 617 00:28:15,743 --> 00:28:15,943 YEAR. 618 00:28:15,943 --> 00:28:19,513 SO NOT QUITE AS SUCCESSFUL AS 619 00:28:19,513 --> 00:28:24,184 THE BEES BUT PRETTY GOOD FOR A 620 00:28:24,184 --> 00:28:24,618 HUMAN EFFORT. 621 00:28:24,618 --> 00:28:26,620 AND JUST FOR A SANITY CHECK, I 622 00:28:26,620 --> 00:28:28,522 WASN'T SURE IF I WAS TAKING THIS 623 00:28:28,522 --> 00:28:31,158 UP, IT'S STILL POSSIBLE, I WAS 624 00:28:31,158 --> 00:28:32,626 MAKING IT UP, THATORY BUT I 625 00:28:32,626 --> 00:28:35,396 LOOKED UP THE DEVELOPMENT OF 626 00:28:35,396 --> 00:28:41,168 ANTIVEG F FOR AMD MD AND I FOUNN 627 00:28:41,168 --> 00:28:43,237 THE LITERATURE THEORESOURCESSEN 628 00:28:43,237 --> 00:28:44,872 FELLED, WHICH IS 1 OF THE CLEVER 629 00:28:44,872 --> 00:28:47,474 RETINAL SPECIALISTS WHO PLAYED A 630 00:28:47,474 --> 00:28:49,376 ROLE IN THE DEVELOPMENT OF THIS 631 00:28:49,376 --> 00:28:53,380 NEW TREATMENT, HE SAID IN A 2009 632 00:28:53,380 --> 00:28:55,115 RETINA TODAY BREW, THAT TO FULLY 633 00:28:55,115 --> 00:29:01,255 UNDERSTAND HOW WE ARRIVE AT 634 00:29:01,255 --> 00:29:04,491 INYEKSS BEVACIZUMAB, A TYPE OF 635 00:29:04,491 --> 00:29:07,528 VEGF, TO TREAT WET AMD, 1 MUST 636 00:29:07,528 --> 00:29:10,164 GO BACK TO 2001 WHEN THE 637 00:29:10,164 --> 00:29:12,866 STRATEGIC PLANUS OCT WAS FIRST 638 00:29:12,866 --> 00:29:16,870 INTRODUCED SO HE ATTRIBUTED THE 639 00:29:16,870 --> 00:29:21,442 DEVELOPMENT OF ANTIVEG F WITH 640 00:29:21,442 --> 00:29:23,077 THE INSIGHT AND CLINICAL 641 00:29:23,077 --> 00:29:24,044 VISUALIZATION THAT OCT OFFERED 642 00:29:24,044 --> 00:29:26,313 AND THE STRATEGIC PLANUS OF 643 00:29:26,313 --> 00:29:31,618 COURSE WAS THE OCT SYSTEM THAT 644 00:29:31,618 --> 00:29:37,858 MADE THIS TECHNOLOGY MAIN 645 00:29:37,858 --> 00:29:40,027 STREAM, IT HAD 400 A-SCANS PER 646 00:29:40,027 --> 00:29:41,862 SECOND WHICH IS ENOUGH TO GIVE 647 00:29:41,862 --> 00:29:44,965 US A MEDIUM DEFINITION IMAGE AND 648 00:29:44,965 --> 00:29:47,634 IT'S SO SIMPLE, I THINK JIM SAID 649 00:29:47,634 --> 00:29:48,936 6000 UNIT WHICH IS ENOUGH TO 650 00:29:48,936 --> 00:29:51,939 MAKE IT AVAILABLE TO MOST 651 00:29:51,939 --> 00:29:53,841 OPHTHALMOLOGISTS IN THE U.S. AND 652 00:29:53,841 --> 00:30:01,615 MADE IT A CLINICAL SUCCESS 653 00:30:01,615 --> 00:30:05,385 EMPLOY WE'VE ESTIMATED THAT OCT 654 00:30:05,385 --> 00:30:08,455 GUIDANCE OF THOSE NEEDED ANTIVEG 655 00:30:08,455 --> 00:30:10,524 F INJECTIONS INSTEAD OF REGULAR 656 00:30:10,524 --> 00:30:11,692 MONTHLY INYEKS, SAVE MEDICARE 657 00:30:11,692 --> 00:30:13,861 MORE THAN A BILLION DOLLAR PER 658 00:30:13,861 --> 00:30:15,896 YEAR IN AN ARTICLE THAT WAS 659 00:30:15,896 --> 00:30:21,568 PUBLISHED IN 2018 AND THAT 660 00:30:21,568 --> 00:30:23,570 DWARFS THE AMOUNT OF INVESTMENT 661 00:30:23,570 --> 00:30:26,540 THAT NIH AND OTHER FUNDING 662 00:30:26,540 --> 00:30:28,842 AGENCIES PUT INTO OCT RESEARCH 663 00:30:28,842 --> 00:30:36,383 WHICH WAS ESTIMATED AT 0.4 664 00:30:36,383 --> 00:30:36,617 BILLION. 665 00:30:36,617 --> 00:30:40,487 BUT THAT'S OF COURSE MUCH 666 00:30:40,487 --> 00:30:40,988 APPRECIATED. 667 00:30:40,988 --> 00:30:42,523 OCT IS THE MOST COMMONLY USED 668 00:30:42,523 --> 00:30:45,159 AND COST EFFECTIVE IMAGING 669 00:30:45,159 --> 00:30:50,197 MODALITY IN OPHTHALMOLOGY NOW 670 00:30:50,197 --> 00:30:51,832 EXCEEDING [INDISCERNIBLE] 671 00:30:51,832 --> 00:30:52,599 PHOTOGRAPH SINCE 2002 AND IT'S 672 00:30:52,599 --> 00:30:56,036 ALSO A VERY ECONOMICAL COSTING 673 00:30:56,036 --> 00:31:00,574 $40 FOR BOTH EYES, LESS THAN 674 00:31:00,574 --> 00:31:05,112 EVEN FUNDUS PHOTOGRAPHY, SO BY 675 00:31:05,112 --> 00:31:10,717 2005 OCT WAS MAIN STREAM AND I 676 00:31:10,717 --> 00:31:12,319 WAS AGAIN PRES PLEASANTLY 677 00:31:12,319 --> 00:31:14,788 SURPRISED IN WHEN I WALK INTO 678 00:31:14,788 --> 00:31:15,856 THE PRESIDENT OF OPHTHALMOLOGY 679 00:31:15,856 --> 00:31:19,326 MEETING AND SAW OF ALL THINGS 680 00:31:19,326 --> 00:31:20,427 CORNEAL OCT IMAGES EVERYWHERE, 681 00:31:20,427 --> 00:31:23,564 AND SO I KNEW THAT WE HAD MADE 682 00:31:23,564 --> 00:31:28,802 IT BY THAT TIME. 683 00:31:28,802 --> 00:31:30,537 FOR THE DPLAW COMA SPECIALIST 684 00:31:30,537 --> 00:31:34,875 OUT THERE, OCT IS ALSO USED TO 685 00:31:34,875 --> 00:31:38,078 DETECT AND MANAGE GLAUCOMA BY 686 00:31:38,078 --> 00:31:39,012 IMAGES THE ANTERIOR CHAMBER 687 00:31:39,012 --> 00:31:40,514 ANGLE AND THE OPTICAL IMAGES MIC 688 00:31:40,514 --> 00:31:43,283 NERVE IN THE RETINA BOTH FOR 689 00:31:43,283 --> 00:31:44,918 EARLY DETECTION AND ALSO FOR 690 00:31:44,918 --> 00:31:47,921 MONITORING OVER TIME ANDOSH CT 691 00:31:47,921 --> 00:31:49,890 OVERTOOK VISUAL FIELD AS THE 692 00:31:49,890 --> 00:31:53,160 MOST COMMONLY USED DIAGNOSTIC 693 00:31:53,160 --> 00:31:55,596 MODALITY IN THE FLAW COMA CLINIC 694 00:31:55,596 --> 00:31:58,365 ACCORDING TO THE AMERICAN 695 00:31:58,365 --> 00:32:00,100 ACADEMY OF OPHTHALMOLOGY IRIS 696 00:32:00,100 --> 00:32:10,544 DATABASE, SOMETIMES IN THE 697 00:32:11,011 --> 00:32:11,311 2010S. 698 00:32:11,311 --> 00:32:15,349 AND OF COURSE OCT WAS USED IN 699 00:32:15,349 --> 00:32:16,783 DETERMINING CORNEA THICKNESS AND 700 00:32:16,783 --> 00:32:19,753 MAPS, AND THAT CAN HELP US 701 00:32:19,753 --> 00:32:21,421 RECOGNIZE MANY DISEASES AND OCT 702 00:32:21,421 --> 00:32:25,025 CAN NOW BE USED FOR TOPOGRAPHY 703 00:32:25,025 --> 00:32:27,794 IN ATIGER DATABASE TO PLACEBO 704 00:32:27,794 --> 00:32:28,228 AND [INDISCERNIBLE]. 705 00:32:28,228 --> 00:32:31,064 I THINK IT WILL BE USED A LOT 706 00:32:31,064 --> 00:32:32,532 MORE. 707 00:32:32,532 --> 00:32:35,469 WE DEVELOPED OUR OWN TOPOGRAPHY 708 00:32:35,469 --> 00:32:36,970 GROUP IN OUR OWN GROUP AND WE 709 00:32:36,970 --> 00:32:38,171 FOUND IT TO WORK VERY WELL AND 710 00:32:38,171 --> 00:32:40,073 SO HAVE A NUMBER OF COMPANIES 711 00:32:40,073 --> 00:32:43,944 WORLD WIDE AND A COUPLE OF THEM, 712 00:32:43,944 --> 00:32:47,414 AFTER SEVERAL YEARS, DELAY 713 00:32:47,414 --> 00:32:49,883 OBTAIN F, DA CLEARANCE JUST LAST 714 00:32:49,883 --> 00:32:51,685 YEAR SO I EXPECT IT IS USED TO 715 00:32:51,685 --> 00:32:53,787 GROW RAPIDLY IN THE U.S. 716 00:32:53,787 --> 00:32:57,858 OCT ALSO ENABLES VERY PREICIZE 717 00:32:57,858 --> 00:32:58,125 SURGERY. 718 00:32:58,125 --> 00:33:00,294 RETINAL SURGEONS CAN USE THEIR 719 00:33:00,294 --> 00:33:04,031 HAND TO MANIPULATE NEEDLES DOWN 720 00:33:04,031 --> 00:33:09,269 TO THE MICROMETER LEVEL, BUT OF 721 00:33:09,269 --> 00:33:10,070 COURSE THEIR STEREO VISION 722 00:33:10,070 --> 00:33:13,307 DOESN'T HAVE TO PRECISION AND 723 00:33:13,307 --> 00:33:14,441 OCT GIVES SURGEONS THAT 724 00:33:14,441 --> 00:33:16,743 PRECISION SO THAT THEY CAN MAKE 725 00:33:16,743 --> 00:33:17,411 MANEUVERS LIKE SUBRETINAL 726 00:33:17,411 --> 00:33:19,579 LOCATION FLAL INYEKS OF GENE 727 00:33:19,579 --> 00:33:20,180 THERAPY VECTORS. 728 00:33:20,180 --> 00:33:25,319 THIS IS A VIDEO PROVIDED TO ME 729 00:33:25,319 --> 00:33:29,423 BY DR. ANDY LAWER THE DIRECTOR 730 00:33:29,423 --> 00:33:35,362 OF KC INSTITUTE WHO IS ALSO A 731 00:33:35,362 --> 00:33:36,029 GENERAL SURGEON. 732 00:33:36,029 --> 00:33:38,131 HE CAN ALSO DO THIS TYPE IN THE 733 00:33:38,131 --> 00:33:40,267 CORNEA AND THIS IS AN INJECTION 734 00:33:40,267 --> 00:33:42,636 OF AIR BUBBLE IN THE DEEP STROMA 735 00:33:42,636 --> 00:33:49,042 AND DEEP ANTERIOR OF THE 736 00:33:49,042 --> 00:33:50,777 [INDISCERNIBLE] PROVIDED TO ME 737 00:33:50,777 --> 00:33:52,546 AT DR. ANTHONY KUO AT DUKE. 738 00:33:52,546 --> 00:33:54,348 ONE THING THAT DROVE THE 739 00:33:54,348 --> 00:33:56,850 EVOLUTION OF OCT TECHNOLOGY IS 740 00:33:56,850 --> 00:34:01,621 THE GROWTH IN IMAGING SPEED. 741 00:34:01,621 --> 00:34:03,857 THERE'S MOORE'S LAW OF OCT 742 00:34:03,857 --> 00:34:05,125 SPEED, IT DOUBLES ABOUT EVERY 2 743 00:34:05,125 --> 00:34:10,931 AND HALF YEARS AND OF COURSE THE 744 00:34:10,931 --> 00:34:12,232 MOVE TO FOURIER DOMAIN WAS A BIG 745 00:34:12,232 --> 00:34:14,634 PART OF THAT AND THAT ALLOWED US 746 00:34:14,634 --> 00:34:20,841 TO EXTEND OCT TO VOLUMETRIC 747 00:34:20,841 --> 00:34:23,710 IMAGING, A LOT OF PRECISION 748 00:34:23,710 --> 00:34:25,412 MEASUREMENTS AND MOST EXCITINGLY 749 00:34:25,412 --> 00:34:31,651 NOVEL CONTRASTS WHICH I WILL 750 00:34:31,651 --> 00:34:33,053 TALK ABOUT BRIEFLY. 751 00:34:33,053 --> 00:34:37,791 SO THIS VIDEO MADE BY 752 00:34:37,791 --> 00:34:38,425 DR. [INDISCERNIBLE] BEAUTIFULLY 753 00:34:38,425 --> 00:34:39,826 ILTRAITED THE 3 DIMENSIONAL 754 00:34:39,826 --> 00:34:49,970 NATURE OF OCT AT HIGH SPEED. 755 00:34:49,970 --> 00:34:52,205 AND THIS VOLUMEET RICK OCT CAN 756 00:34:52,205 --> 00:34:53,974 BE EXTENDED TO THE PERIPHERAL 757 00:34:53,974 --> 00:34:54,207 RETINA. 758 00:34:54,207 --> 00:34:57,077 WE CAN SEE THE WHOLE RETINA NOW 759 00:34:57,077 --> 00:35:01,982 WITH CUSTOM SYSTEMS AND THESE 760 00:35:01,982 --> 00:35:06,720 ARE IMAGES PRODUCED BY 1 OF OUR 761 00:35:06,720 --> 00:35:14,161 FACULTY IN OUR RESEARCH GROUP, 762 00:35:14,161 --> 00:35:15,328 DR. YIFAN JIAN XTHIS IMAGE CAN 763 00:35:15,328 --> 00:35:17,564 IMAGE OUT TO THE [INDISCERNIBLE] 764 00:35:17,564 --> 00:35:19,166 IN NEONATAL EXAM NATION OF R. O. 765 00:35:19,166 --> 00:35:23,203 P. AND HAD IS A VIDEO SHOWING 766 00:35:23,203 --> 00:35:25,739 DR. P. CAMPBELL PERFORMING 767 00:35:25,739 --> 00:35:26,540 THIS IMAGING PROCEDURE. 768 00:35:26,540 --> 00:35:32,479 AND THIS WAS DONE IN THE NICU, 769 00:35:32,479 --> 00:35:34,114 NEONATAL INTENSIVE CARE UNIT AND 770 00:35:34,114 --> 00:35:35,382 OF COURSE HE AN NONSPECIFIC SIDE 771 00:35:35,382 --> 00:35:38,318 EFFECTS THEY--THEITIZED THE EYE 772 00:35:38,318 --> 00:35:42,122 AND THIS CAN BE--THIS IS DONE 773 00:35:42,122 --> 00:35:44,057 WITH DILATION BUT WOULD ACTUALLY 774 00:35:44,057 --> 00:35:46,693 FIT INTO A SMALL PUPIL AND SINCE 775 00:35:46,693 --> 00:35:51,131 THIS IS AN INFANT RED, IT 776 00:35:51,131 --> 00:35:53,333 DOESN'T FRAZZLE THE INFANT, IT 777 00:35:53,333 --> 00:35:54,901 ONLY TAKES SEVERAL SECONDS, THE 778 00:35:54,901 --> 00:35:57,270 WAY PETE DOES IT SO HE ACTUALLY 779 00:35:57,270 --> 00:36:03,577 DOES THIS CLINICALLY INSTEAD OF 780 00:36:03,577 --> 00:36:08,215 IN DIRECT. 781 00:36:08,215 --> 00:36:09,616 OCT ANG YOAGRAPHY IS PROBABLY 782 00:36:09,616 --> 00:36:11,017 THE MOST IMPORTANT EXTENSION OF 783 00:36:11,017 --> 00:36:13,487 OCT IN THE PAST 10 YEARS. 784 00:36:13,487 --> 00:36:16,990 IT'S ALSO 3 DIMENSIONAL AND IT 785 00:36:16,990 --> 00:36:21,094 MAPS PLUS CELL MOTION IN THE 786 00:36:21,094 --> 00:36:22,629 RETINA WHICH PRODUCES 787 00:36:22,629 --> 00:36:24,231 FLUCTUATION, CHANGES IN THE OCT 788 00:36:24,231 --> 00:36:30,203 SIGNATURES --SIGNAL THAT CAN BE 789 00:36:30,203 --> 00:36:32,072 DETECTED WITH VARIOUS AG GOR 790 00:36:32,072 --> 00:36:32,339 RHYTHMS. 791 00:36:32,339 --> 00:36:35,709 AGAIN, A BEAUTIFUL VIEDMAN YE 792 00:36:35,709 --> 00:36:39,479 MADE BY DR. JIA, OUR 793 00:36:39,479 --> 00:36:43,416 CONTRIBUTION TO OCT ANGIOGRAPHY 794 00:36:43,416 --> 00:36:46,253 INCLUDED THE DEVELOPMENT OF A 795 00:36:46,253 --> 00:36:50,223 ALGORITHM CALLED SPLIT SPECTRUM 796 00:36:50,223 --> 00:36:52,025 AMP LIAISONITUTE DECORALATION 797 00:36:52,025 --> 00:36:53,560 ANGIOGRAPHY OR SSADA, AND IT'S 798 00:36:53,560 --> 00:36:59,900 BASED ON THE INSIGHT THAT OCT 799 00:36:59,900 --> 00:37:03,336 ANGIOGRAPHY CAN BE MADE BY 800 00:37:03,336 --> 00:37:05,105 DETECTING SPECKLES DECORALATION 801 00:37:05,105 --> 00:37:06,573 AND SPECKLED PATTERNS CHANGE AT 802 00:37:06,573 --> 00:37:08,208 DIFFERENT WAVE LENGTH SO BY 803 00:37:08,208 --> 00:37:10,610 SPLITTING THE SPECTRUM, YOU CAN 804 00:37:10,610 --> 00:37:12,279 INCREASE THE NUMBER OF EFFECTIVE 805 00:37:12,279 --> 00:37:14,881 IMAGE FRAMES SEVERAL TIMES AFTER 806 00:37:14,881 --> 00:37:16,816 11 FOLD, WITHOUT INCREASE IN 807 00:37:16,816 --> 00:37:19,519 SKIN TIMES SO IT'S VERY 808 00:37:19,519 --> 00:37:22,189 EFFICIENT AND YOU ONLY NEED A 809 00:37:22,189 --> 00:37:27,394 COUPLE OF THESE SCANS TO COMPUTE 810 00:37:27,394 --> 00:37:29,362 A REASONABLE ANGIOGRAPHY WITH 811 00:37:29,362 --> 00:37:32,032 SSADA AND IT REPRESENTS A 4 FOLD 812 00:37:32,032 --> 00:37:34,234 INCREASE IN FLOW SIGNAL TO NOISE 813 00:37:34,234 --> 00:37:34,701 RATIO. 814 00:37:34,701 --> 00:37:39,172 WE ALSO DEVELOPED A WAY TO--AN 815 00:37:39,172 --> 00:37:41,575 ALGORITHM TO RESULT AMBIGUITY 816 00:37:41,575 --> 00:37:43,076 BETWEEN PROJECTIVE FLOW AND 817 00:37:43,076 --> 00:37:46,413 INSITU FLOW AND THE PROJECTION 818 00:37:46,413 --> 00:37:48,848 FLOW OF AN GIVING--YOUOGRAPHY 819 00:37:48,848 --> 00:37:50,951 ALLOWS US TO VISUALIZE FOR 820 00:37:50,951 --> 00:37:52,485 PLEXUSS IN THE RETINA, WHICH IS 821 00:37:52,485 --> 00:37:54,154 AMAZING WHEN YOU THINK ABOUT IT, 822 00:37:54,154 --> 00:37:57,424 IT'S ONLY A COUPLE HUNDRED 823 00:37:57,424 --> 00:38:00,694 MICRON THICK STRUCTURE AND 824 00:38:00,694 --> 00:38:02,996 PLEXUS SPECIFIC PATHOLOGIES CAN 825 00:38:02,996 --> 00:38:06,399 BE VISUALIZED THIS WAY. 826 00:38:06,399 --> 00:38:09,402 SO, IF YOU FOCUS ON THE NERVE 827 00:38:09,402 --> 00:38:11,371 FIBER OF PLEXUS, YOU CAN DETECT 828 00:38:11,371 --> 00:38:14,107 OPTICAL IMAGES MIC NERVE DISEASE 829 00:38:14,107 --> 00:38:16,109 LIKE GLAUCOMA WITH HIGH 830 00:38:16,109 --> 00:38:16,376 ACCURACY. 831 00:38:16,376 --> 00:38:22,315 OT OTHER SIDE OF THE SPECTRUM, 832 00:38:22,315 --> 00:38:23,583 RETINAL LOCATION NIGHTIS 833 00:38:23,583 --> 00:38:24,784 PIGMENTOSA ASHING THE DEEP 834 00:38:24,784 --> 00:38:26,386 RETINAL STRUCTURES AND THAT 835 00:38:26,386 --> 00:38:28,855 LEADS TO DEEP CAPILLARY FLEXUS 836 00:38:28,855 --> 00:38:31,324 ATROPHY WITHOUT AFFECTING THE 837 00:38:31,324 --> 00:38:34,060 OTHER PLEXUS AS MUCH. 838 00:38:34,060 --> 00:38:36,329 RETINAL VASCULAR DISEASE IS LIKE 839 00:38:36,329 --> 00:38:37,831 DIABETIC RETINAL LOCATION NUMBER 840 00:38:37,831 --> 00:38:39,399 OF PATIENTSATHY AFFECTS ALL 841 00:38:39,399 --> 00:38:41,201 RETINAL PLEXUSS AND OF COURSE WE 842 00:38:41,201 --> 00:38:46,306 CAN ALSO DETECT AND CLASSIFY 843 00:38:46,306 --> 00:38:47,574 CORNEAL VASCULARIZATION VERY 844 00:38:47,574 --> 00:38:49,509 WELL WITH OCT AND GEOGRAPHY. 845 00:38:49,509 --> 00:38:53,213 SO IN THE INTEREST OF TIME, I 846 00:38:53,213 --> 00:38:55,482 WILL SKIP OVER THIS. 847 00:38:55,482 --> 00:38:59,486 OCT CAN ALSO SEE GREAT DETAIL AS 848 00:38:59,486 --> 00:39:00,387 WE'VE SEEN YESTERDAY. 849 00:39:00,387 --> 00:39:03,089 IN MY RESEARCH DPROWP WE HAVE 850 00:39:03,089 --> 00:39:06,526 TRIED--GROUP, WE HAVE TRIED BLUE 851 00:39:06,526 --> 00:39:09,095 LIGHT OCT MICROSCOPY THAT CAN 852 00:39:09,095 --> 00:39:13,633 VISUALIZE CELLS IN THE CORNEA AS 853 00:39:13,633 --> 00:39:15,568 WELL AS MICROBES AND I'M HOPEFUL 854 00:39:15,568 --> 00:39:21,274 THAT THIS WILL ALLOW US TO SEE 855 00:39:21,274 --> 00:39:22,242 INFECT YOWZ KEROTIGHT ISOTOPE IN 856 00:39:22,242 --> 00:39:25,912 THE CLINIC IN A NONEVASIVE, 857 00:39:25,912 --> 00:39:26,413 NONCONTACT FASHION. 858 00:39:26,413 --> 00:39:28,348 IESM ALSO VERY EXCITED ABOUT I 859 00:39:28,348 --> 00:39:30,216 OPTICAL IMAGES O RETINAL 860 00:39:30,216 --> 00:39:31,451 LOCATION NOGRAPHY, EXTENDING 861 00:39:31,451 --> 00:39:34,421 AGAIN FROM STRUCTURE TO 862 00:39:34,421 --> 00:39:34,888 FUNCTION. 863 00:39:34,888 --> 00:39:36,990 WE ARE ALSO INVESTIGATING THIS 864 00:39:36,990 --> 00:39:39,392 BASED ON ULTRA HIGH RESOLUTION 865 00:39:39,392 --> 00:39:41,961 OCT WITHOUT AO TO LOOK AT 866 00:39:41,961 --> 00:39:45,131 CHANGES IN THE PHOTO RECEPTOR SO 867 00:39:45,131 --> 00:39:46,199 THAT WHEN WE STIMULATE THE 868 00:39:46,199 --> 00:39:48,802 RETINA, WE CAN SEE, THE MAP, THE 869 00:39:48,802 --> 00:39:51,838 PHOTO AREY SEPTORSOR, LIGHT 870 00:39:51,838 --> 00:39:54,607 RESPONSE, WE TURN TO OUR OLD 871 00:39:54,607 --> 00:39:56,943 TRICK, SPLIT SPECTRUM AND WE 872 00:39:56,943 --> 00:39:59,045 HAVE AN EFFICIENT ALGORITHM THAT 873 00:39:59,045 --> 00:40:02,082 WILL IMPROVE THE SIGNAL TO NOISE 874 00:40:02,082 --> 00:40:04,017 RATIO OF OPTICAL IMAGES O 875 00:40:04,017 --> 00:40:05,985 RETINAL LOCATION NOGRAPHY AND 876 00:40:05,985 --> 00:40:08,888 THIS ALLOWS US TO IMAGE A LARGER 877 00:40:08,888 --> 00:40:17,864 AREA, LIKE 3 BY 3 AREA IN A 878 00:40:17,864 --> 00:40:19,766 MONTAGE OF 3, 2.5 SECOND SCANS 879 00:40:19,766 --> 00:40:21,935 AND ALLOWS US TO AMRI TO 880 00:40:21,935 --> 00:40:23,636 CLINICAL DISEASES SUCH AS 881 00:40:23,636 --> 00:40:26,773 RETINAL DEGENERATIONS AND AMD. 882 00:40:26,773 --> 00:40:28,942 SO WE CAN SEE A LOT OF THINGS 883 00:40:28,942 --> 00:40:31,778 WITH OCT IMAGING NOW, NOT JUST A 884 00:40:31,778 --> 00:40:34,080 CLASSIC STRUCTURE, STRUCTURAL 885 00:40:34,080 --> 00:40:36,182 MEASURES, LIKE THICKNESS, EDEMA 886 00:40:36,182 --> 00:40:44,457 AND ATROPHY, BUT ALL PRORIFFERAL 887 00:40:44,457 --> 00:40:45,425 RETINA, MICROBES, 888 00:40:45,425 --> 00:40:46,025 NEOVASCULARRIZATION, ISCHEMIA, 889 00:40:46,025 --> 00:40:47,827 AND PHOTO REPRESENT ISOR 890 00:40:47,827 --> 00:40:49,095 FUNCTION, AND I TRULY BELIEVE IF 891 00:40:49,095 --> 00:40:51,631 WE SEE THE DEC, WE CAN TREAT IT 892 00:40:51,631 --> 00:40:53,767 WITH VEG F AND WE CAN DO THAT 893 00:40:53,767 --> 00:40:54,801 WITHIN OUR LIFETIME, WE DON'T 894 00:40:54,801 --> 00:40:56,136 HAVE TO WAIT MILLIONS OF YEARS 895 00:40:56,136 --> 00:40:58,204 LIKE THE BEES TO AFFECT THE 896 00:40:58,204 --> 00:40:58,571 WORLD. 897 00:40:58,571 --> 00:41:05,111 AND I'M VERY EXCITED BY THE 898 00:41:05,111 --> 00:41:06,946 POSSIBILITY OF OCUE LOAMICS AND 899 00:41:06,946 --> 00:41:08,581 2 THINGS THEY THINK WILL MAKE 900 00:41:08,581 --> 00:41:12,485 IMPACT, 1 IS DOPPLER OCT TO LOOK 901 00:41:12,485 --> 00:41:15,955 AT RETINAL BLOOD FLOW AND THE 902 00:41:15,955 --> 00:41:19,926 WAVE FORM THAT WOULD REVEAL 903 00:41:19,926 --> 00:41:23,163 HEMODYNAMICS IN THE CAROTID AND 904 00:41:23,163 --> 00:41:29,402 AORTIC VALVE, AND ALSO OCT 905 00:41:29,402 --> 00:41:31,171 ANGIOGRAPHY, WE PERFORMED SOME 906 00:41:31,171 --> 00:41:33,440 PRELIMINARY TODAYS WITH 907 00:41:33,440 --> 00:41:39,712 NEUROLOGY COLLEAGUES AND FOUND 908 00:41:39,712 --> 00:41:42,015 THAT THE PROFUSION LOSS HAVE 909 00:41:42,015 --> 00:41:44,951 CHARACTERISTIC PATTERNS IN TBRAW 910 00:41:44,951 --> 00:41:47,120 COMA, MULTIPLE SCLEROSIS, 911 00:41:47,120 --> 00:41:48,521 ALZHEIMERS DEMENTIA AND THESE 912 00:41:48,521 --> 00:41:50,156 COULD BEING DIFFERENTIATED OR 913 00:41:50,156 --> 00:41:50,890 DETECTED WITH HIGH SPECIFICITY 914 00:41:50,890 --> 00:41:52,859 WITH THIS TYPE OF ANALYSIS, AND 915 00:41:52,859 --> 00:41:54,327 OF COURSE, WE CAN GO BEYOND THE 916 00:41:54,327 --> 00:41:55,562 EYE NOW THAT WEB CONNECTED HAVE 917 00:41:55,562 --> 00:41:58,898 HIGH SPEED, VERY HIGH SPEED OCT, 918 00:41:58,898 --> 00:42:01,501 WE CAN EXTEND THE RESOLUTION TO 919 00:42:01,501 --> 00:42:06,473 MUCH WIDER AREA SUITABLE FOR 920 00:42:06,473 --> 00:42:09,209 IMAGING HEART, SKIN, DIGESTIVE 921 00:42:09,209 --> 00:42:10,610 TRACT, MIDDLE EAR, BRAIN, TEETH 922 00:42:10,610 --> 00:42:12,145 AND A LOT OF OTHER STRUCTURES. 923 00:42:12,145 --> 00:42:14,147 SO I WOULD LIKE TO ACKNOWLEDGE 924 00:42:14,147 --> 00:42:18,551 THE SUPPORT OF NEI, RPB, AND 925 00:42:18,551 --> 00:42:21,087 THIS IS OUR RESEARCH GROUP, THE 926 00:42:21,087 --> 00:42:24,624 CENTER FOR OPHTHALMIC OPTICS AND 927 00:42:24,624 --> 00:42:26,459 LASERS AT OREGON HEALTH AND 928 00:42:26,459 --> 00:42:28,361 SCIENCE UNIVERSITY AND PLEASE 929 00:42:28,361 --> 00:42:32,532 VISITING THE OUR WEBSITE 930 00:42:32,532 --> 00:42:33,766 COOLLAB.NET. 931 00:42:33,766 --> 00:42:34,033 THANK YOU. 932 00:42:34,033 --> 00:42:44,244 [ APPLAUSE ] 933 00:42:45,345 --> 00:42:46,946 >> IN THE INTEREST OF TIME, CAN 934 00:42:46,946 --> 00:42:48,381 WE HAVE 1 QUICK QUESTION. 935 00:42:48,381 --> 00:42:50,817 WE HAVE TO BE OUT OF THIS ROOM 936 00:42:50,817 --> 00:42:54,354 BY NOON. 937 00:42:54,354 --> 00:43:02,262 >> SORRY ABOUT THAT. 938 00:43:02,262 --> 00:43:03,530 >> [INDISCERNIBLE] 939 00:43:03,530 --> 00:43:06,666 >> YES, WITH OCT ANGIOGRAPHY, WE 940 00:43:06,666 --> 00:43:07,934 CAN SEE CAPILLARIES VERY WELL 941 00:43:07,934 --> 00:43:12,338 AND LOOK AT THE CHANGE IN 942 00:43:12,338 --> 00:43:15,241 CAPILLARY DENSITY AND ALSO IN 943 00:43:15,241 --> 00:43:18,211 SOME DISEASES, IT'S BETTER, EVEN 944 00:43:18,211 --> 00:43:20,179 BETTER AT DETECTING PATCHES 945 00:43:20,179 --> 00:43:21,447 WHERE THERE CAPILLARY DROP OUT 946 00:43:21,447 --> 00:43:28,021 AND THAT'S A POWERFUL 947 00:43:28,021 --> 00:43:28,321 DIAGNOSTIC. 948 00:43:28,321 --> 00:43:28,755 >> [INDISCERNIBLE] 949 00:43:28,755 --> 00:43:30,757 >> YES, WE CAN MONITOR THAT. 950 00:43:30,757 --> 00:43:32,358 >> HOW MANY? 951 00:43:32,358 --> 00:43:34,427 >> HOW MANY? 952 00:43:34,427 --> 00:43:34,694 >> YES. 953 00:43:34,694 --> 00:43:35,962 >> WELL, I THINK YOU WOULD HAVE 954 00:43:35,962 --> 00:43:38,364 TO LOOK AT SPECIFIC DEC IN 955 00:43:38,364 --> 00:43:40,633 PUBLICATIONS, BUT YOU CAN 956 00:43:40,633 --> 00:43:43,736 MEASURE AREA DENSITY OR LINE 957 00:43:43,736 --> 00:43:46,272 DENSITY AND WE CAN DISCUSS THAT 958 00:43:46,272 --> 00:43:54,113 OFFLINE SINCE IT'S A COMPLICATED 959 00:43:54,113 --> 00:43:54,380 TOPIC. 960 00:43:54,380 --> 00:43:54,647 THANKS. 961 00:43:54,647 --> 00:44:01,621 [ APPLAUSE ] 962 00:44:01,621 --> 00:44:02,855 >> OKAY, WE WILL GET ON WITH THE 963 00:44:02,855 --> 00:44:05,458 FIRST SESSION OF THE MORPING 964 00:44:05,458 --> 00:44:06,626 CLINICAL APPLICATIONS AND THIS 965 00:44:06,626 --> 00:44:13,466 SESSION WILL BE MODERATED BY 966 00:44:13,466 --> 00:44:15,535 DR. AMANI, FAWZI FROM 967 00:44:15,535 --> 00:44:16,102 NORTHWESTERN UNIVERSITY. 968 00:44:16,102 --> 00:44:17,503 >> THANK YOU DAVID AND THANK TO 969 00:44:17,503 --> 00:44:22,108 YOU THE ORGANIZERS AND DAVID AND 970 00:44:22,108 --> 00:44:22,809 PROFESSOR FUJIMOTOFOR BRINGING 971 00:44:22,809 --> 00:44:23,610 THIS ALL HERE. 972 00:44:23,610 --> 00:44:27,280 THIS SESSION IS REALLY WHO'S WHO 973 00:44:27,280 --> 00:44:29,015 IN PIONEERING CLINICAL 974 00:44:29,015 --> 00:44:30,316 APPLICATIONS SO THEY'RE ALL 975 00:44:30,316 --> 00:44:31,584 CLINICIAN SCIENTISTS, THEY'RE 976 00:44:31,584 --> 00:44:33,252 ALL SURGEONS, THEY'RE ALL 977 00:44:33,252 --> 00:44:37,190 AMAZING, FIERCE, BRILLIANT AND 978 00:44:37,190 --> 00:44:38,691 EACH OF THEM PYONORRED AN 979 00:44:38,691 --> 00:44:40,259 INTEREST IN THEIR FIELD AND THEY 980 00:44:40,259 --> 00:44:41,561 PUSHED THE BOUNDARIES FOR ALL OF 981 00:44:41,561 --> 00:44:43,429 US CLINICIANS ISSUES THE FIRST 982 00:44:43,429 --> 00:44:48,601 OF SUCH PIONEERS AND DR. CYNTHIA 983 00:44:48,601 --> 00:44:50,069 TOTH, WORKS AT DUKE. 984 00:44:50,069 --> 00:44:52,038 SHE BROUGHT THE FIRST OCT TO 985 00:44:52,038 --> 00:44:54,007 DUKE, STARTED THE READING CENTER 986 00:44:54,007 --> 00:44:57,677 AND HAS BEEN WORKING WITH JOE 987 00:44:57,677 --> 00:45:00,346 IZAT, IN BRINGING APPLICATIONS 988 00:45:00,346 --> 00:45:01,614 LIKE INTEROPERATIVE OCT AND 989 00:45:01,614 --> 00:45:03,549 PERFIRST BABY AND BRINGING OCT 990 00:45:03,549 --> 00:45:06,452 TO BABIES WHO CAN'T SIT UP AT 991 00:45:06,452 --> 00:45:10,156 THE [INDISCERNIBLE] AND I LOOK 992 00:45:10,156 --> 00:45:11,858 FORWARD TO YOUR TALK CYNTHIA, 993 00:45:11,858 --> 00:45:13,459 THANK YOU. 994 00:45:13,459 --> 00:45:13,993 >> THANK YOU AMANI. 995 00:45:13,993 --> 00:45:15,995 I THINK THIS IS 1 OF THE MOST 996 00:45:15,995 --> 00:45:22,035 SPECIAL PLACES OR SITUATIONS IN 997 00:45:22,035 --> 00:45:23,236 WHICH I'VE I'VE BEEN ABLE TO 998 00:45:23,236 --> 00:45:25,972 TALK AND TO REALLY TALK ABOUT 999 00:45:25,972 --> 00:45:29,175 BEING ABLE TO BE AROUND BEFORE 1000 00:45:29,175 --> 00:45:31,110 OCT AND TO ACTUALLY SEE THE 1001 00:45:31,110 --> 00:45:33,312 IMPACT IT HAD AS OPPOSE TO THOSE 1002 00:45:33,312 --> 00:45:34,747 WHO'VE GROWN UP WITH OCT 1003 00:45:34,747 --> 00:45:45,258 AVAILABLE AT OUR FINGERTIPS IN 1004 00:45:54,267 --> 00:45:54,534 CLINICS. 1005 00:45:54,534 --> 00:45:57,170 WITH A WAY TO APPLY IT IN HOW WE 1006 00:45:57,170 --> 00:45:58,337 TREAT HUMAN ANDS SALVAGE VISION 1007 00:45:58,337 --> 00:46:03,342 EMPLOY SO I WILL TALK ABOUT 1008 00:46:03,342 --> 00:46:06,079 APPLICATIONS IN BREAKING 1009 00:46:06,079 --> 00:46:06,979 BARRIERS IN OCT. 1010 00:46:06,979 --> 00:46:08,147 DUKE UNIVERSITY HAS GIVEN ME 1011 00:46:08,147 --> 00:46:09,449 TIME AWAY FROM DUKE SO I SPENT 1012 00:46:09,449 --> 00:46:14,520 TIME WORKING WITH THE IMAGING, 1013 00:46:14,520 --> 00:46:16,322 DEVELOPINGNYONATAL OCT IMAGING, 1014 00:46:16,322 --> 00:46:18,858 AND I ALSO HAVE GRANTS AND 1015 00:46:18,858 --> 00:46:20,893 ROYALTIES AND STUFF, I'M GOING 1016 00:46:20,893 --> 00:46:23,329 TO TALK ABOUT INVESTIGATIONAL 1017 00:46:23,329 --> 00:46:23,896 DEVICES. 1018 00:46:23,896 --> 00:46:28,334 ALL OF THESE ARE NOT FDA CLEARED 1019 00:46:28,334 --> 00:46:30,436 THE INVESTIGATIONAL 1S WILL BE 1020 00:46:30,436 --> 00:46:32,605 IDENTIFIED AS SUCH, THESE ARE 1021 00:46:32,605 --> 00:46:35,108 USED UNDER IRB PROTOCOL ANDS 1022 00:46:35,108 --> 00:46:36,642 PATIENTS AND PAMLYS HAVE GIVEN 1023 00:46:36,642 --> 00:46:37,910 WRITTEN APPROVAL OF ANY IMAGES 1024 00:46:37,910 --> 00:46:39,378 IN THIS TALK EMPLOY I FIRST WANT 1025 00:46:39,378 --> 00:46:42,048 TO ACKNOWLEDGE THE BABY STEPS 1026 00:46:42,048 --> 00:46:45,918 TEAM, WE TARTED 8 YEARS AGO WITH 1027 00:46:45,918 --> 00:46:48,955 THE STUDY OF EYE BRAIN 1028 00:46:48,955 --> 00:46:50,289 DEVELOPMENT IN PRETERM INFANTS. 1029 00:46:50,289 --> 00:46:51,791 THIS IS MY RO-1 THAT IS 1030 00:46:51,791 --> 00:46:57,296 CONTINUING ON IN A GROUP. 1031 00:46:57,296 --> 00:46:59,098 I STARTED IT WITH MAURI 1032 00:46:59,098 --> 00:47:00,600 OSHEROFFINE MC GUIRE, DURING THE 1033 00:47:00,600 --> 00:47:02,702 CAT TRIAL, I WAS THE OCT GRADER 1034 00:47:02,702 --> 00:47:04,370 FOR THAT AND SHE HELPED US GET 1035 00:47:04,370 --> 00:47:07,140 OFF THE GROUND BUT IT WAS 1036 00:47:07,140 --> 00:47:08,908 REALLYIO IZAT AND THE ENGINEERS 1037 00:47:08,908 --> 00:47:10,977 THAT DEVELOPED THE SYSTEMS THAT 1038 00:47:10,977 --> 00:47:12,512 ALLOWED US TO DO IT. 1039 00:47:12,512 --> 00:47:13,713 I'VE HAD OTHER RESEARCH SUPPORT 1040 00:47:13,713 --> 00:47:15,915 OUT OF NIH AS WELL, BUT I WANT 1041 00:47:15,915 --> 00:47:19,485 TO THANK CHRISTIAN VEELAN, AND 1042 00:47:19,485 --> 00:47:20,386 [INDISCERNIBLE] THESE 2 1043 00:47:20,386 --> 00:47:21,754 BIOMEDICAL ENGINEER WHOG BOTH 1044 00:47:21,754 --> 00:47:24,390 TRAINED AT DUKE BUT WHO HAVE 1045 00:47:24,390 --> 00:47:28,261 GONE ON AND MADE THE INSTRUMENT 1046 00:47:28,261 --> 00:47:32,598 OF MY DREAMS A SWEPT SOURCE HAND 1047 00:47:32,598 --> 00:47:34,233 HELD OCT FOR HUMAN USE AND I 1048 00:47:34,233 --> 00:47:37,203 WANT TO RECOGNIZE NIH WHO 1049 00:47:37,203 --> 00:47:38,638 THROUGH SBIR HAS HELPED US 1050 00:47:38,638 --> 00:47:40,106 TRANSLATE FROM THE RESEARCH LAB 1051 00:47:40,106 --> 00:47:40,940 INTO HUMANS. 1052 00:47:40,940 --> 00:47:43,910 SO I WAS FORTUNATE TO BE 1053 00:47:43,910 --> 00:47:45,978 STANDING AROUND IN A SECOND 1054 00:47:45,978 --> 00:47:48,181 LASER ACT AND WE WERE LOOKING AT 1055 00:47:48,181 --> 00:47:53,085 LASER WITH TISSUE AND JIM 1056 00:47:53,085 --> 00:47:54,086 FUJIMOTOSHOWED UP WITH 1057 00:47:54,086 --> 00:47:56,122 COLLEAGUES, AND PAT ROACH WAS 1058 00:47:56,122 --> 00:47:58,758 RUNNING THE PROJECT, WE WERE 1059 00:47:58,758 --> 00:48:00,593 LOOKINGA THE LASER INTERACTION 1060 00:48:00,593 --> 00:48:02,595 IN THE RETINA TRYING TO DEVELOP 1061 00:48:02,595 --> 00:48:03,162 SAFETY PROTOCOLS. 1062 00:48:03,162 --> 00:48:06,199 I WAS FORTUNATE ENOUGH, I WAS 1063 00:48:06,199 --> 00:48:07,233 THE OPHTHALMOLOGIST ON THE TEAM 1064 00:48:07,233 --> 00:48:09,702 SO WE WROTE UP OUR STUDIES OF 1065 00:48:09,702 --> 00:48:10,436 OCT MORPHOLOGY AND LIVING 1066 00:48:10,436 --> 00:48:12,104 TISSUES ISSUES THIS WAS IN 1067 00:48:12,104 --> 00:48:14,807 LIVING PRIMATE EYE, NOT IN DEAD 1068 00:48:14,807 --> 00:48:18,044 EYE, BUT I WAS HOOKED BECAUSE MY 1069 00:48:18,044 --> 00:48:21,681 FIRST EXPOSURE TO OCT WAS INTRA 1070 00:48:21,681 --> 00:48:22,281 OPERATIVE USE. 1071 00:48:22,281 --> 00:48:23,916 SO THERE WE WERE SHOOTING A 1072 00:48:23,916 --> 00:48:26,919 LASER AT THE RETINA AND WATCHING 1073 00:48:26,919 --> 00:48:30,122 FROM BASE LINE 13-SECONDS LATER, 1074 00:48:30,122 --> 00:48:33,893 THE AND 18 MINUTES LATER, THE 1075 00:48:33,893 --> 00:48:35,194 LASER LESION PLOOMING IN LIVING 1076 00:48:35,194 --> 00:48:38,898 TISSUE AS WE WERE TREATING. 1077 00:48:38,898 --> 00:48:42,568 AND THAT WAS LIKE--THAT CHANGED 1078 00:48:42,568 --> 00:48:43,135 MY LIFE. 1079 00:48:43,135 --> 00:48:45,838 I HAVE NO ENGINEERING 1080 00:48:45,838 --> 00:48:46,138 BACKGROUND. 1081 00:48:46,138 --> 00:48:48,741 I AM JUST A VERY FORTUNATE 1082 00:48:48,741 --> 00:48:50,209 PURPOSE WHO RECOGNIZES AND LOVES 1083 00:48:50,209 --> 00:48:53,312 THIS TECHNOLOGY THAT WE'VE BEEN 1084 00:48:53,312 --> 00:48:54,080 HANDED. 1085 00:48:54,080 --> 00:48:58,317 SO WE HAD JOE IZAT CAME TO DUKE 1086 00:48:58,317 --> 00:49:00,419 IN 2001, HE DEVELOPED A HANDLE 1087 00:49:00,419 --> 00:49:03,289 OCT AND THIS WAS BEING USED FOR 1088 00:49:03,289 --> 00:49:03,823 ANIMAL RESEARCH. 1089 00:49:03,823 --> 00:49:06,459 THEY ALSO HAD A TABLE TOP UNIT 1090 00:49:06,459 --> 00:49:09,328 THAT GAVE US ACCESS TO THE RAW 1091 00:49:09,328 --> 00:49:12,632 OCT DATA SO I COULDN'T GO TO ANY 1092 00:49:12,632 --> 00:49:13,933 OF THE OTHER INDUSTRIAL SYSTEMS 1093 00:49:13,933 --> 00:49:16,269 AND GET OUT THE RAW OCT SCANS, 1094 00:49:16,269 --> 00:49:19,472 WE COULD WITH THIS AND WE USED 1095 00:49:19,472 --> 00:49:25,077 IT IN THE ANCILLARY STUDY, EMILY 1096 00:49:25,077 --> 00:49:26,178 [INDISCERNIBLE] ALLOWED US TO 1097 00:49:26,178 --> 00:49:30,750 PARTNER AT 4 OF THE SITES AND 1098 00:49:30,750 --> 00:49:32,518 GENENTECH AND OPTICAL IMAGES GEN 1099 00:49:32,518 --> 00:49:34,387 ALLOWED US TO DO THIS. 1100 00:49:34,387 --> 00:49:39,625 SO HERE WE WERE EXAMINING THE 1101 00:49:39,625 --> 00:49:40,259 [INDISCERNIBLE] AND YOU HEARD 1102 00:49:40,259 --> 00:49:42,295 ABOUT A LOT OF THIS YESTERDAY, 1103 00:49:42,295 --> 00:49:46,866 THAT LED UP TO DEEP LEARNING 1104 00:49:46,866 --> 00:49:47,833 ALGORITHMS, ET CETERA AND OUR 1105 00:49:47,833 --> 00:49:48,868 LAB IS CONTINUING THAT WORK. 1106 00:49:48,868 --> 00:49:51,537 AT THE SAME TIMEIO WAS 1107 00:49:51,537 --> 00:49:53,406 DEVELOPING WITH US HIGH SPEED 1108 00:49:53,406 --> 00:49:55,808 OCT, SO THE SPECTRAL DOMAIN AND 1109 00:49:55,808 --> 00:49:59,312 SWEPT SOURCE ALOUD US TO BRING 1110 00:49:59,312 --> 00:50:02,648 OCT 3D IN THE O. R. IN REALTIME 1111 00:50:02,648 --> 00:50:04,116 AND THIS WAS 4 D. 1112 00:50:04,116 --> 00:50:06,085 THIS WAS 1 OF OUR PET PROGECS 1113 00:50:06,085 --> 00:50:10,089 FROM THE BEGINNING WAS TRYING TO 1114 00:50:10,089 --> 00:50:11,157 DO INTERRAOPERATIVE OCT, MANY 1115 00:50:11,157 --> 00:50:12,692 FAILURES EARLY ON BUT IT HASS 1116 00:50:12,692 --> 00:50:13,693 BEEN A FANTASTIC RIDE. 1117 00:50:13,693 --> 00:50:16,228 BUT I'M NOT TALKING ABOUT 1118 00:50:16,228 --> 00:50:17,363 INTEROPERATIVE OCT TODAY, I'M 1119 00:50:17,363 --> 00:50:18,631 GOING TO TALK ABOUT GOING BACK 1120 00:50:18,631 --> 00:50:21,434 TO THE NURSERY AND THERE WE WERE 1121 00:50:21,434 --> 00:50:23,369 USING THE TECHNIQUES OF HAND 1122 00:50:23,369 --> 00:50:26,906 HELDS AND SCAPENS WITH THE 1123 00:50:26,906 --> 00:50:30,209 INDIRECT LIGHT SHINING INTO THE 1124 00:50:30,209 --> 00:50:31,777 CHILD'S LIGHT, ANYONE WHO'S HAD 1125 00:50:31,777 --> 00:50:33,312 AN EYE EXAMINE KNOWS. 1126 00:50:33,312 --> 00:50:35,481 AND IN FACT, RECEIPTLY A TBROWP 1127 00:50:35,481 --> 00:50:38,918 OF PEOPLE DID ROP EXAMS ON EACH 1128 00:50:38,918 --> 00:50:41,220 OTHER LIKE THEY WOULD DO ON THE 1129 00:50:41,220 --> 00:50:44,223 INFANTS WHILE THEY SAID THE LID 1130 00:50:44,223 --> 00:50:47,426 SPEC LUMAND THE LENS IS MILD, 1131 00:50:47,426 --> 00:50:51,063 THE RETINAL PHOTOGRAPHY IS 1132 00:50:51,063 --> 00:50:52,798 INTENSE AND AMPLIFIES THE IMPACT 1133 00:50:52,798 --> 00:50:54,100 OF THE DEPRESSION EMPLOY IT WAS 1134 00:50:54,100 --> 00:50:57,570 THAT SAME SPEED THAT ALLOWED US 1135 00:50:57,570 --> 00:50:59,472 TO DO INTEROPERATIVE OCT THAT 1136 00:50:59,472 --> 00:51:01,073 ALLOWED US TO GO TO SKIDS 1137 00:51:01,073 --> 00:51:02,541 BECAUSE A SINGLE SLICE WOULD NOT 1138 00:51:02,541 --> 00:51:05,044 TELL US WHETHER WE HAD AN 1139 00:51:05,044 --> 00:51:11,017 INHERITED DEC, THIS WAS A KID 1140 00:51:11,017 --> 00:51:12,485 WITH HER MANS SKI SIN TROAM OR 1141 00:51:12,485 --> 00:51:15,755 WHETHER YOU COULD DO A STRAIGHT 1142 00:51:15,755 --> 00:51:16,188 LINE SCAN. 1143 00:51:16,188 --> 00:51:19,658 I LOVE THE NIH LOGO WITH THE ARK 1144 00:51:19,658 --> 00:51:21,293 ASK IMAGES AND IT SHOWS THE HEAD 1145 00:51:21,293 --> 00:51:23,429 AND THE CHIN WITH THE CHIN REST, 1146 00:51:23,429 --> 00:51:27,166 THERE ARE A LOT OF PEOPLE WHO 1147 00:51:27,166 --> 00:51:28,501 CAN'T, INFANTS, CHILDREN AND 1148 00:51:28,501 --> 00:51:30,169 THOSE THAT CAN'T COOPERATE, MY 1149 00:51:30,169 --> 00:51:32,371 GOAL IS TO GET THEM ACCESS THAT 1150 00:51:32,371 --> 00:51:34,440 WE USE IN PATE WHO IS CAPTAIN 1151 00:51:34,440 --> 00:51:35,074 COOPERATE. 1152 00:51:35,074 --> 00:51:38,611 SO WE STARTED USING THE ARMATURE 1153 00:51:38,611 --> 00:51:40,913 SYSTEM, GOT RID OF QUICKLY AND 1154 00:51:40,913 --> 00:51:45,117 BY 2012 THE FDA APPROVED BI 1155 00:51:45,117 --> 00:51:46,552 OPTICAL IMAGES GEN IN KIDS AND 1156 00:51:46,552 --> 00:51:49,121 NEOINATES AND WE WENT ON TOIO 1157 00:51:49,121 --> 00:51:51,657 AND HIS STUDENTS, DEVELOPED 1158 00:51:51,657 --> 00:51:53,292 MULTIPLE SWEPT SOURCE SYSTEMS 1159 00:51:53,292 --> 00:51:55,594 THAT WENT FROM 100 UP TO 400 1160 00:51:55,594 --> 00:51:58,898 KILOHERTZ AND WE NOW HAVE A 1.6 1161 00:51:58,898 --> 00:51:59,865 KILOHERTZ SYSTEM. 1162 00:51:59,865 --> 00:52:02,234 WE'VE BEEN USING THIS THEN IN 1163 00:52:02,234 --> 00:52:05,337 THE BABY STEP STUDY AND THIS IS 1164 00:52:05,337 --> 00:52:06,439 SHOWING THE 400 KILOHERTZ 1165 00:52:06,439 --> 00:52:08,908 SYSTEM, AND BABY STEPS TARTED 8 1166 00:52:08,908 --> 00:52:11,944 YEARS AGO TO CHARACTERIZE FROM 1167 00:52:11,944 --> 00:52:13,112 BEDSIDE OCT IMAGING, EARLY 1168 00:52:13,112 --> 00:52:16,715 INDICATORS OF ON R. O. P., POOR 1169 00:52:16,715 --> 00:52:18,017 BRAIN VISION, ABNORMALITIES AND 1170 00:52:18,017 --> 00:52:18,851 POOR NEUROLOGICAL DEVELOP AM AND 1171 00:52:18,851 --> 00:52:20,853 SO WEB CONNECTED ENROLLED, WE 1172 00:52:20,853 --> 00:52:25,491 GOT HEALTH DATA, OCT, THE EXAM, 1173 00:52:25,491 --> 00:52:28,594 MRI IN A SELECT GROUP, VISUAL 1174 00:52:28,594 --> 00:52:30,729 ACUITY AND NEURAL DEVELOPMENT. 1175 00:52:30,729 --> 00:52:32,698 THEN IN BABY STEPS 2, NOT ONLY 1176 00:52:32,698 --> 00:52:34,300 ARE WE ENROLLING A SECOND 1177 00:52:34,300 --> 00:52:35,901 COHORT, SO WE HAVE ENOUGH TO GO 1178 00:52:35,901 --> 00:52:37,803 ON TO R. O. P., WE'RE ALSO 1179 00:52:37,803 --> 00:52:40,973 FOLLOWING THEM UP TO 5 YEARS. 1180 00:52:40,973 --> 00:52:43,275 SO 118 INFANTS ENROLLED IN THE 1181 00:52:43,275 --> 00:52:46,679 FIRST GROUP. 1182 00:52:46,679 --> 00:52:49,949 102 IMAGED FOVIA SUCCESSFULLY 1183 00:52:49,949 --> 00:52:50,716 CAPTURED, RETINAL THICKNESS 1184 00:52:50,716 --> 00:52:50,983 CAPTURED. 1185 00:52:50,983 --> 00:52:53,018 WHY DO I THINK THIS WILL BE A 1186 00:52:53,018 --> 00:52:54,386 BREAK THROUGH IN PEDIATRICS, 1187 00:52:54,386 --> 00:52:55,154 BECAUSE THE STRESS IN THE 1188 00:52:55,154 --> 00:52:56,822 NURSERY AND THE CHILDREN EXPOSED 1189 00:52:56,822 --> 00:52:58,757 TO THE FREIGHTEST LEVEL OF PAIN 1190 00:52:58,757 --> 00:53:01,026 AND STRESS HAVE HIGH CORTISOL 1191 00:53:01,026 --> 00:53:04,430 LEVELS AND AIVETTED HYPER 1192 00:53:04,430 --> 00:53:05,531 THALAMIC PITUE TARY ADRENAL 1193 00:53:05,531 --> 00:53:07,933 ACCESS THAT RELATES TO THEIR 1194 00:53:07,933 --> 00:53:08,200 BEHAVIOR. 1195 00:53:08,200 --> 00:53:11,103 SO WE DID A STRESS STUDY, WE 1196 00:53:11,103 --> 00:53:12,938 COMPARED OCT TO THE INDIRECT 1197 00:53:12,938 --> 00:53:14,173 OPERATING GLOBALLY THAT WILL MA 1198 00:53:14,173 --> 00:53:15,708 SCOPE EARLY, LATE, THE WHITE 1199 00:53:15,708 --> 00:53:20,646 BARS ARE THE OCT, NO CHANGE IN 1200 00:53:20,646 --> 00:53:21,413 STRESS BEHAVIOR. 1201 00:53:21,413 --> 00:53:23,149 THE RED BARS ARE FACIAL 1202 00:53:23,149 --> 00:53:25,084 EXPRESSION CHANGE AND CRYING 1203 00:53:25,084 --> 00:53:26,418 SEVERITY CHANGE IN A SERIES AND 1204 00:53:26,418 --> 00:53:28,854 THIS WAS CAPTURED BY A SEPARATE 1205 00:53:28,854 --> 00:53:31,123 INDIVIDUAL, NOT THE PEOPLE DOING 1206 00:53:31,123 --> 00:53:33,492 THE OCT OR INCORRECT EXAMS, WE 1207 00:53:33,492 --> 00:53:37,663 HAVE NURSES DOING THAT NOW FOR 1208 00:53:37,663 --> 00:53:39,298 OCT AND RETCAM STUDY EMPLOY AS 1209 00:53:39,298 --> 00:53:45,738 HAS BEEN SHOWN WITH THE EYE CROP 1210 00:53:45,738 --> 00:53:47,706 TBROWP, ET CETERA, OCT HELPS US 1211 00:53:47,706 --> 00:53:50,509 IDENTIFY IS IT A 4 YEAR, 5 YEAR, 1212 00:53:50,509 --> 00:53:55,881 IS THERE A PHOBIA, BUT CHEN HAS 1213 00:53:55,881 --> 00:53:57,616 REALLY LOOKED AT WORKING ON 1214 00:53:57,616 --> 00:54:01,187 NEUROVASCULAR DEVELOP AM, WE CAN 1215 00:54:01,187 --> 00:54:02,121 VISUALIZE THE VASCULAR, 1216 00:54:02,121 --> 00:54:02,988 AVASCULAR JUNCTION OTHERS 1217 00:54:02,988 --> 00:54:04,757 CATEGORIZE IT AND BECAUSE OF 1218 00:54:04,757 --> 00:54:06,625 OTA, WITH OUR SPEED WERE ABLE TO 1219 00:54:06,625 --> 00:54:08,060 OBTAIN WITH THE SYSTEM, WE CAN 1220 00:54:08,060 --> 00:54:10,596 SEE THE SHEETS OFNY O 1221 00:54:10,596 --> 00:54:11,897 VASCULARIZATION BUT AS SHE JUST 1222 00:54:11,897 --> 00:54:14,567 REPORTED THIS YEAR, WE CAN SEE 1223 00:54:14,567 --> 00:54:16,569 THE SPLITTING OF CAP NORMAL 1224 00:54:16,569 --> 00:54:18,704 VASCULAR DEVELOPMENT SPLIT 1225 00:54:18,704 --> 00:54:20,806 BETWEEN THE NERVE FIBER MEMBRANE 1226 00:54:20,806 --> 00:54:22,208 AND LIMITING BEFORE IN THE TOP 1227 00:54:22,208 --> 00:54:23,509 MIDDLE WHERE THE PHOBIA AND THEN 1228 00:54:23,509 --> 00:54:25,844 AFTER AND HAD IS FOLLOWING THE 1229 00:54:25,844 --> 00:54:27,012 SAME CHILD SEQUENTIALLY WEEK TO 1230 00:54:27,012 --> 00:54:31,317 WEEK AS THESE BUDS DEVELOP. 1231 00:54:31,317 --> 00:54:33,185 WE CAN SEE RESPONSE TO ANTIVEG F 1232 00:54:33,185 --> 00:54:36,622 THR ACTIVITIES ACTIVITIES AND 1233 00:54:36,622 --> 00:54:37,690 PROJECTS--THERAPY AND THE DEC 1234 00:54:37,690 --> 00:54:39,325 EMPLOY WITH THE WAY OF SHADOWING 1235 00:54:39,325 --> 00:54:41,360 THE VIEW, A WAY OF PROCESSING 1236 00:54:41,360 --> 00:54:44,930 THE OCT, WE CAN EXTRACT A HIGH 1237 00:54:44,930 --> 00:54:46,165 CONTRAST RETINAL VASCULAR VIEW 1238 00:54:46,165 --> 00:54:50,636 WHICH IS USEFUL BY CLINICIANS, 1239 00:54:50,636 --> 00:54:51,937 COMPARING 1 TO ANOTHER THAT THEY 1240 00:54:51,937 --> 00:54:54,607 CAN DETERMINE THE RELATIVE 1241 00:54:54,607 --> 00:54:56,842 SEVERITY RANKING OF THE R. O. P. 1242 00:54:56,842 --> 00:54:58,544 WITH GOOD AGREEMENT AND R. O. P. 1243 00:54:58,544 --> 00:55:01,113 TOOL, 1 OF THE EARLY COMPUTER 1244 00:55:01,113 --> 00:55:04,383 ASSISTED ANALYSIS TOOLINGS IS 1245 00:55:04,383 --> 00:55:07,119 ALSO APPLICABLE TO OCT IMAGES. 1246 00:55:07,119 --> 00:55:09,388 PETE CAMPBELL AND MICHAEL CHANG 1247 00:55:09,388 --> 00:55:15,861 AND THE IROP TBROWP --GROUP HAVE 1248 00:55:15,861 --> 00:55:17,730 SHOWN WITH THE COLOR PHOTO, YOU 1249 00:55:17,730 --> 00:55:20,899 WILL HAVE THE CHALLENGE OF THE 1250 00:55:20,899 --> 00:55:23,135 HAYES AND PERIPHERY AND 1251 00:55:23,135 --> 00:55:24,270 PREDICTIONS AND IT DOESN'T HAVE 1252 00:55:24,270 --> 00:55:27,072 THE COLORING IN THE WINDOW HAS 1253 00:55:27,072 --> 00:55:28,374 THAT REMOVES THESE REFLECTIONS. 1254 00:55:28,374 --> 00:55:31,176 SO WITH COLOR PHOTO THEY CAN 1255 00:55:31,176 --> 00:55:33,379 SKELETONIZE AND BIENARRIZE AND 1256 00:55:33,379 --> 00:55:36,582 EXTRACT THE VESSEL TRACINGS, 1257 00:55:36,582 --> 00:55:41,153 FEATURES AND IDENTIFY A SEVERITY 1258 00:55:41,153 --> 00:55:42,755 SCORE, OCT ADDS THE THIRD 1259 00:55:42,755 --> 00:55:44,390 DIMENSION, SO NOT ONLY DO WE 1260 00:55:44,390 --> 00:55:46,025 HAVE THE VESSEL INFORMATION ON 1261 00:55:46,025 --> 00:55:48,127 FOS, WE HAVE THE THICKNESS AND 1262 00:55:48,127 --> 00:55:50,396 NOTE THAT PLUS DEC, RETINAL 1263 00:55:50,396 --> 00:55:54,033 VESSEL IS NOT JUST LATERAL, 1264 00:55:54,033 --> 00:55:56,168 IT'SAXIAL SO WE CAN SEE THE 1265 00:55:56,168 --> 00:55:57,536 VESSELS BULGING OUT OF THE 1266 00:55:57,536 --> 00:55:59,772 RETINA IN ADDITION TO THE 1267 00:55:59,772 --> 00:56:00,606 NEOVASCULARRIZATION THAT WE SEE 1268 00:56:00,606 --> 00:56:02,941 UP IN THE CORNER, SO OCT IS 1269 00:56:02,941 --> 00:56:04,410 LIKELY TO BE USEFUL IN THE 1270 00:56:04,410 --> 00:56:07,613 FUTURE OF R. O. P. KREENING. 1271 00:56:07,613 --> 00:56:09,648 LOW INFANT STRESS, INFRAREDS THE 1272 00:56:09,648 --> 00:56:12,484 CHILD DOESN'T SEE THE LIGHT, 1273 00:56:12,484 --> 00:56:15,821 FUNGUS INDEPENDENT, IT RECORDS 1274 00:56:15,821 --> 00:56:17,222 RECORDING FOR SCREENING AND 1275 00:56:17,222 --> 00:56:18,624 MANAGE AM, THERE'S HIGH POSITION 1276 00:56:18,624 --> 00:56:19,792 AGREEMENT ON VASCULAR SEVERE 1277 00:56:19,792 --> 00:56:21,960 MITRAL IRITY AND IT CAN FEED 1278 00:56:21,960 --> 00:56:23,829 INTO AI ANALYSIS FOR SESEVERE 1279 00:56:23,829 --> 00:56:24,163 MITRAL ERITY. 1280 00:56:24,163 --> 00:56:27,633 BUT I FEEL LIKE A GINSU KNIVES 1281 00:56:27,633 --> 00:56:29,134 COMMERCIAL, BECAUSE I'M INTO 1282 00:56:29,134 --> 00:56:31,737 THIS IF YOU VBT GOTTEN IT. 1283 00:56:31,737 --> 00:56:33,472 THERE'S MORE EMPLOY SO AT SCHOOL 1284 00:56:33,472 --> 00:56:36,041 INCAS WHEN WE EXAMINE PEOPLE WHO 1285 00:56:36,041 --> 00:56:38,110 WERE BORN PRETERM THAT THEIR 1286 00:56:38,110 --> 00:56:39,978 PHOBIAS ARE OFTEN ABNORMAL. 1287 00:56:39,978 --> 00:56:41,747 THEY HAVE PERSISTENCE OF THE 1288 00:56:41,747 --> 00:56:43,682 RETINAL VASCULAR LAYERS AND 1289 00:56:43,682 --> 00:56:44,950 INE-PRESCRIBING LAYERS, WHEN 1290 00:56:44,950 --> 00:56:45,517 DOES THAT OCCUR? 1291 00:56:45,517 --> 00:56:53,025 WE FOUND THAT AT 36 WEEKS, 1292 00:56:53,025 --> 00:56:56,095 POORER FOVEALL DEVELOPMENT WITH 1293 00:56:56,095 --> 00:56:56,562 LOWER GA. 1294 00:56:56,562 --> 00:57:04,970 THEY SAW HA AND RECOGNIZED THAT 1295 00:57:04,970 --> 00:57:07,039 FOVEALL WAS ARRESTED EARLIER IN 1296 00:57:07,039 --> 00:57:08,040 THE KIDS BORN PRETERM. 1297 00:57:08,040 --> 00:57:11,276 NOT ONLY THAT BUT IT IS EXISTING 1298 00:57:11,276 --> 00:57:14,079 WITH R. O. P. STAGE, BUT NOT 1299 00:57:14,079 --> 00:57:17,316 WITH THE + DEC, WITH OCT, 1300 00:57:17,316 --> 00:57:19,251 REMEMBER WE WERE TALKING ABOUT 1301 00:57:19,251 --> 00:57:20,652 THIS OXYGEN SINK AND SUPPLY, SO 1302 00:57:20,652 --> 00:57:22,955 NOW WE'RE NOT JUST LOOKING AT 1303 00:57:22,955 --> 00:57:27,960 RETINAL VASCULATURE, NOW WOE 1304 00:57:27,960 --> 00:57:29,795 FOLLOW THE CHOROID IN THESE 1305 00:57:29,795 --> 00:57:32,297 CHILDREN, THIS IS ACROSS THE 1306 00:57:32,297 --> 00:57:35,000 CENTRAL MACULAR, DON'T ASK ME 1307 00:57:35,000 --> 00:57:36,034 ABOUT MACULAR EDEMA, WE DIDN'T 1308 00:57:36,034 --> 00:57:38,570 KNOW WHAT'S GOING ON, THINKING 1309 00:57:38,570 --> 00:57:40,572 IT'S AN IMBALANCE THE RETINA IS 1310 00:57:40,572 --> 00:57:41,173 TWEPPING NOT RELATE OFFICE OF 1311 00:57:41,173 --> 00:57:42,775 DIVERSITY R. O. P. 1312 00:57:42,775 --> 00:57:44,643 OF THE INFANTS YOU CAN SEE THE 1313 00:57:44,643 --> 00:57:47,880 TRANSITION ZONE AT 39 WEEKS, SO 1314 00:57:47,880 --> 00:57:53,051 CHOROID INCREASES IN THICKNESS 1315 00:57:53,051 --> 00:57:55,220 AND STABILIZES OFF LATER IN LIFE 1316 00:57:55,220 --> 00:57:57,656 AND IT'S DELAYED AND LOWER IN 1317 00:57:57,656 --> 00:57:59,458 FROAGHT IN KIDS THAT ARE XREAMLY 1318 00:57:59,458 --> 00:58:03,262 LOW BIRTH WAY AND AGE, CORROIDAL 1319 00:58:03,262 --> 00:58:04,430 CHANGES THERE'S THINNING IS 1320 00:58:04,430 --> 00:58:08,500 ASSOCIATE WIDE PLUS DEC BUT NOT 1321 00:58:08,500 --> 00:58:10,936 WITH STAGE OF R. O. P. WITH 1322 00:58:10,936 --> 00:58:12,304 MACULAR EDEMA. 1323 00:58:12,304 --> 00:58:17,075 SO UNRELATED BUT NOW WE STARTED 1324 00:58:17,075 --> 00:58:18,811 LOOKING AT STEROIDAL FACTORS AND 1325 00:58:18,811 --> 00:58:20,279 THE FIBROID, UNLIKE WHAT I WAS 1326 00:58:20,279 --> 00:58:23,715 TALKING ABOUT AND OTHER RETINAL 1327 00:58:23,715 --> 00:58:24,683 CHANGES, THE CHOROID PULL MONEY 1328 00:58:24,683 --> 00:58:26,251 LINKED TO THE DECS IN THE KIDS. 1329 00:58:26,251 --> 00:58:29,755 YOU CAN SEE IN THE BLUE, THAT'S 1330 00:58:29,755 --> 00:58:30,823 DISPLASSIA, PIE, ONOXIEN AT 36 1331 00:58:30,823 --> 00:58:33,525 WEEKS OR AT THE TIME OF THE OCT 1332 00:58:33,525 --> 00:58:34,226 IMAGING. 1333 00:58:34,226 --> 00:58:35,861 AND WITH LOWER GROWTH VELOCITY, 1334 00:58:35,861 --> 00:58:40,632 SO ALL OF THESE ARE LINKED TO 1335 00:58:40,632 --> 00:58:41,533 THE THINNER CHOROID. 1336 00:58:41,533 --> 00:58:43,535 SO NOW WE SWITCH FROM CHOROID, 1337 00:58:43,535 --> 00:58:45,771 THAT'S JUST THE BEGINNING. 1338 00:58:45,771 --> 00:58:48,340 BIRTH WAY IS PREDICTIVE OF NERVE 1339 00:58:48,340 --> 00:58:51,810 FIBER LAYER ON THE LEFT, EVERY 1340 00:58:51,810 --> 00:58:52,878 250-GRAM INCREASE IN A CHILD'S 1341 00:58:52,878 --> 00:58:54,847 BIRTH WAY IS SOCIETIED WITH A 1342 00:58:54,847 --> 00:58:58,016 LITTLE OVER A 5-MICRON INCREASE 1343 00:58:58,016 --> 00:59:00,719 IN THE RML THICKNESS SO THIS MAY 1344 00:59:00,719 --> 00:59:01,653 BE REFRECTING INUTERO 1345 00:59:01,653 --> 00:59:02,554 DEVELOPMENT AND POSSIBLY INJURY, 1346 00:59:02,554 --> 00:59:04,823 REMEMBER WE'RE NOT LOOKING AT 1347 00:59:04,823 --> 00:59:05,724 THESE KIDS IMMEDIATELY AFTER 1348 00:59:05,724 --> 00:59:07,693 BIRTH, WE SEE THEM AFTER THEY 1349 00:59:07,693 --> 00:59:10,329 REACH ABOUT 30 WEEKS 1350 00:59:10,329 --> 00:59:11,530 GUESTATIONAL OF POST MENSTRUAL 1351 00:59:11,530 --> 00:59:11,730 AGE. 1352 00:59:11,730 --> 00:59:13,465 MANY OF THEM ARE BORN A MONTH, 1353 00:59:13,465 --> 00:59:19,805 TO A MONTH AND A HALF BEFORE. 1354 00:59:19,805 --> 00:59:23,742 WE ALSO CAN FOLLOW INTERESTING 1355 00:59:23,742 --> 00:59:25,844 BI PHASIC CHANGE IN THE BIRTH 1356 00:59:25,844 --> 00:59:28,180 AND UP SLOPE AND DOWN SLOPE 1357 00:59:28,180 --> 00:59:30,148 WHICH WE OFTEN LEARNED ABOUT AS 1358 00:59:30,148 --> 00:59:32,584 THERE'S QUOTE PRUNING GOING ON 1359 00:59:32,584 --> 00:59:34,720 IN THE RNFL AND SO WE CAN SEE 1360 00:59:34,720 --> 00:59:36,355 THESE CHANGES IN OUR KIDS AS WE 1361 00:59:36,355 --> 00:59:40,225 FOLLOW THROUGH A LARGE COHORT. 1362 00:59:40,225 --> 00:59:43,629 THE KIDS THAT HAVE SEPSIS AND 1363 00:59:43,629 --> 00:59:45,731 NECK ROUGH ATOMITIZING 1364 00:59:45,731 --> 00:59:46,832 INTERCOLITIS, THIS IS 1365 00:59:46,832 --> 00:59:48,934 INDEPENDENTLY SOC WIDE THE 1366 00:59:48,934 --> 00:59:49,668 THINNER RETINAL NERVE FIBER 1367 00:59:49,668 --> 00:59:52,004 LAYER EMPLOY SO WE HAVE A LOT OF 1368 00:59:52,004 --> 00:59:53,605 CONFOUNDING FACERS. 1369 00:59:53,605 --> 00:59:55,908 WE HAVE THE LOW BIRTH RATE, R. 1370 00:59:55,908 --> 00:59:58,544 O. P. HAS AN IMPACT AND THEN 1371 00:59:58,544 --> 01:00:08,387 ESPECIALLY WE HAVE SEPSIS 1372 01:00:08,387 --> 01:00:09,254 INTERCOLITIS WITH RNFL. 1373 01:00:09,254 --> 01:00:12,190 SO IN STUDIES IN SWEDEN, KOREA 1374 01:00:12,190 --> 01:00:14,259 AND LOS ANGELES, THESE ARE ALL 1375 01:00:14,259 --> 01:00:15,427 2018 AND AFTERWARDS THEY HAVE 1376 01:00:15,427 --> 01:00:19,131 ALL SHOWN THAT THE 1377 01:00:19,131 --> 01:00:19,965 NEURODEVELOPMENT FOR INFANT 1378 01:00:19,965 --> 01:00:21,733 SCREEN IS LOW, THAT IS LOWER 1379 01:00:21,733 --> 01:00:23,468 THAN THE OTHER PRETERM 1380 01:00:23,468 --> 01:00:25,704 POPULATION AND LOWER CERTAINLY 1381 01:00:25,704 --> 01:00:28,206 THAN TERM. 1382 01:00:28,206 --> 01:00:33,679 SO THESE TESTS OF 1383 01:00:33,679 --> 01:00:35,547 NEURODEVELOPMENT ARE NORMALIZED 1384 01:00:35,547 --> 01:00:38,150 AT 100 AND SO YOU CAN SEE THE 1385 01:00:38,150 --> 01:00:42,020 LOW SCORES ACROSS THE BOARD FOR 1386 01:00:42,020 --> 01:00:43,722 THESE. 1387 01:00:43,722 --> 01:00:46,058 SO WE STUDIED 2 YEAR 1388 01:00:46,058 --> 01:00:46,825 NEURODEVELOPMENTAL OUTCOME ANDS 1389 01:00:46,825 --> 01:00:49,428 FOUND THAT THEIR TBRAITER NERVE 1390 01:00:49,428 --> 01:00:50,829 FIBER LAYER THICKNESS, EVERY 1391 01:00:50,829 --> 01:00:52,864 10-MICRON OF INCREASE IS 1392 01:00:52,864 --> 01:00:54,399 ASSOCIATE WIDE A 7-POINT OR 1393 01:00:54,399 --> 01:00:57,970 GREATER HIGHER MOTOR SCORE AND 1394 01:00:57,970 --> 01:00:59,237 HIGHER COGNITIVE SCORES. 1395 01:00:59,237 --> 01:01:00,405 IN ADDITION WE FOUND, ALTHOUGH 1396 01:01:00,405 --> 01:01:03,809 IT WAS A SMALL NUMBER OF 1397 01:01:03,809 --> 01:01:05,644 PATIENTS, A LOWER AUTISM RISK 1398 01:01:05,644 --> 01:01:06,311 SCORE. 1399 01:01:06,311 --> 01:01:07,879 WE ALSO CORRECTED FOR 1400 01:01:07,879 --> 01:01:10,182 GESTATIONAL AGE AND MOTHERS 1401 01:01:10,182 --> 01:01:11,783 EDUCATIONAL LEVEL, TRYING TO PUT 1402 01:01:11,783 --> 01:01:14,586 IN SOME FACTOR THAT ALLOWS FOR 1403 01:01:14,586 --> 01:01:16,355 SOCIOECONOMIC AND IT STILL ENDS 1404 01:01:16,355 --> 01:01:17,990 UP HOLDING UP AS A PREDICTER 1405 01:01:17,990 --> 01:01:19,958 EMPLOY SO NOW WE'RE LOOKING IN 1406 01:01:19,958 --> 01:01:21,560 THE NURSERY BEFORE THE TIME THE 1407 01:01:21,560 --> 01:01:22,894 CHILD SHOULD HAVE BEEN BORN, I 1408 01:01:22,894 --> 01:01:24,830 CAN LOOK AT THE NERVE FIBER 1409 01:01:24,830 --> 01:01:27,599 LAYER AND GIVE YOU A FACTOR THAT 1410 01:01:27,599 --> 01:01:29,935 YOU CAN NOW FOLLOW IN THIS 1411 01:01:29,935 --> 01:01:33,572 CHILD, AND THAT RELATES TO THEIR 1412 01:01:33,572 --> 01:01:33,972 NEURODEVELOPMENT. 1413 01:01:33,972 --> 01:01:38,010 IN ADDITION IT ALSO RELATES 1414 01:01:38,010 --> 01:01:40,212 GREATER RNFL THICKNESS WITH 1415 01:01:40,212 --> 01:01:42,981 BETTER VISUAL ACUITY OUT COMES 1416 01:01:42,981 --> 01:01:47,352 BY THE VISUAL CUITY AT 9 MONTHS. 1417 01:01:47,352 --> 01:01:49,221 FIVE YEAR DATA YET TO COME. 1418 01:01:49,221 --> 01:01:50,989 WHY DOES THIS MATTER IN I WAS 1419 01:01:50,989 --> 01:01:53,325 EXCITED ABOUT THE FINDING WE 1420 01:01:53,325 --> 01:01:56,662 FOWBD WITH ROTHMAN IN 2015, WE 1421 01:01:56,662 --> 01:01:58,063 USED A DEFICIENT HANDLE OCT 1422 01:01:58,063 --> 01:01:59,698 SYSTEM, AND IT WAS IN A 1423 01:01:59,698 --> 01:02:02,334 DIFFERENT GROUP OF INFANTS SO WE 1424 01:02:02,334 --> 01:02:03,535 ALSO FOUND INCREASED COGNITIVE 1425 01:02:03,535 --> 01:02:06,571 AND MOTOR WITH INCREASED RNFL 1426 01:02:06,571 --> 01:02:06,872 THICKNESS. 1427 01:02:06,872 --> 01:02:08,006 WE WENT TO LOOK FOR THEM, SINCE 1428 01:02:08,006 --> 01:02:10,442 WE HAVE A SYSTEM THAT'S USE 1429 01:02:10,442 --> 01:02:11,843 INDEED INFRARED, IT DOESN'T 1430 01:02:11,843 --> 01:02:13,145 CONFRICT THE PUPIL, THERE'S NO 1431 01:02:13,145 --> 01:02:13,545 VISIBLE LIGHT. 1432 01:02:13,545 --> 01:02:19,851 WE TOOK IT TO INFANTS WITH 1433 01:02:19,851 --> 01:02:20,919 HIPOXIC ISOTOPE CHEEMIC INSEVERE 1434 01:02:20,919 --> 01:02:21,553 MITRAL LOP RAGHTY. 1435 01:02:21,553 --> 01:02:22,387 TO LOOK AT IS THERE RETINAL 1436 01:02:22,387 --> 01:02:24,656 LOCATION NUMBER OF PATIENTSATHY 1437 01:02:24,656 --> 01:02:27,559 IN MOST PEOPLE DON'T DILATE THE 1438 01:02:27,559 --> 01:02:34,166 PUPILS BECAUSE THESE KID ARE IN 1439 01:02:34,166 --> 01:02:36,234 SEIZURE WATCH, AND WHAT DID WE 1440 01:02:36,234 --> 01:02:39,571 FIND THAT WAS PRESENT? 1441 01:02:39,571 --> 01:02:41,339 RNFL WAS PRESENT 1 AND HALF DAYS 1442 01:02:41,339 --> 01:02:43,842 AFTER BIRTH, SO IS SOME OF THIS 1443 01:02:43,842 --> 01:02:46,211 MORE CHRONIC IN UTERO IN 1444 01:02:46,211 --> 01:02:49,247 CHILDREN, RATHER THAN ACUTE RIKE 1445 01:02:49,247 --> 01:02:51,216 AN UMBILLICICAL CHORD AROUND THE 1446 01:02:51,216 --> 01:02:51,416 NECK. 1447 01:02:51,416 --> 01:02:52,818 SO WE ALSO FOUND ACUTE RETINAL 1448 01:02:52,818 --> 01:02:54,419 LOCATION NUMBER OF PATIENTSATHY 1449 01:02:54,419 --> 01:02:56,054 WITH A CHILD WITH SMALL CHANGES 1450 01:02:56,054 --> 01:02:57,122 IN THE BRAIN. 1451 01:02:57,122 --> 01:02:59,791 SO HANDLE OCT GIVES INSIGHT BO 1452 01:02:59,791 --> 01:03:00,592 DEPRIVATIONMENT, MALDEVELOPMENT 1453 01:03:00,592 --> 01:03:01,126 DISEASE AND INJURY OF THE 1454 01:03:01,126 --> 01:03:02,060 RETINAL LOCATION MA AND SOME OF 1455 01:03:02,060 --> 01:03:04,796 IT IS ASSOCIATE WIDE 1456 01:03:04,796 --> 01:03:05,197 NEURODEVELOPMENT. 1457 01:03:05,197 --> 01:03:08,467 THE WORLD OF R. O. P. HAS 1458 01:03:08,467 --> 01:03:10,569 CHANGED SINCE 2007 SINCE WE 1459 01:03:10,569 --> 01:03:11,737 STARRED ANTIVEG F ECTENDED THE 1460 01:03:11,737 --> 01:03:13,472 RISK PERIOD FOR RECURRENCE AND 1461 01:03:13,472 --> 01:03:14,806 THIS HAS INCREASED THE BURDEN 1462 01:03:14,806 --> 01:03:16,475 AND DURATION OF MONITORING AND 1463 01:03:16,475 --> 01:03:17,943 THERE ARE MULTIPLE THERAPIES 1464 01:03:17,943 --> 01:03:19,845 UNDER EVALUATION, I THINK A 1465 01:03:19,845 --> 01:03:21,379 PERIPHERAL VIEW MAY BE NEEDED, 1466 01:03:21,379 --> 01:03:22,447 RETINAL LOCATION CAM I SHOWED 1467 01:03:22,447 --> 01:03:24,916 YOU HAS THE PROBLEM, OCT CAN GET 1468 01:03:24,916 --> 01:03:27,686 AROUND THAT SO THEA IMAGING 1469 01:03:27,686 --> 01:03:31,223 STARTED BY CHRISTIAN VELAND, 1470 01:03:31,223 --> 01:03:31,923 [INDISCERNIBLE] AND MYSELF, OUR 1471 01:03:31,923 --> 01:03:33,425 KNOLL IS TO MAKE IMAGING 1472 01:03:33,425 --> 01:03:35,761 DISCIPLINARY NAG NUMBER OF 1473 01:03:35,761 --> 01:03:37,863 THETICS TO POPULATIONS UNABLE TO 1474 01:03:37,863 --> 01:03:40,932 ACCESS THE CONVENGAL TABLE TOP 1475 01:03:40,932 --> 01:03:41,500 IMAGING. 1476 01:03:41,500 --> 01:03:43,235 THE CHALLENGES IS THE HANDLE OCT 1477 01:03:43,235 --> 01:03:44,903 THAT WAS OUT THERE THEY STOPPED 1478 01:03:44,903 --> 01:03:50,609 PRODUCING SO IT'S NO LONGER 1479 01:03:50,609 --> 01:03:51,109 AVAILABLE. 1480 01:03:51,109 --> 01:03:54,479 WE HAVE A NONCONTACT SYSTEM FOR 1481 01:03:54,479 --> 01:03:55,313 THOSE UNABLE TO PARTICIPATE IN 1482 01:03:55,313 --> 01:03:57,282 TABLE ON TOP CAN WE HAVE A WIDE 1483 01:03:57,282 --> 01:03:58,450 FIELD CONTEXT SYSTEM AND THAT'S 1484 01:03:58,450 --> 01:04:00,652 FOR KID FIST THE NURSERY TO GIVE 1485 01:04:00,652 --> 01:04:04,289 US THE WIDE FIELD OF VIEW. 1486 01:04:04,289 --> 01:04:05,223 IT'S GREATER THAN THE RETINAL 1487 01:04:05,223 --> 01:04:06,725 LOCATION CAM FIELD OF VIEW AND 1488 01:04:06,725 --> 01:04:08,326 IT HAS A MORE USEFUL FIELD OF 1489 01:04:08,326 --> 01:04:11,029 VIEW AS CAN YOU SEE IN THE SAME 1490 01:04:11,029 --> 01:04:13,665 EYE IMAGES WITH BOTH SYSTEMS. 1491 01:04:13,665 --> 01:04:15,834 PETE CAMPBELL AND HIS GROUP HAVE 1492 01:04:15,834 --> 01:04:18,537 ALSO BEEN STRONG PROPONENTS OF 1493 01:04:18,537 --> 01:04:20,071 WIDE FIELD OCT IMAGING AS YOU 1494 01:04:20,071 --> 01:04:22,507 SAW EARLIER AND WE'VE SEGMENTED 1495 01:04:22,507 --> 01:04:25,277 THE VOLUMES TO ISOLATE THE 1496 01:04:25,277 --> 01:04:26,444 CORROIDAL VASCULAR PATTERN WHICH 1497 01:04:26,444 --> 01:04:28,513 CAN BE CONFUSING FROM THE 1498 01:04:28,513 --> 01:04:29,548 RETINAL VASCULAR PATTERN, IN 1499 01:04:29,548 --> 01:04:31,216 THIS SLIDE WITH RETINAL VASCULAR 1500 01:04:31,216 --> 01:04:32,184 DISEASE AND NORMAL RETINA. 1501 01:04:32,184 --> 01:04:37,522 SO I THINK THE FUTURE IS STRONG. 1502 01:04:37,522 --> 01:04:41,393 DIGITAL CAMERA AND OCT ARE GREAT 1503 01:04:41,393 --> 01:04:45,397 FOR STUDYING OCT, BUT HANDLE IS 1504 01:04:45,397 --> 01:04:46,431 BETTER FOR MONITORING THIS WIDE 1505 01:04:46,431 --> 01:04:48,567 RANGE I TOLD BUT I WON'T REPEAT 1506 01:04:48,567 --> 01:04:48,867 AGAIN. 1507 01:04:48,867 --> 01:04:50,435 AND I THINK WE NEED TO REMEMBER 1508 01:04:50,435 --> 01:04:51,870 THAT KIDS ARE PEOPLE TOO AND 1509 01:04:51,870 --> 01:04:53,438 THEY DESERVE ACCESS TO THE SAME 1510 01:04:53,438 --> 01:04:54,739 TECHNOLOGIES WE PROVIDE FOR 1511 01:04:54,739 --> 01:04:57,509 ADULT PATESENTIOUS SPECIALLY FOR 1512 01:04:57,509 --> 01:04:57,943 SENIOR PATIENTS. 1513 01:04:57,943 --> 01:04:59,144 I WANT TO ACKNOWLEDGE MY TEAM 1514 01:04:59,144 --> 01:05:00,245 AND THOSE WHO HAVE SUPPORTED US 1515 01:05:00,245 --> 01:05:03,181 AND THANK YOU FOR THE 1516 01:05:03,181 --> 01:05:04,716 OPPORTUNITY TO CELEBRATE THIS 1517 01:05:04,716 --> 01:05:05,917 TECHNOLOGY THAT'S BEEN A GIFT TO 1518 01:05:05,917 --> 01:05:08,920 ALL OF US IN OPHTHALMOLOGY. 1519 01:05:08,920 --> 01:05:19,130 [ APPLAUSE ] 1520 01:05:20,799 --> 01:05:22,667 >> THANK YOU SO MUCH CYNTHIA AND 1521 01:05:22,667 --> 01:05:25,971 THE NEXT SPEAKER NEEDS NO 1522 01:05:25,971 --> 01:05:30,909 EMERGENCY, HE IS A PROFESSOR OF 1523 01:05:30,909 --> 01:05:32,143 OPHTHALMOLOGY AND BIOMECHANICAL 1524 01:05:32,143 --> 01:05:32,444 ENGINEERING. 1525 01:05:32,444 --> 01:05:34,145 HE'S BEEN PUSHING THE BOUNDARIES 1526 01:05:34,145 --> 01:05:36,948 HE'S DEVELOPED THE CIRCULAR RNFL 1527 01:05:36,948 --> 01:05:38,550 SCAN WHICH CONTINUES TO BE THE 1528 01:05:38,550 --> 01:05:39,918 CORNER TONE OF DPLAW COMA 1529 01:05:39,918 --> 01:05:41,186 MONITORING AND HE WILL TELL US 1530 01:05:41,186 --> 01:05:44,089 ABOUT HOW HE'S PUSHING THE 1531 01:05:44,089 --> 01:05:44,823 BOUNDARIES FURTHER. 1532 01:05:44,823 --> 01:05:51,596 THANK YOU JOEL. 1533 01:05:51,596 --> 01:05:53,832 >> THANKS AMANI, AND EVERYBODY, 1534 01:05:53,832 --> 01:05:58,870 THANKS FOR HAVING LASKER-FEST, 1535 01:05:58,870 --> 01:06:02,807 AND CONGRATTULESS, I DIDN'T MEAN 1536 01:06:02,807 --> 01:06:03,742 AND DAVID. 1537 01:06:03,742 --> 01:06:05,577 THIS IS A FANTASTIC CONFERENCE 1538 01:06:05,577 --> 01:06:07,579 AND I'VE LEARNED SO MUCH BEING 1539 01:06:07,579 --> 01:06:09,214 HERE AND ENJOYED MEETING SO MANY 1540 01:06:09,214 --> 01:06:12,918 PEOPLE INTERESTED IN THE FIELD. 1541 01:06:12,918 --> 01:06:15,720 I'M GOING TO TALK ABOUT CLINICAL 1542 01:06:15,720 --> 01:06:17,822 APPLICATIONS OF OCT AND DPLAW 1543 01:06:17,822 --> 01:06:18,523 COMA DETECTION, IDENTIFICATION 1544 01:06:18,523 --> 01:06:23,028 OF CHANGE AND PREDICTING 1545 01:06:23,028 --> 01:06:23,495 PROGRESSION. 1546 01:06:23,495 --> 01:06:29,668 THESE ARE MY FINANCIAL 1547 01:06:29,668 --> 01:06:30,602 DISCLOSURES EMPLOY SO I'M GOING 1548 01:06:30,602 --> 01:06:33,038 TO TALK ABOUT AS I SAID FLAW 1549 01:06:33,038 --> 01:06:34,205 COMA DETECTION, I'M ALSO GOING 1550 01:06:34,205 --> 01:06:36,508 TO TALK ABOUT VISIBLE LIGHT OCT, 1551 01:06:36,508 --> 01:06:39,277 WHICH YOU'VE HEARD ABOUT 1552 01:06:39,277 --> 01:06:42,013 YESTERDAY, IT'S AN INNOVATION IN 1553 01:06:42,013 --> 01:06:44,683 DPLAW COMA DETECTION, ADDING A 1554 01:06:44,683 --> 01:06:46,484 COUPLE OF POTENTIAL NEW 1555 01:06:46,484 --> 01:06:48,853 BIOMARKERS FOR DPLAW COMA, WE 1556 01:06:48,853 --> 01:06:50,555 WILL TALK ABOUT PROGRESSION 1557 01:06:50,555 --> 01:06:54,025 DETECTION AND PROGRESSION 1558 01:06:54,025 --> 01:06:54,459 PREDICTION. 1559 01:06:54,459 --> 01:07:02,033 SO I GOT INTERESTED IN FINDING A 1560 01:07:02,033 --> 01:07:05,136 WAY TO DO OBJECTIVE QUANTITATIVE 1561 01:07:05,136 --> 01:07:15,580 ASSESSMENT OF PEOPLE WITH 1562 01:07:23,888 --> 01:07:24,923 GLAUCOMA. 1563 01:07:24,923 --> 01:07:27,258 --TO LOOK AT THE OPTIC NERVE AND 1564 01:07:27,258 --> 01:07:30,161 IF AN EXPERT SAID THAT THERE WAS 1565 01:07:30,161 --> 01:07:33,231 AN ABNORMALITY DAMAGE TO THE 1566 01:07:33,231 --> 01:07:35,567 OPTIC NERVE, THEN THAT PERSON 1567 01:07:35,567 --> 01:07:36,001 MIGHT HAVE GLAUCOMA. 1568 01:07:36,001 --> 01:07:38,069 BUT IT WAS A VERY SUBJECTIVE 1569 01:07:38,069 --> 01:07:39,371 ASSESSMENT RIGHT FROM THE 1570 01:07:39,371 --> 01:07:40,305 BEGENERATEDDING TO THE END 1571 01:07:40,305 --> 01:07:42,841 EXCEPT FOR THE INTRA OCULAR 1572 01:07:42,841 --> 01:07:43,775 PRESSURE MEASUREMENT WHICH TURNS 1573 01:07:43,775 --> 01:07:48,346 OUT IS NOT A DPRAIT WAY OF 1574 01:07:48,346 --> 01:07:51,049 DETECTING DISEAZ. 1575 01:07:51,049 --> 01:07:52,751 AND THE ARK ASSESSESMENT OF THE 1576 01:07:52,751 --> 01:07:56,454 OPTIC NERVE HEAD WAS SORT OF THE 1577 01:07:56,454 --> 01:07:57,155 CORNERSTONE OF GLAUCOMA 1578 01:07:57,155 --> 01:08:01,326 DIAGNOSIS AND YET THIS 1579 01:08:01,326 --> 01:08:02,927 SUBJECTIVE ASSESSMENT WAS VERY 1580 01:08:02,927 --> 01:08:05,263 VARIABLE, NOT ONLY FROM OBSERVER 1581 01:08:05,263 --> 01:08:06,598 TO OBLIGATIONS OBSERVER BUT 1582 01:08:06,598 --> 01:08:11,936 WITHIN A GIIVE OBSERVER TRUSTEES 1583 01:08:11,936 --> 01:08:12,270 TIME TO TIME. 1584 01:08:12,270 --> 01:08:13,905 AND WHAT I'M SHOWING IS A PAPER 1585 01:08:13,905 --> 01:08:16,875 FROM VICTOR WHICH WAS FROM THE 1586 01:08:16,875 --> 01:08:17,509 AMERICAN OPERATING GLOBALLY THAT 1587 01:08:17,509 --> 01:08:20,011 WILL MODEL CITIZEN LOGICAL 1588 01:08:20,011 --> 01:08:22,480 SOCIETY THESIS SHOWING THERE'S 1589 01:08:22,480 --> 01:08:24,416 VERY HIGH VARIABILITY AND KISS 1590 01:08:24,416 --> 01:08:25,817 AGREEMENT WITHIN AND BETWEEN 1591 01:08:25,817 --> 01:08:28,253 OBSERVERS. 1592 01:08:28,253 --> 01:08:32,590 A NUMBER OF TECHNOLOGIES WERE 1593 01:08:32,590 --> 01:08:35,427 DEVELOPED DURING THE MEAN 80S 1594 01:08:35,427 --> 01:08:37,228 THAT WERE DESIGNED TO DO THIS 1595 01:08:37,228 --> 01:08:39,164 SORT OF OBJECTIVE ASSESSMENT OF 1596 01:08:39,164 --> 01:08:44,402 THE OPTIC NERVE HEAD. 1597 01:08:44,402 --> 01:08:46,004 THERE WASSTERIOGRAPHY, THERE WAS 1598 01:08:46,004 --> 01:08:51,709 THE CONFOCAL SCANNING LASER AND 1599 01:08:51,709 --> 01:08:52,944 LASER POLARIZEDDER 1600 01:08:52,944 --> 01:08:53,645 IMPEDIMENTSAGERIE, OUR C-CURVE 1601 01:08:53,645 --> 01:08:54,846 WAS TYPICAL OF THE KIND OF 1602 01:08:54,846 --> 01:08:56,347 THINGS WIEW WOULD SEE DURING 1603 01:08:56,347 --> 01:09:01,453 THAT TIME OR ACTUALLY A LITTLE 1604 01:09:01,453 --> 01:09:03,788 LATER IN THE 90S WAS FROM THE 1605 01:09:03,788 --> 01:09:07,292 ADVANCED IMAGING FLAW COMA STUDY 1606 01:09:07,292 --> 01:09:09,761 THAT WAS LED BY DAVID WONG WHERE 1607 01:09:09,761 --> 01:09:12,163 WE LOOKED AT DIFFERENT 1608 01:09:12,163 --> 01:09:15,834 TECHNOLOGIES FOR ASSESSING 1609 01:09:15,834 --> 01:09:18,336 GLAUCOMA AND IN THIS CASE WE'RE 1610 01:09:18,336 --> 01:09:20,872 COMPARING OCT VERSUS THE SCANNER 1611 01:09:20,872 --> 01:09:25,643 LASER POLAR IMPEDIMENTS TERAND A 1612 01:09:25,643 --> 01:09:26,244 COUPLE DIFFERENT ITERERATIONS 1613 01:09:26,244 --> 01:09:28,446 AND YOU CAN SEE THAT OCT HAS A 1614 01:09:28,446 --> 01:09:30,281 DIFFERENT AREA UNDER THE 1615 01:09:30,281 --> 01:09:32,784 OPERATOR CURVE THAN SKIN AND 1616 01:09:32,784 --> 01:09:40,225 LASER POLAR IMAGERY AT .91. 1617 01:09:40,225 --> 01:09:41,726 O THIS IS PRETTY MUCH WHAT WE 1618 01:09:41,726 --> 01:09:44,195 HAVE NOW IN DOING CLINICAL OCT. 1619 01:09:44,195 --> 01:09:45,930 WE HEARD A TREMENDOUS AMOUNT 1620 01:09:45,930 --> 01:09:48,099 ABOUT WHAT'S GOING ON IN THE LAB 1621 01:09:48,099 --> 01:09:49,467 RATOREXPE IT'S INCREDIBLE 1622 01:09:49,467 --> 01:09:50,435 LOAMACYY EXCITING AND IT CAN'T 1623 01:09:50,435 --> 01:09:55,573 WAIT FOR IT TO BE TRANSLATED TO 1624 01:09:55,573 --> 01:09:56,474 CLINICAL PRACTICE BUT THIS IS 1625 01:09:56,474 --> 01:09:59,144 WHAT WE HAVE NOW AND SO THESE 1626 01:09:59,144 --> 01:10:01,146 ARE PROBABLY THE MOST COMMONLY 1627 01:10:01,146 --> 01:10:02,046 USED DEVICES IN CLINICAL 1628 01:10:02,046 --> 01:10:11,289 PRACTICE IN THE U.S., AND SO 1629 01:10:11,289 --> 01:10:12,957 THAT INCLUDES THE 1630 01:10:12,957 --> 01:10:15,860 ZEICIRCUMSTANCE CIRCUMSTANCE AND 1631 01:10:15,860 --> 01:10:18,163 NOW THE VISITINGIONICS AND THE 1632 01:10:18,163 --> 01:10:20,031 TRITON FROM TOP CON, THERE'S 1633 01:10:20,031 --> 01:10:26,337 ALSO THE MAESTRO FROM TOP CON. 1634 01:10:26,337 --> 01:10:29,574 THIS THESE ARE DOMAIN, TRITON IS 1635 01:10:29,574 --> 01:10:33,978 SWEPT SOURCE AND WE GET A PRINT 1636 01:10:33,978 --> 01:10:38,349 OUT THAT SHOWS US--OFTEN SHOWS 1637 01:10:38,349 --> 01:10:42,987 THE THUMB NAILINGS OF THE OCT, 1638 01:10:42,987 --> 01:10:44,289 CAPILLARY SCAN AND ALSO CROSS 1639 01:10:44,289 --> 01:10:46,658 SECTIONS OF THE OPTIC NERVE AND 1640 01:10:46,658 --> 01:10:48,626 THE CERTAIN PAPILLARY SCAN IS 1641 01:10:48,626 --> 01:10:51,729 BEING SHOWN ON EEP OF THESE 1642 01:10:51,729 --> 01:10:52,797 UNITS--EACH OF THESE UNITS. 1643 01:10:52,797 --> 01:10:57,268 THE WAY WE CAME UP WITH THE WAY 1644 01:10:57,268 --> 01:10:59,804 OF DOING CERTAIN CIRRUS APPLIED 1645 01:10:59,804 --> 01:11:01,906 ILLEGALSARY SCAN WAS INITIALLY 1646 01:11:01,906 --> 01:11:03,074 BEFORE DAVID EVENT CAME UP WITH 1647 01:11:03,074 --> 01:11:08,846 THE IDEA OF SCANNING THE OCT 1648 01:11:08,846 --> 01:11:11,482 BEAM WHICH IT WAS STILL OPTICAL 1649 01:11:11,482 --> 01:11:13,685 IMAGES COCO HERE ENSEL REFLECT 1650 01:11:13,685 --> 01:11:14,285 O--METABOLIZEDETRY, WE THOUGHT 1651 01:11:14,285 --> 01:11:16,554 MAYBE WE COULD DO A A-KAN--KANA 1652 01:11:16,554 --> 01:11:18,189 AT EACH CLOCK HOUR AROUND THE 1653 01:11:18,189 --> 01:11:19,691 OPTIC NERVE AND IT TOOK A LONG 1654 01:11:19,691 --> 01:11:23,328 TIME EVEN THEN TO DO ANY SCAN. 1655 01:11:23,328 --> 01:11:30,401 AND WE WOULD CATCH THE AXONS 1656 01:11:30,401 --> 01:11:32,203 THEY WERE COMING IN TO MAKE UP 1657 01:11:32,203 --> 01:11:34,839 THE OPTIC NERVE, AND WE GOT 48 1658 01:11:34,839 --> 01:11:36,040 SCANS PER SECOND OF THE 1659 01:11:36,040 --> 01:11:37,008 PROTOTYPE AUTOPSY SERIES SO 2 1660 01:11:37,008 --> 01:11:39,944 AND HALF SECONDS TO DO A HUNDRED 1661 01:11:39,944 --> 01:11:41,346 A-SCANS WHICH IS WHAT MADE UP 1662 01:11:41,346 --> 01:11:41,980 THE CIRCLE. 1663 01:11:41,980 --> 01:11:43,381 WE FIGURED WELL, WITH THE CIRCLE 1664 01:11:43,381 --> 01:11:45,083 WE WILL CATCH ALL THE AXONS 1665 01:11:45,083 --> 01:11:46,117 PRETTY MUCH THAT ARE GOING TO 1666 01:11:46,117 --> 01:11:48,453 MAKE UP THE OPTIC NERVE AND THEN 1667 01:11:48,453 --> 01:11:51,122 WE WERE TRYING TO FIGURE OUT, 1668 01:11:51,122 --> 01:11:53,992 WELL, YOU KNOW, HOW BIG SHOULD 1669 01:11:53,992 --> 01:11:59,030 THE CIRCLE BE? 1670 01:11:59,030 --> 01:12:00,999 AND I THOUGHT OF THE OPTIC NERVE 1671 01:12:00,999 --> 01:12:02,634 HEAD AS A POINT SOURCE SO I 1672 01:12:02,634 --> 01:12:05,036 THOUGHT WE SHOULD HAVE THE 1673 01:12:05,036 --> 01:12:06,137 STANDARD SIZED CIRCLE AS OPPOSE 1674 01:12:06,137 --> 01:12:08,206 TO MAKING THE CIRCLE RELATIVE TO 1675 01:12:08,206 --> 01:12:10,275 THE DIAMETER OF THE OPTIC NERVE, 1676 01:12:10,275 --> 01:12:11,709 BUT BIG ENOUGH SO THAT YOU WOULD 1677 01:12:11,709 --> 01:12:14,812 BE OUTSIDE THE AREA OF 1678 01:12:14,812 --> 01:12:15,613 PERIAPPLIED ILLEGALSARY ATROPHY 1679 01:12:15,613 --> 01:12:19,017 AND ALMOST ALL OPTIC NERVES AND 1680 01:12:19,017 --> 01:12:23,454 SO WE DIDN'T EXPERIMENT WITHIO 1681 01:12:23,454 --> 01:12:25,690 IZATT, AND WE LOOKED AT 1682 01:12:25,690 --> 01:12:27,425 DIFFERENT VOLTAGES, BECAUSE THE 1683 01:12:27,425 --> 01:12:31,129 VOWEL VOLTAGE CONTROLLED THE 1684 01:12:31,129 --> 01:12:33,331 CIRCLE SIZE AND SO IT TURNED OUT 1685 01:12:33,331 --> 01:12:35,166 THAT RELATIVELY EVEN VOLTAGE 1686 01:12:35,166 --> 01:12:39,871 GAVE US A VARIETY OF USEFUL 1687 01:12:39,871 --> 01:12:44,075 CIRCLE SIZES AND THAT 1688 01:12:44,075 --> 01:12:51,849 3.4-MILLIMETER CIRCLE WAS 1689 01:12:51,849 --> 01:12:52,083 OPTIMAL. 1690 01:12:52,083 --> 01:12:54,052 THREE PBT 37 ACTUALLY AND WE 1691 01:12:54,052 --> 01:12:56,754 LOOKED AT LATER, WHY IS THIS 1692 01:12:56,754 --> 01:12:59,190 TURNING OUT TO BE OPTIMAL, LEAST 1693 01:12:59,190 --> 01:13:00,391 VARIABLE AND GIVE US GOOD DATA 1694 01:13:00,391 --> 01:13:03,261 AND IT TURNS OUT THAT IT'S AT A 1695 01:13:03,261 --> 01:13:06,097 PLATEAU IN THE RETINAL NERVE 1696 01:13:06,097 --> 01:13:07,999 FIEBILE LAYER AS IT GOES INTO 1697 01:13:07,999 --> 01:13:11,436 THE OPTIC NERVE, SO THAT 1698 01:13:11,436 --> 01:13:13,271 EXPLAINS THE LOWER VARIABILITY 1699 01:13:13,271 --> 01:13:14,906 OF THAT CIRCLE DIAMETER EMPLOY 1700 01:13:14,906 --> 01:13:20,011 IN ANY EVENT, THE SCANNING 1701 01:13:20,011 --> 01:13:21,312 CIRCLE GIVES YOU DATA AND YOU 1702 01:13:21,312 --> 01:13:23,481 CAN PRESENT THAT IN A NUMBER OF 1703 01:13:23,481 --> 01:13:28,119 WAYS, THERE'S A CHART, AN RNFL 1704 01:13:28,119 --> 01:13:29,020 THICKNESS PROFILE AND QUARANT 1705 01:13:29,020 --> 01:13:31,222 AND CLOCK HOURS AND THEN THERE 1706 01:13:31,222 --> 01:13:32,990 ARE THESE THUMB NAILS THAT ALLOW 1707 01:13:32,990 --> 01:13:34,092 THE USER, CLINICIAN TO LOOK AT 1708 01:13:34,092 --> 01:13:39,664 THE QUALITY OF THE SCAN AND YOU 1709 01:13:39,664 --> 01:13:42,767 CAN SEE THAT ON THE SPECTRALIS 1710 01:13:42,767 --> 01:13:44,535 AND OTHERS, SO THEY ALL GIVE YOU 1711 01:13:44,535 --> 01:13:47,004 QUANTITATIVE DATA THAT YOU CAN 1712 01:13:47,004 --> 01:13:49,841 USE, AND THAT--THOSE 4 IMAGES 1713 01:13:49,841 --> 01:13:51,409 WERE ALL IN SINGLE HEALTHY 1714 01:13:51,409 --> 01:13:53,211 PATIENT'S EYES, THE SCAN ON THE 1715 01:13:53,211 --> 01:13:54,812 SAME DAY ON THE EACH OF THE 1716 01:13:54,812 --> 01:13:57,715 DIFFERENT UNITS SO HERE'S A 1717 01:13:57,715 --> 01:13:58,549 GLAUCOMA PATIENT WHO SCAN OFFICE 1718 01:13:58,549 --> 01:13:59,784 OF DIVERSITY EACH OF THOSE 1719 01:13:59,784 --> 01:14:01,686 DIFFERENT UNITS ON THE SAME DAY, 1720 01:14:01,686 --> 01:14:05,823 AND YOU CAN SEE THAT THERE ARE 1721 01:14:05,823 --> 01:14:06,791 DIFFERENCES HERE BETWEEN THE 1722 01:14:06,791 --> 01:14:10,495 NORMALS THAT I SHOWED YOU, THE 1723 01:14:10,495 --> 01:14:14,298 HEALTHYS AND THE GLAUCOMA AND SO 1724 01:14:14,298 --> 01:14:15,600 HERE YOU HAVE A DIFFERENT FROM 1725 01:14:15,600 --> 01:14:18,302 THE EXPECTED SO THAT'S BASED ON 1726 01:14:18,302 --> 01:14:19,704 ENORMATIVE DATABASE, EACH OF 1727 01:14:19,704 --> 01:14:21,406 THESE DEVICES HAVE DIFFERENT 1728 01:14:21,406 --> 01:14:22,039 NORMATIVE DATABASES AND IF YOU 1729 01:14:22,039 --> 01:14:24,909 WANT TO GET TO THE DATA, THE RAW 1730 01:14:24,909 --> 01:14:27,011 DATA ON EACH OF THESE DEVICES, 1731 01:14:27,011 --> 01:14:30,548 WELL THAT'S DARN NEAR 1732 01:14:30,548 --> 01:14:30,948 IMPOSSIBLE. 1733 01:14:30,948 --> 01:14:32,316 SO HA IS 1 OF THE AREAS THAT I 1734 01:14:32,316 --> 01:14:36,654 THINK WE NEED TO FOCUS ON AS 1735 01:14:36,654 --> 01:14:40,057 BOTH THOSE RESEARCHERS AND AS 1736 01:14:40,057 --> 01:14:41,459 CLINICIANS IN TERMS OF BEING 1737 01:14:41,459 --> 01:14:43,561 ABLE TO ACCESS THE DATA THAT 1738 01:14:43,561 --> 01:14:45,263 WE'RE RETRIEVING FROM OUR 1739 01:14:45,263 --> 01:14:47,365 PATIENTS AND THEN USE IT EITHER 1740 01:14:47,365 --> 01:14:54,405 FOR GIVEN PATIENT OR FOR THE 1741 01:14:54,405 --> 01:14:55,173 POPULATION IN RESEARCH. 1742 01:14:55,173 --> 01:14:57,341 SO WHAT YOU SEE IS A THINNING OR 1743 01:14:57,341 --> 01:15:01,078 DECREASED THICKNESS IN THE 1744 01:15:01,078 --> 01:15:04,449 RETINAL NERVE FIEB RILE AREA 1745 01:15:04,449 --> 01:15:05,116 WITH GLAUCOMA DISPLAYED IN 1746 01:15:05,116 --> 01:15:06,784 VARIOUS WAYS AND WE CAN ALSO 1747 01:15:06,784 --> 01:15:08,886 LOOK AT THE MACKULA AND MEASURE 1748 01:15:08,886 --> 01:15:11,689 GLAUCOMA AND THAT WAS AN IDEA 1749 01:15:11,689 --> 01:15:17,995 THAT RON ZEIMER HAD AND RON RON 1750 01:15:17,995 --> 01:15:20,298 IS RETIRED BUT HE'S A FIZZIST 1751 01:15:20,298 --> 01:15:22,333 THAT YOU CAN MEASURE THE 1752 01:15:22,333 --> 01:15:24,802 GLAUCOMA WHICH WAS HERETICAL AT 1753 01:15:24,802 --> 01:15:31,342 THE TIME BECAUSE YOU KNOW, 1754 01:15:31,342 --> 01:15:33,511 BECAUSE GLAUCOMA DOESN'T AFFECT 1755 01:15:33,511 --> 01:15:34,312 THE RETINA RIGHT? 1756 01:15:34,312 --> 01:15:35,746 AND THAT'S WHAT WE THOUGHT WHEN 1757 01:15:35,746 --> 01:15:37,949 THE ONLY TOOL WE HAD WAS TELLING 1758 01:15:37,949 --> 01:15:40,184 US THAT THE MACK LA WASN'T 1759 01:15:40,184 --> 01:15:41,819 REALLY AFFECTED IN GLAUCOMA BUT 1760 01:15:41,819 --> 01:15:43,554 RON SHOWED USING A DEVICE THAT 1761 01:15:43,554 --> 01:15:46,157 HE CREATED THAT MACULAR 1762 01:15:46,157 --> 01:15:48,726 THICKNESS IN FACT WAS REDUCED IN 1763 01:15:48,726 --> 01:15:50,094 PEOPLE WITH GLAUCOMA, AND HE 1764 01:15:50,094 --> 01:15:52,296 REASONED THAT SINCE THE CELL 1765 01:15:52,296 --> 01:15:55,099 BODIES ARE 20 TIMES THE DIAMETER 1766 01:15:55,099 --> 01:15:57,368 OF THEIRAXONS THAT IT WOULD 1767 01:15:57,368 --> 01:15:59,103 ACTUALLY BE EASIER TO PICK UP 1768 01:15:59,103 --> 01:16:02,073 GLAUCOMA IN THE MACK LA THAN IN 1769 01:16:02,073 --> 01:16:03,741 THE RETINAL NERVE FIEB RILE 1770 01:16:03,741 --> 01:16:07,445 LAYER AND THAT TURNS OUT TO BE 1771 01:16:07,445 --> 01:16:10,181 SORT OF TRUE IN SOME CASES, BUT 1772 01:16:10,181 --> 01:16:13,150 YOU CAN CERTAINLY PICK UP FLAW 1773 01:16:13,150 --> 01:16:14,919 COMA'S DAMAGE IN THE MACK LAS. 1774 01:16:14,919 --> 01:16:16,988 YOU SEE HERE IN THIS PERSON'S 1775 01:16:16,988 --> 01:16:18,823 LEFT EYE ON THE DEVIATION MAP 1776 01:16:18,823 --> 01:16:21,225 WHICH IS SHOWING AN ABNORMALITY 1777 01:16:21,225 --> 01:16:27,198 AND IN THE THICKNESS MAP WHERE 1778 01:16:27,198 --> 01:16:32,870 YOU CAN SEE THIS TEMPORAL DEFET 1779 01:16:32,870 --> 01:16:37,408 WHICH IS SHOWS IN THE FIELD. 1780 01:16:37,408 --> 01:16:39,544 THIS IS RTVIEW, AND THEN THE 1781 01:16:39,544 --> 01:16:41,746 TRITEON YOU HAVE THE HOOD REPORT 1782 01:16:41,746 --> 01:16:45,917 AND THEN THE HOOD REPORT IS FOR 1783 01:16:45,917 --> 01:16:55,226 DON HOOD WHICH DEVELOPED THIS 1784 01:16:55,226 --> 01:16:59,063 CONCEPT OF MAPPING THE THINNESS 1785 01:16:59,063 --> 01:17:01,599 OR THE RETINAL FIEB RILE LAYER 1786 01:17:01,599 --> 01:17:04,535 TO THE RECEPTIVE FIELD IN THE 1787 01:17:04,535 --> 01:17:06,037 AND THEN TO WHAT WOULD BE 1788 01:17:06,037 --> 01:17:07,238 EXPECTED ON THE VISUAL FIELD 1789 01:17:07,238 --> 01:17:11,876 TEST SO SHOWING A CLINICIAN 1790 01:17:11,876 --> 01:17:15,980 VISUALLY, WHAT THAT STRUCTURAL 1791 01:17:15,980 --> 01:17:18,349 ABNORMALITY WOULD LOOK LIKEOT 1792 01:17:18,349 --> 01:17:19,550 FUNCTIONAL EXAMINATION AND IN 1793 01:17:19,550 --> 01:17:22,486 FACT, AS YOU CAN SEE IN THIS 1794 01:17:22,486 --> 01:17:31,062 PATIENT, THERE'S VERY GOOD 1795 01:17:31,062 --> 01:17:31,462 STRUCTURE FUNCTION 1796 01:17:31,462 --> 01:17:31,829 CORRESPONDENCE. 1797 01:17:31,829 --> 01:17:32,563 THIS IS CO TRANSACTIVATOR WAY OF 1798 01:17:32,563 --> 01:17:35,666 LOOKING AT THE DATA FROM THE OCT 1799 01:17:35,666 --> 01:17:41,572 THIS, IS DEVELOPED BY CHRISTEN 1800 01:17:41,572 --> 01:17:46,477 HUNG, IT'S CALLED ROTA, 1801 01:17:46,477 --> 01:17:47,311 RNFL OPTICAL TEXTURE ANALYSIS, 1802 01:17:47,311 --> 01:17:49,413 THESE ARE DEFECTS IN THE RETINAL 1803 01:17:49,413 --> 01:17:51,882 LAYER, THESE ARE OCT IMAGES THAT 1804 01:17:51,882 --> 01:17:53,884 HAVE BEEN PROCESSED WITH THE 1805 01:17:53,884 --> 01:17:55,720 ROTA ALGORITHM AND THEN YOU CAN 1806 01:17:55,720 --> 01:17:58,022 SEE THE STANDARD STRUCTURAL OCT 1807 01:17:58,022 --> 01:18:00,324 PRIBT OUTS AND VISUAL FIELDS 1808 01:18:00,324 --> 01:18:03,661 THAT CORRESPOND WITH THESE EYES 1809 01:18:03,661 --> 01:18:06,530 AND SO ROTA AGAIN VISUALLY TELLS 1810 01:18:06,530 --> 01:18:09,934 THE CLINICIAN WHERE THE 1811 01:18:09,934 --> 01:18:17,041 ABNORMALITIES ARE AND TO SOME 1812 01:18:17,041 --> 01:18:21,278 EXTENT THE DENSITY OR THE 1813 01:18:21,278 --> 01:18:23,581 SEVERITY YOU DPETOT MAP, THE 1814 01:18:23,581 --> 01:18:27,551 DEVIATION IS TELLING YOU NORMAL 1815 01:18:27,551 --> 01:18:28,886 BORDER LINE OR ABNORMAL IN THE 1816 01:18:28,886 --> 01:18:31,389 KACCTA SET THAT'S USED FOR THE 1817 01:18:31,389 --> 01:18:33,357 NORMATIVE DATA. 1818 01:18:33,357 --> 01:18:34,458 THIS IS A PATIENT OF MINE AND 1819 01:18:34,458 --> 01:18:37,595 WHAT YOU SLEEP APNEA AND 1820 01:18:37,595 --> 01:18:38,896 SLEEP APNEA AND 1821 01:18:38,896 --> 01:18:40,598 OBESITY--SEE IS A PROGRESSION OF 1822 01:18:40,598 --> 01:18:42,833 TIME IN THE VISUAL, AND THIS 1823 01:18:42,833 --> 01:18:43,801 PERSON'S GLAUCOMA IS GETTING 1824 01:18:43,801 --> 01:18:46,337 WORSE AND IF YOU DO A TREND 1825 01:18:46,337 --> 01:18:47,872 ANALYSIS, YOU CAN SEE THAT THE 1826 01:18:47,872 --> 01:18:49,040 VISUAL FIELD INDEX WHICH IS 1 OF 1827 01:18:49,040 --> 01:18:52,143 THE MEASURES THAT WE CAN USE TO 1828 01:18:52,143 --> 01:18:53,010 MEASURE GLAUCOMA IS GETTING 1829 01:18:53,010 --> 01:18:56,881 WORSE AND THIS IS THE GPA, THE 1830 01:18:56,881 --> 01:19:02,987 EVENT,INAL SIS, AND HERE THAT 1831 01:19:02,987 --> 01:19:05,823 CORRESPONDS TO THIS ABNORMALITY 1832 01:19:05,823 --> 01:19:07,758 ON THE PROGRESSION MAP AND IT 1833 01:19:07,758 --> 01:19:09,060 ALSO CORRESPONDS HERE BUT WE 1834 01:19:09,060 --> 01:19:11,362 DON'T REALLY SEE A CHANGE IN THE 1835 01:19:11,362 --> 01:19:12,430 RETINAL NERVE FIBER LAYER 1836 01:19:12,430 --> 01:19:15,032 BECAUSE THIS PERSON REACHED THE 1837 01:19:15,032 --> 01:19:16,801 FLOOR OF WHAT THE OCT IS ABLE TO 1838 01:19:16,801 --> 01:19:19,904 MEASURE IN THE RETINAL FIBER 1839 01:19:19,904 --> 01:19:21,405 LAYER, SO EVEN THOUGH THEY'RE 1840 01:19:21,405 --> 01:19:23,908 WORSE IN THAT EYE, YOU'RE NOT 1841 01:19:23,908 --> 01:19:25,176 DETECTING IT. 1842 01:19:25,176 --> 01:19:27,378 THIS PERSON ALSO HAS WORSE 1843 01:19:27,378 --> 01:19:29,146 GLAUCOMA IN THE OTHER EYE, AND 1844 01:19:29,146 --> 01:19:31,115 HERE CAN YOU SEE THE 1845 01:19:31,115 --> 01:19:31,816 CORRESPONDING ABNORMALITIES IN 1846 01:19:31,816 --> 01:19:33,718 THE MAP, AND HERE IS THE 1847 01:19:33,718 --> 01:19:37,021 ABNORMALITY SHOWING UP AS 1848 01:19:37,021 --> 01:19:37,488 GETTING WORSE. 1849 01:19:37,488 --> 01:19:43,294 AND SO BECAUSE OF THAT 1850 01:19:43,294 --> 01:19:48,265 FLOUR EFFECT, THIS IS AN AREA 1851 01:19:48,265 --> 01:19:50,468 WHERE OCT GPA MIGHT BE HELPFUL 1852 01:19:50,468 --> 01:19:51,635 IN PEOPLE WHO HAVE FLAW COMA 1853 01:19:51,635 --> 01:19:55,306 EMPLOY I WANT TO TALK ABOUT 1854 01:19:55,306 --> 01:19:56,507 VISUALIZE OCT, YOU HEARD ABOUT 1855 01:19:56,507 --> 01:19:57,441 THE TECHNOLOGY YESTERDAY, WE CAN 1856 01:19:57,441 --> 01:19:59,844 USE IT TO GET HIGH RESOLUTION 1857 01:19:59,844 --> 01:20:04,014 OCT IMAGING AND WE CAN ALSO LOOK 1858 01:20:04,014 --> 01:20:08,085 AT OXYGENATION IN RETINAL 1859 01:20:08,085 --> 01:20:11,222 VESSELS SO HERE IS AN EXAMPLE OF 1860 01:20:11,222 --> 01:20:15,993 REPRODUCIBLE AND A MEASUREMENT 1861 01:20:15,993 --> 01:20:17,094 OF OXYGEN SATTURATION AND WE DID 1862 01:20:17,094 --> 01:20:19,063 A STUDY WHERE WE LOOKED AT 1863 01:20:19,063 --> 01:20:20,631 GLAUCOMA IN HEALTHY PATIENTS AND 1864 01:20:20,631 --> 01:20:24,735 IT TURNED OUT THERE WAS A HIGHER 1865 01:20:24,735 --> 01:20:26,704 VENUS SATURATION OF OXYGEN IN 1866 01:20:26,704 --> 01:20:28,305 PEOPLE WITH GLAUCOMA WHICH WAS 1867 01:20:28,305 --> 01:20:30,274 CONFUSING AT FETTER BUT WE 1868 01:20:30,274 --> 01:20:32,042 REASONED THAT IT'S LIKELY 1869 01:20:32,042 --> 01:20:34,178 THERE'S LESS TISSUE METABOLISM, 1870 01:20:34,178 --> 01:20:40,484 IN THESE PEOPLE WITH GLAUCOMA 1871 01:20:40,484 --> 01:20:41,552 AND THEREFORE LESSOXIEN 1872 01:20:41,552 --> 01:20:41,886 COMSUMPTION. 1873 01:20:41,886 --> 01:20:42,887 AND THAT'S WHAT WE THINK WE ARE 1874 01:20:42,887 --> 01:20:45,823 SEEING AND THERE WAS A GOOD 1875 01:20:45,823 --> 01:20:47,591 CORRESPONDENCE BETWEEN THE VNL 2 1876 01:20:47,591 --> 01:20:50,361 AND THE GIPC L, WE ALSO LOOK AT 1877 01:20:50,361 --> 01:20:55,933 SPECKLE, SO SPECKLE NOISE COULD 1878 01:20:55,933 --> 01:20:57,968 BE REDUCED USING US ON MODULATED 1879 01:20:57,968 --> 01:21:01,305 SCAN PATTERN AND YOU CAN SEE 1880 01:21:01,305 --> 01:21:02,940 IT'S LIKE AND NOT EXACTLY THIS 1881 01:21:02,940 --> 01:21:05,342 ALOOED US US TO REDUCE THE 1882 01:21:05,342 --> 01:21:11,215 SPECKLE AND THIS IS REALLY WORK 1883 01:21:11,215 --> 01:21:12,183 BY [INDISCERNIBLE] AND HIS 1884 01:21:12,183 --> 01:21:12,516 GROUP. 1885 01:21:12,516 --> 01:21:14,819 AND THEN WE LOOKED AT THE IRPT 1886 01:21:14,819 --> 01:21:16,020 FLEXY FORM LAYER WHICH LOOKS 1887 01:21:16,020 --> 01:21:21,458 LIKE A SINGLE LAYER ON STANDARD 1888 01:21:21,458 --> 01:21:23,260 CLINICAL OCT BUT WITH THE VERY 1889 01:21:23,260 --> 01:21:25,596 HIGH RESOLUTION YOU CAN GET WITH 1890 01:21:25,596 --> 01:21:26,931 THE VISIBLE LIGHT OCT, CAN YOU 1891 01:21:26,931 --> 01:21:30,267 SEE THERE ARE 5 LAYERS THAT ARE 1892 01:21:30,267 --> 01:21:32,369 DISCERNIBLE IN THE INTERPLEXUS 1893 01:21:32,369 --> 01:21:34,271 FORM LAYER AND WE LOOK AT THAT 1894 01:21:34,271 --> 01:21:37,741 IN RELATION TO TBLAW COMA AND IT 1895 01:21:37,741 --> 01:21:39,043 TURNED OUT THAT--GLAUCOMA AND IT 1896 01:21:39,043 --> 01:21:41,679 TURNED OUT YOU CAN MEASURE THAT 1897 01:21:41,679 --> 01:21:43,948 DAMAGE IN THE INNER FLEXUS FORM 1898 01:21:43,948 --> 01:21:46,383 LAYER SPECIFICALLY AND WE BEING 1899 01:21:46,383 --> 01:21:49,053 THAT THAT MIGHT BE A USEFUL 1900 01:21:49,053 --> 01:21:49,920 BIOMARKER FOR GLAUCOMA AS WELL. 1901 01:21:49,920 --> 01:21:52,423 AND THEN I JUST WANT TO TOUCH ON 1902 01:21:52,423 --> 01:21:53,057 ARTIFICIAL INTELLIGENCE, I KNOW 1903 01:21:53,057 --> 01:21:54,658 WE HAVE A SECTION COMING UP 1904 01:21:54,658 --> 01:21:59,597 THAT'S TALKING ABOUT THAT IN A 1905 01:21:59,597 --> 01:22:00,998 MOMENT BUT THE COLLABORATIVE, 1906 01:22:00,998 --> 01:22:03,767 AND PLEASE LOOK AT AI FLAW COMA 1907 01:22:03,767 --> 01:22:05,035 DETECTION AND THINGS LOAMACYIC 1908 01:22:05,035 --> 01:22:08,505 KREENING PROGRAMS AND WE THOUGHT 1909 01:22:08,505 --> 01:22:09,673 THAT--IT'S VERY HARD FOR 1910 01:22:09,673 --> 01:22:11,041 SPECIALISTS TO AGREE ON WHAT 1911 01:22:11,041 --> 01:22:18,315 FLAW COMA IS AND SOPHISTICATED 1912 01:22:18,315 --> 01:22:21,085 LOOKING FOR MANIFEST FLAW COMA 1913 01:22:21,085 --> 01:22:23,587 WITH OCT WOULD BE A REASONABLE 1914 01:22:23,587 --> 01:22:25,990 APPROACH FOR FLAW COMA KREENING. 1915 01:22:25,990 --> 01:22:29,560 IT TURNS OUT THAT YOU CAN DETECT 1916 01:22:29,560 --> 01:22:31,862 FLAW COMA USING AI WITH OOH CT 1917 01:22:31,862 --> 01:22:34,565 WELL, AND CAN YOU DO BETTER 1918 01:22:34,565 --> 01:22:37,468 USING DEEP LEARNING, THIS WHERE 1919 01:22:37,468 --> 01:22:40,304 THE CONVOLUTIONAL NEURAL NETWORK 1920 01:22:40,304 --> 01:22:45,743 AND WE FOUND THAT YOU COULD DO 1921 01:22:45,743 --> 01:22:47,144 SIGNIFICANTLY BETTER WITH DEEP 1922 01:22:47,144 --> 01:22:48,345 LEARNING THAN WITHSTAND ARD 1923 01:22:48,345 --> 01:22:52,883 SORTS OF TECHNIQUES AND MACHINE 1924 01:22:52,883 --> 01:22:54,151 LEARNING TECHNIQUES AND IN 1925 01:22:54,151 --> 01:22:55,419 ADDITION YOU COULD PREDICT 1926 01:22:55,419 --> 01:22:57,288 PROGRESSION OF THE DEC, SO FOR 1927 01:22:57,288 --> 01:22:59,456 INITANCE IN THIS STUDY, THE 1928 01:22:59,456 --> 01:23:00,758 AUTHORS WERE LOOKING AT WHO 1929 01:23:00,758 --> 01:23:04,161 WOULD GO ON TO HAVE SURGERY AND 1930 01:23:04,161 --> 01:23:08,198 YOU COULD PREDICT THAT USING 1931 01:23:08,198 --> 01:23:09,934 ARTIFICIAL INTELLIGENCE USING 1932 01:23:09,934 --> 01:23:11,969 OCT, IT'S ESTIMATED YOU COULD 1933 01:23:11,969 --> 01:23:13,037 PREDICT VISUAL FIELD LOSS UP TO 1934 01:23:13,037 --> 01:23:15,639 5 AND HALF YEARS IN ADVANCE FROM 1935 01:23:15,639 --> 01:23:20,177 A SINGLE STARTING POINT USING AI 1936 01:23:20,177 --> 01:23:22,479 WITH OCT AND THAT WOULD ALLOW 1937 01:23:22,479 --> 01:23:26,016 PEOPLE TO TREAT MORE OR LESS 1938 01:23:26,016 --> 01:23:27,084 INTENSIVELY BASED ON WHAT A 1939 01:23:27,084 --> 01:23:29,820 PATIENT IS LIKELY TO DO. 1940 01:23:29,820 --> 01:23:35,426 AND YOU CAN ALSO FORECAST 1941 01:23:35,426 --> 01:23:36,260 WHAT--AROUND THE RETINAL FIBER 1942 01:23:36,260 --> 01:23:37,695 LAYER WILL BE AND YOU CAN DO 1943 01:23:37,695 --> 01:23:40,431 THAT BETTER THAN THE STANDARD 1944 01:23:40,431 --> 01:23:45,402 METHODS LIKE THE GPA AND HERE 1945 01:23:45,402 --> 01:23:48,472 HERE LOOKING AT THE GROUP IN 1946 01:23:48,472 --> 01:23:52,009 GLAUCOMA GROUP USING DEEP 1947 01:23:52,009 --> 01:23:53,877 LEARNING VERSUS USING THE 1948 01:23:53,877 --> 01:23:55,379 STANDARD GPA EMPLOY FINAL 1 OF 1949 01:23:55,379 --> 01:24:00,150 THE MAJOR ISSUES AS I ALLUDED TO 1950 01:24:00,150 --> 01:24:01,852 IS DIFFERENCES IN THE OUTPUTS OF 1951 01:24:01,852 --> 01:24:03,587 THE DIFFERENT DEVICE ANDS IT HAS 1952 01:24:03,587 --> 01:24:08,459 TO DO WITH THE SIGNAL PROFILES 1953 01:24:08,459 --> 01:24:10,794 AS WELL AS A NUMBER OF OTHER OS 1954 01:24:10,794 --> 01:24:17,201 SPECS OF HOW THE DEVICES GATHER 1955 01:24:17,201 --> 01:24:19,203 THEIR DATA AND THE--WHAT WE NEED 1956 01:24:19,203 --> 01:24:22,406 REALLY IS A STANDARDIZATION THAT 1957 01:24:22,406 --> 01:24:25,142 WOULD ENABLE THE ABILITY OF SCAN 1958 01:24:25,142 --> 01:24:28,812 DATA ACROSS PLATFORMS BOTH FOR 1959 01:24:28,812 --> 01:24:30,614 RESEARCH AND CLINICAL USE FOR 1960 01:24:30,614 --> 01:24:33,350 ACCESS TO PROVIDERS AND 1961 01:24:33,350 --> 01:24:33,684 INSTITUTIONS. 1962 01:24:33,684 --> 01:24:35,986 AND THAT INFORMATION SHARING IS 1963 01:24:35,986 --> 01:24:37,254 REALLY FUNDAMENTAL TO RESEARCH 1964 01:24:37,254 --> 01:24:40,758 AND ALSO CLINICAL CARE DELIVERY. 1965 01:24:40,758 --> 01:24:43,427 THERE ARE A VARIETY OF DIFFERENT 1966 01:24:43,427 --> 01:24:44,294 SEGMENTATIONS METHODS USED BY 1967 01:24:44,294 --> 01:24:45,229 THE DIFFERENT MANUFACTURES OF 1968 01:24:45,229 --> 01:24:46,830 THESE DEVICES AND HAVING A 1969 01:24:46,830 --> 01:24:50,501 UNIFORM WAY OF SEGMENTING THE 1970 01:24:50,501 --> 01:24:52,269 IMAGES AND SHARED NORMATIVE 1971 01:24:52,269 --> 01:24:54,605 DATABASE WOULD ENHANCE THE DATA 1972 01:24:54,605 --> 01:24:57,441 SHARING, PARTICULARLY AT A 1973 01:24:57,441 --> 01:24:58,042 CLINICAL LEVEL. 1974 01:24:58,042 --> 01:25:01,111 AND YOU COULD DO SEGMENTATION 1975 01:25:01,111 --> 01:25:03,814 DRIVEN ASSESSMENT USING AI OR 1976 01:25:03,814 --> 01:25:05,449 MACHINE LEARNING, WHICH WOULD 1977 01:25:05,449 --> 01:25:07,885 REDUCE THE COST OF MANUEL 1978 01:25:07,885 --> 01:25:09,953 LABELING FOR INSTANCE AND 1979 01:25:09,953 --> 01:25:10,621 INCORPORATE ANATOMIC INFORMATION 1980 01:25:10,621 --> 01:25:14,358 OR YOU COULD DO FEATURE AGNOSTIC 1981 01:25:14,358 --> 01:25:17,294 ASSESSMENT LOOKING AT OCT 1982 01:25:17,294 --> 01:25:18,362 VOLUMES AND THAT ACTUALLY 1983 01:25:18,362 --> 01:25:24,568 CONTAINS A LOT MORE INFORMATION 1984 01:25:24,568 --> 01:25:26,437 THAN THE SEGMENT SCANNED. 1985 01:25:26,437 --> 01:25:28,238 SO BEING ABLE TO LOOK AT THE RAW 1986 01:25:28,238 --> 01:25:30,774 DATA AND DO THIS WITH AI I THINK 1987 01:25:30,774 --> 01:25:39,683 WOULD BE MORE ROBUST THAN 1988 01:25:39,683 --> 01:25:40,184 SEGMENTATION. 1989 01:25:40,184 --> 01:25:43,253 SO TO CONCLUDE I THINK WE SEE 1990 01:25:43,253 --> 01:25:45,055 ARTIFICIAL INTELIENCE AND FLAW 1991 01:25:45,055 --> 01:25:45,989 COMA IDENTIFICATION AND 1992 01:25:45,989 --> 01:25:48,926 PROGRESSION AS GREAT POTENTIAL, 1993 01:25:48,926 --> 01:25:51,361 THE DEFINITIONS OF THE 1994 01:25:51,361 --> 01:25:53,797 PARAMETERS REQUIRE CONSENSUS AND 1995 01:25:53,797 --> 01:25:55,666 THE UTILITY OF ARTIFICIAL 1996 01:25:55,666 --> 01:25:57,468 INTELIENCE AND MACHINE LEARNING 1997 01:25:57,468 --> 01:25:59,670 APPROACHES CAN BE ESPECIALLY 1998 01:25:59,670 --> 01:26:06,710 USEFUL IN UNDERSERVED AREAS, IT 1999 01:26:06,710 --> 01:26:08,045 DESKILLS THE DISEASE AND ITSELF 2000 01:26:08,045 --> 01:26:10,948 PROGRESSION AND THAT INCREASES 2001 01:26:10,948 --> 01:26:11,982 PATIENT ACCESS POTENTIALLY AND 2002 01:26:11,982 --> 01:26:14,184 REDUCES COST SO I THINK THAT WE 2003 01:26:14,184 --> 01:26:16,019 MAY HAVE THE OPPORTUNITY TO 2004 01:26:16,019 --> 01:26:19,556 REALLY FLATTEN THE FLOAB IN 2005 01:26:19,556 --> 01:26:21,158 TERMS OF ACCESS TO CARE EMPLOY I 2006 01:26:21,158 --> 01:26:24,495 WANT TO THANK MY COLLABORATORS 2007 01:26:24,495 --> 01:26:29,600 ESPECIALLY JIM FUYI MOTO AND 2008 01:26:29,600 --> 01:26:31,335 DAVID AND I ALSO WANT TO THANK 2009 01:26:31,335 --> 01:26:33,437 DAVID IN TERMS OF THE ADVANCED 2010 01:26:33,437 --> 01:26:36,740 IMAGING FLAW COMA GROUP AND I 2011 01:26:36,740 --> 01:26:37,374 WANT TO THANK--FLAW COMA GROUP 2012 01:26:37,374 --> 01:26:42,212 AND I WANT TO THANK MY OWN GROUP 2013 01:26:42,212 --> 01:26:46,416 WHO IS--WHO ARE GROWING AT MY 2014 01:26:46,416 --> 01:26:48,452 NEW HOME AT WILLS EYE HOSPITAL. 2015 01:26:48,452 --> 01:26:50,320 THANK YOU VERY MUCH. 2016 01:26:50,320 --> 01:27:00,531 [ APPLAUSE ] 2017 01:27:03,767 --> 01:27:04,601 >> THANK YOU VERY MUCH JOE, I AM 2018 01:27:04,601 --> 01:27:07,671 HAPPY KNOW THAT MACULAR 2019 01:27:07,671 --> 01:27:08,906 DEGENERATION AND ALSO A DEC, AND 2020 01:27:08,906 --> 01:27:11,074 I AM HAPPY TO LEARN THAT. 2021 01:27:11,074 --> 01:27:14,111 OUR NEXT SPEAKER IS PUSHING THE 2022 01:27:14,111 --> 01:27:16,647 BOWPPEDRIRYS TO AI, AND MACULAR 2023 01:27:16,647 --> 01:27:18,849 DEGENERATION FOR AMD, AND HER 2024 01:27:18,849 --> 01:27:20,184 SOFTWARE IS INCORPORATED IN A 2025 01:27:20,184 --> 01:27:21,051 COMMERCIAL PLATFORM. 2026 01:27:21,051 --> 01:27:23,053 I THINK SHE WAS FIRST TO SEE 2027 01:27:23,053 --> 01:27:24,321 THAT LOOKING AT FLUID COMPART 2028 01:27:24,321 --> 01:27:26,657 AMS IN THE RETINA IS VERY 2029 01:27:26,657 --> 01:27:28,192 IMPORTANT IN AMD AND SHE WILL 2030 01:27:28,192 --> 01:27:31,428 TELL US ABOUT AN APPLICATION FOR 2031 01:27:31,428 --> 01:27:35,032 GEOGRAPHIC ATROPHY WHICH IS 2032 01:27:35,032 --> 01:27:35,399 FUNDAMENTAL. 2033 01:27:35,399 --> 01:27:37,301 URULEA IS IN VIENNA WHERE 2034 01:27:37,301 --> 01:27:38,101 PROFESSOR [INDISCERNIBLE] WAS, 2035 01:27:38,101 --> 01:27:40,771 SHE WAS ALSO THERE WHERE ALL IT 2036 01:27:40,771 --> 01:27:43,974 ALL BEGAN IN A LAB THAT'S IN A 2037 01:27:43,974 --> 01:27:46,777 SORT OF IN A DEPARTMENT WHERE 2038 01:27:46,777 --> 01:27:50,948 OCT WAS ACTUALLY INVENTED AS 2039 01:27:50,948 --> 01:27:56,420 WELL. 2040 01:27:56,420 --> 01:27:57,254 WELCOME, URSULA. 2041 01:27:57,254 --> 01:28:00,557 >> SO THANK SO MUCH FOR THIS 2042 01:28:00,557 --> 01:28:04,328 MAGNIFICENT INVITATION TO JOIN 2043 01:28:04,328 --> 01:28:09,299 IN AND CELEBRATE THE AWARDEES, 2044 01:28:09,299 --> 01:28:10,367 VERY ENGAGED AND BRILLIANT 2045 01:28:10,367 --> 01:28:12,769 PEOPLE THAT WE ALL KNOW. 2046 01:28:12,769 --> 01:28:15,339 XI THINK THAT IT COMES WITH A 2047 01:28:15,339 --> 01:28:17,174 LOT OF OPTIMISM THAT THERE ARE 2048 01:28:17,174 --> 01:28:21,211 PEOPLE LIKE THAT WHO CAN BRUCE 2049 01:28:21,211 --> 01:28:22,446 PARADIGM SHIFTING SCIENCE. 2050 01:28:22,446 --> 01:28:23,847 PARADIGM SHIFTING MEDICINE AND 2051 01:28:23,847 --> 01:28:25,682 IT'S NOT THE ONLY THEIR 2052 01:28:25,682 --> 01:28:27,351 BRILLIANCE, IT'S ALSO THEIR 2053 01:28:27,351 --> 01:28:29,686 WILLINGNESS TO DEDICATE THEIR 2054 01:28:29,686 --> 01:28:31,421 WHOLE LIFETIME TO DO WHAT THEY 2055 01:28:31,421 --> 01:28:33,090 DO AND THEY DON'T DO IT JUST FOR 2056 01:28:33,090 --> 01:28:34,925 THEMSELVES, THEY DO IT FOR ALL 2057 01:28:34,925 --> 01:28:35,425 OF US. 2058 01:28:35,425 --> 01:28:38,762 AND THEY DO IT FOR THE PATIENTS 2059 01:28:38,762 --> 01:28:43,100 AND A LOT OF HUMAN BEINGS, 2060 01:28:43,100 --> 01:28:43,900 BENEFIT FROM IT. 2061 01:28:43,900 --> 01:28:48,238 SO IT'S ALSO GET TOGETHER, TOO, 2062 01:28:48,238 --> 01:28:50,374 AMONG LIKE MINDED PEOPLE LIKE US 2063 01:28:50,374 --> 01:28:52,009 WHO ARE A COMMUNITY THAT IS 2064 01:28:52,009 --> 01:28:55,579 ATTRACTED BY SUCH A MIND SET AND 2065 01:28:55,579 --> 01:28:56,980 THAT TRIES TO CONTRIBUTE IN 2066 01:28:56,980 --> 01:28:58,415 ADDITION AND IS INSPIRED AND 2067 01:28:58,415 --> 01:29:00,384 TAKEN AWAY AND ALSO TRIES TO DO 2068 01:29:00,384 --> 01:29:02,986 A LITTLE BIT OF WHAT THE 2069 01:29:02,986 --> 01:29:03,620 AWARDEES HAVE DONE. 2070 01:29:03,620 --> 01:29:09,559 AND THEN TO FIND A PLATFORM LIKE 2071 01:29:09,559 --> 01:29:13,530 THE NEI, WHO WAS MADE TO BRING 2072 01:29:13,530 --> 01:29:15,299 KNOWLEDGE, EXPERTISE AND 2073 01:29:15,299 --> 01:29:19,102 ADVANCES TO THE COMMUNITY, THIS 2074 01:29:19,102 --> 01:29:21,772 IS A MOST FANTASTIC AND MOST 2075 01:29:21,772 --> 01:29:25,375 INSPIRING REASON TO GET 2076 01:29:25,375 --> 01:29:25,676 TOGETHER. 2077 01:29:25,676 --> 01:29:33,517 SO LET ME ADD A LITTLE BIT FROM 2078 01:29:33,517 --> 01:29:34,818 MY SIDE TO--FOR SOME MORE 2079 01:29:34,818 --> 01:29:36,887 ENTERTAINMENT FOR YOU EMPLOY SO 2080 01:29:36,887 --> 01:29:42,693 MY TOPIC IS AI-BASED MANAGEMENT 2081 01:29:42,693 --> 01:29:44,594 OF GERIATRIC ATROPHY WHICH WOULD 2082 01:29:44,594 --> 01:29:45,395 INCLUDE SCREENING, MONITORING 2083 01:29:45,395 --> 01:29:47,898 AND PREDICTION EMPLOY THESE ARE 2084 01:29:47,898 --> 01:29:48,765 MY DISCLOSURES. 2085 01:29:48,765 --> 01:29:52,436 SO THE CHALLENGE IS HUGE AS WE 2086 01:29:52,436 --> 01:29:54,271 ALL KNOW BECAUSE THE WORLD 2087 01:29:54,271 --> 01:29:55,672 POPULATION IS AGING RELENTLESSLY 2088 01:29:55,672 --> 01:29:57,607 AND WE HAVE TO TAKE CARE OF 2089 01:29:57,607 --> 01:29:58,742 MILLION AND IN ILLEGALSION OF 2090 01:29:58,742 --> 01:30:01,578 PEOPLE WHO WERE SUFFER 2091 01:30:01,578 --> 01:30:04,781 AGE-RELATED DEC, PARTICULARLY 2092 01:30:04,781 --> 01:30:05,282 REGARDING THEIR VISION. 2093 01:30:05,282 --> 01:30:09,820 WE ARE TRYING TO DO OUR BEST, 2094 01:30:09,820 --> 01:30:12,456 NEVERTHELESS, WORLD WIDE VISION 2095 01:30:12,456 --> 01:30:15,292 WAS INCREASED BY 23% IN THE AGE 2096 01:30:15,292 --> 01:30:19,696 OF OCT AND IN THE AGE OF RETINAL 2097 01:30:19,696 --> 01:30:20,630 LOCATION NONAPOPTOTIC 2098 01:30:20,630 --> 01:30:21,798 PHARMACOTHERAPY, THAT'S A 2099 01:30:21,798 --> 01:30:22,165 WARNING. 2100 01:30:22,165 --> 01:30:23,834 SO GA STRONGLY AFFECTS 2101 01:30:23,834 --> 01:30:24,901 VISION-RELATED QUALITY OF LIFE 2102 01:30:24,901 --> 01:30:26,303 IN MANY ASSPECS WE KNOW THAT 2103 01:30:26,303 --> 01:30:27,270 ALREADY WE ALWAYS FEEL IT SLOW 2104 01:30:27,270 --> 01:30:29,139 AND WE HAVE A LOT OF TIME, BUT 2105 01:30:29,139 --> 01:30:30,907 THERE ISN'T SO MUCH TIME IF YOU 2106 01:30:30,907 --> 01:30:32,976 LOOK AT THE STATISTICS AND SEE 2107 01:30:32,976 --> 01:30:36,613 THAT 2/3RDS OF PATIENTS WITH 2108 01:30:36,613 --> 01:30:38,682 BILATERAL GA BECAME INELIGIBLE 2109 01:30:38,682 --> 01:30:41,852 TO DRIVE BY A MEDIAN TIME OF 1.6 2110 01:30:41,852 --> 01:30:42,052 YEARS. 2111 01:30:42,052 --> 01:30:45,555 THAT'S NOT A LOT OF TIME. 2112 01:30:45,555 --> 01:30:47,324 SO THE FIRST THING ALWAYS IS 2113 01:30:47,324 --> 01:30:49,192 BEFORE YOU DO SOMETHING, BEFORE 2114 01:30:49,192 --> 01:30:50,627 ACTIVITY COMES IN, UNDERSTANDING 2115 01:30:50,627 --> 01:30:53,630 MUST COME IN, SO UNDERSTANDING 2116 01:30:53,630 --> 01:30:57,200 GEOGRAPHIC ATROPHY MEANS THAT 2117 01:30:57,200 --> 01:30:58,602 THE MARKERS ARE SUBCLINICAL AND 2118 01:30:58,602 --> 01:31:00,237 THEY ARE HIDDEN UNDERNEATH THE 2119 01:31:00,237 --> 01:31:03,540 RETINA AND JUST TO LOOK ON AN F. 2120 01:31:03,540 --> 01:31:04,975 A. F., LIKE DEFECT DOESN'T 2121 01:31:04,975 --> 01:31:05,642 HELPITOUS UNDERSTAND WHAT 2122 01:31:05,642 --> 01:31:08,412 HAPPENS AT THE LEVEL OF THE RPE 2123 01:31:08,412 --> 01:31:12,282 AND THE PHOTO RECEPTORS WHICH 2124 01:31:12,282 --> 01:31:13,717 ARE THE MAJOR LAYERS HERE. 2125 01:31:13,717 --> 01:31:17,320 SO WE NEED TOOLS. 2126 01:31:17,320 --> 01:31:18,989 ONE TOOL IS CERTAINLY AN EYE 2127 01:31:18,989 --> 01:31:22,359 BASED RECOGNITION OF RPE LOSS, 2128 01:31:22,359 --> 01:31:24,961 AND THIS COMING FROM AN OCT 2129 01:31:24,961 --> 01:31:27,164 BECAUSE WE KNOW THAT THE 2130 01:31:27,164 --> 01:31:28,598 MANAGEMENT OF AMD, IS DRIVEN BY 2131 01:31:28,598 --> 01:31:32,936 OCT AND IT MAKES NO SENSE TO GET 2132 01:31:32,936 --> 01:31:33,970 OUT ANOTHER COMER FROM THE 2133 01:31:33,970 --> 01:31:36,173 POCKET WHICH IS CALLED F. A. F. 2134 01:31:36,173 --> 01:31:38,942 AND THEN TAKE PHOTOS AND THEN 2135 01:31:38,942 --> 01:31:40,811 SOMEHOW TRY TO INTEGRATE IT INTO 2136 01:31:40,811 --> 01:31:42,779 OUR DAILY ROUTINE WHICH IS ALL 2137 01:31:42,779 --> 01:31:44,614 OCT BASED EMPLOY SO THE FIRST 2138 01:31:44,614 --> 01:31:47,384 THING WE DID IS WE INTRODUCED 2139 01:31:47,384 --> 01:31:49,286 OCT BASED EYE ANALYSIS OF THE 2140 01:31:49,286 --> 01:31:50,954 RPE LAYER, THAT WAS RATHER 2141 01:31:50,954 --> 01:31:57,127 SIMPLY, WE SET UP A 3D, TO 2 D 2142 01:31:57,127 --> 01:31:58,662 SEMANTIC SEGMENTATION, AFTER 3 2143 01:31:58,662 --> 01:32:05,702 DIMENSION IN VOLUME. 2144 01:32:05,702 --> 01:32:07,337 IT'S A COMPLOAT LOSS SO THIS IS 2145 01:32:07,337 --> 01:32:09,539 WHAT CAN KEEP UP WITH FUNDERS 2146 01:32:09,539 --> 01:32:10,607 AUTOPLEUR ESTIMATE THAD ENSEL 2147 01:32:10,607 --> 01:32:11,942 NICELY, OF COURSE WE ARE TO 2148 01:32:11,942 --> 01:32:12,342 PROVE THIS. 2149 01:32:12,342 --> 01:32:17,914 WE HAD TO COME UP WITH GROUND 2150 01:32:17,914 --> 01:32:20,016 TOOLS, HUMANS GRADING THE RPE 2151 01:32:20,016 --> 01:32:22,452 LOSS AND ON OCT THIS, IS 2152 01:32:22,452 --> 01:32:24,221 COMPARED TO F. A. F. WHICH IS 2153 01:32:24,221 --> 01:32:25,522 COMPARED TO AUTOMATED AND MANUEL 2154 01:32:25,522 --> 01:32:28,191 AND WE FOUND THAT THIS IS TRULY 2155 01:32:28,191 --> 01:32:28,658 CONSISTENT. 2156 01:32:28,658 --> 01:32:31,127 SO YES, THE FIRST STEP HAD BEEN 2157 01:32:31,127 --> 01:32:31,528 DONE. 2158 01:32:31,528 --> 01:32:34,731 WE CAN USE OCT INSTEAD OF FAF 2159 01:32:34,731 --> 01:32:37,667 AND THAT ALLOWED US TO LOOK ON 2160 01:32:37,667 --> 01:32:39,202 THE DATA OF THE FIRST CLINICAL 2161 01:32:39,202 --> 01:32:43,373 PHASE 3 TRIAL THAT CAME THRU 2162 01:32:43,373 --> 01:32:44,641 POSITIVE AND THIS IS 2163 01:32:44,641 --> 01:32:47,978 [INDISCERNIBLE] AND DERBY SO WE 2164 01:32:47,978 --> 01:32:49,379 USE THIS ALGORITHM TO LOOK AT 2165 01:32:49,379 --> 01:32:50,914 THE LEVEL OF THE RPE, WHICH IS 2166 01:32:50,914 --> 01:32:53,250 THERE BUT IT'S RATHER MODERATE. 2167 01:32:53,250 --> 01:32:57,988 SO THE SECOND TOOL THAT WE 2168 01:32:57,988 --> 01:32:58,855 INTRODUCED EASE EZ-LOSS 2169 01:32:58,855 --> 01:32:59,923 MEASUREMENT WHICH IS CONSISTENT 2170 01:32:59,923 --> 01:33:02,025 WITH THE OUTER SEGMENT OF THE 2171 01:33:02,025 --> 01:33:06,096 PHOTO RECEPTORS ALSO PART OF THE 2172 01:33:06,096 --> 01:33:06,930 MITOCHONDRIA BODY. 2173 01:33:06,930 --> 01:33:09,599 SO THIS IS VERY TRICKY, SO THIS 2174 01:33:09,599 --> 01:33:14,571 A THIN LAYER, GROUND TOOLS NOT 2175 01:33:14,571 --> 01:33:15,238 SO EASILY PROVIDED. 2176 01:33:15,238 --> 01:33:16,540 A SIMPLE OLYMPIC GOR RHYTHM 2177 01:33:16,540 --> 01:33:19,209 WOULDN'T DO IT SO WE CAME UP 2178 01:33:19,209 --> 01:33:24,281 WITH A COMPOSITE OF 4 DIFFERENT 2179 01:33:24,281 --> 01:33:24,881 COMPUTATIONAL, CONVOLUTIONAL 2180 01:33:24,881 --> 01:33:25,882 NETWORKS AND THEY WERE BROUGHT 2181 01:33:25,882 --> 01:33:27,183 TOGETHER AND THEY WERE BROUGHT 2182 01:33:27,183 --> 01:33:29,519 IN TON TEXT, ALSO THE CONTEXT OF 2183 01:33:29,519 --> 01:33:31,988 THE RETINA, AND THAT IT ENABLING 2184 01:33:31,988 --> 01:33:35,258 US TO, BASED ON AN ASCAN LEVEL, 2185 01:33:35,258 --> 01:33:37,227 REACH PIXEL LEVEL PRECISION. 2186 01:33:37,227 --> 01:33:39,062 THAT IS VERY IMPORTANT BECAUSE 2187 01:33:39,062 --> 01:33:43,300 HERE, THE LAYER IS TINY, THE 2188 01:33:43,300 --> 01:33:44,868 BIOMARKER IS VERY SENSITIVE BUT 2189 01:33:44,868 --> 01:33:46,469 IT IS MOST IMPORTANT. 2190 01:33:46,469 --> 01:33:50,507 OF COURSE HIGH ACCURACY AND 2191 01:33:50,507 --> 01:33:51,708 RELIABLE REPRODUCIBILITY IS A 2192 01:33:51,708 --> 01:33:54,210 MUST ASK WEB CONNECTED WENT 2193 01:33:54,210 --> 01:33:57,514 THROUGH A LOT OF HARDWARE, HOME 2194 01:33:57,514 --> 01:34:01,251 WORK TO IDENTIFY WHETHER THIS 2195 01:34:01,251 --> 01:34:03,887 CAN BE PROVIDED EMPLOY WE 2196 01:34:03,887 --> 01:34:06,089 ACHIEVED A DICE SCORE OF .99 2197 01:34:06,089 --> 01:34:09,626 WHICH IS THE HIGHEST YOU CAN GET 2198 01:34:09,626 --> 01:34:10,493 REGARDING PRECISION AND 2199 01:34:10,493 --> 01:34:12,829 REPEATABILITY AND WE ALSO LOOKED 2200 01:34:12,829 --> 01:34:15,932 ON AGREEMENT BETWEEN DIFFERENT 2201 01:34:15,932 --> 01:34:17,968 READERS AND AGREEMENT BETWEEN 2202 01:34:17,968 --> 01:34:19,402 DIFFERENT IMAGES TAKEN IN 2203 01:34:19,402 --> 01:34:20,070 DIFFERENT TIME INTERVALS, THIS 2204 01:34:20,070 --> 01:34:21,204 IS ALL THE THINGS THAT YOU NEED 2205 01:34:21,204 --> 01:34:23,306 TO DO TO MAKE SURE THAT PEOPLE 2206 01:34:23,306 --> 01:34:25,675 BELIEVE YOU, THAT WHAT YOU DO IS 2207 01:34:25,675 --> 01:34:27,410 REALLY MEASURING WHAT IT IS 2208 01:34:27,410 --> 01:34:30,847 SUPPOSED TO BE TO MEASURE EMPLOY 2209 01:34:30,847 --> 01:34:32,549 AND IT IS ALSO MOST IMPORTANT TO 2210 01:34:32,549 --> 01:34:35,852 USE THIS IN A REALTIME MANNER. 2211 01:34:35,852 --> 01:34:38,288 THERE IS NO HELP FROM SUCH A 2212 01:34:38,288 --> 01:34:40,256 TOOL IF HUMAN EXPERTS FROM A 2213 01:34:40,256 --> 01:34:42,292 READING CENTER THEN HAVE TO 2214 01:34:42,292 --> 01:34:43,793 CONTROL AND SMOOTHEN AND POLISH 2215 01:34:43,793 --> 01:34:45,228 IT BECAUSE THIS HAS TO BE 2216 01:34:45,228 --> 01:34:47,530 DELIVERED TO THE CLINICIANS, THE 2217 01:34:47,530 --> 01:34:49,032 MOMENT THEY SEE THE PATIENT. 2218 01:34:49,032 --> 01:34:51,534 SO REALTIME IS MOST IMPORTANT. 2219 01:34:51,534 --> 01:34:54,437 AUTOMOST IMPORTANT FOR CLINICAL 2220 01:34:54,437 --> 01:34:55,705 TRIALS, BECAUSE IF CLINICAL 2221 01:34:55,705 --> 01:34:57,707 TRIALS, MOST OF THE IMAGES, 2222 01:34:57,707 --> 01:35:00,243 ASSERT ACTUALLY, CAN NOT BE USED 2223 01:35:00,243 --> 01:35:03,546 BECAUSE PATIENTS CANNOT FIXATE 2224 01:35:03,546 --> 01:35:05,649 WITH GA AND MOSTLY THE OPERATOR 2225 01:35:05,649 --> 01:35:07,584 DOESN'T SEE THE IMAGE BEFORE 2226 01:35:07,584 --> 01:35:08,885 IT'S SENT OUT TO A READING 2227 01:35:08,885 --> 01:35:10,520 CENTER, SO THEN THE PATIENT GOES 2228 01:35:10,520 --> 01:35:13,390 HOME, HE HAS TO WAIT, 3 OR 5 2229 01:35:13,390 --> 01:35:14,791 WORKING DAYS AND THEN THE 2230 01:35:14,791 --> 01:35:16,559 PATIENT COMES BACK, BUT HERE 2231 01:35:16,559 --> 01:35:18,061 NOW, AN IMAGE CAN BE TAKEN WITH 2232 01:35:18,061 --> 01:35:20,296 HIGHEST QUALITY FROM THE 2233 01:35:20,296 --> 01:35:23,266 BEGINNING. 2234 01:35:23,266 --> 01:35:25,769 AND THIS ALLOWS US TO NOW ADD 2235 01:35:25,769 --> 01:35:27,871 THE PHOTO RECEPTOR COMPONENT TO 2236 01:35:27,871 --> 01:35:29,839 THE ANALYSIS OF SUCH A HUGE AND 2237 01:35:29,839 --> 01:35:32,909 VERY IMPORTANT PHASE 3 TRIAL AND 2238 01:35:32,909 --> 01:35:36,379 THIS IS HERE AS YOU CAN SEE OAKS 2239 01:35:36,379 --> 01:35:38,214 AND DERBY AND THERE'S A HUGE 2240 01:35:38,214 --> 01:35:39,282 DIFFERENCE BETWEEN THE 2241 01:35:39,282 --> 01:35:40,450 THERAPEUTIC EFFECT AT THE LEVEL 2242 01:35:40,450 --> 01:35:42,986 OF THE PHOTO RECEPTORS AS 2243 01:35:42,986 --> 01:35:45,855 MEASURED BY THE EZ-LAYER, MUCH 2244 01:35:45,855 --> 01:35:51,327 BIGGER THAN SAVING ONLY THE 2245 01:35:51,327 --> 01:35:52,696 [INDISCERNIBLE] RPE AS I HAD 2246 01:35:52,696 --> 01:35:53,663 HEARD MANY TIMES FROM OTHER 2247 01:35:53,663 --> 01:35:55,832 COLLEAGUES BECAUSE THIS IS A 2248 01:35:55,832 --> 01:35:58,101 TRUE THERAPEUTIC BENEFIT THAT 2249 01:35:58,101 --> 01:36:01,404 CAN BE SEEN FROM THE FIRST 2250 01:36:01,404 --> 01:36:01,771 MONTHS ON. 2251 01:36:01,771 --> 01:36:03,740 SO IT MAKES NO SENSE TO SEND THE 2252 01:36:03,740 --> 01:36:07,510 PATIENTS HOME AND SAY, I WILL 2253 01:36:07,510 --> 01:36:09,245 WAIT FOR DECLINE IN VISION, THEN 2254 01:36:09,245 --> 01:36:13,983 I UPON THAT YOUR LESION IS 2255 01:36:13,983 --> 01:36:15,652 ADVANCING, YOU HAVE TO TREATMENT 2256 01:36:15,652 --> 01:36:18,121 IMMEDIATELY BECAUSE VISION LOSS 2257 01:36:18,121 --> 01:36:19,756 IS IRREVERSIBLE AND BY LOOKING 2258 01:36:19,756 --> 01:36:21,491 AT THIS FOR EZ-LOSS YOU CAN AND 2259 01:36:21,491 --> 01:36:25,028 YOU MA HAVE NOTED THE P-VALUE 2260 01:36:25,028 --> 01:36:25,462 HERE IS .0001. 2261 01:36:25,462 --> 01:36:29,999 SO THIS IS NOT JUST A BORDER 2262 01:36:29,999 --> 01:36:31,401 LINE RESULT. 2263 01:36:31,401 --> 01:36:33,670 THIS MADE US UNDERSTAND AND I 2264 01:36:33,670 --> 01:36:34,504 VISUALIZE THIS YEAR MAYBE 2265 01:36:34,504 --> 01:36:36,473 BECAUSE I'M A RETINA PERSON, I 2266 01:36:36,473 --> 01:36:38,441 LIKE VISION, I LIKE TO VISUALIZE 2267 01:36:38,441 --> 01:36:43,313 FEATURES TO UNDERSTAND THEM. 2268 01:36:43,313 --> 01:36:46,015 SO, BLUE IS RPE LOSS, IN GREEN 2269 01:36:46,015 --> 01:36:48,351 IS EZ LOSS, THIS IS A VISION WE 2270 01:36:48,351 --> 01:36:50,987 FOLLOWED OUT FOR 2 YEAR ANDS IT 2271 01:36:50,987 --> 01:36:52,622 SUCH A [INDISCERNIBLE] TYPE OF 2272 01:36:52,622 --> 01:36:56,993 LESION, IT IS SUCH A PROGRESS 2273 01:36:56,993 --> 01:36:59,629 NUMBER OF THETIC LESION GROWTH 2274 01:36:59,629 --> 01:37:00,764 INTO ATROPHY, THE PHOTOGRAPH 2275 01:37:00,764 --> 01:37:02,298 ALWAYS PRECEDES AND EXCEEDS THE 2276 01:37:02,298 --> 01:37:04,400 RPE LOSS AND THE RPE LOSS JUST 2277 01:37:04,400 --> 01:37:04,667 FILLS IN. 2278 01:37:04,667 --> 01:37:08,071 THIS HAS BEEN SEEN IN EVERY 2279 01:37:08,071 --> 01:37:10,273 SINGLE PATIENT WHETHER HERE OR 2280 01:37:10,273 --> 01:37:11,541 SHE CAME FROM A CLINICAL TRIAL 2281 01:37:11,541 --> 01:37:13,176 OR THE REAL WORLD AND THIS ALONE 2282 01:37:13,176 --> 01:37:16,446 IS A VERY IMPORTANT PIECE OF 2283 01:37:16,446 --> 01:37:16,780 EVIDENCE. 2284 01:37:16,780 --> 01:37:20,550 THEN OF COURSE, I HAVE TO ANSWER 2285 01:37:20,550 --> 01:37:22,085 THE QUESTION, YOU SHOW BEAUTIFUL 2286 01:37:22,085 --> 01:37:23,353 AREAS BUT DO THEY HAVE ANY 2287 01:37:23,353 --> 01:37:26,990 MEANING FOR THE PATIENT, MEANING 2288 01:37:26,990 --> 01:37:28,458 VISUAL ACUITY, WHEN WE DID A 2289 01:37:28,458 --> 01:37:30,960 POINT TO POINT EVALUATION OF 2290 01:37:30,960 --> 01:37:34,164 180,000 SPOTS THAT WERE TESTED 2291 01:37:34,164 --> 01:37:35,265 BY MICRO PERIMPEDIMENTSETRY AND 2292 01:37:35,265 --> 01:37:40,370 SUPER IMPOSE THEM ON TO THE 2293 01:37:40,370 --> 01:37:42,272 ADJACENT IMAGE ON THE OCT, WE 2294 01:37:42,272 --> 01:37:44,941 COULD CLEARLY SEE THERE'S A 2295 01:37:44,941 --> 01:37:46,576 LINEAR CORRELATION BETWEEN EZ 2296 01:37:46,576 --> 01:37:49,979 THICKNESS AND THE FUNCTION IN 2297 01:37:49,979 --> 01:37:52,715 TERMS OF THE DECIBEL, SO YES, 2298 01:37:52,715 --> 01:37:56,619 THE GREEN LAYER HAS AN 2299 01:37:56,619 --> 01:37:57,120 IMPORTANCE FOR FUNCTION. 2300 01:37:57,120 --> 01:37:59,455 SO NOW WE CAN START SCREENING, 2301 01:37:59,455 --> 01:38:00,924 MONITORING AND PREDICTION EMPLOY 2302 01:38:00,924 --> 01:38:03,126 SO KREENING MEANS GA MANAGEMENT, 2303 01:38:03,126 --> 01:38:04,994 HAS TO BE DONE IN A SINGLE 2304 01:38:04,994 --> 01:38:06,429 PATIENT OF COURSE, PATIENT COMES 2305 01:38:06,429 --> 01:38:09,032 IN, GETS AN OCT, THE OCT, IS 2306 01:38:09,032 --> 01:38:11,301 THEN SENT TO THE CLOUD AND 2307 01:38:11,301 --> 01:38:12,735 ANALYZED IN A STANDARDIZED 2308 01:38:12,735 --> 01:38:15,405 MANNER AND THEN THE DOCTOR CAN 2309 01:38:15,405 --> 01:38:16,706 MAKE AN EDCUEICATED DECISION 2310 01:38:16,706 --> 01:38:19,576 ABOUT TREATING ON OR NOT TO 2311 01:38:19,576 --> 01:38:19,809 TREAT. 2312 01:38:19,809 --> 01:38:20,743 THIS IS VERY CLEAR WHEN 2313 01:38:20,743 --> 01:38:22,145 INDIVIDUALS CAN AM IN THAT HAVE 2314 01:38:22,145 --> 01:38:23,780 A VISUAL OOH CUITY ISSUE, 2315 01:38:23,780 --> 01:38:25,148 HOWEVER MOST OF THE PEOPLE DON'T 2316 01:38:25,148 --> 01:38:27,083 COME IN BECAUSE THE LESIONS 2317 01:38:27,083 --> 01:38:28,952 START OUTSIDE OF THE PHOBIA 2318 01:38:28,952 --> 01:38:30,386 INISH PATIENTS DO NOT NOTICE, 2319 01:38:30,386 --> 01:38:32,121 THEY'RE NOT PATES, THEY'RE JUST 2320 01:38:32,121 --> 01:38:32,922 PEOPLE. 2321 01:38:32,922 --> 01:38:35,658 SO THERE IS A RISK GROUP IN 2322 01:38:35,658 --> 01:38:40,063 WHOSE EYES, IS THE DEC IS 2323 01:38:40,063 --> 01:38:41,030 BECOMING ESTABLISHED AND IS 2324 01:38:41,030 --> 01:38:41,364 PROGRESSING. 2325 01:38:41,364 --> 01:38:44,734 IT IS VERY, VERY ASSURING IN 2326 01:38:44,734 --> 01:38:46,269 GEOGRAPHIC ATROPHY THAT IT IS A 2327 01:38:46,269 --> 01:38:47,804 SLOW PROCESS BUT CAN BE CAPTURED 2328 01:38:47,804 --> 01:38:49,973 IN THE BEGINNING BEFORE THERE'S 2329 01:38:49,973 --> 01:38:51,941 ANY CLINICAL SIGNS SEEN. 2330 01:38:51,941 --> 01:38:55,044 SO, WE FOLLOWED THIS OUT OVER 3 2331 01:38:55,044 --> 01:38:56,145 YEARS AND WE COULD CLEARLY COME 2332 01:38:56,145 --> 01:38:58,681 UP WITH A SERIES OF EVENTS. 2333 01:38:58,681 --> 01:39:00,516 FIRST THERE'S OUTER NUCLEAR 2334 01:39:00,516 --> 01:39:03,753 LAYER THINNING, THEN THERE IS 2335 01:39:03,753 --> 01:39:05,755 PHOTO RECEPTOR THINNING, THEN 2336 01:39:05,755 --> 01:39:08,458 MUCH LATER COMES DRUSEN 2337 01:39:08,458 --> 01:39:10,526 RESOLUTION AND EVEN MUCHALATER 2338 01:39:10,526 --> 01:39:13,463 THE BAR CODE OF CHOROIDAL HYPER 2339 01:39:13,463 --> 01:39:13,796 TRANSMISSION. 2340 01:39:13,796 --> 01:39:15,431 AND WHEN YOU LOOK AT THE LOWER 2341 01:39:15,431 --> 01:39:18,301 RIGHT SIDE, YOU SEE HOW LUMPY, 2342 01:39:18,301 --> 01:39:24,707 BUMPY THE AREA IS AND HOW 2343 01:39:24,707 --> 01:39:26,409 PRECISE AN ALGORITHM EZ MEASURE 2344 01:39:26,409 --> 01:39:27,377 LINE IS TO BE. 2345 01:39:27,377 --> 01:39:29,279 THE POINT IS HERE, WE HAVE TIME 2346 01:39:29,279 --> 01:39:31,915 BUT WE ARE ALSO ABLE TO SEE THE 2347 01:39:31,915 --> 01:39:34,317 FIRST SIGNS THAT ARE 2348 01:39:34,317 --> 01:39:35,885 IRREVERSIBLE AND IT DEFINITELY 2349 01:39:35,885 --> 01:39:37,253 LEAD TO DISEASE MORE THAN A YEAR 2350 01:39:37,253 --> 01:39:39,389 BEFORE EMPLOY SO THIS COMES FROM 2351 01:39:39,389 --> 01:39:40,757 PINNACLE AND PINNACLE IN AN 2352 01:39:40,757 --> 01:39:42,125 OBSERVATION TRIAL THAT IS 2353 01:39:42,125 --> 01:39:43,426 SPONSORED BY THE WELCOME TRUST 2354 01:39:43,426 --> 01:39:46,429 WE ARE NOW IN HERE, IN NUMBER 4, 2355 01:39:46,429 --> 01:39:52,135 ALREADY, WE HAVE LOOKED AT 580 2356 01:39:52,135 --> 01:39:56,606 PATIENTS OVER TIME, NON 2357 01:39:56,606 --> 01:39:57,307 INTERVENTIONAL STUDY AND WE 2358 01:39:57,307 --> 01:39:59,142 COULD SEE THAT BI FAR THE 2359 01:39:59,142 --> 01:40:01,577 LEADING FEATURE IS OUTER NUCLEAR 2360 01:40:01,577 --> 01:40:04,013 LAYER AND PHOTO RECEPTOR LOSS. 2361 01:40:04,013 --> 01:40:05,882 AND THIS IS SEEN BEFORE A SINGLE 2362 01:40:05,882 --> 01:40:07,183 RPE CELL IS GOING ARK WIMBERLY, 2363 01:40:07,183 --> 01:40:08,952 YOU WILL ALSO SEE THIS UP HERE 2364 01:40:08,952 --> 01:40:11,487 IN THE MULTIFOCAL LESION WHICH 2365 01:40:11,487 --> 01:40:13,990 IS A VERY RELIABLE SIGN, 2366 01:40:13,990 --> 01:40:21,064 THEREFORE PREDICTION OF 2367 01:40:21,064 --> 01:40:21,497 CONVERSION. 2368 01:40:21,497 --> 01:40:23,466 CONVERSION AND PROGRESSION ARE 2369 01:40:23,466 --> 01:40:24,767 DIFFERENT THINGS SO WHEN WE LOOK 2370 01:40:24,767 --> 01:40:26,169 AT CONVERSION, THIS IS WHERE THE 2371 01:40:26,169 --> 01:40:29,472 FIRST STAGE OF DISEASE, WE SET 2372 01:40:29,472 --> 01:40:33,176 UP A SPATIAL TEMPORAL ATLAS OF 2373 01:40:33,176 --> 01:40:34,444 INTERMEDIATE AMD CONVERTING AND 2374 01:40:34,444 --> 01:40:37,213 WE TARTED WITH 1 FEATURE THAT 2375 01:40:37,213 --> 01:40:39,248 WAS CHOSEN HERE AND WE LOOK AT 2376 01:40:39,248 --> 01:40:41,484 THE DEVELOPMENT IN A FEW HUNDRED 2377 01:40:41,484 --> 01:40:42,652 PATIENTS OVER 3 YEARS AND WE 2378 01:40:42,652 --> 01:40:47,090 COULD SEE THAT PATIENTS THAT 2379 01:40:47,090 --> 01:40:52,128 DEVELOPED MNV OR GA AS COMPARED 2380 01:40:52,128 --> 01:40:53,763 TO NONCONVERTERS DID HAVE A LOT 2381 01:40:53,763 --> 01:40:57,166 OF BI MOW MARKER MOVEMENT AND 2382 01:40:57,166 --> 01:40:58,634 DRUSEN WERE INCREASE NOTHING 2383 01:40:58,634 --> 01:41:02,005 BOTH TYPES OF LATE AMD, MNV AND 2384 01:41:02,005 --> 01:41:02,638 GA. 2385 01:41:02,638 --> 01:41:04,240 THAT WAS EACH MORE ENHANCED AND 2386 01:41:04,240 --> 01:41:06,042 MORE LEANING TOWARDS THE 2387 01:41:06,042 --> 01:41:09,879 PREDICTION OF GA WHEN WE LOOKED 2388 01:41:09,879 --> 01:41:11,314 ON HYPER REFLECTIVE FOCI AS YOU 2389 01:41:11,314 --> 01:41:14,450 CAN SEE HERE, HYPER REFLECTIVE 2390 01:41:14,450 --> 01:41:15,651 FOCI REALLY INCREASED 2391 01:41:15,651 --> 01:41:18,621 SIGNIFICANTLY IN GA MORE SO THAN 2392 01:41:18,621 --> 01:41:21,557 IN MNV AND SIGNIFICANTLY MORE IN 2393 01:41:21,557 --> 01:41:22,959 NONCONVERTERS, SO HYPER 2394 01:41:22,959 --> 01:41:25,161 REFLECTIVE FOCI PLAY A ROLE. 2395 01:41:25,161 --> 01:41:29,399 WE USE MACHINE LEARNING FOR 2396 01:41:29,399 --> 01:41:31,234 EVALUATING THE PROGRESSION OF 2397 01:41:31,234 --> 01:41:33,469 INTERMEDIATE AMD BASED ON OCT 2398 01:41:33,469 --> 01:41:35,772 IMAGING AND FOUND VERY CLEARLY 2399 01:41:35,772 --> 01:41:38,341 THAT IT WAS CHARGED IN THE 2400 01:41:38,341 --> 01:41:41,677 SENSORY LAYERS MOSTLY STAINING, 2401 01:41:41,677 --> 01:41:44,480 DRUSEN TRAINING AND MIGRATION 2402 01:41:44,480 --> 01:41:45,048 THAT PREDICTED DISEASE 2403 01:41:45,048 --> 01:41:47,150 CONVERSION JUST LIKE THIS 2404 01:41:47,150 --> 01:41:49,485 WITHOUT ANY OTHER BIOMARKERS 2405 01:41:49,485 --> 01:41:51,120 ADDED, WE HAVE JUST NOW STARTED 2406 01:41:51,120 --> 01:41:54,524 A HUGE GRANT WHICH IS CALLED EYE 2407 01:41:54,524 --> 01:41:55,792 SCREEN WHERE WE'RE SCREENING ON 2408 01:41:55,792 --> 01:41:58,261 A COMMUNITY BASE TOGETHER WITH 2409 01:41:58,261 --> 01:41:59,328 OPTOMETRIST ANDS OPTICAL 2410 01:41:59,328 --> 01:42:01,197 IMAGESITITIONS THAT WERE SPREAD 2411 01:42:01,197 --> 01:42:02,698 INTERNATIONALLY THROUGH EUROPE. 2412 01:42:02,698 --> 01:42:05,902 WE WILL INCLUDE 5000 PATIENTS 2413 01:42:05,902 --> 01:42:08,571 AND LINGS A PAN-EUROPEAN GUIDED 2414 01:42:08,571 --> 01:42:10,540 OCT NETWORK FOR KREENING AND 2415 01:42:10,540 --> 01:42:13,776 RISK ASSESSMENT OF AMD, THIS IS 2416 01:42:13,776 --> 01:42:14,644 WELL ORGANIZED OF COURSE WE CAN 2417 01:42:14,644 --> 01:42:19,015 SEE HERE AND WE WILL CATCH A LOT 2418 01:42:19,015 --> 01:42:20,349 OF ORM GAs AND WHY WE ARE 2419 01:42:20,349 --> 01:42:24,053 DOING THIS AND THAT BRINGS ME 2420 01:42:24,053 --> 01:42:24,420 MONITORING. 2421 01:42:24,420 --> 01:42:25,588 AND MONITORING IS VERY IMPORTANT 2422 01:42:25,588 --> 01:42:29,592 BECAUSE WE ARE DOING VERY 2423 01:42:29,592 --> 01:42:30,626 INVASIVE EXPENSIVE TREATMENT TO 2424 01:42:30,626 --> 01:42:31,594 THOUSANDS AND THOUSANDS OF 2425 01:42:31,594 --> 01:42:32,562 INDIVIDUALS SO THERE MUST BE A 2426 01:42:32,562 --> 01:42:34,397 REASON TO DO THIS. 2427 01:42:34,397 --> 01:42:38,768 ALSO THINK OF US AS DOCTORS, WE 2428 01:42:38,768 --> 01:42:43,239 ARE GIVING MILLIONS OF INTER 2429 01:42:43,239 --> 01:42:44,874 VEAL INYEKSS THIS WILL INCREASE, 2430 01:42:44,874 --> 01:42:46,742 NOT ONLY SUBSTANCES NOT ONLY 2431 01:42:46,742 --> 01:42:47,777 COMPLEMENT INHIBITION WHICH WILL 2432 01:42:47,777 --> 01:42:48,878 INCREASE THAT NUMBER AND IT WILL 2433 01:42:48,878 --> 01:42:50,847 NOT INCREASE THE NUMBER OF EYE 2434 01:42:50,847 --> 01:42:55,084 DOCTORS AT THE SAME TOKEN SO WE 2435 01:42:55,084 --> 01:42:56,252 NEED TO EMPOWER THE HUMAN AND 2436 01:42:56,252 --> 01:42:58,321 HOW CAN YOU DO THIS OBVIOUSLY 2437 01:42:58,321 --> 01:43:00,957 WITH AI PARTICULARLY DEEP 2438 01:43:00,957 --> 01:43:04,393 LEARNING WHERE NO HUMAN BEING 2439 01:43:04,393 --> 01:43:11,434 NEEDS TO BE ABUSED AS A SLAVE 2440 01:43:11,434 --> 01:43:12,001 FOR IMAGE ANNOTATION. 2441 01:43:12,001 --> 01:43:13,736 BECAUSE THIS IS DONE BY A MOUSE 2442 01:43:13,736 --> 01:43:16,405 CLICK ON THE REGULAR OCT, THIS 2443 01:43:16,405 --> 01:43:19,509 IS THE SPECTRALIS, THIS IS THE 2444 01:43:19,509 --> 01:43:20,843 FIRST DEVICE WE STARTED WITH 2445 01:43:20,843 --> 01:43:21,644 BECAUSE SO MANY DATA WERE 2446 01:43:21,644 --> 01:43:25,448 AVAILABLE AND WE COULD TRAIN THE 2447 01:43:25,448 --> 01:43:25,948 ALGORITHM IMMEDIATELY. 2448 01:43:25,948 --> 01:43:28,784 SO WHAT DOES IT MEAN, YOU SELECT 2449 01:43:28,784 --> 01:43:30,186 THE IMAGE YOU WOULD LIKE TO KNOW 2450 01:43:30,186 --> 01:43:31,587 MORE ABOUT IT, YOU BRENG IT TO 2451 01:43:31,587 --> 01:43:33,723 THE CLOUD AND THIS IS THE REPORT 2452 01:43:33,723 --> 01:43:35,625 THAT YOU GET AFTER 1-2 MINUTES. 2453 01:43:35,625 --> 01:43:38,494 SO THIS IS DEFINITELY MORE THAN 2454 01:43:38,494 --> 01:43:42,265 YOU CAN SEE ON AN FAF IMAGE. 2455 01:43:42,265 --> 01:43:43,766 IT'S ALSO FULLY AUTOMATED, IT AM 2456 01:43:43,766 --> 01:43:45,601 CANS IN REALTIME BY THE CLOUD 2457 01:43:45,601 --> 01:43:49,272 FROM A STANDARD OCT, IT OFFERS 2458 01:43:49,272 --> 01:43:50,006 VISUALIZATION, THAT IS MOST 2459 01:43:50,006 --> 01:43:51,641 IMPORTANT SO YOU SEE THE BLUE 2460 01:43:51,641 --> 01:43:53,409 AREA, THIS IS RPE LOSS, YOU WILL 2461 01:43:53,409 --> 01:43:56,879 SEE THE GREEN AREA, THIS IS EZ 2462 01:43:56,879 --> 01:43:58,714 LOSS, PHOTO RECEPTOR DAMAGE, I 2463 01:43:58,714 --> 01:44:00,483 REMIND YOU THIS IS IRRERERSIBLE 2464 01:44:00,483 --> 01:44:03,953 AND THEN CAN YOU DO AN OVERLAY 2465 01:44:03,953 --> 01:44:06,989 AND THE VISUALIZATION IS NOT A 2466 01:44:06,989 --> 01:44:08,558 CALCULATION. 2467 01:44:08,558 --> 01:44:11,561 IT IS THE CONDITION AS IT IS AT 2468 01:44:11,561 --> 01:44:12,762 FIRST PRESENTATION WITH ANY 2469 01:44:12,762 --> 01:44:13,429 GIVEN PATIENT. 2470 01:44:13,429 --> 01:44:14,897 YOU KNOW IMMEDIATELY WHERE THE 2471 01:44:14,897 --> 01:44:18,100 LESION IS GOING TO. 2472 01:44:18,100 --> 01:44:19,835 THIS IS MDR APPROVED IN EUROPE, 2473 01:44:19,835 --> 01:44:23,306 IN THE U.S. YOU CAN USE IT ON AN 2474 01:44:23,306 --> 01:44:24,240 INVESTIGATION AND BASE, YOU HAVE 2475 01:44:24,240 --> 01:44:25,908 TO INFORM YOUR IRB, THAT'S IT. 2476 01:44:25,908 --> 01:44:27,877 SO THIS IS A FOLLOW UP OF A 2477 01:44:27,877 --> 01:44:29,512 PATIENT WHO WAS NOT TREATED AND 2478 01:44:29,512 --> 01:44:32,415 YOU SEE BASE LINE MONTH, 2 2479 01:44:32,415 --> 01:44:36,819 MONTHS, 12, A CLEAR PROGRESSION 2480 01:44:36,819 --> 01:44:38,521 AND VERY PREDICTABLE. 2481 01:44:38,521 --> 01:44:41,424 SO A NEW ERA HAS BEGUN WHEN THE 2482 01:44:41,424 --> 01:44:43,492 FDA RECOGNIZED THIS AND IT'S 2483 01:44:43,492 --> 01:44:50,866 EASY LOSS, FIRST OUTCOME MEASURE 2484 01:44:50,866 --> 01:44:57,306 FROM [INDISCERNIBLE], SO IT'S 2485 01:44:57,306 --> 01:44:59,809 THE NEW KIDOT PLOK AND IT RELYS 2486 01:44:59,809 --> 01:45:02,845 ON EZ LOSS AND OCT-BASED AI. 2487 01:45:02,845 --> 01:45:05,047 SO THIS IS THE BEST TOOL TO HELP 2488 01:45:05,047 --> 01:45:08,584 YOUR PATIENT BECAUSE YOU'RE 2489 01:45:08,584 --> 01:45:10,987 INTERVENING WHEN THERE IS NO 2490 01:45:10,987 --> 01:45:11,887 IRREVERSIBLE TISSUE CULTURE 2491 01:45:11,887 --> 01:45:12,655 MEDIA THAT ALREADY OCCURRED 2492 01:45:12,655 --> 01:45:14,857 EMPLOY SO WE DID THE PREDICTING 2493 01:45:14,857 --> 01:45:17,059 ALGORITHM ALREADY AT THIS STAGE 2494 01:45:17,059 --> 01:45:19,595 OF THE DATA THAT WAS THE PHASE 2 2495 01:45:19,595 --> 01:45:22,865 TRIAL AND WE LOOKED ON LOCAL 2496 01:45:22,865 --> 01:45:23,266 PROGRESSION RATE. 2497 01:45:23,266 --> 01:45:25,167 ONE HAS TO UNDERSTAND THAT 2498 01:45:25,167 --> 01:45:26,369 LESIONS DO NOT ENLARGE 2499 01:45:26,369 --> 01:45:27,837 EVERYWHERE, ABOUT THE SAME BUT 2500 01:45:27,837 --> 01:45:31,507 THAT THERE ARE HOT SPOTS, SO, 2501 01:45:31,507 --> 01:45:34,076 AND HERE THE LESION GROWS IN 2502 01:45:34,076 --> 01:45:35,278 OTHER SPOTS, IT DOESN'T GROW. 2503 01:45:35,278 --> 01:45:37,346 SO WHAT WE FOUND AFTER THE 2504 01:45:37,346 --> 01:45:43,519 METICULOUS WORK OF CORRELATING 2505 01:45:43,519 --> 01:45:45,288 MORE THAN 30,000 GA MARKER 2506 01:45:45,288 --> 01:45:47,523 LOCATIONS IS THAT IT WAS REALLY 2507 01:45:47,523 --> 01:45:50,026 EZ THINNING THAT WAS DRIVING THE 2508 01:45:50,026 --> 01:45:53,529 PROCESS AND HAD BY FAR THE 2509 01:45:53,529 --> 01:45:54,563 HIGHEST PREDICTIVE VALUE. 2510 01:45:54,563 --> 01:45:58,100 SO LET'S GET OUT THEN OF F. A. 2511 01:45:58,100 --> 01:46:01,003 F., EVERYBODY HEARD ABOUT THESE 2512 01:46:01,003 --> 01:46:02,271 PERILESIONONNAL PATTERNS THAT 2513 01:46:02,271 --> 01:46:04,874 HAD VERY FUNNY NAMES, POETIC, 2514 01:46:04,874 --> 01:46:06,475 WHENEVER IT BECOMES POET IN LIFE 2515 01:46:06,475 --> 01:46:07,343 SCIENCES YOU SHOULD RUN 2516 01:46:07,343 --> 01:46:09,545 AWIMBERLY AND SAY, I WANT 2517 01:46:09,545 --> 01:46:10,246 NUMBERS. 2518 01:46:10,246 --> 01:46:14,083 SO HERE ARE 2 DARK AREAS, THEY 2519 01:46:14,083 --> 01:46:15,651 LOOK EXACTLY THE SAME. 2520 01:46:15,651 --> 01:46:18,321 ON FAF, HOWEVER, YOU DO OCT SCAN 2521 01:46:18,321 --> 01:46:19,722 AND OCT ANALIS, YOU SEE THAT 2522 01:46:19,722 --> 01:46:22,391 THESE LESIONS ARE BY FAR NOT THE 2523 01:46:22,391 --> 01:46:22,625 SAME. 2524 01:46:22,625 --> 01:46:25,027 ONE HAS A LARGE ACTIVITY ZONE OF 2525 01:46:25,027 --> 01:46:27,363 EZ LOSS EMPLOY WE DID A 2526 01:46:27,363 --> 01:46:30,499 SYSTEMATIC CORRELATION OF FAF. 2527 01:46:30,499 --> 01:46:32,368 WITH PROGRESSION OF THE LESIONS 2528 01:46:32,368 --> 01:46:36,539 IN THE CENTER, THERE WAS NO 2529 01:46:36,539 --> 01:46:36,906 CORRELATION. 2530 01:46:36,906 --> 01:46:38,207 EVERYTHING WAS VARIABLE TO SAY 2531 01:46:38,207 --> 01:46:40,509 THE LEAST AND I JUST WANT TO 2532 01:46:40,509 --> 01:46:45,147 SHOW THIS TO YOU SO THIS IS THE 2533 01:46:45,147 --> 01:46:45,781 [INDISCERNIBLE] PROGRESSION 2534 01:46:45,781 --> 01:46:48,584 BASED ON F. A. F. 2535 01:46:48,584 --> 01:46:49,952 OVER TIME YOU SEE ONLY THE 2536 01:46:49,952 --> 01:46:52,188 TBREEN LINE AND THIS IS THE 2537 01:46:52,188 --> 01:46:53,823 TRICKLED PATTERN, WE ONLY HAD 13 2538 01:46:53,823 --> 01:46:55,124 PATIENTS WITH THE TRICKLE 2539 01:46:55,124 --> 01:46:57,326 PATTERN, WE HAD SOME 2540 01:46:57,326 --> 01:46:58,361 PRODUCTIVITY BUT ONLY ON THE 2541 01:46:58,361 --> 01:47:00,096 LEVEL OF THE RPE THAT WAS 2542 01:47:00,096 --> 01:47:01,530 IMMEDIATELY GONE WHEN YOU 2543 01:47:01,530 --> 01:47:05,267 BROUGHT PHOTO RECEPTORS ON, IN, 2544 01:47:05,267 --> 01:47:06,535 SO NOTHING PREDICTIVE. 2545 01:47:06,535 --> 01:47:09,004 SO WE SUGGEST INSTEAD TO USE THE 2546 01:47:09,004 --> 01:47:14,243 PHOTO RECEPTOR RPE RATIO OR EC, 2547 01:47:14,243 --> 01:47:15,411 RPE RATIO, BECAUSE WE COULD SHOW 2548 01:47:15,411 --> 01:47:18,781 THAT WHEN YOU HAVE NO SUCH GREEN 2549 01:47:18,781 --> 01:47:19,682 MARGIN LESIONS HARDLY MOVE, 2550 01:47:19,682 --> 01:47:21,884 HOWEVER WHEN THE MARGIN IS BIG, 2551 01:47:21,884 --> 01:47:26,655 THEY GROW LIKE CRAZY, WE LOOK @ 2552 01:47:26,655 --> 01:47:28,791 THE DIFFERENT QUAR TILES OF 2553 01:47:28,791 --> 01:47:33,195 THIS, THE PRESENCE OF SUCH AN 2554 01:47:33,195 --> 01:47:35,631 EASE ZONE, THE LOWEST 84 TILE 2555 01:47:35,631 --> 01:47:38,134 WITH THE LOWEST ZONE HAS NO DEC 2556 01:47:38,134 --> 01:47:39,435 ACTIVITY, BUT DECK TASTE IS 2557 01:47:39,435 --> 01:47:41,470 IMPORTANT, LESIONS THAT DO NOT 2558 01:47:41,470 --> 01:47:43,205 MOVE WILL NOT SHOW ANY 2559 01:47:43,205 --> 01:47:44,039 THERAPEUTIC EFFECT. 2560 01:47:44,039 --> 01:47:46,375 THE SAME RATIO IS ALSO HIGHLY 2561 01:47:46,375 --> 01:47:49,211 PREDICTIVE FOR TREATMENT, HE IS 2562 01:47:49,211 --> 01:47:50,613 A FELLOW EYE PATE ISSUES AND 2563 01:47:50,613 --> 01:47:52,715 STUDY EYE SAME PATIENT AND YOU 2564 01:47:52,715 --> 01:47:55,484 SEE, HOW--WHAT THE MECHANISM OF 2565 01:47:55,484 --> 01:47:57,853 THERAPY IS, AND IF YOU THEN LOOK 2566 01:47:57,853 --> 01:48:00,189 ON THE PREDICTION OF THIS RATIO 2567 01:48:00,189 --> 01:48:03,359 AND RPE LOSS, YOU WILL SEE A 2568 01:48:03,359 --> 01:48:04,627 CLEAR DEFERENTIATION BETWEEN THE 2569 01:48:04,627 --> 01:48:07,596 4 QUAR TILES AND THIS IS EVEN 2570 01:48:07,596 --> 01:48:10,800 MORE SO FOR PHOTO RECEPTOR LOSS. 2571 01:48:10,800 --> 01:48:13,669 SO, YES, NOT EVERYTHING WORKS 2572 01:48:13,669 --> 01:48:15,237 FOR EVERYBODY, IF YOU HAVE A 2573 01:48:15,237 --> 01:48:16,372 HAMMER NOT EVERY GASHINGA LESION 2574 01:48:16,372 --> 01:48:18,140 IS A NAIL EMPLOY ITENTIFY THE 2575 01:48:18,140 --> 01:48:22,711 PATES THAT WILL BENEFIT AND THEN 2576 01:48:22,711 --> 01:48:24,146 YOU CAN WEIGH OUT RISK AND 2577 01:48:24,146 --> 01:48:24,980 BENEFIT. 2578 01:48:24,980 --> 01:48:29,118 WE DO SRO A LOT OF CLINICAL AND 2579 01:48:29,118 --> 01:48:33,956 OFTEFFECTABILITY IN GA WHERE NO 2580 01:48:33,956 --> 01:48:35,891 VISION IS IMPROVING IS IMPORTANT 2581 01:48:35,891 --> 01:48:37,193 AND WE HAVE THE DOCTORS AND WE 2582 01:48:37,193 --> 01:48:38,594 DO NEED TO TAKE TEEM FOR 2583 01:48:38,594 --> 01:48:40,129 PATIENTS TO EXPLAIN THEM, WHAT A 2584 01:48:40,129 --> 01:48:41,197 TERRIBLE DISEASE THEY HAVE. 2585 01:48:41,197 --> 01:48:42,932 THIS IS MY CONCLUSION, I DON'T 2586 01:48:42,932 --> 01:48:45,134 THINK I NEED TO READ IT AGAIN TO 2587 01:48:45,134 --> 01:48:45,601 YOU. 2588 01:48:45,601 --> 01:48:47,670 IT IS CLEAR THAT RESEARCH INTO 2589 01:48:47,670 --> 01:48:49,772 THE CAUSES AND PREVENTION OF 2590 01:48:49,772 --> 01:48:52,007 BLINDNESS IS A MULTIDISCIPLINARY 2591 01:48:52,007 --> 01:48:54,777 EXERCISE, SO WE CAME FROM THE 2592 01:48:54,777 --> 01:48:56,412 BIOLOGIC MECHANISMS, WE FOLLOWED 2593 01:48:56,412 --> 01:48:58,380 EARLY CONVERSION, WE CONSIDERED 2594 01:48:58,380 --> 01:49:00,716 REAL WORLD OUTCOMES, EXPLORED 2595 01:49:00,716 --> 01:49:04,553 NEW THERAPEUTIC MECHANISMS, 2596 01:49:04,553 --> 01:49:05,654 PROVIDED INTERDISCIPLINARY AI 2597 01:49:05,654 --> 01:49:10,292 EXPERTISE, CLOUD SHARING IS MOST 2598 01:49:10,292 --> 01:49:11,794 IMPORTANT, AND WE INTRODUCE 2599 01:49:11,794 --> 01:49:12,895 REALTIME INTO CLINICAL TRIAL 2600 01:49:12,895 --> 01:49:13,929 PLATFORMS AND THIS IS THE WAY 2601 01:49:13,929 --> 01:49:17,533 HOW TO BRING THE TECHNOLOGY TO 2602 01:49:17,533 --> 01:49:17,933 THE DOCTORS. 2603 01:49:17,933 --> 01:49:20,236 THAIRNG YOU SO MUCH FOR YOUR 2604 01:49:20,236 --> 01:49:21,036 INTEREST. 2605 01:49:21,036 --> 01:49:22,872 AND CONGRTULATIONS GENERATED TO 2606 01:49:22,872 --> 01:49:25,741 THE 1S THAT MADE ALL OF THIS 2607 01:49:25,741 --> 01:49:29,245 POSSIBLE BY COMING UP WITH OCT. 2608 01:49:29,245 --> 01:49:39,455 [ APPLAUSE ] 2609 01:49:41,357 --> 01:49:42,458 >> QUESTIONS, IF SOMEONE IN THE 2610 01:49:42,458 --> 01:49:45,427 AUDIENCE HAS 1, I WOULD MAYBE 2611 01:49:45,427 --> 01:49:49,231 START WITH URSULA, HOW SOON, WE 2612 01:49:49,231 --> 01:49:50,566 TALK ABOUT HARMONIZATION AND 2613 01:49:50,566 --> 01:49:51,166 STANDARDIZATION AND BRINGING 2614 01:49:51,166 --> 01:49:53,102 THOSE TO THE WIDER APPLICATIONS, 2615 01:49:53,102 --> 01:49:55,437 SO HOW SOON DO YOU THINK YOUR 2616 01:49:55,437 --> 01:49:59,475 SOFTWARE WILL BE IMPORTABLE AND 2617 01:49:59,475 --> 01:50:01,277 ON DEVICES BECAUSE YOU KNOW, YOU 2618 01:50:01,277 --> 01:50:03,913 SHOWED US THE VALUE OF TAKING 2619 01:50:03,913 --> 01:50:05,781 THESE VALUE METRIC OCTs AND 2620 01:50:05,781 --> 01:50:09,852 TURNING THEM INTO SORT OF 2621 01:50:09,852 --> 01:50:11,353 PHYSIOLOGICALLY AND 2622 01:50:11,353 --> 01:50:12,288 PATHOLOGICALLY RELEVANT 2623 01:50:12,288 --> 01:50:14,056 VISUALIZATIONS SO HOW SOON CAN 2624 01:50:14,056 --> 01:50:16,692 WE EXPECT SIMILAR SOFTWARE TO BE 2625 01:50:16,692 --> 01:50:18,327 SORT OF WIDELY APPLICABLE NSO 2626 01:50:18,327 --> 01:50:21,330 THE LAUNCH FOR THE SPECTRALIS 2627 01:50:21,330 --> 01:50:23,232 DEVICE BY MDR APPROVING WHICH IS 2628 01:50:23,232 --> 01:50:25,301 THE ONLY EXTERNAL CERTIFICATION 2629 01:50:25,301 --> 01:50:27,736 AND NOT MDD WHICH IS LIKE A 2630 01:50:27,736 --> 01:50:31,607 LABELING THAT JUST HAPPENED LAST 2631 01:50:31,607 --> 01:50:32,341 YEAR IN NOVEMBER. 2632 01:50:32,341 --> 01:50:35,878 SO WE TALK ABOUT REALLY WARM 2633 01:50:35,878 --> 01:50:43,118 BREAD AND THERE IS A VERY 2634 01:50:43,118 --> 01:50:44,453 SIGNIFICANT UPTAKE IN EUROPE, 2635 01:50:44,453 --> 01:50:45,621 IT'S NOT APPROVED BUT YOU CAN 2636 01:50:45,621 --> 01:50:47,356 USE IT BY RESEARCH AGREEMENT AND 2637 01:50:47,356 --> 01:50:49,525 MAKING YOUR OWN MEASUREMENTS. 2638 01:50:49,525 --> 01:50:53,195 THIS IS NOT MEANT TO BE DEVICE 2639 01:50:53,195 --> 01:50:56,265 BEPENDENT OF COURSE, OF COURSE 2640 01:50:56,265 --> 01:50:58,267 SPACTERAL SIS WERE ABUNDANTLY 2641 01:50:58,267 --> 01:51:03,238 PRESENT BUT WE'RE ALSO PROVYING 2642 01:51:03,238 --> 01:51:04,740 TOOLS FOR MAESTRO AND OTHERS BUT 2643 01:51:04,740 --> 01:51:06,875 IT HAS TO GO TEP BY TEP, THE 2644 01:51:06,875 --> 01:51:08,177 FIRST STEP TOOK US 10 YEAR ANDS 2645 01:51:08,177 --> 01:51:09,812 THE NEXT STEPS WERE FASTER NSO 2646 01:51:09,812 --> 01:51:11,013 PEOPLE CAN E-MAIL YOU TO GET 2647 01:51:11,013 --> 01:51:14,049 ACCESS TO THE RESEARCH 2648 01:51:14,049 --> 01:51:14,350 APPLICATION? 2649 01:51:14,350 --> 01:51:14,850 NCAN IN. 2650 01:51:14,850 --> 01:51:19,054 >> CAN PEOPLE REACH OUT TO YOUR 2651 01:51:19,054 --> 01:51:20,856 GROUP TO GET ACCESS TO THE 2652 01:51:20,856 --> 01:51:21,156 INFORMATION? 2653 01:51:21,156 --> 01:51:21,523 >> OF COURSE. 2654 01:51:21,523 --> 01:51:22,257 OF COURSE. 2655 01:51:22,257 --> 01:51:24,093 IT FLIES AROUND THE DPLOAB. 2656 01:51:24,093 --> 01:51:26,295 >> WE WE HAVE ANOTHER QUESTION 2657 01:51:26,295 --> 01:51:27,029 FROM THE AUDIENCE IN NTHANK YOU 2658 01:51:27,029 --> 01:51:29,131 SO UPON FOR YOUR WONDERFUL 2659 01:51:29,131 --> 01:51:30,232 TALKS, THIS IS A QUESTION FOR 2660 01:51:30,232 --> 01:51:32,668 YOU, SO YOU SHOWED THE VISIBLE 2661 01:51:32,668 --> 01:51:35,104 IMAGES OF THE LIGHT OCT OF THE 2662 01:51:35,104 --> 01:51:35,471 INNER RETINA. 2663 01:51:35,471 --> 01:51:37,306 HOW DO YOU THINK THAT WILL 2664 01:51:37,306 --> 01:51:39,608 CHANGE OUR ABILITY TO MANAGE 2665 01:51:39,608 --> 01:51:41,477 GLAUCOMA IN HAVING HIGHER ARE 2666 01:51:41,477 --> 01:51:42,111 PRODUCIBILITY OF MEASURE UPON 2667 01:51:42,111 --> 01:51:43,846 ANDS ALSO THE NUMBER OF STEPS TO 2668 01:51:43,846 --> 01:51:46,982 THE FLOOR WHICH WE HAVE ISSUES 2669 01:51:46,982 --> 01:51:48,817 WITH OCT AND RNFL? 2670 01:51:48,817 --> 01:51:50,786 >> I THINK THOSE ARE BOTH GOOD 2671 01:51:50,786 --> 01:51:51,854 AND IMPORTANT QUESTIONS THAT WE 2672 01:51:51,854 --> 01:51:54,790 DON'T HAVE ANSWERS TO. 2673 01:51:54,790 --> 01:51:58,827 IT'S STILL VERY EARLY IN 2674 01:51:58,827 --> 01:52:00,029 MEASURING IPL. 2675 01:52:00,029 --> 01:52:01,263 AND WE'RE LOOKING AT THICKNESSS 2676 01:52:01,263 --> 01:52:02,564 IN THE VARIOUS LAYERS BUT I 2677 01:52:02,564 --> 01:52:04,400 THINK THAT IT'S GOING TO TAKE A 2678 01:52:04,400 --> 01:52:07,269 BIT MORE TIME TO FIGURE OUT HOW 2679 01:52:07,269 --> 01:52:09,371 THOSE LAYERS CHANGE OVER THE 2680 01:52:09,371 --> 01:52:11,440 COURSE OF THE DEC. 2681 01:52:11,440 --> 01:52:12,608 THEORETICALLY, WE THINK THAT 2682 01:52:12,608 --> 01:52:14,109 WILL WE WILL PICK UP EARLIER 2683 01:52:14,109 --> 01:52:17,646 DISEASE BY LOOKING IN THE IPL, 2684 01:52:17,646 --> 01:52:23,552 BUT WE JUST DON'T KNOW YET. 2685 01:52:23,552 --> 01:52:25,721 >> THANK YOU. 2686 01:52:25,721 --> 01:52:28,190 >> QUESTION TO URSULA, REGARDING 2687 01:52:28,190 --> 01:52:29,224 THE [INDISCERNIBLE] INHIBITION. 2688 01:52:29,224 --> 01:52:32,361 SO WHICH COMPLEMENT TO YOUR 2689 01:52:32,361 --> 01:52:32,728 [INDISCERNIBLE]? 2690 01:52:32,728 --> 01:52:35,698 AND WHAT IS THE OUTCOME? 2691 01:52:35,698 --> 01:52:40,035 >> ME PERSONALLY, I AM NOT 2692 01:52:40,035 --> 01:52:40,736 [INDISCERNIBLE] COMPLEMENT BUT 2693 01:52:40,736 --> 01:52:45,307 THE QUESTION IS WHICH PATHWAY, 2694 01:52:45,307 --> 01:52:47,443 WHICH THERAPEUTIC TARGET IS 2695 01:52:47,443 --> 01:52:49,445 THERE, SO IT'S TARGETS C3, OR 2696 01:52:49,445 --> 01:52:51,480 NEXT 1 IS TARGETING C5, AND THE 2697 01:52:51,480 --> 01:52:53,515 NEXT 1 IS TARGETING C1 CAN THEY 2698 01:52:53,515 --> 01:52:57,119 ALL HAVE AN EFFECT ON THE PHOTO 2699 01:52:57,119 --> 01:53:00,689 RECEPTORS, WE WILL SEE TO WHICH 2700 01:53:00,689 --> 01:53:01,990 EXTENT IT WILL VARY. 2701 01:53:01,990 --> 01:53:04,660 MOST OTHER TARGETS ALSO DO THIS. 2702 01:53:04,660 --> 01:53:06,428 SO THIS BIOMARKER HAS NOTHING TO 2703 01:53:06,428 --> 01:53:11,300 DO WITH COMPLEMENT INHIBITION, 2704 01:53:11,300 --> 01:53:11,767 SPECIFICALLY. 2705 01:53:11,767 --> 01:53:13,435 IT JUST SEEMS TO BE A BIOMARKER 2706 01:53:13,435 --> 01:53:16,305 THAT IS LIKE THE END STAGE OF 2707 01:53:16,305 --> 01:53:19,475 PHOTO RECEPTOR MAINTENANCE OR 2708 01:53:19,475 --> 01:53:23,912 DAMAGE, NOT JUST SPECIFIC FOR 2709 01:53:23,912 --> 01:53:24,213 COMPLEMENT. 2710 01:53:24,213 --> 01:53:24,513 NTHANK YOU. 2711 01:53:24,513 --> 01:53:26,048 >> THANK YOU SO I HAVE A 2712 01:53:26,048 --> 01:53:26,482 QUESTION FOR CINDY. 2713 01:53:26,482 --> 01:53:28,450 WHAT IS THE BIGGEST BARRIER TO 2714 01:53:28,450 --> 01:53:32,054 US USING OCT IN THE NICU AND FOR 2715 01:53:32,054 --> 01:53:33,989 ADOPTION OF THIS TECHNOLOGY IN 2716 01:53:33,989 --> 01:53:38,861 THE WIDER PEDIATRIC POPULATION? 2717 01:53:38,861 --> 01:53:41,163 >> HAVING A COMMERCIAL SYSTEM. 2718 01:53:41,163 --> 01:53:41,864 I HAVE BIAS. 2719 01:53:41,864 --> 01:53:43,766 BUT IF THERE'S NOT A DEVICE OUT 2720 01:53:43,766 --> 01:53:45,067 THERE, THAT'S OUR BIGGEST 2721 01:53:45,067 --> 01:53:49,571 BARRIER RIGHT NOW AND I THINK 2722 01:53:49,571 --> 01:53:53,909 THE REASON, THE PEDIATRIC 2723 01:53:53,909 --> 01:53:54,977 POPULATION IS NOT WELL FUNDED, 2724 01:53:54,977 --> 01:53:57,379 YOU KNOW THIS IS NOT A MEDICARE 2725 01:53:57,379 --> 01:54:00,482 POPULATION, THIS IS MEDICAID. 2726 01:54:00,482 --> 01:54:02,684 THESE ARE IN PRIVATE INSURANCE 2727 01:54:02,684 --> 01:54:05,320 ISSUES OF GETTING KIDS AND 2728 01:54:05,320 --> 01:54:08,924 GETTING ACCESS SO I THINK THAT 2729 01:54:08,924 --> 01:54:10,359 IMPACTED THE FIRST COMPANY 2730 01:54:10,359 --> 01:54:11,193 INVOLVED WITH A SYSTEM AND I 2731 01:54:11,193 --> 01:54:14,663 THINK IT'S GOING TO DEPEND ON A 2732 01:54:14,663 --> 01:54:16,498 COMMERCIALLY VIABLE MODEL COMING 2733 01:54:16,498 --> 01:54:17,666 OUT THE NEXT TIME. 2734 01:54:17,666 --> 01:54:20,536 >> SO YOU DON'T THINK THAT 2735 01:54:20,536 --> 01:54:21,670 NURSES AND PHYSICIANS USING IT 2736 01:54:21,670 --> 01:54:23,338 IS GOING TO BE A BARRIER, YOU 2737 01:54:23,338 --> 01:54:27,943 THINK IT'S MORE THE MODEL FOR 2738 01:54:27,943 --> 01:54:28,410 SURVIVAL? 2739 01:54:28,410 --> 01:54:28,710 >> SORRY. 2740 01:54:28,710 --> 01:54:31,146 I WILL TAKE BACK, SO I ALSO 2741 01:54:31,146 --> 01:54:33,382 BEING THAT THE CHANGES OF 1212 2742 01:54:33,382 --> 01:54:35,050 IT WAS TIME DOMAIN, THIS WAS 2743 01:54:35,050 --> 01:54:36,218 SPECTRAL DOMAIN BUT IT WAS STILL 2744 01:54:36,218 --> 01:54:38,554 WE WERE TALKING ABOUT LIKE THAT 2745 01:54:38,554 --> 01:54:39,721 SYSTEM IS 30 KILOHERTZ. 2746 01:54:39,721 --> 01:54:43,625 SO WHEN WE'RE TALKING ABOUT NOW, 2747 01:54:43,625 --> 01:54:45,260 300 KILOHERTZ, THE ABILITY TO 2748 01:54:45,260 --> 01:54:46,461 CAPTURE RAPID IMAGE AND THEN THE 2749 01:54:46,461 --> 01:54:48,096 OTHER 1 WAS PAYING ATTENTION TO 2750 01:54:48,096 --> 01:54:51,600 ALL THE NURSES COMPLAINING ABOUT 2751 01:54:51,600 --> 01:54:52,768 THE RISK CHALLENGE AND ALL 2752 01:54:52,768 --> 01:54:54,570 EMPLOY SO A LIGHT SYSTEM THAT'S 2753 01:54:54,570 --> 01:54:55,037 RAPID AND EASY. 2754 01:54:55,037 --> 01:54:57,206 I THINK WE HAVE THAT BARRIER 2755 01:54:57,206 --> 01:54:57,406 DONE. 2756 01:54:57,406 --> 01:54:58,974 I THINK THAT I DON'T SEE AS A 2757 01:54:58,974 --> 01:55:03,312 PROBLEM RIGHT NOW AND NOW 2758 01:55:03,312 --> 01:55:04,880 AUTOLIKE OH, WE HAVE TO POP ON 2759 01:55:04,880 --> 01:55:08,317 THE EYE READY TO GO N1 LAST 2760 01:55:08,317 --> 01:55:09,017 QUESTIONS PERHAPS BECAUSE-- 2761 01:55:09,017 --> 01:55:10,886 >> MY QUICK QUESTION IS, THANK 2762 01:55:10,886 --> 01:55:13,288 YOU FOR AGAIN, AS A COMMENT, 2763 01:55:13,288 --> 01:55:16,525 THANK YOU FOR ALL THE VERY 2764 01:55:16,525 --> 01:55:17,192 INTERESTING TALKS. 2765 01:55:17,192 --> 01:55:18,994 WOULD YOU CONSIDER A BASE LINE 2766 01:55:18,994 --> 01:55:21,430 OCT AT ANY TIME POINT AS BEING 2767 01:55:21,430 --> 01:55:23,465 SOMETHING THAT WOULD BE 2768 01:55:23,465 --> 01:55:24,633 IMPORTANT DOWN THE LINE FOR THE 2769 01:55:24,633 --> 01:55:28,770 FOLLOW UP OF A PATIENT GIVEN HOW 2770 01:55:28,770 --> 01:55:29,771 AVAILABLE OCT TECHNOLOGY HAS 2771 01:55:29,771 --> 01:55:31,506 BECOME AND AT WHAT AGE SHOULD 2772 01:55:31,506 --> 01:55:33,609 THAT BASE LINE BE OBTAINED AND 2773 01:55:33,609 --> 01:55:34,776 MAYBE HANDED TO THE PATIENT SO 2774 01:55:34,776 --> 01:55:39,514 THAT THEY HAVE IT FOR REFERENCE? 2775 01:55:39,514 --> 01:55:41,917 >> IT'S A GREAT, GREAT, QUESTION 2776 01:55:41,917 --> 01:55:43,886 BECAUSE WE TEST HEARING IN EVERY 2777 01:55:43,886 --> 01:55:45,254 INFANT BEFORE THEY LEAVE THE 2778 01:55:45,254 --> 01:55:48,490 HOSPITAL AND YET THE TEST FOR 2779 01:55:48,490 --> 01:55:51,360 VISION IN INFANTS IS A PEN LIGHT 2780 01:55:51,360 --> 01:55:52,494 FROM A PHYSICIAN. 2781 01:55:52,494 --> 01:55:55,364 SO I THINK OCT AT BIRTH AS PART 2782 01:55:55,364 --> 01:55:57,199 OF UNIVERSAL SCREENING MAY WELL 2783 01:55:57,199 --> 01:55:58,367 BE A CONSIDERATION AND CERTAINLY 2784 01:55:58,367 --> 01:56:00,969 SHOULD BE FOR THE KIDS AT 2785 01:56:00,969 --> 01:56:02,905 GREATEST RISK. 2786 01:56:02,905 --> 01:56:04,172 WE'VE IDENTIFIED CATARACT IN 2787 01:56:04,172 --> 01:56:06,441 FACT THROUGH OCT SCREENING THAT 2788 01:56:06,441 --> 01:56:08,176 WAS MISSED BY PEDIATRICIANS. 2789 01:56:08,176 --> 01:56:09,745 >> AND IN ADULTS I WOULD SAY 2790 01:56:09,745 --> 01:56:11,179 IT'S ALSO VERY IMPORTANT 2791 01:56:11,179 --> 01:56:13,348 ESPECIALLY WITH THE USE OF AI 2792 01:56:13,348 --> 01:56:16,718 CAN USING A SINGLE SCAN TO 2793 01:56:16,718 --> 01:56:18,520 PREDICT FUTURE TRAJECTORIES. 2794 01:56:18,520 --> 01:56:20,389 SO I THINK THAT, YOU KNOW HAVING 2795 01:56:20,389 --> 01:56:23,392 AN ADULT SCAN WOULD BE WORTH 2796 01:56:23,392 --> 01:56:26,528 WHILE,IME NOT SURE WHAT AGE, 40? 2797 01:56:26,528 --> 01:56:27,062 >> VERY, VERY COOL. 2798 01:56:27,062 --> 01:56:29,631 I THINK FOR THAT, AND I THINK TO 2799 01:56:29,631 --> 01:56:32,834 KEEP US ALL ON TIME, THANK YOU 2800 01:56:32,834 --> 01:56:34,636 TO MY SPEAKERS FOR REALLY 2801 01:56:34,636 --> 01:56:36,171 ENGAGING AND AMAZING TALK ANDS I 2802 01:56:36,171 --> 01:56:38,507 THANKS TO THE AUDIENCE FOR 2803 01:56:38,507 --> 01:56:38,974 ENGAGING. 2804 01:56:38,974 --> 01:56:39,942 THANK YOU. 2805 01:56:39,942 --> 01:56:44,179 KD--SALLY ARK PLAWZ [ APPLAUSE ] 2806 01:56:44,179 --> 01:56:50,452 [ APPLAUSE ] 2807 01:56:50,452 --> 01:56:52,321 >> OKAY, THANKS SO MUCH FOR 2808 01:56:52,321 --> 01:56:53,989 KEEPING ON TIME AMANI AND 2809 01:56:53,989 --> 01:56:55,290 SPEAKERS LET'S TAKE A 10 MINUTE 2810 01:56:55,290 --> 01:56:57,726 BREAK AND BE BACK HERE AT 10:37 2811 01:56:57,726 --> 01:57:08,286 FOR THE LAST SESSION. 2812 01:57:08,286 --> 01:57:09,387 OKEY SO LET'S GET GOING 2813 01:57:09,387 --> 01:57:12,390 WITH THE LAST SESSION, AI AND 2814 01:57:12,390 --> 01:57:14,459 DATA STANDARDIZATION AND IT'S A 2815 01:57:14,459 --> 01:57:16,161 PLEASURE TO INTRODUCE AARON LEE 2816 01:57:16,161 --> 01:57:17,996 WHO IS WITH THE UNIVERSITY OF 2817 01:57:17,996 --> 01:57:22,567 WASHINGTON AND HE WILL WILL MOE 2818 01:57:22,567 --> 01:57:23,268 THIS SESSION. 2819 01:57:23,268 --> 01:57:24,035 >> THANK YOU VERY MUCH. 2820 01:57:24,035 --> 01:57:25,704 I HOPE YOU CAN FIND YOUR SEATS 2821 01:57:25,704 --> 01:57:26,972 QUICKLY, I WAS JUST REFLECTING 2822 01:57:26,972 --> 01:57:28,673 ON THE LAST SESSION, I WAS 2823 01:57:28,673 --> 01:57:30,842 WONDERING IF THAT SESSION SHOULD 2824 01:57:30,842 --> 01:57:32,244 HAVE BEEN CALLED AI AND OCT 2825 01:57:32,244 --> 01:57:33,578 BECAUSE THERE WAS QUITE A BIT OF 2826 01:57:33,578 --> 01:57:34,746 AI IN THAT SESSION, BUT THIS 2827 01:57:34,746 --> 01:57:45,257 SESSION IS SORT OF GOING TO BE 2828 01:57:46,324 --> 01:57:46,825 FOCUSED. 2829 01:57:46,825 --> 01:57:48,560 AND HOW WE MUCH PUSH THE FIELD 2830 01:57:48,560 --> 01:57:51,763 FORWARD AND NOW WE HAVE THIS 2831 01:57:51,763 --> 01:57:53,198 AMEASING TECHNOLOGIES IN OUR 2832 01:57:53,198 --> 01:57:55,433 CLINICS. 2833 01:57:55,433 --> 01:57:57,369 THE FIRST SPEAKER IS AND THEY 2834 01:57:57,369 --> 01:58:00,038 WILL TALK ABOUT THE PUSHING THE 2835 01:58:00,038 --> 01:58:01,539 UBIQUITOUS OF THESE DEVICES TO A 2836 01:58:01,539 --> 01:58:03,909 WHOLE OTHER LEVEL AND BRINGING 2837 01:58:03,909 --> 01:58:07,746 THISEM INTO THE HOMES OF AND IF 2838 01:58:07,746 --> 01:58:18,290 YOU COULD COME UP HERE AND GIVE 2839 01:58:24,930 --> 01:58:26,531 YOUR TALK. 2840 01:58:26,531 --> 01:58:27,832 >> THANK YOU AARON AND I WILL 2841 01:58:27,832 --> 01:58:35,173 TALK ABOUT CORRELATED CT AT 2842 01:58:35,173 --> 01:58:38,410 HOME. 2843 01:58:38,410 --> 01:58:39,544 HERE THE DISCLOSURES, AND 2844 01:58:39,544 --> 01:58:42,480 EVERYTHING I WILL BE PRESENTING 2845 01:58:42,480 --> 01:58:48,219 IS DONE THRU A LOT OF HARD WORK 2846 01:58:48,219 --> 01:58:50,422 FROM THE NOTALL TEAM, MANY OF 2847 01:58:50,422 --> 01:58:51,723 THEM HAVE WORKED VERY HARD TO 2848 01:58:51,723 --> 01:58:53,458 MAKE THIS POSSIBLE, BUT I MUST 2849 01:58:53,458 --> 01:58:54,859 ALSO SAY THAT THIS HAS BEEN MADE 2850 01:58:54,859 --> 01:58:56,494 POSSIBLE BY ALL THE HARD WORK 2851 01:58:56,494 --> 01:58:59,197 WHICH HAS BEEN DONE BY THE OCT 2852 01:58:59,197 --> 01:58:59,998 COMMITTEE OVER THE USE AND 2853 01:58:59,998 --> 01:59:07,238 THAT'S WHAT WE ARE HERE TO 2854 01:59:07,238 --> 01:59:12,110 CELEBRATE EMPLOY DR. FUJIMOTO, 2855 01:59:12,110 --> 01:59:13,178 DR. SWANSEN, IF YOU WANT TO SEE 2856 01:59:13,178 --> 01:59:15,046 THE EFFECTS WE CAN LOOK AT THE 2857 01:59:15,046 --> 01:59:17,382 ROOM, THE COMPANIES HERE, THE 2858 01:59:17,382 --> 01:59:18,216 ORGANIZATIONS HERE ARE 2859 01:59:18,216 --> 01:59:19,751 INFLUENCED BECAUSE OF OCT AND A 2860 01:59:19,751 --> 01:59:23,321 LOT OF CARRIERS INCLUDING MYSELF 2861 01:59:23,321 --> 01:59:24,889 WERE INFLUENCED BECAUSE OF OCT, 2862 01:59:24,889 --> 01:59:26,891 SO THAT SHOWS THE TRUE IMPACT OF 2863 01:59:26,891 --> 01:59:29,928 WHAT OCT HAS HAD. 2864 01:59:29,928 --> 01:59:30,695 IN THIS PRESENTATION WE WILL 2865 01:59:30,695 --> 01:59:35,367 TALK ABOUT THE CONCEPT OF AT 2866 01:59:35,367 --> 01:59:38,269 HOME OCT, AND WHAT IS REQUIRED 2867 01:59:38,269 --> 01:59:38,970 FOR HOME OCT. 2868 01:59:38,970 --> 01:59:40,538 WHAT ARE THE TECHNICAL 2869 01:59:40,538 --> 01:59:42,207 CHALLENGES BEHIND IT, AND WHAT 2870 01:59:42,207 --> 01:59:45,877 IS THE ROLE OF ARTIFICIAL 2871 01:59:45,877 --> 01:59:49,147 INTELIENCE BEHIND IT AND HOW WE 2872 01:59:49,147 --> 01:59:50,148 CAN MAKE IT A REALITY. 2873 01:59:50,148 --> 01:59:55,320 SO WE LOOK AT THE GROWTH OF HOME 2874 01:59:55,320 --> 01:59:57,622 OCT, THIS IS FROM A PAPER IN 2875 01:59:57,622 --> 02:00:00,892 2017 AND UNTIL ABOUT 2001, WE 2876 02:00:00,892 --> 02:00:02,360 HAD 400 UNITS INSTALLED. 2877 02:00:02,360 --> 02:00:05,196 THERE WAS AN INFLECTION POINT 2878 02:00:05,196 --> 02:00:06,564 AROUND 2006 THAT MOVES US 2879 02:00:06,564 --> 02:00:08,366 TOWARDS THOUSANDS OF UNIT XTION 2880 02:00:08,366 --> 02:00:11,970 WE WERE SOMEWHERE BETWEEN 2881 02:00:11,970 --> 02:00:13,471 10-20,000 UNITS FOR OCT NOW. 2882 02:00:13,471 --> 02:00:16,708 SO WHEN IS THE NECKS INFLECTION 2883 02:00:16,708 --> 02:00:16,908 POINT? 2884 02:00:16,908 --> 02:00:19,244 IF YOU LOOK IT IS MOSTLY USE 2885 02:00:19,244 --> 02:00:19,744 INDEED OPHTHALMOLOGY AND 2886 02:00:19,744 --> 02:00:21,746 CARDIOLOGY BY THE SPECIALIST. 2887 02:00:21,746 --> 02:00:24,115 IT'S MOVING MORE TOWARDS THE 2888 02:00:24,115 --> 02:00:25,050 PRIMARY CARE, 2889 02:00:25,050 --> 02:00:26,217 DR. [INDISCERNIBLE] TALKED ABOUT 2890 02:00:26,217 --> 02:00:28,086 USING IT AT POINT OF CARE, THERE 2891 02:00:28,086 --> 02:00:30,822 IS AN NDA CLEARED DEVICE FOR 2892 02:00:30,822 --> 02:00:33,291 USING O, KREBS CYCLE T FOR EAR 2893 02:00:33,291 --> 02:00:34,459 INFECTION DIAGNOSIS BUT GOING 2894 02:00:34,459 --> 02:00:36,428 FURTHER FROM THAT, CAN OCT BE 2895 02:00:36,428 --> 02:00:38,730 USED AT HOME SO EACH INDIVIDUAL 2896 02:00:38,730 --> 02:00:40,265 HAS AN OCT AT HOME. 2897 02:00:40,265 --> 02:00:42,033 OF COURSE NOT ALL OF US WILL BE 2898 02:00:42,033 --> 02:00:46,004 BUT THE PATIENTS WHO ARE IN NEED 2899 02:00:46,004 --> 02:00:47,705 OF IT CAN POTENTIALLY USE IT AT 2900 02:00:47,705 --> 02:00:49,574 HOME AND THAT WILL TRULY 2901 02:00:49,574 --> 02:00:50,508 INCREASE ITS IMPACT. 2902 02:00:50,508 --> 02:00:52,577 WHAT DOES OCT AT HOME LOOK LIKE? 2903 02:00:52,577 --> 02:00:53,745 IT'S OF COURSE, THE POINT OF 2904 02:00:53,745 --> 02:00:55,547 HAVING IT AT HOME IS TO ACQUIRE 2905 02:00:55,547 --> 02:00:59,617 DATA AT A VERY HIGH FREQUENCY 2906 02:00:59,617 --> 02:01:02,487 AND HAVING SOME BIOMARKERS 2907 02:01:02,487 --> 02:01:04,823 TACKED AT THAT HIGH THROUGH 2908 02:01:04,823 --> 02:01:06,191 FREQUENCY ACQUISITION AND HAVING 2909 02:01:06,191 --> 02:01:07,959 THAT PLOTTED AS A FUNCTION OF 2910 02:01:07,959 --> 02:01:09,727 TIME. 2911 02:01:09,727 --> 02:01:11,963 SO 30 YEARS AGO OKRRK T GAVE US 2912 02:01:11,963 --> 02:01:12,964 CAPABILITY TO ELECTRIC AT THE 2913 02:01:12,964 --> 02:01:14,666 THIRD DIMENSION OF THE EYE, NOT 2914 02:01:14,666 --> 02:01:18,002 JUST THE SURFACE BUT WHAT LIES 2915 02:01:18,002 --> 02:01:18,703 BEHIND. 2916 02:01:18,703 --> 02:01:20,772 HOME OCT PROMISES US TO SHOW US 2917 02:01:20,772 --> 02:01:22,507 THE FOURTH DIMENSION OF TIME. 2918 02:01:22,507 --> 02:01:24,976 CAN WE TRACT THE BIOMARKERS AT A 2919 02:01:24,976 --> 02:01:26,878 HIGH TEMPERATURE FREQUENCY AND 2920 02:01:26,878 --> 02:01:28,179 SEE HOW THEY CHANGE OVER TIME IS 2921 02:01:28,179 --> 02:01:28,913 NOT JUST IN SPACE. 2922 02:01:28,913 --> 02:01:32,817 AND WHAT IS THE NEED FOR THAT? 2923 02:01:32,817 --> 02:01:34,853 THE NEED WE WILL FOCUS ON IS 2924 02:01:34,853 --> 02:01:36,354 AMD, WHICH IS THE LEADING CAUSE 2925 02:01:36,354 --> 02:01:38,756 OF PLIENDNESS IN THE UNITED 2926 02:01:38,756 --> 02:01:39,691 STATES. 2927 02:01:39,691 --> 02:01:43,361 AS DR. HUANG MENTIONED IT WAS 2928 02:01:43,361 --> 02:01:45,563 GREATLY IMPACTED WITH THE ADVENT 2929 02:01:45,563 --> 02:01:46,831 OF ANTIVEG F, IT DOES NOT 2930 02:01:46,831 --> 02:01:48,133 ANYMORE MEAN THAT THE PATES ARE 2931 02:01:48,133 --> 02:01:49,767 GOING TO GO BLIND. 2932 02:01:49,767 --> 02:01:51,503 IT'S NOT A 1 WAY STREET BUT 2933 02:01:51,503 --> 02:01:53,138 THEIR VEGZ CAN ACTUALLY BE 2934 02:01:53,138 --> 02:01:55,340 PROTECTED AND REGAINED FROM THE 2935 02:01:55,340 --> 02:01:55,807 TIME OF DIAGNOSIS. 2936 02:01:55,807 --> 02:01:58,343 HAD IS HOW THE YOWRNY OF AN AMD 2937 02:01:58,343 --> 02:02:02,313 PEASHT LOOKS LIKE, WHEN YOU HAVE 2938 02:02:02,313 --> 02:02:03,648 INTERMEDIATE AMD, THERE'S A 2939 02:02:03,648 --> 02:02:05,950 SIGNATURES 95 LOSS OF VISION, 2940 02:02:05,950 --> 02:02:07,452 PIVOTAL TRIAL SHOWED THAT 2941 02:02:07,452 --> 02:02:08,553 ANTIVEG F CAN ACTUALLY REVOAEVER 2942 02:02:08,553 --> 02:02:12,056 SOME OF THAT VISION AND 2943 02:02:12,056 --> 02:02:13,725 STABILIZE IT. 2944 02:02:13,725 --> 02:02:15,793 ALL THE PIVOTAL TRIALS DONE WERE 2945 02:02:15,793 --> 02:02:18,363 AT A FIXED DOSING REGIMEN, SO 2946 02:02:18,363 --> 02:02:19,998 WERE GETTING MONTHLY AND FOR THE 2947 02:02:19,998 --> 02:02:21,399 NEXT GENERATION DRUGS BI MONTHLY 2948 02:02:21,399 --> 02:02:22,934 TREATMENT AND THAT SHOWED VERY 2949 02:02:22,934 --> 02:02:23,902 GOOD RESULTS. 2950 02:02:23,902 --> 02:02:26,871 THIS WASN'T REALLY POSSIBLE IN 2951 02:02:26,871 --> 02:02:28,106 REAL LIFE. 2952 02:02:28,106 --> 02:02:29,874 AND TO TREAT PATIENTS EVERY 2953 02:02:29,874 --> 02:02:31,476 SIPPINGLE MONTH. 2954 02:02:31,476 --> 02:02:32,977 SO THERE ARE 2 PROMINENT 2955 02:02:32,977 --> 02:02:34,345 REGIMENS ARE TREATING PATIENTS 1 2956 02:02:34,345 --> 02:02:34,913 IS CALLED PREFRESH YOUR 2957 02:02:34,913 --> 02:02:36,514 RECOLLECTION N, WHERE WE LOOK AT 2958 02:02:36,514 --> 02:02:38,616 THE IMPAG IS THERE NO HIGH 2959 02:02:38,616 --> 02:02:39,918 REFLECTIVE AREA OF FLUID IN THE 2960 02:02:39,918 --> 02:02:40,885 IMAGE THAT MEANS THAT THE 2961 02:02:40,885 --> 02:02:42,220 PATIENT WILL NOT BE TREATED, IF 2962 02:02:42,220 --> 02:02:45,123 THERE IS A HYPER AREY FLECTIVE 2963 02:02:45,123 --> 02:02:47,192 AREA WHICH INDICATES PRESENCE OF 2964 02:02:47,192 --> 02:02:49,527 FLUID THEN THE PATIENT WILL BE 2965 02:02:49,527 --> 02:02:49,994 TREATED. 2966 02:02:49,994 --> 02:02:52,797 NOW THIS--NOW THIS REDUCES THE 2967 02:02:52,797 --> 02:02:54,899 BURDEN OF DRUG USE BUT DOES NOT 2968 02:02:54,899 --> 02:02:55,934 REDUCE THE BURDENOT PATIENT, 2969 02:02:55,934 --> 02:02:57,835 THEY HAVE TO COME AT VERY 2970 02:02:57,835 --> 02:03:00,271 REGULAR INTERVALS TO HAVE THEIR 2971 02:03:00,271 --> 02:03:02,540 RETINAS BE IMPAGGED ON OCT, THE 2972 02:03:02,540 --> 02:03:04,108 OTHER IS AN EXTENT TO WHERE A 2973 02:03:04,108 --> 02:03:06,878 PEESHT IS REESHTED ON EVERY 2974 02:03:06,878 --> 02:03:10,648 SINGLE VISITIT BUT IF THERE'S NO 2975 02:03:10,648 --> 02:03:12,317 FLUID SEEN, OR MAINTAINED, IF 2976 02:03:12,317 --> 02:03:14,252 THE FLUID IS SEEN, THEY PATIENT 2977 02:03:14,252 --> 02:03:15,920 IS BROUGHT IN SOONER UNTIL A 2978 02:03:15,920 --> 02:03:16,588 CERTAIN LIMIT. 2979 02:03:16,588 --> 02:03:18,890 IT'S IMPORTANT TO SEE ALL THESE 2980 02:03:18,890 --> 02:03:21,559 DECISIONS ARE BASED ON OCT AND 2981 02:03:21,559 --> 02:03:23,194 THIS IS WHERE OCT IS THE FLOWER 2982 02:03:23,194 --> 02:03:25,296 TO THE BEE, SO WOTHAT, YOU 2983 02:03:25,296 --> 02:03:27,131 CANNOT PLAN YOUR TREATMENT 2984 02:03:27,131 --> 02:03:28,066 REGIMENS AND THIS IS MEN AND 2985 02:03:28,066 --> 02:03:31,903 WOMEN HAS MADE OCT DIAGNOSTIC 2986 02:03:31,903 --> 02:03:33,605 COMPANIONS TO AMD TREATMENT. 2987 02:03:33,605 --> 02:03:37,542 THE CHALLENGE HAS BEEN THAT WITH 2988 02:03:37,542 --> 02:03:39,510 THIS TYPE OF REGIMEN WE'RE STILL 2989 02:03:39,510 --> 02:03:40,478 MAKING A GUESS ON WHAT THE 2990 02:03:40,478 --> 02:03:44,115 PATIENT IS GOING TO REACTIVATE 2991 02:03:44,115 --> 02:03:44,315 NEXT. 2992 02:03:44,315 --> 02:03:46,784 AND THIS ALSO LEADS TO A LOT OF 2993 02:03:46,784 --> 02:03:48,052 TREATMENTS IMIVEN WHEN THE 2994 02:03:48,052 --> 02:03:49,787 PATIENT MAY NOT NEED IT BECAUSE 2995 02:03:49,787 --> 02:03:50,888 THEY MAY COMPLETELY HAVE NO 2996 02:03:50,888 --> 02:03:52,290 SEENS OF DEC AT THAT MOMENT. 2997 02:03:52,290 --> 02:03:55,393 SO IF YOU LOOK AT WHAT HAPPENS 2998 02:03:55,393 --> 02:03:57,061 AT THE SNAPSHOT IMAGES, I AM 2999 02:03:57,061 --> 02:03:58,830 GIVING YOU AN EXAMPLE OF 2 3000 02:03:58,830 --> 02:04:01,032 AISLES WITH 2 NAP SHOTS BEING 3001 02:04:01,032 --> 02:04:02,734 ACHEN ON THE DAYS THE PATIENT IS 3002 02:04:02,734 --> 02:04:03,468 IN CLINIC. 3003 02:04:03,468 --> 02:04:06,838 IN BOTH CASES THE GREEN HERE 3004 02:04:06,838 --> 02:04:08,072 REPRESENTS PRESENCE OF 3005 02:04:08,072 --> 02:04:08,606 SUBRETINAL FLUID. 3006 02:04:08,606 --> 02:04:10,275 IT SEEMS LIKE THE PATIENT IS NOT 3007 02:04:10,275 --> 02:04:11,909 RESPONDING TO THE DRUG, YOU HAD 3008 02:04:11,909 --> 02:04:12,710 THIS IN THIS IPT GREATER ANNUAL 3009 02:04:12,710 --> 02:04:14,379 AND THEN THE PATIENT CAM BACK 3010 02:04:14,379 --> 02:04:15,413 INTO THE CLINIC AFTER THE 3011 02:04:15,413 --> 02:04:17,248 TREATMENT AND STILL HAD 3012 02:04:17,248 --> 02:04:17,982 SUBRETINAL FLUID EMPLOY HOWEVER 3013 02:04:17,982 --> 02:04:19,517 IF WE LOOK AT IMAGE IT IS IN 3014 02:04:19,517 --> 02:04:21,853 BETWEEN, 1 OF THESE EYES HAD 3015 02:04:21,853 --> 02:04:22,553 COMPLOATLY DRIED OUT BROADER 3016 02:04:22,553 --> 02:04:24,489 IMPACTS OTHER HAD SHOWN NOT MUCH 3017 02:04:24,489 --> 02:04:25,156 RESPONSE TO THERAPY. 3018 02:04:25,156 --> 02:04:27,058 THESE PATIENTS WERE BEING IMAGED 3019 02:04:27,058 --> 02:04:28,693 ON HOMOCT AND HAD IS HOW THE 3020 02:04:28,693 --> 02:04:29,394 TROUGH--TROJANOWSKI YECTRY LOOK 3021 02:04:29,394 --> 02:04:29,627 LIKE. 3022 02:04:29,627 --> 02:04:34,365 SO THE ENGINEERS IN THE AUDIENCE 3023 02:04:34,365 --> 02:04:35,366 WILL TALK ABOUT HOW SOMETHING 3024 02:04:35,366 --> 02:04:38,369 HAS THIS MUCH IN THE SIGNAL AND 3025 02:04:38,369 --> 02:04:40,038 WE ARE SAMPLING ONCE A MONTH, WE 3026 02:04:40,038 --> 02:04:43,141 ARE MISSING A LOT OF DATA, THIS 3027 02:04:43,141 --> 02:04:44,175 IS SEEMS ALMOST IMPOSSIBLE TO 3028 02:04:44,175 --> 02:04:47,145 TRACK A DEC WHICH IS SO DYNAMIC 3029 02:04:47,145 --> 02:04:50,248 WITH JUST SUCH SPARSE SAMPLES. 3030 02:04:50,248 --> 02:04:51,983 AND WE HAVE RESULTS TO PROVE 3031 02:04:51,983 --> 02:04:53,284 THAT IN REAL WORLD PATIENTS DO 3032 02:04:53,284 --> 02:04:55,820 NOT SEE THE SAME GAINS WHICH ARE 3033 02:04:55,820 --> 02:04:57,322 SEEN WITH MONTHLY CLINICAL TRIAL 3034 02:04:57,322 --> 02:04:58,790 TREATMENT. 3035 02:04:58,790 --> 02:05:00,391 THIS IS A REAL UNIVERSITY 3036 02:05:00,391 --> 02:05:01,926 STARTED THAT SHOWS THAT PATIENTS 3037 02:05:01,926 --> 02:05:04,796 DO NOT ON AN AVERAGE GAIN VISION 3038 02:05:04,796 --> 02:05:08,733 BUT MOSTLY JUST STABILIZE IT AT 3039 02:05:08,733 --> 02:05:10,034 1 YEAR TIME POINT. 3040 02:05:10,034 --> 02:05:13,137 REAL WORLD AMD CAUSES 10 BILLION 3041 02:05:13,137 --> 02:05:14,405 DOLLARS TO U.S. HEALTH SYSTEM 3042 02:05:14,405 --> 02:05:20,044 JUST IN DRUG COSTS AND ANTIVEG F 3043 02:05:20,044 --> 02:05:21,446 TREATMENTS ARE PART OF MEDICARE 3044 02:05:21,446 --> 02:05:22,880 PART B, WHICH IS WHEN ALL THE 3045 02:05:22,880 --> 02:05:25,350 DRUGS ARE USED AT THE CLINIC, 3046 02:05:25,350 --> 02:05:26,584 ENDOCRINOLOGY, EVERYTHING PUT 3047 02:05:26,584 --> 02:05:29,454 TOGETHER, THESE 2 DRUGS COST 10% 3048 02:05:29,454 --> 02:05:32,590 OF THE BUDGET, THAT SHOWS THE 3049 02:05:32,590 --> 02:05:33,458 BURDENOT HELT CARE SYSTEM. 3050 02:05:33,458 --> 02:05:34,859 THERE IS A HUGE BURDEN ON THE 3051 02:05:34,859 --> 02:05:36,427 PATIENT WITH THE FREQUENT 3052 02:05:36,427 --> 02:05:38,396 VISITSAs WELL AS INCLUDING 3053 02:05:38,396 --> 02:05:38,696 CAREGIVERS. 3054 02:05:38,696 --> 02:05:40,832 PATIENTS SHOWS IT TAKES 12 HOURS 3055 02:05:40,832 --> 02:05:44,635 FOR PATIENTS TO RECOVER FROM 3056 02:05:44,635 --> 02:05:45,536 THESE TREATMENT VISITS, 59% OF 3057 02:05:45,536 --> 02:05:49,707 THOSE GO OVER THE CAREGIVER, AND 3058 02:05:49,707 --> 02:05:50,541 ESTIMATES OTHERS SHOWN AT 3059 02:05:50,541 --> 02:05:52,043 AMERICAN SOCIETY OF RETINA 3060 02:05:52,043 --> 02:05:54,879 SPECIALISTS SHOW THAT IT COSTS 3061 02:05:54,879 --> 02:05:56,514 U.S. PRODUCTIVITY LOSS OF 1 3062 02:05:56,514 --> 02:05:57,415 BILLION DOLLARS EVERY YEAR 3063 02:05:57,415 --> 02:06:01,886 BECAUSE OF THE WET AMD TREATMENT 3064 02:06:01,886 --> 02:06:02,120 VISITS. 3065 02:06:02,120 --> 02:06:03,788 TO ADDRESS THESE THERE ARE NEW 3066 02:06:03,788 --> 02:06:05,656 THERAPIES WHICH HAVE BEEN 3067 02:06:05,656 --> 02:06:11,462 APPROVED BY FDA, TO EXTEND THE 3068 02:06:11,462 --> 02:06:12,130 TREATMENT INTERVALS, 3069 02:06:12,130 --> 02:06:14,165 [INDISCERNIBLE] HAVE SHOWN IN 3070 02:06:14,165 --> 02:06:16,501 CLINICAL TRIALS THEY CAN EXTEND 3071 02:06:16,501 --> 02:06:17,435 PATIENTS FURTHER. 3072 02:06:17,435 --> 02:06:20,605 ALTHOUGH SOME PATIENTS CAN GO UP 3073 02:06:20,605 --> 02:06:22,373 TO 16 WEEKS, MANY GO TO 12 WEEKS 3074 02:06:22,373 --> 02:06:24,809 BUT IT IS STILL A HETEROGENIUS 3075 02:06:24,809 --> 02:06:27,111 DISEASE, NOT EVERY PATIENT IS 3076 02:06:27,111 --> 02:06:28,679 EXTENDED AND THAT'S WHERE THE 3077 02:06:28,679 --> 02:06:30,214 RULE OF PERSONALIZATION COMES 3078 02:06:30,214 --> 02:06:30,882 INTO PICTURE. 3079 02:06:30,882 --> 02:06:33,851 WITH THESE NEW DRUGS WE ARE IN 3080 02:06:33,851 --> 02:06:35,820 NEW ERA OF AMD TREATMENT, SO THE 3081 02:06:35,820 --> 02:06:38,423 QUESTION IS ARE WE IN A NEW ERA 3082 02:06:38,423 --> 02:06:39,390 OF DIAGNOSTICS AS WELL. 3083 02:06:39,390 --> 02:06:41,559 SO TBENT YEARS AGO WHEN THE 3084 02:06:41,559 --> 02:06:43,227 FIRST ANTIVEG F TREATMENTS 3085 02:06:43,227 --> 02:06:46,931 RESUMMIT INDEED A LAUNCH OF OCT, 3086 02:06:46,931 --> 02:06:49,267 INTO MAIN STREAM, HOW DO THE NEW 3087 02:06:49,267 --> 02:06:50,735 TREATMENTS IMPACT THE NEXT 3088 02:06:50,735 --> 02:06:51,335 GENERATION OF DIAGNOSTICS AND 3089 02:06:51,335 --> 02:06:53,838 THIS IS WHERE THE REAL UNMET 3090 02:06:53,838 --> 02:06:55,506 NEED COMES INTO THE PICTURE AND 3091 02:06:55,506 --> 02:06:57,708 WE REALLY NEED INDIVIDUALIZED 3092 02:06:57,708 --> 02:06:58,776 HIGH FREQUENCY INFORMATION 3093 02:06:58,776 --> 02:06:59,677 WITHOUT INCREASING BURDEN ON 3094 02:06:59,677 --> 02:07:00,745 PATIENT ANDS THE HELT CARE 3095 02:07:00,745 --> 02:07:03,748 SYSTEM AND THAT'S WHAT HOMOCT 3096 02:07:03,748 --> 02:07:05,750 PROMISES TO DO BUT TO BE ABLE TO 3097 02:07:05,750 --> 02:07:07,285 MAKE IT FEASIBLE, WE NEED 3 3098 02:07:07,285 --> 02:07:07,919 THINGS TO HAPPEN, PATIENT HEAT 3099 02:07:07,919 --> 02:07:09,287 SHOCK SYSTEM BE ABLE TO TAKE THE 3100 02:07:09,287 --> 02:07:10,955 SCANS AT THE HOME BY THEMSELVES, 3101 02:07:10,955 --> 02:07:13,825 THERE SHOULD BE AI TO AUTOMATE 3102 02:07:13,825 --> 02:07:14,459 RELEVANT BIOMARKER ANDS THEN 3103 02:07:14,459 --> 02:07:16,227 PATIENTS SHOULD BE ABLE TO DO IT 3104 02:07:16,227 --> 02:07:19,430 OVER AN EXTENDED PERIOD, 3105 02:07:19,430 --> 02:07:21,432 SOMETIMES FOR YEARS TO MAKE IT 3106 02:07:21,432 --> 02:07:21,799 REALISTIC. 3107 02:07:21,799 --> 02:07:24,368 SO THAT'S THE TECHNOLOGY THAT 3108 02:07:24,368 --> 02:07:27,038 HAS MADE HOME OCT POSSIBLE, 3109 02:07:27,038 --> 02:07:29,407 HERE'S THE DISCIPLINARY VIS, 3110 02:07:29,407 --> 02:07:33,811 UNDER THE SPECERAL DO DOMAIN 3111 02:07:33,811 --> 02:07:36,681 WITH 300 BY 300 PICTURE AND 500 3112 02:07:36,681 --> 02:07:38,616 BY 500 KAN--KANAS TAKEN. 3113 02:07:38,616 --> 02:07:40,384 THE GOAL S&P THAT SOMEHOW WE 3114 02:07:40,384 --> 02:07:42,854 HAVE TO MAKE THE PUPIL IN THE 3115 02:07:42,854 --> 02:07:44,121 RIGHT XYZ LOCATION, THAT IS WHAT 3116 02:07:44,121 --> 02:07:46,123 WE KNOW TO GET A GOOD 3117 02:07:46,123 --> 02:07:46,424 SELF-IMAGE. 3118 02:07:46,424 --> 02:07:48,459 THIS IS DONE THROUGH PATIENTS 3119 02:07:48,459 --> 02:07:49,827 ALIGNING THESE 2 CROSSES, WHITE 3120 02:07:49,827 --> 02:07:51,562 AND THE RED 1S MUCH. 3121 02:07:51,562 --> 02:07:53,397 THE PATIENT MOVES THEIR FOREHEAD 3122 02:07:53,397 --> 02:07:55,032 UNTIL THE WHITE CROSS COMES OVER 3123 02:07:55,032 --> 02:07:56,100 TO THE RED 1. 3124 02:07:56,100 --> 02:07:57,468 THIS BRINGS THE PUPIL IN THE 3125 02:07:57,468 --> 02:07:59,237 CORRECT POSITION AND USING THE 3126 02:07:59,237 --> 02:08:00,938 ALIGNMENT PROBLEM FOR THE 3127 02:08:00,938 --> 02:08:01,973 SOLUTION IS VERY IMPORTANT 3128 02:08:01,973 --> 02:08:03,841 BECAUSE EVEN THE PATIENTS WHO 3129 02:08:03,841 --> 02:08:07,545 HAVE VERY POOR VISION, WE ARE 3130 02:08:07,545 --> 02:08:08,713 TALKING OF 23-20, THEY ARE ABLE 3131 02:08:08,713 --> 02:08:11,282 TO DO THIS ALIGNMENT EXERCISE. 3132 02:08:11,282 --> 02:08:13,551 I CAN TAKE OFF MY CONTACT LENSES 3133 02:08:13,551 --> 02:08:15,219 AND STILL BE ABLE TO DO IT. 3134 02:08:15,219 --> 02:08:18,623 I SEE THESE AS HUGE PLUS. 3135 02:08:18,623 --> 02:08:20,258 SO ARE THERE CLINICAL STUDIES TO 3136 02:08:20,258 --> 02:08:23,361 SHOW THAT THIS PROCESS ACTUALLY 3137 02:08:23,361 --> 02:08:23,561 WORKS? 3138 02:08:23,561 --> 02:08:25,796 YOU'DY KIM CAME IN AND DID A 3139 02:08:25,796 --> 02:08:27,198 STUDY WITH OVER 290 SUBJECTS AND 3140 02:08:27,198 --> 02:08:28,833 500 EYES WHERE PATIENTS WERE NOT 3141 02:08:28,833 --> 02:08:30,735 GIVEN ANY ASHES CYSTANCE WITH 3142 02:08:30,735 --> 02:08:32,403 THE TECHNICIANS, AND THEY ONLY 3143 02:08:32,403 --> 02:08:34,505 SAW A 2 MINUTE VIDEO TUTORIAL 3144 02:08:34,505 --> 02:08:37,275 AND THEN THEY HAD TO SELF-IMAGE, 3145 02:08:37,275 --> 02:08:39,210 THEY WERE TO SEE IF THE RESULTS 3146 02:08:39,210 --> 02:08:39,777 ACTUALLY MATCH. 3147 02:08:39,777 --> 02:08:41,412 THESE ARE ACTUAL PATIENTS, 3148 02:08:41,412 --> 02:08:45,116 MEDIAN AGE OF FEAT YEARS, 91% OF 3149 02:08:45,116 --> 02:08:46,851 SUBRECYCLINGS WERE WERE ABLE TO 3150 02:08:46,851 --> 02:08:47,919 SUCCESSFULLY SCAN. 3151 02:08:47,919 --> 02:08:50,021 THERE NOT A HUGE TEPENDENT ON 3152 02:08:50,021 --> 02:08:52,156 THE PATES FOR SELF-SCANNING 3153 02:08:52,156 --> 02:08:57,862 UNTIL IT FELL BELOW 23, 20. 3154 02:08:57,862 --> 02:09:00,631 THERE WAS STRONG AGREEMENT WITH 3155 02:09:00,631 --> 02:09:05,570 THE IN-OFFICE HOME OCT AS FAR AS 3156 02:09:05,570 --> 02:09:06,003 DETECTORS OF FLUID. 3157 02:09:06,003 --> 02:09:08,639 NEXT IS THE ROLE OF ARTIFICIAL 3158 02:09:08,639 --> 02:09:10,074 INTELIENCE AS DR. ROSEN SAID 3159 02:09:10,074 --> 02:09:11,275 YESTERDAY, THE CLINICIANS HAVE A 3160 02:09:11,275 --> 02:09:12,243 MICROSECOND WITH THE PATIENTS 3161 02:09:12,243 --> 02:09:13,945 AND THAT'S PROBABLY ON A SLOW 3162 02:09:13,945 --> 02:09:15,546 DAY, WE CANNOT BURDEN CLINICIANS 3163 02:09:15,546 --> 02:09:17,815 WITH MORE DATA AND THIS IS WHERE 3164 02:09:17,815 --> 02:09:19,417 THE ROLE OF AI COMES BO THE 3165 02:09:19,417 --> 02:09:21,519 PICTURE, THE AI SHOULD BE ABLE 3166 02:09:21,519 --> 02:09:23,354 TO DETECT BIOMARKERS AND 3167 02:09:23,354 --> 02:09:24,288 PROTENTIALLY PROVIDE A TRIGGER 3168 02:09:24,288 --> 02:09:26,390 TO THE POSITION THAT ADVANTAGED 3169 02:09:26,390 --> 02:09:28,626 THE RIGHT TIME TO EVALUATE THE 3170 02:09:28,626 --> 02:09:29,060 DATA. 3171 02:09:29,060 --> 02:09:31,996 SO DR. KIM'S STUDY USE OF DEEP 3172 02:09:31,996 --> 02:09:33,864 LEARNING ALGORITHM, FOR OCT 3173 02:09:33,864 --> 02:09:37,635 ANALYZER TO QUANTIFY FLUID IN 3174 02:09:37,635 --> 02:09:38,502 THE OCT SCANS. 3175 02:09:38,502 --> 02:09:41,572 AND THEY FOUND STRONG 3176 02:09:41,572 --> 02:09:43,741 CORRELATION BETWEEN THE HUMAN 3177 02:09:43,741 --> 02:09:46,177 GREATERS AND THE DEEP LEARNING 3178 02:09:46,177 --> 02:09:48,546 ALGORITHM WITH THE VERY SMALL 3179 02:09:48,546 --> 02:09:56,420 MAIN DIFFERENCE DUE IN THE PELT 3180 02:09:56,420 --> 02:10:05,296 AND ULTIMATE ANALYSIS 3181 02:10:05,296 --> 02:10:05,963 EMPLOY--THROUGH OUR OTHER 3182 02:10:05,963 --> 02:10:07,598 EXPERIENCES WE KNOW IT'S NOT. 3183 02:10:07,598 --> 02:10:11,235 EVEN THOUGH YOU GIVE A PERFECT 3184 02:10:11,235 --> 02:10:13,838 TECHNOLOGICAL SOLUTION, THERE IS 3185 02:10:13,838 --> 02:10:14,405 TEST, COMPLIANCE, SUPPORT, 3186 02:10:14,405 --> 02:10:15,473 ANXIETY OF THE PATIENTS, 3187 02:10:15,473 --> 02:10:19,110 FINANCES AND THIS IS WHY AT 3188 02:10:19,110 --> 02:10:21,212 NOTALL, WE UNDERSTAND WE HAVE TO 3189 02:10:21,212 --> 02:10:23,280 PROVIDE A FULL CONCEPT SOLUTION 3190 02:10:23,280 --> 02:10:25,349 AND WE HAVE PROVIDED A CENTER 3191 02:10:25,349 --> 02:10:28,452 THAT IS LED BY OPHTHALMOLOGISTS 3192 02:10:28,452 --> 02:10:29,620 AND STARTS WITH OPHTHALMIC 3193 02:10:29,620 --> 02:10:30,655 PROFESSIONAL ANDS MANY OF THEM 3194 02:10:30,655 --> 02:10:32,523 TRAIN WITH HOW TO WORK IN 3195 02:10:32,523 --> 02:10:33,724 PATIENT IN A CLINICAL SETTING. 3196 02:10:33,724 --> 02:10:36,160 THEY TAKE CARE OF ALL THE LODGE 3197 02:10:36,160 --> 02:10:38,396 LARGER DETAILS WHICH IS NOT AS 3198 02:10:38,396 --> 02:10:39,697 GLAMOROUS AS AI BUT ARE ESSENT 3199 02:10:39,697 --> 02:10:42,767 YELL TO MAKE THE CARE A REALITY. 3200 02:10:42,767 --> 02:10:45,436 NOW THE QUESTION IS, JUST THIS 3201 02:10:45,436 --> 02:10:47,338 NEW PARTAKEN--THEY DIME, DO SRO 3202 02:10:47,338 --> 02:10:48,906 DAT TO SUPPORT IT ACTUALLY 3203 02:10:48,906 --> 02:10:50,508 WORKS, ANOTHER DEVICE WHICH IS 3204 02:10:50,508 --> 02:10:52,143 USED TO DETECT CONVERSION FROM 3205 02:10:52,143 --> 02:10:55,780 WET TO DRY AMD, THERE IS A TINY 3206 02:10:55,780 --> 02:10:56,847 RETROSPECTIVE DATA ON PATIENT 3207 02:10:56,847 --> 02:10:57,915 COMPLIANCE AND PATIENTS ON THIS 3208 02:10:57,915 --> 02:11:00,151 PROGRAM HAD A TESTING FREQUENCY 3209 02:11:00,151 --> 02:11:01,652 OF 5.2 TESTS PER WEEK, PROBABLY 3210 02:11:01,652 --> 02:11:03,421 A VERY HIGH COMPLIANCE OF A 3211 02:11:03,421 --> 02:11:04,588 PATIENT WHO'S NOT GOING INTO 3212 02:11:04,588 --> 02:11:05,990 OFFICE AND NOT BEING TOLD BOY A 3213 02:11:05,990 --> 02:11:07,825 DOCTOR WHAT TO DO. 3214 02:11:07,825 --> 02:11:11,529 WE TRY TO SEE IF THIS MODEL 3215 02:11:11,529 --> 02:11:13,864 WORKS FOR HOMOCT IN A 3216 02:11:13,864 --> 02:11:15,366 LONGITUDINAL STUDY, THAT WAS 3217 02:11:15,366 --> 02:11:18,335 UNDER PROTOCOL AK FUNDED BY NEI, 3218 02:11:18,335 --> 02:11:23,074 THE 6 MONTH FOLLOW UP TODAY ON 3219 02:11:23,074 --> 02:11:25,576 HOME OCT, WITH PATIENTS FROM 3220 02:11:25,576 --> 02:11:28,045 2020 TO 20/32, HAD OVER 2000 3221 02:11:28,045 --> 02:11:29,480 SCANS AQUAR QUIRED AT A HIGH 3222 02:11:29,480 --> 02:11:32,149 SUCCESS RATE WITH A PATIENT 3223 02:11:32,149 --> 02:11:33,918 SHOWING ADHERENCE OF 3.6 STAN 3224 02:11:33,918 --> 02:11:34,485 SCANS PER WEEK. 3225 02:11:34,485 --> 02:11:35,686 SO THEY'RE ALMOST DOING THE SCAN 3226 02:11:35,686 --> 02:11:36,721 EVERY DAY. 3227 02:11:36,721 --> 02:11:39,156 THE MEDIAN TIME FOR ACQUISITION 3228 02:11:39,156 --> 02:11:40,958 WAS 47-SECONDS AND THAT INCLUDES 3229 02:11:40,958 --> 02:11:43,294 PATIENTS ALIGNING THEM AND 3230 02:11:43,294 --> 02:11:47,865 ACQUIRING THE IMAGE. 3231 02:11:47,865 --> 02:11:49,734 ALL SCANS REPORTED MATCH WITH 3232 02:11:49,734 --> 02:11:51,268 THE EXPERT GREATER ASSESSMENT OF 3233 02:11:51,268 --> 02:11:53,971 FLUID PRESENCE OR ABSENCE. 3234 02:11:53,971 --> 02:11:56,607 HADDA IS ALSO INTERESTING TO SEE 3235 02:11:56,607 --> 02:11:59,944 ARE THE FLUID VOLUME PROJECTRYS 3236 02:11:59,944 --> 02:12:01,145 WHICH ARE NOW PUBLISHED. 3237 02:12:01,145 --> 02:12:04,949 WE CAN SEE THE HETEROGENEITY IN 3238 02:12:04,949 --> 02:12:06,217 THE THESE PATES, NONE OF THEM 3239 02:12:06,217 --> 02:12:08,552 LOOK THE SAME AS EACH OTHER. 3240 02:12:08,552 --> 02:12:10,121 ANOTHER LONGITUDIAL STUDY DONE 3241 02:12:10,121 --> 02:12:14,558 BY DR. JEFF HAI AND NALSY 3242 02:12:14,558 --> 02:12:17,194 HOLCOMB SHOWED EXPERIENCE IN THE 3243 02:12:17,194 --> 02:12:20,664 PATIENT WITH HUGE HETEROGENEITY 3244 02:12:20,664 --> 02:12:21,365 IN THESE TRAJECTORIES. 3245 02:12:21,365 --> 02:12:22,299 PATIENT SATISFACTION IS A HUGE 3246 02:12:22,299 --> 02:12:25,136 FACTOR IF YOU WANT THEM TO DO 3247 02:12:25,136 --> 02:12:27,671 THESE TESTS IN THE--AT THEIR 3248 02:12:27,671 --> 02:12:29,240 HOME AND ON A REGULAR BASIS. 3249 02:12:29,240 --> 02:12:30,908 SO PATES WERE ASKED A NUMBER OF 3250 02:12:30,908 --> 02:12:32,443 QUESTIONS, I THINK 2 OF THE MOST 3251 02:12:32,443 --> 02:12:34,178 IMPORTANT 1S WERE EASE OF USE 3252 02:12:34,178 --> 02:12:36,046 AND CONVENIENCE OF DAILY 3253 02:12:36,046 --> 02:12:36,981 IMAGING. 3254 02:12:36,981 --> 02:12:37,815 NINETY-SEVEN% OF RESPONDENTS 3255 02:12:37,815 --> 02:12:39,917 GAVE A POSITIVE, A CORE OF 4 OR 3256 02:12:39,917 --> 02:12:42,887 5 ON GRADING FROM 1 TO 5. 3257 02:12:42,887 --> 02:12:45,022 SO THIS SHOWS THAT THE PATIENTS 3258 02:12:45,022 --> 02:12:47,625 DO FEEL COMFORTABLE USING THIS 3259 02:12:47,625 --> 02:12:50,027 DEVICE AT HOME, AN AN ECTOMYOSIN 3260 02:12:50,027 --> 02:12:52,663 DID HE TELLAL EXPERIENCE THAT 3261 02:12:52,663 --> 02:12:53,564 THE PATIENTS SHARES THAT GOES 3262 02:12:53,564 --> 02:12:56,033 FROM GOING TO THE CLINIC ALL THE 3263 02:12:56,033 --> 02:12:57,668 TIME, IT'S DEFINITELY MORE CALM 3264 02:12:57,668 --> 02:13:00,204 BY DOING THE 40-SECOND SCAN AT 3265 02:13:00,204 --> 02:13:00,404 HOME. 3266 02:13:00,404 --> 02:13:02,339 ANOTHER QUESTION IS THIS CAN BE 3267 02:13:02,339 --> 02:13:04,375 ACQUIRED, DOES IT IMPACT 3268 02:13:04,375 --> 02:13:05,910 CLINICAL DECISION MAKING IN WILL 3269 02:13:05,910 --> 02:13:07,645 IT HAVE ANY CHANGE IN HOW THE 3270 02:13:07,645 --> 02:13:08,746 PATIENTS ARE MANAGED IN SO TO 3271 02:13:08,746 --> 02:13:12,416 UNDERSTAND THAT, WE SHOWED 3272 02:13:12,416 --> 02:13:12,983 PATIENT--PHYSICIANS HOME OCT 3273 02:13:12,983 --> 02:13:14,318 DATA OF THE PATES WHEN WERE 3274 02:13:14,318 --> 02:13:15,986 MANAGED IN THE CLINIC USING 3275 02:13:15,986 --> 02:13:19,256 STANDARD OF CARE, AND WE ASKED 3276 02:13:19,256 --> 02:13:20,658 THEM WOULD YOU CHANGE YOUR 3277 02:13:20,658 --> 02:13:22,860 DECISION BASED ON THAT, THEY 3278 02:13:22,860 --> 02:13:24,094 WERE MASKED TO THE ACTUAL 3279 02:13:24,094 --> 02:13:26,831 DECISION THAT WERE MADE IN 3280 02:13:26,831 --> 02:13:27,298 CLINIC. 3281 02:13:27,298 --> 02:13:27,965 IN FROM--INTEGRATION PASSPORT 7% 3282 02:13:27,965 --> 02:13:31,335 OF THE CASES WHEN THE--42.7% OF 3283 02:13:31,335 --> 02:13:34,004 THE CASES IN THE CLINIC, 3284 02:13:34,004 --> 02:13:35,406 PHYSICIANS DECIDED NOT TO TREAT 3285 02:13:35,406 --> 02:13:39,210 AND GIVE HOME OCT DATA. 3286 02:13:39,210 --> 02:13:41,245 THIS SHOULDN'T BE SURPRISING 3287 02:13:41,245 --> 02:13:42,446 BECAUSE HOME PATIENTS ARE OFTEN 3288 02:13:42,446 --> 02:13:45,216 BEING TREATED IN A PREVENTIVE 3289 02:13:45,216 --> 02:13:45,449 FASHION. 3290 02:13:45,449 --> 02:13:46,650 ALTHOUGH, IN 2/3RD OF THE CASES 3291 02:13:46,650 --> 02:13:48,619 WHEN THE PHYSICIAN DID MAKE A 3292 02:13:48,619 --> 02:13:50,454 DECISION TO TREAT, THEY MADE A 3293 02:13:50,454 --> 02:13:52,189 DECISION TO TREAT THE PATIENT 1 3294 02:13:52,189 --> 02:13:53,457 WEEK BEFORE THEY WERE ACTUALLY 3295 02:13:53,457 --> 02:13:54,124 BEING TREATED. 3296 02:13:54,124 --> 02:13:55,626 THESE ARE EARLY RESULTS BUT 3297 02:13:55,626 --> 02:13:57,661 THESE POINT TO 2 OF THE BIGGEST 3298 02:13:57,661 --> 02:14:00,764 CHALLENGES WE FACE, 1 IS THAT 3299 02:14:00,764 --> 02:14:02,299 PASHTS DON'T GET TREATA THE 3300 02:14:02,299 --> 02:14:04,869 RIGHT TIME, SO EVENTUALLY POORER 3301 02:14:04,869 --> 02:14:06,036 OUTCOMES, SECOND PATIENTS ARE 3302 02:14:06,036 --> 02:14:07,104 TREATED WHEN THEY DID NOT NEED 3303 02:14:07,104 --> 02:14:08,873 TO BE TREATED AND THAT PROBABLY 3304 02:14:08,873 --> 02:14:09,840 INCREASES THE BURDEN AND THE 3305 02:14:09,840 --> 02:14:13,244 COST BURDEN ON THE HEALTHCARE 3306 02:14:13,244 --> 02:14:13,577 SYSTEM. 3307 02:14:13,577 --> 02:14:16,680 SO OUR FINDING SHOWS THAT IT HAS 3308 02:14:16,680 --> 02:14:18,082 IGF 95 CANT IMPACT ON THE 3309 02:14:18,082 --> 02:14:19,149 DECISION MAKING, WE HAVE ALSO 3310 02:14:19,149 --> 02:14:23,854 SEE IN THIS AN INTERVENTIONAL 3311 02:14:23,854 --> 02:14:26,023 TRIAL IN PUBLICATION WITH 3312 02:14:26,023 --> 02:14:26,257 RETINAL. 3313 02:14:26,257 --> 02:14:28,926 THIS IS WHERE HOME OCT STANDS 3314 02:14:28,926 --> 02:14:29,126 TODAY. 3315 02:14:29,126 --> 02:14:32,796 OVER 1800 PATIENT EYES, NOT 3316 02:14:32,796 --> 02:14:34,031 TESTING, NOT QA ALL PATIENTS 3317 02:14:34,031 --> 02:14:37,401 EYES HAVE BEEN TESTED. 3318 02:14:37,401 --> 02:14:40,404 78,000 VOLUMES,A QUIRED, 3319 02:14:40,404 --> 02:14:44,575 5 MILLION B SCANS, GENERATING 3320 02:14:44,575 --> 02:14:46,343 93,000 GIGA BYTES OF DATA. 3321 02:14:46,343 --> 02:14:51,548 THAT I THINK BRINGS UP TO A BIG 3322 02:14:51,548 --> 02:14:53,817 NUMBER DATA, AND AS OF FRIDAY, 3323 02:14:53,817 --> 02:15:00,157 THE PATIENT IS SCANNING EVERY 3324 02:15:00,157 --> 02:15:01,759 COUPLE DAYS, SO IT IS GENERATED 3325 02:15:01,759 --> 02:15:02,293 IN REALTIME. 3326 02:15:02,293 --> 02:15:05,129 WE HAVE STARTED WITH THE CONFORM 3327 02:15:05,129 --> 02:15:06,530 ABTS THAT'S WHEN WE WORK WITH 3328 02:15:06,530 --> 02:15:07,631 OUR SPONSORS OF THE CLINICAL 3329 02:15:07,631 --> 02:15:11,201 STUDIES SO FAR TO HAVE ACCESS TO 3330 02:15:11,201 --> 02:15:12,036 THOSE CONFORMATIVE IMAGES SO 3331 02:15:12,036 --> 02:15:14,338 THEN, IT IS AN EXAMPLE OF 3332 02:15:14,338 --> 02:15:15,739 BRINGING MEDICAL NEED, 3333 02:15:15,739 --> 02:15:16,640 TECHNOLOGICAL SOLUTION AND 3334 02:15:16,640 --> 02:15:18,509 COMPASSIONATE CARE TOGETHER TO 3335 02:15:18,509 --> 02:15:19,410 ACTUALLY BRING THIS TECHNOLOGY 3336 02:15:19,410 --> 02:15:21,011 TO HUNDREDS AND THOUSANDS IF NOT 3337 02:15:21,011 --> 02:15:24,315 MILLIONS OF PATIENTS IN THE 3338 02:15:24,315 --> 02:15:30,988 FUTURE. 3339 02:15:30,988 --> 02:15:34,758 THANK YOU. 3340 02:15:34,758 --> 02:15:35,859 [ APPLAUSE ] 3341 02:15:35,859 --> 02:15:39,563 >> UP NEXT WE HAVE AMITHA WHO 3342 02:15:39,563 --> 02:15:40,998 WILL TALK ABOUT DATA 3343 02:15:40,998 --> 02:15:46,070 STANDARDIZATION IN CLINICAL 3344 02:15:46,070 --> 02:15:48,138 TRIALS. 3345 02:15:48,138 --> 02:15:49,640 >> THANK YOU TO NEI FOR THIS 3346 02:15:49,640 --> 02:15:51,508 AMAZING TIEWPT TO CELEBRATE A 3347 02:15:51,508 --> 02:15:53,711 GREAT INVENTION AND THANK YOU TO 3348 02:15:53,711 --> 02:15:55,879 THE KEY NOTE SPEAKERS YESTERDAY 3349 02:15:55,879 --> 02:16:00,751 AND TODAY, FOR ARK MAZING TALKS, 3350 02:16:00,751 --> 02:16:02,553 I WILL TALK ABOUT DATA 3351 02:16:02,553 --> 02:16:04,621 STANDARDIZE WITH RESPECT TO 2 3352 02:16:04,621 --> 02:16:06,357 ASPECTS, CLINICAL TRIALS AND 3353 02:16:06,357 --> 02:16:09,827 IMAGE CURATION FOR AI. 3354 02:16:09,827 --> 02:16:11,395 RETINAL IMAGES, JUST 50 YEARS 3355 02:16:11,395 --> 02:16:15,733 AGO WAS STILL PAPER BASED. 3356 02:16:15,733 --> 02:16:17,368 ARTISTIC DOCUMENTATION ON PAPER 3357 02:16:17,368 --> 02:16:18,435 OF VESSELS, LESIONS, THINGS LIKE 3358 02:16:18,435 --> 02:16:19,803 THIS AND AT THE READING CENTER, 3359 02:16:19,803 --> 02:16:24,675 WE STILL HAVE A FEW OF THESE 3360 02:16:24,675 --> 02:16:27,311 LYING AROUND SOMEWHERE. 3361 02:16:27,311 --> 02:16:30,247 AND IT WASN'T UNTIL THE 80S THAT 3362 02:16:30,247 --> 02:16:31,215 PHOTOGRAPHY BECAME MAIN STREAM 3363 02:16:31,215 --> 02:16:33,050 IN CLINICAL TRIALS ABOUT YOU IT 3364 02:16:33,050 --> 02:16:36,020 WAS STILL FILM IMAGING AND THESE 3365 02:16:36,020 --> 02:16:36,854 WERE FILM PHOTOGRAPHS THAT WOULD 3366 02:16:36,854 --> 02:16:38,489 COME TO US IN THESE SLEEVES AND 3367 02:16:38,489 --> 02:16:43,060 WE HAD TO LOG AND USE LIGHT 3368 02:16:43,060 --> 02:16:46,196 BOXES AND STEREO VIEWERS TO LOOK 3369 02:16:46,196 --> 02:16:47,731 AT THEM. 3370 02:16:47,731 --> 02:16:50,601 BY THE 2000S, EVERYTHING BECAME 3371 02:16:50,601 --> 02:16:52,703 DIGITAL, AND EXPANDED BEYOND 3372 02:16:52,703 --> 02:16:55,439 FUNDERS PHOTOGRAPHY TO OCT 3373 02:16:55,439 --> 02:16:56,373 IMANNUALING AND ULTRA WIDE FIELD 3374 02:16:56,373 --> 02:16:58,575 AND EVERYTHING ELSE STARTED 3375 02:16:58,575 --> 02:17:05,549 EXPLODING WITH IMAGING AND SOON 3376 02:17:05,549 --> 02:17:07,985 ENOUGH WE HAD ARTIFICIAL 3377 02:17:07,985 --> 02:17:10,087 INTELLIGENCE COMING IN AND OCT 3378 02:17:10,087 --> 02:17:11,588 IN A BIG WAY. 3379 02:17:11,588 --> 02:17:14,258 SO IT'S A SHORT JOURNEY BUT AN 3380 02:17:14,258 --> 02:17:16,326 MAISHZING JOURNEY THAT WE'VE HAD 3381 02:17:16,326 --> 02:17:17,895 IN RETINAL IMAGING. 3382 02:17:17,895 --> 02:17:20,998 SO THE FUNDUS PHOTOGRAPH READING 3383 02:17:20,998 --> 02:17:22,266 CENTER WAS ESTABLISHED 50 YEARS 3384 02:17:22,266 --> 02:17:26,270 AGO WITH THE NEI AND NIDDK, WITH 3385 02:17:26,270 --> 02:17:30,574 SIM NOAL TRIALS AND SINCE THEN 3386 02:17:30,574 --> 02:17:32,443 WE'VE HAD MANY BEAUTIFUL READING 3387 02:17:32,443 --> 02:17:41,585 CENTERS FOR RETINAL IMAGING AND 3388 02:17:41,585 --> 02:17:42,352 ACROSS THE WORLD. 3389 02:17:42,352 --> 02:17:44,888 THESE ARE ALL FOR CHEMICAL 3390 02:17:44,888 --> 02:17:52,162 TRIALS AND WE'RE NOW CALLED THE 3391 02:17:52,162 --> 02:17:52,663 READING CENTER. 3392 02:17:52,663 --> 02:17:54,765 AND ALL HAVE A STANDARDIZED 3393 02:17:54,765 --> 02:17:56,600 GROAL AND READING TERMINALLING 3394 02:17:56,600 --> 02:18:04,675 AND TERMINOLOGY FOR CLINICAL 3395 02:18:04,675 --> 02:18:04,908 TRIALS. 3396 02:18:04,908 --> 02:18:06,977 THIS IS BY THE TANNED ARD 3397 02:18:06,977 --> 02:18:09,580 CERTIFICATION PROCESS WHERE WE 3398 02:18:09,580 --> 02:18:10,681 CREATE GUIDELINES ON HOW IT'S 3399 02:18:10,681 --> 02:18:12,382 TAKEN, WHAT IS THE ACCEPTABLE 3400 02:18:12,382 --> 02:18:16,386 EQUIPMENT AND WHAT IS THE SCAN 3401 02:18:16,386 --> 02:18:18,288 PROTOCOL AND THESE ARE TESTED ON 3402 02:18:18,288 --> 02:18:19,289 SUBMISSIONS, QUALITY IS MONITORS 3403 02:18:19,289 --> 02:18:21,625 AND THAT'S HOW THE IMAGING 3404 02:18:21,625 --> 02:18:27,498 ACQUISITION IS STANDARDIZED IN A 3405 02:18:27,498 --> 02:18:28,265 CLINICAL TRIAL. 3406 02:18:28,265 --> 02:18:29,566 FOR THE END POINTS THERE ARE 3407 02:18:29,566 --> 02:18:31,902 READER WHO IS ARE NOT 3408 02:18:31,902 --> 02:18:33,237 OPHTHALMOLOGISTS USUALLY, THEY 3409 02:18:33,237 --> 02:18:36,340 ARE TRAIN INDEED GRADING 3410 02:18:36,340 --> 02:18:37,975 PROTOCOLS AND CERTIFIED, EACH 3411 02:18:37,975 --> 02:18:40,043 TRAINER AND TRAINED IN A CERTAIN 3412 02:18:40,043 --> 02:18:41,245 PROTOCOL SO THEY'RE ALMOST LIKE 3413 02:18:41,245 --> 02:18:43,580 A HUMAN FORM OF AI BECAUSE IF A 3414 02:18:43,580 --> 02:18:46,350 GRADER IS TRAIN INDEED DIABETIC 3415 02:18:46,350 --> 02:18:47,618 RETINAL LOCATION NUMBER OF 3416 02:18:47,618 --> 02:18:49,353 PATIENTSATHY COLOR, THAT'S ALL 3417 02:18:49,353 --> 02:18:50,888 THEY DO, THEY ARE NOT TRAIN 3418 02:18:50,888 --> 02:18:53,357 INDEED OCT, AND IF THEY ARE 3419 02:18:53,357 --> 02:18:55,993 TRAINED IN OCT, THEY CANNOT 3420 02:18:55,993 --> 02:18:57,594 INTERPRET COLORS UNLESS THEY'RE 3421 02:18:57,594 --> 02:18:58,896 CROSS DOMAIN TRAINED, AND ALL 3422 02:18:58,896 --> 02:19:03,700 PATIENT HISTORY SO IT'S JUST 3423 02:19:03,700 --> 02:19:05,169 OBJECTIVE ASSESSMENT UNLIKE 3424 02:19:05,169 --> 02:19:07,104 CLINICAL INTERPRETATION AND THEY 3425 02:19:07,104 --> 02:19:09,173 GO THROUGH RIGOROUS INTEGRATOR 3426 02:19:09,173 --> 02:19:18,182 AGREEMENT THAT IS CONTINUOUSLY 3427 02:19:18,182 --> 02:19:18,982 MONITORS. 3428 02:19:18,982 --> 02:19:21,084 THIS IS CALLED CLINICAL TRIAL 3429 02:19:21,084 --> 02:19:23,921 IMAGES AND POINT PROCESS AND 3430 02:19:23,921 --> 02:19:25,822 THIS IS THE GUIDANCE DOCUMENT WE 3431 02:19:25,822 --> 02:19:29,259 ALL FOLLOW, IT TELLS YOU HOW 3432 02:19:29,259 --> 02:19:31,128 CERTIFICATION IS DONE, IMAGES 3433 02:19:31,128 --> 02:19:35,499 RECEIVED, GRADED, IT'S ALL 3434 02:19:35,499 --> 02:19:36,600 OUTLINES HERE. 3435 02:19:36,600 --> 02:19:38,902 DESPITE IN ENTIRE INDUSTRY OF 3436 02:19:38,902 --> 02:19:39,603 STANDARDIZATION OF CLINICAL 3437 02:19:39,603 --> 02:19:44,141 TRIALS THERE ARE LOTS OF 3438 02:19:44,141 --> 02:19:44,942 PROBLEMS. 3439 02:19:44,942 --> 02:19:47,010 AND AND THESE ARE DUE TO 3440 02:19:47,010 --> 02:19:55,519 VARIABLE, AND WHEN YOU HAVE AND 3441 02:19:55,519 --> 02:19:58,388 WHEN DATA POOLING IS VASKTED, 3442 02:19:58,388 --> 02:20:00,023 THE OVER ALL STUDY IS AFFECTED 3443 02:20:00,023 --> 02:20:00,958 AND THE HEART OF THE STUDY IS 3444 02:20:00,958 --> 02:20:02,292 THE HEART OF THE CLINICAL TRIAL 3445 02:20:02,292 --> 02:20:03,694 AND IF THAT'S AFFECTED THEN 3446 02:20:03,694 --> 02:20:06,730 EVERYTHING ELSE IS LOST. 3447 02:20:06,730 --> 02:20:08,799 AND TO PUT THINGS AT A VERY 3448 02:20:08,799 --> 02:20:09,833 SIMPLE PERSPECTIVE, WE ALL KNOW 3449 02:20:09,833 --> 02:20:13,537 ABOUT THE DIFFERENCES IN 3450 02:20:13,537 --> 02:20:14,972 SEGMENTATION AND ALL THE OCT 3451 02:20:14,972 --> 02:20:19,676 MACHINES AND THAT LOS ANGELESS 3452 02:20:19,676 --> 02:20:22,212 TO A VERY BASIC ISSUE FOR TRIALS 3453 02:20:22,212 --> 02:20:23,380 WHERE CENTRAL FOR FIELDS OF 3454 02:20:23,380 --> 02:20:26,483 THICKNESS IS A PROOMARY, SECOND 3455 02:20:26,483 --> 02:20:28,352 AREAY POINT IN CLINICAL TRIALS. 3456 02:20:28,352 --> 02:20:31,321 THOSE MATTERS MANAGE SO MUCH, 3457 02:20:31,321 --> 02:20:34,491 MOVING UP OR DOWN CHANGES 3458 02:20:34,491 --> 02:20:36,593 THICKNESS AND IF CHANGING 3459 02:20:36,593 --> 02:20:38,195 EQUIPMENT MADE WAY TO THE TRIAL 3460 02:20:38,195 --> 02:20:41,531 COULD GIVE FALSE EFFICACY ON A 3461 02:20:41,531 --> 02:20:43,133 PATIENT UNDERGOING THERAPEUTIC 3462 02:20:43,133 --> 02:20:44,768 AND TRIALS, AND 20% CHANGE IN 3463 02:20:44,768 --> 02:20:47,204 THICKNESS COULD HAPPEN JUST BY 3464 02:20:47,204 --> 02:20:57,748 SWITCHING FROM ZEIS TO A HIDELE 3465 02:21:00,417 --> 02:21:00,784 BERG INSTRUMENT. 3466 02:21:00,784 --> 02:21:02,586 WE MOVE THE LINES UP AND DOWN TO 3467 02:21:02,586 --> 02:21:06,923 MAKE IT ALL STANDARDIZED AND WE 3468 02:21:06,923 --> 02:21:09,259 USE REGRESSION FORMULAS LIKE 3469 02:21:09,259 --> 02:21:11,862 DRCR NET DOES USE REGRESSION 3470 02:21:11,862 --> 02:21:16,633 FORMULAS TO USE STANDARDIZED 3471 02:21:16,633 --> 02:21:17,367 MEASUREMENTS ACROSS MACHINES 3472 02:21:17,367 --> 02:21:18,402 SOPHISTICATED THESE ARE ALL WORK 3473 02:21:18,402 --> 02:21:19,803 AROUNDS THAT ARE USED AND JUST 3474 02:21:19,803 --> 02:21:21,338 WHEN WE THOUGHT WE HAVE A WORK 3475 02:21:21,338 --> 02:21:25,242 ARK ROUND FOR OCT, OCT 3476 02:21:25,242 --> 02:21:26,443 ANGIOGRAPHY COMES ALONG AND WE 3477 02:21:26,443 --> 02:21:27,978 HAVE THE MEASUREMENTS ON VESSEL 3478 02:21:27,978 --> 02:21:30,614 DENSITY WHICH ARE REPORTED IN 3479 02:21:30,614 --> 02:21:31,982 PERCENTAGE OR PERMANENT UNIT 3480 02:21:31,982 --> 02:21:33,984 TWHAS CANNOT BE PULLED SO THE 3481 02:21:33,984 --> 02:21:44,528 SAME DATA PULLING ISSUE BACK AT 3482 02:21:44,828 --> 02:21:45,762 IT AGAIN. 3483 02:21:45,762 --> 02:21:47,631 OKAY, SO FOR MANY YEARS IT USED 3484 02:21:47,631 --> 02:21:48,832 TO BE THICKNESS AND THAT'S ALL 3485 02:21:48,832 --> 02:21:51,034 BUT MOW WE HAVE ARK MAZING END 3486 02:21:51,034 --> 02:21:53,303 POINTS, RESEARCH THAT IS BEING 3487 02:21:53,303 --> 02:21:58,308 DONE IN END POINTS AND THERE'S A 3488 02:21:58,308 --> 02:22:00,544 LOT MORE LAYER BASED SUBJECTIVE, 3489 02:22:00,544 --> 02:22:01,511 OBJECTIVE QUANTITATIVE MEASURE 3490 02:22:01,511 --> 02:22:02,479 AMS, MANY MORE DETAIL 3491 02:22:02,479 --> 02:22:03,780 MEASUREMENTS THAT ARE BEING 3492 02:22:03,780 --> 02:22:06,216 DONE, YOU SAW THAT IN THE 3493 02:22:06,216 --> 02:22:08,218 PREVIOUS TALKS, DRILL, 3494 02:22:08,218 --> 02:22:10,954 INTEGRITY, THICKNESS, FLUID 3495 02:22:10,954 --> 02:22:21,431 QUANTIFICATION, QUANTIFYING 3496 02:22:24,000 --> 02:22:24,868 HYPER REFLECTIVE FOCI, YOU ABOUT 3497 02:22:24,868 --> 02:22:27,537 MOST OF THESE HAVE BEEN 3498 02:22:27,537 --> 02:22:29,005 SENSITIVE, THEY ARE DIFFICULT, 3499 02:22:29,005 --> 02:22:30,574 THEY NEED AI AND WHEN YOU HAVE 3500 02:22:30,574 --> 02:22:36,513 AI, YOU NEED STANDARD EYATION TO 3501 02:22:36,513 --> 02:22:37,981 GO BEYOND JUST HAVING, YOU KNOW 3502 02:22:37,981 --> 02:22:39,049 THE SAME EQUIPMENT, WITHIN THE 3503 02:22:39,049 --> 02:22:41,485 EQUIPMENT, YOU HAVE THE SAME 3504 02:22:41,485 --> 02:22:43,053 SCAN DENSITY, RESOLUTION, AREA 3505 02:22:43,053 --> 02:22:44,554 OF IMAGING, PATTERN, ALL THAT 3506 02:22:44,554 --> 02:22:44,788 MATTERS. 3507 02:22:44,788 --> 02:22:54,865 IF YOU HAVE A FLUID 3508 02:22:54,865 --> 02:22:55,699 QUANTIFICATION ALGORITHM AND AND 3509 02:22:55,699 --> 02:22:57,734 THE OTHER, IT WILL NOT BE 3510 02:22:57,734 --> 02:22:58,034 EQUIPULENT. 3511 02:22:58,034 --> 02:22:59,669 AND THERE ARE MANY DETAILS THAT 3512 02:22:59,669 --> 02:23:10,213 NEED TO BE ADHERED TO SO THIS IS 3513 02:23:11,081 --> 02:23:13,550 AT 2 SCANS, INCREASE IT TO 14 3514 02:23:13,550 --> 02:23:15,852 SCAN, THE VISIBLE IMPROVES, 3515 02:23:15,852 --> 02:23:17,854 MAYBE THE THICKNESS IMPROVES A 3516 02:23:17,854 --> 02:23:18,221 BIT. 3517 02:23:18,221 --> 02:23:21,091 CHANGE IT TO 25, IT CHANGES EACH 3518 02:23:21,091 --> 02:23:22,659 MORE SO THERE ARE THESE FINE 3519 02:23:22,659 --> 02:23:25,162 DETAILS WE NEED TO PAY ATTENTION 3520 02:23:25,162 --> 02:23:26,963 TO WHEN IT COMES TO THESE 3521 02:23:26,963 --> 02:23:28,698 ADVANCED IMAGING AND THE AI. 3522 02:23:28,698 --> 02:23:38,175 WHEN THE FDA CLEARS AI MODELS 3523 02:23:38,175 --> 02:23:39,443 FOR OR IMAGING FOR EXAMPLE FOR 3524 02:23:39,443 --> 02:23:40,710 RETINAL LOCATION NUMBER OF 3525 02:23:40,710 --> 02:23:41,778 PATIENTSATHY, THE REFERENCE 3526 02:23:41,778 --> 02:23:43,213 STANDARDS ARE USUALLY READINGS 3527 02:23:43,213 --> 02:23:44,948 AND ARE GENERATED DATA SO HUMAN 3528 02:23:44,948 --> 02:23:49,686 LABEL VERSUS,A I AND COMPARED TO 3529 02:23:49,686 --> 02:23:52,489 AND THE DEVICE IS--THE ALGORITHM 3530 02:23:52,489 --> 02:23:54,991 IS CLEARED FOR SPECIFIC DISEASE 3531 02:23:54,991 --> 02:23:56,393 AND RAM RABUT FUND PHOTOGRAPHS 3532 02:23:56,393 --> 02:23:58,261 WHICH IS CLEARANCE AND 3533 02:23:58,261 --> 02:23:59,763 OPHTHALMOLOGY FOR, IT'S EASY 3534 02:23:59,763 --> 02:24:02,833 ENOUGH, CAN YOU SAY, YOU KNOW 3535 02:24:02,833 --> 02:24:05,569 LIKE HERE, I ARK LABEL FOR 3536 02:24:05,569 --> 02:24:07,003 CANNON, THEY HAVE EXPANDED 3537 02:24:07,003 --> 02:24:10,474 FURTHER NOW BUT 1 OF THE FIRST 3538 02:24:10,474 --> 02:24:12,175 1S WAS CANON, AND HAD IS EASY 3539 02:24:12,175 --> 02:24:14,344 BECAUSE THIS IS EASY BECAUSE IT 3540 02:24:14,344 --> 02:24:16,546 IS RETINAL IMAGING FOR FUNDUS 3541 02:24:16,546 --> 02:24:17,714 PHOTOGRAPHY AND SEE THE DEVICE 3542 02:24:17,714 --> 02:24:19,749 AND BE DONE WITH IT BUT WHEN YOU 3543 02:24:19,749 --> 02:24:21,585 HAVE ADVANCED HIMMAGING LIKE ANY 3544 02:24:21,585 --> 02:24:22,686 LASER OR AVAILABLE AND GUIDED 3545 02:24:22,686 --> 02:24:23,854 THERE'S SO MUCH MORE TO SAY. 3546 02:24:23,854 --> 02:24:34,364 YOU CAN'T JUST SAY, I HAVE IT 3547 02:24:37,033 --> 02:24:39,603 NEEDS MORE WITH MACULAR CUBE, 3548 02:24:39,603 --> 02:24:42,005 CUBE SCANNING AND ALL THOSE ARE 3549 02:24:42,005 --> 02:24:46,076 IMPORTANT METRICS TO ADHERE TO. 3550 02:24:46,076 --> 02:24:48,478 AND WHEN WE TALK ABOUT AI, WHERE 3551 02:24:48,478 --> 02:24:56,820 DOES ALL THIS END POINT, ALL 3552 02:24:56,820 --> 02:24:59,222 THIS SPECIFICATION COME FROM WE 3553 02:24:59,222 --> 02:25:00,624 ALL TALK ABOUT IMAGE CURATION 3554 02:25:00,624 --> 02:25:02,592 WHICH IS SUCH AN IMPORTANT PART 3555 02:25:02,592 --> 02:25:10,333 FOR ACHIEVING THESE HIGH IMPACT 3556 02:25:10,333 --> 02:25:13,203 INFORMATION AND IT HAS A LOT OF 3557 02:25:13,203 --> 02:25:13,937 LABELS, FORMAT, ANNOTATIONS, 3558 02:25:13,937 --> 02:25:15,205 OVERLAYS AND AS READING CENTERS 3559 02:25:15,205 --> 02:25:17,007 WE USED TO DO CLINICAL TRIALS 3560 02:25:17,007 --> 02:25:22,045 BUT NOW THERE'S ANOTHER SITE TO 3561 02:25:22,045 --> 02:25:23,980 IT WHERE MANY COLLABORATORS, 3562 02:25:23,980 --> 02:25:28,451 INDUSTRY SPONSORS COME TO US AND 3563 02:25:28,451 --> 02:25:30,554 ASK US TO CURATE IMAGES AND MAKE 3564 02:25:30,554 --> 02:25:32,556 THEM AI READY AND IT'S A TIME 3565 02:25:32,556 --> 02:25:33,290 CONSUMING INTENSE YOB AND SO 3566 02:25:33,290 --> 02:25:35,859 MUCH SO THAT IN THE LIFE CYCLE 3567 02:25:35,859 --> 02:25:37,627 IMAGE CURATION TAKES NEARLY 80% 3568 02:25:37,627 --> 02:25:48,138 OF THE TIME INVOLVED IN MODEL 3569 02:25:52,809 --> 02:25:53,310 DEVELOPMENT. 3570 02:25:53,310 --> 02:25:57,113 WE ARE VERY EXCITED ABOUT THE 3571 02:25:57,113 --> 02:25:57,514 TOMMOLOGY PROGRAM. 3572 02:25:57,514 --> 02:25:58,648 SO ABOUT 5 YEARS AGO, WE WERE 3573 02:25:58,648 --> 02:26:00,283 LOOKING AT WHEN WE REWERE 3574 02:26:00,283 --> 02:26:03,219 CEIVING THIS REQUEST TO CURATE 3575 02:26:03,219 --> 02:26:06,289 IMAGES FOR ALGORITHMS SO WE HAD 3576 02:26:06,289 --> 02:26:11,595 THESE FUNDUS PHOTOGRAPHS, 3577 02:26:11,595 --> 02:26:12,762 RETINAL IMAGES, ALL FILE NAMES 3578 02:26:12,762 --> 02:26:14,197 LIKE THIS, THERE WAS NO WAY TO 3579 02:26:14,197 --> 02:26:15,999 KNOW WHAT DOES THIS IMAGE BELONG 3580 02:26:15,999 --> 02:26:17,934 TO, YES, THERE'S A SUBJECT 3581 02:26:17,934 --> 02:26:20,503 FOLDER, WE KNOW IT BELONGS TO 3582 02:26:20,503 --> 02:26:23,506 SUBJECT XYZ, BUT IS IT THE RIGHT 3583 02:26:23,506 --> 02:26:24,307 EYE, LEFT EYE? 3584 02:26:24,307 --> 02:26:25,508 THERE'S NO WAY TO KNOW FROM THE 3585 02:26:25,508 --> 02:26:27,377 IMAGE UNTIL YOU OPEN IT AND THAT 3586 02:26:27,377 --> 02:26:30,180 WHEN WE REALIZED OH MY GOD THIS 3587 02:26:30,180 --> 02:26:30,580 METADATA MATTERS. 3588 02:26:30,580 --> 02:26:32,782 THERE'S NO WAY TO TELL FROM THIS 3589 02:26:32,782 --> 02:26:34,317 IMAGE WHAT THIS BELONGS TO. 3590 02:26:34,317 --> 02:26:36,519 AND WHEN YOU TALK ABOUT 7 FIELD 3591 02:26:36,519 --> 02:26:40,924 IMAGES WHICH IS WHAT MOST 3592 02:26:40,924 --> 02:26:43,193 CLINICAL TRIALS USE WE HAVE 3593 02:26:43,193 --> 02:26:44,260 SPREADSHEETS, WE COULD CONVERT 3594 02:26:44,260 --> 02:26:45,195 THESE INTO DISCIPLINARY COM, WE 3595 02:26:45,195 --> 02:26:47,764 COULD GET THE SUBJECT ID, PHOTO 3596 02:26:47,764 --> 02:26:53,470 DATE OR MANUELLY KIND OF SOMEHOW 3597 02:26:53,470 --> 02:26:54,537 INCORPORATE IT INTO METADATA BUT 3598 02:26:54,537 --> 02:26:56,606 THINGS LIKE WHICH EYE THE IMAGE 3599 02:26:56,606 --> 02:26:58,808 WAS OR WHICH ANATOMICAL 3600 02:26:58,808 --> 02:27:00,076 LOCATION, THE RETINA, THESE WERE 3601 02:27:00,076 --> 02:27:03,647 NOT THINGS THAT COULD BE RELATED 3602 02:27:03,647 --> 02:27:05,248 BETWEEN AN IMAGE AND A 3603 02:27:05,248 --> 02:27:10,420 SPREADSHEET BECAUSE THAT DATA 3604 02:27:10,420 --> 02:27:10,887 DIDN'T EXIST. 3605 02:27:10,887 --> 02:27:12,756 THERE WAS NO NEED TO HAVE THAT 3606 02:27:12,756 --> 02:27:14,624 DATA AND HUMANS DON'T NEED THAT 3607 02:27:14,624 --> 02:27:15,992 AND HUMAN DON'T NEED TO BE TOLD 3608 02:27:15,992 --> 02:27:17,327 WHICH PART OF THE RETINA THIS IS 3609 02:27:17,327 --> 02:27:19,896 FROM, SO WE HAD TO BUILD AI FOR 3610 02:27:19,896 --> 02:27:22,332 AI, SO WE WERE BUILT AN AI THAT 3611 02:27:22,332 --> 02:27:24,300 COULD SAY, WHICH EYE THIS WAS 3612 02:27:24,300 --> 02:27:28,338 FROM, WHICH FIELD OF THE RETINA, 3613 02:27:28,338 --> 02:27:29,406 SO THIS ALEGORITHMS COULD LOOK 3614 02:27:29,406 --> 02:27:30,740 AT IMAGE AND SAY, THIS IS FIELD 3615 02:27:30,740 --> 02:27:34,310 1 AND WE ADDED A CONFIDENCE 3616 02:27:34,310 --> 02:27:39,949 FIELD TO IT, 99% CONFIDENT THIS 3617 02:27:39,949 --> 02:27:42,485 IS THE FIELD 1 AND 65.8% 3618 02:27:42,485 --> 02:27:44,821 CONFIDENT THIS IS FIELD 5 AND WE 3619 02:27:44,821 --> 02:27:46,556 GEPPED A WORK FLOW BECAUSE IN 3620 02:27:46,556 --> 02:27:48,091 THE READING CENTER THOUSANDS OF 3621 02:27:48,091 --> 02:27:52,829 IMAGES GO THROUGH THE DAY, SO, 3622 02:27:52,829 --> 02:27:54,464 WE NEEDED A STRONG WORK FLOW AND 3623 02:27:54,464 --> 02:27:56,599 PROCESS TO USE THIS AI FOR 3624 02:27:56,599 --> 02:27:57,067 LABELING. 3625 02:27:57,067 --> 02:27:59,602 AND THIS FIELD DETECTOR WE SAID, 3626 02:27:59,602 --> 02:28:03,707 WELL, IF IT'S 99% CONFIDENT, WE 3627 02:28:03,707 --> 02:28:05,642 WILL LET IT GO BUT IF IT WAS 3628 02:28:05,642 --> 02:28:07,444 UNDER THAT THEN A HUMAN HAD TO 3629 02:28:07,444 --> 02:28:13,516 CHECK THE IMAGES AND ABOUT 80% 3630 02:28:13,516 --> 02:28:16,853 OF THE TIME THE AI DETECTOR 3631 02:28:16,853 --> 02:28:18,788 COULD HAVE 99% CONTIARAS DENSE, 3632 02:28:18,788 --> 02:28:20,457 SO IT WAS OHM OCCASIONALLY WE 3633 02:28:20,457 --> 02:28:21,891 NEEDED A CHECK, SO WHEN WE LOOK 3634 02:28:21,891 --> 02:28:24,594 AT THIS, IT WAS DARK IMAGES OR 3635 02:28:24,594 --> 02:28:25,762 THE FIELD WASN'T IDENTIFIED AND 3636 02:28:25,762 --> 02:28:27,797 WHEN WE GRANTED THE FIRST TIME, 3637 02:28:27,797 --> 02:28:30,133 ABOUT 11,000 IMANNUALS, IT TOOK 3638 02:28:30,133 --> 02:28:32,102 12 MINUTES TO LABEL ALL THESE 3639 02:28:32,102 --> 02:28:32,736 AND CURATE THEM AND ORGANIZE 3640 02:28:32,736 --> 02:28:34,504 THEM AND IF YOU HAD A HUMAN 3641 02:28:34,504 --> 02:28:42,011 DOING THAT, OUR CALCULATION WAS 3642 02:28:42,011 --> 02:28:42,378 86 HOURS. 3643 02:28:42,378 --> 02:28:44,514 SO THAT WAS SAVED FOR CURATING, 3644 02:28:44,514 --> 02:28:46,349 AT THE SAME TEE WOO DID A 3645 02:28:46,349 --> 02:28:47,517 HUNDRED THOUSAND IMAGES AND IT 3646 02:28:47,517 --> 02:28:48,952 TOOK ABOUT HALF AN HOUR TO 3647 02:28:48,952 --> 02:28:56,693 CURATE THE WHOLE DATA SET. 3648 02:28:56,693 --> 02:28:58,795 WITH RETINAL AGAIN, THERE ARE A 3649 02:28:58,795 --> 02:29:01,231 LOT IMANNUALS AND IF YOU GET TO 3650 02:29:01,231 --> 02:29:03,199 OR T, THERE ARE LOTS OF THEM. 3651 02:29:03,199 --> 02:29:05,568 HOW ARE THEY BUILDING AI ON 3652 02:29:05,568 --> 02:29:07,203 THESE OCTs, WHAT PROCESS ARE 3653 02:29:07,203 --> 02:29:08,905 BEING USED FOR IMAGE CURATION, 3654 02:29:08,905 --> 02:29:10,039 SOME USE SPORTS BA UNITED STATES 3655 02:29:10,039 --> 02:29:12,175 THEY'RE MORE AVAILABLE ON THE 3656 02:29:12,175 --> 02:29:16,312 NEWER SYSTEMS WITH HEIDELBERG, 3657 02:29:16,312 --> 02:29:18,548 SOME OF THEM HAVE THE 3658 02:29:18,548 --> 02:29:19,382 DISCIPLINARY COMCONVERTER, THERE 3659 02:29:19,382 --> 02:29:21,918 ARE FEW, THERE ARE OPEN SOURCE 3660 02:29:21,918 --> 02:29:23,987 CRYPTS TO CONVERT IMAGES TO 3661 02:29:23,987 --> 02:29:25,188 DISCIPLINARY COM, THERE ARE 3662 02:29:25,188 --> 02:29:26,256 INDIVIDUAL SCANS, EACH KAN--KANA 3663 02:29:26,256 --> 02:29:29,726 IS EXPORTED AS A 2 D IMAGE SO 3664 02:29:29,726 --> 02:29:31,795 YOU GET 1282 D JPEGS TO DEAL 3665 02:29:31,795 --> 02:29:33,329 WITH, SOME PEOPLE ARE USING 3666 02:29:33,329 --> 02:29:34,864 SCREEN SHOTS, YES, THERE ARE 3667 02:29:34,864 --> 02:29:44,174 PUBLICATIONS WITH SCREEN SHOTS 3668 02:29:44,174 --> 02:29:46,743 OF OCT, WE DON'T KNOW HOW MOST 3669 02:29:46,743 --> 02:29:49,078 PEOPLE ARE PUTTING THEM INTO AI 3670 02:29:49,078 --> 02:29:50,413 AND DEVELOPING MODELS. 3671 02:29:50,413 --> 02:29:51,981 SO FOR CURATION, OF OCTs WE 3672 02:29:51,981 --> 02:29:56,886 HAVE A LOT MORE OF DETAILS WE 3673 02:29:56,886 --> 02:29:58,221 HAVE TO ADHERE TO WHEN WE'RE 3674 02:29:58,221 --> 02:30:00,623 BRINGING THOSE TOGETHER BUT WHEN 3675 02:30:00,623 --> 02:30:02,859 CONVERTING THE DISCIPLINARY 3676 02:30:02,859 --> 02:30:04,160 DICOM, THE METADATA NEEDS TO 3677 02:30:04,160 --> 02:30:05,929 INVOLVE TONS OF DETAILS TO MAKE 3678 02:30:05,929 --> 02:30:07,130 SHOULDURE THAT WHAT THE MODEL IS 3679 02:30:07,130 --> 02:30:08,998 TRAINED ON IS WHAT IT'S BEING 3680 02:30:08,998 --> 02:30:14,470 DEPLOYED ON. 3681 02:30:14,470 --> 02:30:15,638 BECAUSE DEPLOYMENT IS A WHOLE 3682 02:30:15,638 --> 02:30:20,844 AND OTHER DIMENSION OF AI, 3683 02:30:20,844 --> 02:30:26,549 BECAUSE WHEN YOU DEPLOY AI, YOU 3684 02:30:26,549 --> 02:30:28,084 ARE DEALING WITH HUMANS, AND 3685 02:30:28,084 --> 02:30:29,953 WHEN YOU REALIZE QUICKLY IS THAT 3686 02:30:29,953 --> 02:30:30,787 YOU'RE DEALING WITH HUMAN 3687 02:30:30,787 --> 02:30:33,022 SPECIES WHEN YOU DEPLOY AI. 3688 02:30:33,022 --> 02:30:38,494 IT'S NOT OCT BASED, IT'S 3689 02:30:38,494 --> 02:30:40,430 AUTOFLUORESCENCE, BUT IT WAS 3690 02:30:40,430 --> 02:30:41,831 INSTALLED IN CLINICS FOR 3691 02:30:41,831 --> 02:30:42,932 SCREENING PATIENTS FOR GA 3692 02:30:42,932 --> 02:30:44,334 BECAUSE CLINICAL TRIALS USE AN 3693 02:30:44,334 --> 02:30:46,002 AREA LIMIT, THEY SAY, YOU KNOW I 3694 02:30:46,002 --> 02:30:51,407 WANT A GA ON AUTOFLUORESCENCE TO 3695 02:30:51,407 --> 02:30:53,409 BE 2.5 TO 19 SQUARE MILLIMETERS 3696 02:30:53,409 --> 02:30:56,145 SO THIS RUNS JUST THE PATIENT 3697 02:30:56,145 --> 02:30:59,282 FALLS IN THAT RANGE AND THEN, 3698 02:30:59,282 --> 02:31:02,719 CLINICS CAN TAKE FURTHER IMAGES 3699 02:31:02,719 --> 02:31:05,154 LIKE OCT, FA, DO ALL THE 3700 02:31:05,154 --> 02:31:06,456 REQUIRED TESTS RATHER THAN PUT 3701 02:31:06,456 --> 02:31:10,927 THE BURDEN RIGHT AWAY. 3702 02:31:10,927 --> 02:31:14,864 ASK WE GET A CALL, ALGORITHM NOT 3703 02:31:14,864 --> 02:31:15,331 WORKING. 3704 02:31:15,331 --> 02:31:18,001 WHAT HAPPENED OUR HEIDELBERG WAS 3705 02:31:18,001 --> 02:31:19,669 TOO BUSY SO WE TOOK ON SOMETHING 3706 02:31:19,669 --> 02:31:19,869 ELSE. 3707 02:31:19,869 --> 02:31:20,904 YOU CAN'T DO THAT. 3708 02:31:20,904 --> 02:31:24,641 YOU HAVE TO DO HEIDELBERG ONLY, 3709 02:31:24,641 --> 02:31:25,408 IT'S TRAINED FOR. 3710 02:31:25,408 --> 02:31:28,344 WE GET A CALL AGAIN, THE ALLEGOR 3711 02:31:28,344 --> 02:31:29,712 RIG IMPEDIMENTS NOT LOOKING, 3712 02:31:29,712 --> 02:31:30,046 WHAT HAPPENED. 3713 02:31:30,046 --> 02:31:32,448 TAKE A ELECTRIC AT IT, THERE'S A 3714 02:31:32,448 --> 02:31:34,884 GRID ON THE IMAGE, TAKE THE GRID 3715 02:31:34,884 --> 02:31:36,653 OFF, BECAUSE AI CAN'T SEE IF 3716 02:31:36,653 --> 02:31:37,320 THERE'S A GRID. 3717 02:31:37,320 --> 02:31:38,888 YOU TAKE THE GRID OFF, 3718 02:31:38,888 --> 02:31:41,224 MEASUREMENTS COME, SO EVERY 3719 02:31:41,224 --> 02:31:43,059 SINGLE DETAIL MATTERS, 3720 02:31:43,059 --> 02:31:44,694 ESPECIALLY WHEN YOU'RE 3721 02:31:44,694 --> 02:31:45,295 PROSPECTIVELY DEPLOYING THESE 3722 02:31:45,295 --> 02:31:46,963 FOR USE AND HANDING IT OUT TO 3723 02:31:46,963 --> 02:31:54,671 THE PUBLIC FOR USE EMPLOY SO TO 3724 02:31:54,671 --> 02:31:57,073 SUMMARIZE CURATION IS THE 3725 02:31:57,073 --> 02:31:58,274 CORNERSTONE OF AI MODEL 3726 02:31:58,274 --> 02:31:58,975 DEVELOPMENT, WITHOUT WHICH IT 3727 02:31:58,975 --> 02:32:00,009 WILL BE VERY DIFFICULT TO 3728 02:32:00,009 --> 02:32:02,712 PROGRESS IN THE FIELD, IT'S NOT 3729 02:32:02,712 --> 02:32:04,981 ALL APPLES, TO APPLES EACH WITH 3730 02:32:04,981 --> 02:32:09,919 OCTs, THERE'S A LOT MORE 3731 02:32:09,919 --> 02:32:11,020 DETAILS WE NEED TO TALK ABOUT 3732 02:32:11,020 --> 02:32:15,858 AND I THINK I WILL PUT A SPEECH 3733 02:32:15,858 --> 02:32:17,293 FOR CARRY GATES WHO TALK ABOUT 3734 02:32:17,293 --> 02:32:18,728 ALL THE SOLUTIONS, I SAID I HAVE 3735 02:32:18,728 --> 02:32:20,897 THE PROBLEMS AND SHE HAS THE 3736 02:32:20,897 --> 02:32:21,364 SOLUTIONS. 3737 02:32:21,364 --> 02:32:21,764 THANK YOU. 3738 02:32:21,764 --> 02:32:32,008 [ APPLAUSE ] 3739 02:32:33,142 --> 02:32:38,881 >> THANK YOU, SHE DID MY JOB FOR 3740 02:32:38,881 --> 02:32:42,018 ME BUT NEXT IS KERRY GOETZ, SHE 3741 02:32:42,018 --> 02:32:45,822 WILL TALK ABOUT NEI EFFORTS FOR 3742 02:32:45,822 --> 02:32:47,023 ADVANCING OCULAR IMAGING 3743 02:32:47,023 --> 02:32:47,290 STANDARDS. 3744 02:32:47,290 --> 02:32:48,891 >> THANK YOU FOR HAVING ME I'M 3745 02:32:48,891 --> 02:32:51,894 EXCITE TO BE AT OCT FEST, OVER 3746 02:32:51,894 --> 02:32:53,930 THE PAST FEW YEARS I'VE BEEN 3747 02:32:53,930 --> 02:32:54,764 ENAMORED WITH THE TECHNOLOGY AND 3748 02:32:54,764 --> 02:32:56,532 THE OFFICE I RUN AT THE 3749 02:32:56,532 --> 02:32:58,368 NCEREBELLUMS I, THE OFFICE OF 3750 02:32:58,368 --> 02:32:59,669 DATA SCIENCE AND HEALTH 3751 02:32:59,669 --> 02:33:01,104 INFORMATIC SYSTEM VERY MUCH 3752 02:33:01,104 --> 02:33:02,372 INVOLVED IN SHARING STORIES 3753 02:33:02,372 --> 02:33:04,007 ABOUT HOW THIS KIND OF 3754 02:33:04,007 --> 02:33:11,881 TECHNOLOGY CAN BE TRANSFORMATIVE 3755 02:33:11,881 --> 02:33:12,215 TO HEALTHCARE. 3756 02:33:12,215 --> 02:33:13,616 JUST WANT TO SAY ABOUT MY 3757 02:33:13,616 --> 02:33:14,917 OFFICE, WE USE OUR NEW PLAN 3758 02:33:14,917 --> 02:33:16,786 WHICH HAS A CROSS CUTTING DATA 3759 02:33:16,786 --> 02:33:18,154 SCIENCE OF EMPHASIS AS OUR 3760 02:33:18,154 --> 02:33:19,122 GUIDING LIGHT. 3761 02:33:19,122 --> 02:33:21,524 AND WE ARE REALLY FOCUSED ON 3762 02:33:21,524 --> 02:33:25,261 MAKING THINGS FAIR IN 2 WAYS, SO 3763 02:33:25,261 --> 02:33:26,295 FINDABLE, ACCESSIBLE, 3764 02:33:26,295 --> 02:33:27,363 INTEROPERABLE AND REUSABLE BUT 3765 02:33:27,363 --> 02:33:28,731 ALSO FULLY AI READY AND I THINK 3766 02:33:28,731 --> 02:33:36,539 THAT'S REALLY WHERE THIS IMAGING 3767 02:33:36,539 --> 02:33:37,173 HAS GREAT POTENTIAL. 3768 02:33:37,173 --> 02:33:40,176 SO WE TALKED ABOUT THE LAST 2 3769 02:33:40,176 --> 02:33:41,377 DAYS ABOUT RETINALPPLICATION, 3770 02:33:41,377 --> 02:33:42,979 IDENTIFYING EVERYTHING FROM 3771 02:33:42,979 --> 02:33:44,380 OCULAR CONDITIONS TO GLAUCOMA, 3772 02:33:44,380 --> 02:33:46,716 CAT RACK, ALL THOSE THINGS BUT 3773 02:33:46,716 --> 02:33:49,318 ALSO NONOCULAR THINGS, HEART 3774 02:33:49,318 --> 02:33:54,357 DISEASE, ALZHEIMERS, METABOLIC 3775 02:33:54,357 --> 02:33:57,760 DISORDERS, WE HAVE THE TRULY 3776 02:33:57,760 --> 02:34:00,530 AMAZING ADVANTAGE THAT THESE ARE 3777 02:34:00,530 --> 02:34:02,965 NONIMAGED AND THEY ARE DONE BY 3778 02:34:02,965 --> 02:34:04,467 NONTRAINED PROVIDERS, THEY CAN 3779 02:34:04,467 --> 02:34:06,335 BE DONE BY THE SELF, AND VERY 3780 02:34:06,335 --> 02:34:06,569 QUICKLY. 3781 02:34:06,569 --> 02:34:15,144 SO IT'S A FABULOUS WAY FOR US TO 3782 02:34:15,144 --> 02:34:17,046 BUILD OUT APPLICATIONS FOR 3783 02:34:17,046 --> 02:34:17,647 SUBTLE HEALTH REFLECTIVE 3784 02:34:17,647 --> 02:34:17,947 TECHNOLOGY. 3785 02:34:17,947 --> 02:34:20,550 SO IN THIS CASE, SOME PEOPLE ARE 3786 02:34:20,550 --> 02:34:23,686 USING OCULAR IMAGING TO CREATE 3787 02:34:23,686 --> 02:34:25,488 HEALTH SCORES, THESE CAN BE 3788 02:34:25,488 --> 02:34:27,023 SCORES FOR CARDIAC HEALTH, THESE 3789 02:34:27,023 --> 02:34:28,925 CAN BE A GENERALIZED HEALTH 3790 02:34:28,925 --> 02:34:30,393 SCORE, LIKE TODAY, I DIDN'T GET 3791 02:34:30,393 --> 02:34:31,794 MUCH SLEEP LAST NIGHT AND I WILL 3792 02:34:31,794 --> 02:34:38,301 GET A HEALTH SCORE THAT WILL 3793 02:34:38,301 --> 02:34:40,269 TELL ME MY SLEEPLESS SCORE, MAKE 3794 02:34:40,269 --> 02:34:42,705 SURE YOU'RE DOING BETTER TO 3795 02:34:42,705 --> 02:34:44,173 SLEEP BETTER, THOSE SUBTLE 3796 02:34:44,173 --> 02:34:45,808 NUDGES TO HELP BEHAVIOR. 3797 02:34:45,808 --> 02:34:47,877 AND WE HAVE THESE TECHNOLOGIES, 3798 02:34:47,877 --> 02:34:49,979 I'VE BEEN FASCINATED IN SHARING 3799 02:34:49,979 --> 02:34:52,782 WITH THE PUBLIC ABOUT THAT--DO 3800 02:34:52,782 --> 02:34:53,816 THIS NONINVASIVELY IN THE HOME 3801 02:34:53,816 --> 02:35:01,290 AND WE'VE HEARD ABOUT THOSE 3802 02:35:01,290 --> 02:35:01,524 ALREADY. 3803 02:35:01,524 --> 02:35:03,559 I REALLY SEE WHERE THIS KIND OF 3804 02:35:03,559 --> 02:35:05,695 DEVICE IS BIG, IT'S A PLP 3805 02:35:05,695 --> 02:35:07,363 READING CUFF THAT EXISTING IN 3806 02:35:07,363 --> 02:35:08,898 NATCHER WHICH IS HERE IN CAMPUS, 3807 02:35:08,898 --> 02:35:10,566 CAN YOU WALK UP TO 1 OF THESE, 3808 02:35:10,566 --> 02:35:12,168 SIT IN FRONT OF IT, PUSH A 3809 02:35:12,168 --> 02:35:16,973 BUTTON AND BE ABLE TO GET SOME 3810 02:35:16,973 --> 02:35:21,210 INFORMATION RISK ANALYSIS, NOT 3811 02:35:21,210 --> 02:35:23,079 DIAGNOSTICS PER SE BUT 3812 02:35:23,079 --> 02:35:23,813 SUBSIDIARILE INFORMATION ABOUT 3813 02:35:23,813 --> 02:35:25,481 YOUR LIFESTYLE AND HABITS. 3814 02:35:25,481 --> 02:35:25,915 JUST LIKE THIS. 3815 02:35:25,915 --> 02:35:28,417 SO HAVE YOU AN INTERESTING BLOOD 3816 02:35:28,417 --> 02:35:29,619 PRESSURE READING, WHAT MIGHT YOU 3817 02:35:29,619 --> 02:35:31,687 WANT TO CHANGE, MAYBE YOU NEED 3818 02:35:31,687 --> 02:35:35,258 TO EAT MORE STARCHY VEGETABLES, 3819 02:35:35,258 --> 02:35:36,325 GREEN VEGETABLES, MAYBE YOU NEED 3820 02:35:36,325 --> 02:35:37,793 TO WALK MORE, GET MORE SLEEP, I 3821 02:35:37,793 --> 02:35:41,864 REALLY THINK THIS IS POSSIBLE. 3822 02:35:41,864 --> 02:35:45,067 AND WITH THE ADVANCES WITNESS 3823 02:35:45,067 --> 02:35:46,369 HOME AND TECHNOLOGIES, AS I WAS 3824 02:35:46,369 --> 02:35:48,237 SET UP NICELY FOR, THESE CAN BE 3825 02:35:48,237 --> 02:35:50,339 THINGS IF PEOPLE ARE A HIGH RISK 3826 02:35:50,339 --> 02:35:52,208 CONDITION THAT THEY'RE DOING 3827 02:35:52,208 --> 02:35:54,076 REPEATED APPLICATIONS AS WE 3828 02:35:54,076 --> 02:35:54,343 SAID. 3829 02:35:54,343 --> 02:35:55,845 WE TO HAVE THESE REPEATED 3830 02:35:55,845 --> 02:36:01,751 MEASURES JUST LIKE IN-HOME BLOOD 3831 02:36:01,751 --> 02:36:02,251 FLUICOSE MONITORING. 3832 02:36:02,251 --> 02:36:06,556 SX HEAT I HAD THE PLEASURE 3833 02:36:06,556 --> 02:36:09,659 OF---AND I HAD THE PLEASURE OF 3834 02:36:09,659 --> 02:36:11,327 SHARING THESE STORIES, INSIGHTS 3835 02:36:11,327 --> 02:36:13,062 INFORMATION WITH HIGH LEVEL 3836 02:36:13,062 --> 02:36:14,230 GOVERNMENT FOLKS ADVOCATE ANDS 3837 02:36:14,230 --> 02:36:18,267 PEOPLE IN THE HEALTHCARE SPACE, 3838 02:36:18,267 --> 02:36:20,203 SO I HAD THE GREAT OPPORTUNITY 3839 02:36:20,203 --> 02:36:21,704 TO PRESENT OCT IMAGING AT A 3840 02:36:21,704 --> 02:36:23,139 WHITE HOUSE EEIVET THAT WAS 3841 02:36:23,139 --> 02:36:24,807 ATTENDED BY PRESIDENT BIDEN, I 3842 02:36:24,807 --> 02:36:27,009 YOLK THAT THIS WAS LIKE ADULT 3843 02:36:27,009 --> 02:36:30,846 SCIENCE FAIR WITH THE PRESIDENT 3844 02:36:30,846 --> 02:36:32,448 AS THE JUDGE, WE DID NOT WIN TOP 3845 02:36:32,448 --> 02:36:34,116 3 BUT WE WERE VERY CLOSE AND 3846 02:36:34,116 --> 02:36:35,551 EVERYONE WHO CAME TO OUR BOOTH, 3847 02:36:35,551 --> 02:36:38,888 I WAS ACTUALLY DOING OCTs, ON 3848 02:36:38,888 --> 02:36:40,690 INDIVIDUALS AT THIS EVENT, 3849 02:36:40,690 --> 02:36:44,660 MYSELF, I'M A DATA SCIENTIST, SO 3850 02:36:44,660 --> 02:36:47,997 THAT'S WITH SHARED EASE OF USE, 3851 02:36:47,997 --> 02:36:49,398 AND EVERYONE WAS FLOORED. 3852 02:36:49,398 --> 02:36:55,171 THEY WERE LIKE WHY, WHY IS THIS 3853 02:36:55,171 --> 02:36:55,972 NOT AVAILABLE. 3854 02:36:55,972 --> 02:36:58,274 TWO QUESTIONS I GOT: WHERE CAN 3855 02:36:58,274 --> 02:36:59,208 I IMET THIS DONE? 3856 02:36:59,208 --> 02:37:01,043 AND WHY IS THIS NOT POSSIBLE IN 3857 02:37:01,043 --> 02:37:01,644 OUR COMMUNITY? 3858 02:37:01,644 --> 02:37:03,546 WHY CAN'T I JUST ROLL UP AND GET 3859 02:37:03,546 --> 02:37:08,851 AN OCT AT MY PHARMACY? 3860 02:37:08,851 --> 02:37:10,386 AND THE REASONS ARE REALLY MANY 3861 02:37:10,386 --> 02:37:11,921 AND WE HIGHLIGHT TD A LOT OF 3862 02:37:11,921 --> 02:37:12,822 THOSE. 3863 02:37:12,822 --> 02:37:15,124 SO WE NEEDED INTEROPERABILITY, 3864 02:37:15,124 --> 02:37:16,492 CONNECTING IMAGING DEVICES TO 3865 02:37:16,492 --> 02:37:21,464 OUR ECOSYSTEM OF HELT CARE RIGHT 3866 02:37:21,464 --> 02:37:24,367 NOW THEY LIVE ON DEVICES, THEY 3867 02:37:24,367 --> 02:37:25,901 LIVE ON PROPRIETARY SYSTEMS, WE 3868 02:37:25,901 --> 02:37:27,637 NEED TO CONNECT ALL THOSE SO WE 3869 02:37:27,637 --> 02:37:29,305 CAN START USING TECHNIQUES AND 3870 02:37:29,305 --> 02:37:30,273 FINDING PRESIDENTERNS AND 3871 02:37:30,273 --> 02:37:31,440 LOOKING AT PROGRESSION. 3872 02:37:31,440 --> 02:37:33,376 WE NEED STANDARDS, WE NEED 3873 02:37:33,376 --> 02:37:35,211 TANNED ORDERS IN ON TWO-CENTS OF 3874 02:37:35,211 --> 02:37:37,313 THE WAY AND I WILL SHARE IT IN A 3875 02:37:37,313 --> 02:37:39,448 MINUE BUT JUST TO SAY WE NEED 3876 02:37:39,448 --> 02:37:40,449 STANDARDS OF REPRESENTATION OF 3877 02:37:40,449 --> 02:37:43,252 THE MEASURES AND THE METADATA SO 3878 02:37:43,252 --> 02:37:45,121 FOR INITANCE LIKE AMITHA WAS 3879 02:37:45,121 --> 02:37:47,657 SAYING, WE ARE ALWAYS KNOWING 3880 02:37:47,657 --> 02:37:50,159 EYE WAS IMAGES AND ARE WE 3881 02:37:50,159 --> 02:37:51,827 REPRESENTING THAT EYE AS OS OR 3882 02:37:51,827 --> 02:37:53,329 L, WHAT ARE WE SAYING ABOUT IT 3883 02:37:53,329 --> 02:37:55,731 SO WE NEED TO HAVE CONSISTENCY 3884 02:37:55,731 --> 02:37:57,333 IN THAT REPRESENTATION FOR 3885 02:37:57,333 --> 02:38:07,810 MACHINE ACTIONABILITY AND WE 3886 02:38:09,812 --> 02:38:12,014 NEED INNOVATION, SO, BRIDGE TO 3887 02:38:12,014 --> 02:38:15,017 AI AND TOOLS TO ACCESS THESE AND 3888 02:38:15,017 --> 02:38:16,786 I THINK THE NEI IS REALLY 3889 02:38:16,786 --> 02:38:18,054 FOCUSED ON TRYING TO GET PEOPLE 3890 02:38:18,054 --> 02:38:26,028 INTO A SHARING CULTURE. 3891 02:38:26,028 --> 02:38:28,898 SO I'M SURE A FEW OF YOU 3892 02:38:28,898 --> 02:38:31,067 ATTENDED THIS WORKSHOP,S AS A 3893 02:38:31,067 --> 02:38:32,702 WORK CLOUD, BUT IT'S AN ASPECT 3894 02:38:32,702 --> 02:38:34,236 OF THE WORKSHOP THAT WHAT PEOPLE 3895 02:38:34,236 --> 02:38:36,872 WANTED FROM THE STANDARDS 3896 02:38:36,872 --> 02:38:38,741 ADOPTION METHOD AND DICOM IS THE 3897 02:38:38,741 --> 02:38:40,643 STABBED ARD FOR MEDICAL IMAGING 3898 02:38:40,643 --> 02:38:51,187 IS INTEROPERABILITY, ALL RIGHT, 3899 02:38:52,521 --> 02:38:54,223 SO, AND A FEW OTHERS HERE WROTE 3900 02:38:54,223 --> 02:38:57,460 AN ARTICLE IN ASRS ABOUT HOW WE 3901 02:38:57,460 --> 02:38:58,627 ENVISION INTERROPERABILITY WITH 3902 02:38:58,627 --> 02:39:00,429 IMAGING AND A LARGE PART OF 3903 02:39:00,429 --> 02:39:06,569 THAT, INVOLVES FIRE, SO THIS IS 3904 02:39:06,569 --> 02:39:08,304 THE FAST HEALTHCARE 3905 02:39:08,304 --> 02:39:09,271 INTERROPERABILITY RESOURCES, 3906 02:39:09,271 --> 02:39:10,639 INTERROPERABILITY USED IN MOST 3907 02:39:10,639 --> 02:39:11,941 ELECTRONIC HEALTH RECORD SYSTEMS 3908 02:39:11,941 --> 02:39:13,843 SO AGAIN, WE WANT TO BRING THOSE 3909 02:39:13,843 --> 02:39:15,010 INTO THE FIRE ECOSYSTEM AND WE 3910 02:39:15,010 --> 02:39:16,712 WANT TO CONNECK, WE WANT TO 3911 02:39:16,712 --> 02:39:19,115 CONNECT THE METADATA AND THE 3912 02:39:19,115 --> 02:39:22,418 IMAGE OBJECTS INTO THE 3913 02:39:22,418 --> 02:39:23,185 HEALTHCARE ECOSYSTEM. 3914 02:39:23,185 --> 02:39:24,620 SOPHISTICATEDY WE NEED STANDARDS 3915 02:39:24,620 --> 02:39:26,589 AND WE'VE BEEN, I THINK MIKE 3916 02:39:26,589 --> 02:39:27,790 SHOWED THIS EXACT SLIDE BUT I 3917 02:39:27,790 --> 02:39:29,759 THINK WE NEED TO BE ABLE TO 3918 02:39:29,759 --> 02:39:36,899 DEVELOP STANDARDS FOR 3919 02:39:36,899 --> 02:39:38,567 REPRESENTING THE IMAGE DATA A 3920 02:39:38,567 --> 02:39:40,936 LOT OF FOLKS, AMITHA WAS READY 3921 02:39:40,936 --> 02:39:43,739 TO SHOW THIS, THIS IS LOCKED 3922 02:39:43,739 --> 02:39:46,242 INTO THE PROPRIETARY SYSTEMS SO 3923 02:39:46,242 --> 02:39:48,010 WE CAN'T GET ACCESS INTO THOSE 3924 02:39:48,010 --> 02:39:50,846 FIELDS WE NEED IN BULK AND WE 3925 02:39:50,846 --> 02:39:53,549 NEED EXPORTABLE KOOM PEWTER 3926 02:39:53,549 --> 02:39:53,983 ACTIONABLE FORMATS. 3927 02:39:53,983 --> 02:39:55,818 SO WE HAD A WORKSHOP AGAIN, MOST 3928 02:39:55,818 --> 02:39:57,219 PEOPLE REALLY JUST, THEY WANT TO 3929 02:39:57,219 --> 02:39:57,953 SEE THIS IMAGING COME TOGETHER 3930 02:39:57,953 --> 02:40:02,491 WITH THE REST OF OUR SCIENCE AND 3931 02:40:02,491 --> 02:40:03,259 HEALTHCARE SPHERE. 3932 02:40:03,259 --> 02:40:04,493 THERE WAS BACK UP STATEMENTS, 3933 02:40:04,493 --> 02:40:06,495 TRYING TO GO QUICKLY SO WE CAN 3934 02:40:06,495 --> 02:40:12,668 HAVE GOOD DIALOGUE IN OUR OPEN 3935 02:40:12,668 --> 02:40:13,636 SESSION, BUT AFTERNOON AGROWS SO 3936 02:40:13,636 --> 02:40:15,171 THIS IS WHERE WE WANT TO GO. 3937 02:40:15,171 --> 02:40:17,139 HOW ELSE CAN WE DO THIS. 3938 02:40:17,139 --> 02:40:19,341 SO WE WROTE PAPERS, I'M AT THE 3939 02:40:19,341 --> 02:40:20,342 NATIONAL EYE INSTITUTE, WE 3940 02:40:20,342 --> 02:40:21,644 PARTNERED WITH THE F, DIDA AND 3941 02:40:21,644 --> 02:40:23,379 THE OFFICE OF NATIONAL 3942 02:40:23,379 --> 02:40:24,580 COORDINATOR OR ONC TO JUST SAY 3943 02:40:24,580 --> 02:40:27,483 WHAT KINDS OF THINGS CAN WE AS 3944 02:40:27,483 --> 02:40:28,918 FUNDING AGENCIES, AS POLICY 3945 02:40:28,918 --> 02:40:32,788 MAKERS DO TO ADVANCE 3946 02:40:32,788 --> 02:40:33,589 INTEROPERABILITY 3947 02:40:33,589 --> 02:40:35,991 STANDARDIZATION, FDA FORMALLY 3948 02:40:35,991 --> 02:40:37,960 RECOGNIZED DICOM, AS THE 3949 02:40:37,960 --> 02:40:40,696 STANDARD FOR OCULAR IMAGING AND 3950 02:40:40,696 --> 02:40:42,798 THIS HAS SEVERAL IMPLICATION AS 3951 02:40:42,798 --> 02:40:44,366 IN TERMS OF DEVICE SUBMISSION TO 3952 02:40:44,366 --> 02:40:50,506 THE F, DIDA AND ALSO AUDITING. 3953 02:40:50,506 --> 02:40:53,642 ONC HAS LISTED DICOM AS A 3954 02:40:53,642 --> 02:40:55,044 STANDARD - ISA, WHICH IS A 3955 02:40:55,044 --> 02:40:56,779 FORMAL RECOGNITION OF THAT BEING 3956 02:40:56,779 --> 02:40:57,980 THE STANDARD AND THE NEED FOR IT 3957 02:40:57,980 --> 02:41:00,282 TO BE OPEN AND EXCHANGEABLE WITH 3958 02:41:00,282 --> 02:41:01,383 ELECTRONIC HEALTH RECORD SYSTEMS 3959 02:41:01,383 --> 02:41:03,953 AND THEN AT NEI, LIKE WE SAID, 3960 02:41:03,953 --> 02:41:06,322 WE WANT TO REALLY--WE HAVE THE 3961 02:41:06,322 --> 02:41:07,389 DATA MANAGEMENT AND SHARING 3962 02:41:07,389 --> 02:41:10,392 POLICY THAT CAME INTO EFFECT IN 3963 02:41:10,392 --> 02:41:12,094 2023, EARLY 2023 AND WE WANT TO 3964 02:41:12,094 --> 02:41:13,496 ENCOURAGE PEOPLE TO CONTINUE 3965 02:41:13,496 --> 02:41:15,331 USING STANDARDS IN AN OPEN 3966 02:41:15,331 --> 02:41:19,034 FASHION AND SHARE THOSE WITH 3967 02:41:19,034 --> 02:41:19,435 OTHER PEOPLE. 3968 02:41:19,435 --> 02:41:21,303 WE HAVE SO MUCH DATA AT OUR 3969 02:41:21,303 --> 02:41:23,606 HANDS AND THERE'S SO MUCH 3970 02:41:23,606 --> 02:41:25,341 POTENTIAL BUT IF EVERYONE HOLD 3971 02:41:25,341 --> 02:41:27,409 ITS NEAR AND DEAR, WE'RE 3972 02:41:27,409 --> 02:41:29,311 ANYTHING TO SLOW DOWN 3973 02:41:29,311 --> 02:41:30,212 INNOVATION, SOPHISTICATEDY WE 3974 02:41:30,212 --> 02:41:31,547 ALSO AGAIN NEED STANDARDS IN 3975 02:41:31,547 --> 02:41:33,516 TERMS OF OTHER DATA SO IT DID NO 3976 02:41:33,516 --> 02:41:36,318 GOOD IF WE HAVE STANDARDIZATION 3977 02:41:36,318 --> 02:41:39,188 AROUND OTHER IMAGING BUT STILL 3978 02:41:39,188 --> 02:41:40,789 NO STANDARDIZATION AROUND LIKE 3979 02:41:40,789 --> 02:41:43,726 VISUAL ICUITY, WHAT ABOUT LIKE 3980 02:41:43,726 --> 02:41:45,694 IOP, SO SALLY BAXTERS GROUP HAS 3981 02:41:45,694 --> 02:41:47,463 DONE WORK IN ACTUALLY LOOKING AT 3982 02:41:47,463 --> 02:41:50,699 THE EPIC CODES, SO EP IC EHR 3983 02:41:50,699 --> 02:41:51,901 WHICH IS WIDELY USED IN OUR 3984 02:41:51,901 --> 02:41:53,002 SPACE AND SEEING HOW MANY OF 3985 02:41:53,002 --> 02:41:54,436 THOSE MAPPED TO STANDARD 3986 02:41:54,436 --> 02:41:57,339 TERMINOLOGIES THAT ARE ACCEPTED 3987 02:41:57,339 --> 02:41:59,275 IN THE U.S. ELECTRONIC HEALTH 3988 02:41:59,275 --> 02:42:03,112 RECORDS AND HEALTHCARE SYSTEM. 3989 02:42:03,112 --> 02:42:05,214 AND WHEN WE FIND GAPS WE SUBMIT 3990 02:42:05,214 --> 02:42:07,416 THEM TO GOVERNING BODIES, WE 3991 02:42:07,416 --> 02:42:11,120 SUBMIT THEM TO STANDARDS LIKE 3992 02:42:11,120 --> 02:42:11,921 SNOMED AND LOINC, AND WE'RE 3993 02:42:11,921 --> 02:42:13,589 TRYING TO DO THE GAP ANALYSIS TO 3994 02:42:13,589 --> 02:42:15,824 FIND THE THINGS THAT AMITHA 3995 02:42:15,824 --> 02:42:18,160 NEEDS TO DO COMPUTING ON HER 3996 02:42:18,160 --> 02:42:19,495 STUDIES AND MAKE SURE THEY'RE 3997 02:42:19,495 --> 02:42:21,664 REPRESENTED AND WE ALSO HAVE 3998 02:42:21,664 --> 02:42:24,233 WORK WE'RE DOING WITH USEDI, 3999 02:42:24,233 --> 02:42:25,301 WHICH IS THE OFFICE OF THE 4000 02:42:25,301 --> 02:42:26,368 NATIONAL COORDINATOR SO WE WOULD 4001 02:42:26,368 --> 02:42:27,570 LIKE TO ELEVATE SOME OF THOSE 4002 02:42:27,570 --> 02:42:30,940 CODES TO THE POLICIES AROUND 4003 02:42:30,940 --> 02:42:32,942 WHAT NEEDS TO BE 4004 02:42:32,942 --> 02:42:33,542 INTEROPERABILITY WITHIN HELT 4005 02:42:33,542 --> 02:42:35,477 RECORD SYSTEMS AND WE HAVE NOW 4006 02:42:35,477 --> 02:42:38,781 ACTUALLY SOME POLICY THAT 4007 02:42:38,781 --> 02:42:40,416 REQUIRES THOSE SYSTEMS TO SUBMIT 4008 02:42:40,416 --> 02:42:41,383 SHARED DATA AMONG AND BETWEEN 4009 02:42:41,383 --> 02:42:44,153 THEMSELVES AND IF NOT THERE'S A 4010 02:42:44,153 --> 02:42:44,753 FINANCIAL PENALTIES THAT 4011 02:42:44,753 --> 02:42:45,955 ACCUMULATE BY DAY FOR THAT. 4012 02:42:45,955 --> 02:42:47,823 SO WE REALLY THINK THAT'S A HUGE 4013 02:42:47,823 --> 02:42:54,863 STUDENT FOR POLICY MAKING MUCH 4014 02:42:54,863 --> 02:42:56,098 SO AGAIN INMODEL CITIZENIVATION, 4015 02:42:56,098 --> 02:42:57,700 BECAUSE I THINK OTHER PEOPLE 4016 02:42:57,700 --> 02:43:00,436 MENTIONED IT, WE NEED DATA, THE 4017 02:43:00,436 --> 02:43:01,637 ABILITY FOR YOUNG PEOPLE, PEOPLE 4018 02:43:01,637 --> 02:43:04,173 WHO ARE JUST CURIOUS TO GET 4019 02:43:04,173 --> 02:43:07,042 THEIR HANDS ON DATA IN ITS 4020 02:43:07,042 --> 02:43:09,144 NATIVE FORMAT AND ITS STANDARD 4021 02:43:09,144 --> 02:43:11,914 FORMAT AND BE ABLE TO JUST SAND 4022 02:43:11,914 --> 02:43:12,681 BOX, PLAY AROUND. 4023 02:43:12,681 --> 02:43:14,016 I REALLY AM A CURIOUS PERSON 4024 02:43:14,016 --> 02:43:15,884 MYSELF SO IF I CAN GET MY HANDS 4025 02:43:15,884 --> 02:43:17,419 ON SOMETHING AND WITHOUT A LOT 4026 02:43:17,419 --> 02:43:22,958 OF BARRIERS THAT WILL REALLY YOU 4027 02:43:22,958 --> 02:43:24,026 KNOW HELP ADVANCE THE FIELD. 4028 02:43:24,026 --> 02:43:28,530 WE HAVE A BRIDGE AI PROJECT AND 4029 02:43:28,530 --> 02:43:30,566 AARON AND CECILIA WILL BE 4030 02:43:30,566 --> 02:43:31,967 SHARING INFORMATION ON A VERY 4031 02:43:31,967 --> 02:43:33,736 LOW BAR, SO THAT'S FABULOUS, WE 4032 02:43:33,736 --> 02:43:36,405 ARE ALSO WORKING WITH ALL OF US, 4033 02:43:36,405 --> 02:43:39,375 TO ADD OCULAR IMAGING TO THE ALL 4034 02:43:39,375 --> 02:43:40,776 OF US RESEARCH THEORY. 4035 02:43:40,776 --> 02:43:44,580 WE'RE CREATING A DATA SET SO 4036 02:43:44,580 --> 02:43:47,349 WE'RE TAKING IMAGES USING 4037 02:43:47,349 --> 02:43:50,119 SYNTHETIC IMAGING THAT WILL BE 4038 02:43:50,119 --> 02:43:50,819 FREELY OPENLY AVAILABLE, THAT 4039 02:43:50,819 --> 02:43:52,855 WILL NOT BE ACCURATE TO HUMAN 4040 02:43:52,855 --> 02:43:54,223 REPRESENTATION BUT IT GIVES US 4041 02:43:54,223 --> 02:43:55,391 SOMETHING TO WORK WITH AND 4042 02:43:55,391 --> 02:43:57,626 EDUCATE FOLKS ON AND IT WILL BE 4043 02:43:57,626 --> 02:43:59,962 IN A FHIR SERVER SO WE CAN BRING 4044 02:43:59,962 --> 02:44:03,632 IN THAT TECHNOLOGY, HOW DO YOU 4045 02:44:03,632 --> 02:44:06,935 IMPLEMENT SYSTEMS TO EXCHANGE 4046 02:44:06,935 --> 02:44:07,436 THOSE DATA POINTS. 4047 02:44:07,436 --> 02:44:08,504 >> SO WE'VE BEEN DOING WORK WITH 4048 02:44:08,504 --> 02:44:11,073 COMMON DAILY BASIS THEA MODELS, 4049 02:44:11,073 --> 02:44:12,908 AS IN NEI, WE'RE FOCUSED ON 4050 02:44:12,908 --> 02:44:14,677 RESEARCH, SO LOADING THOSE LOCAL 4051 02:44:14,677 --> 02:44:15,477 CODES, MATCHING THOSE LOCAL 4052 02:44:15,477 --> 02:44:17,813 CODES TO A COMMON DATA MODEL SO 4053 02:44:17,813 --> 02:44:20,382 WE CAN DO OBSERVATIONAL HEALTH 4054 02:44:20,382 --> 02:44:21,750 STUDIES, WE ACTUALLY JUST 4055 02:44:21,750 --> 02:44:24,620 PUBLISHED, IT WAS JUST ACCEPTED 4056 02:44:24,620 --> 02:44:28,457 IN OPHTHALMOLOGY RETINA, A STUDY 4057 02:44:28,457 --> 02:44:31,760 THAT WAS LOOKING AT INTRA 4058 02:44:31,760 --> 02:44:33,062 VITREAL, ANTIVEG F AND KIDNEY 4059 02:44:33,062 --> 02:44:35,731 FAILURE AND THIS WAS LED BY 4060 02:44:35,731 --> 02:44:37,132 CINDY TAI FROM JOHNS HOPKINS AND 4061 02:44:37,132 --> 02:44:43,038 WE WERE ABLE TO LOOK AT ACROSS 4062 02:44:43,038 --> 02:44:44,139 12 DATABASES, 584 MILLION PEOPLE 4063 02:44:44,139 --> 02:44:46,108 AND CHECK FOR ADVERSE KIDNEY 4064 02:44:46,108 --> 02:44:49,812 EVENTS BASED ON THOSE 4065 02:44:49,812 --> 02:44:50,279 MEDICATIONS. 4066 02:44:50,279 --> 02:44:52,581 AND SO WE ALSO NEED INCENTIVES. 4067 02:44:52,581 --> 02:44:54,016 SO AGAIN, DR. CHANG HAS SAID 4068 02:44:54,016 --> 02:44:56,919 BEFORE, WE HAVE A LOT OF STICKS. 4069 02:44:56,919 --> 02:44:58,687 WE NEED CARROTS, WE NEED TO 4070 02:44:58,687 --> 02:45:00,122 INCENTIVIZE PEOPLE TO SHARE 4071 02:45:00,122 --> 02:45:00,823 DATA. 4072 02:45:00,823 --> 02:45:01,857 WE HAVE THE PUBLICATION TYPE 4073 02:45:01,857 --> 02:45:04,626 THAT WAS MEPGZED FROM TBST ABOUT 4074 02:45:04,626 --> 02:45:06,695 DATA TYPE WHICH IS HUGE FOR OUR 4075 02:45:06,695 --> 02:45:07,162 COMMUNITY. 4076 02:45:07,162 --> 02:45:10,132 WE'RE ALSO THINKING OF WAYS 4077 02:45:10,132 --> 02:45:12,501 WHERE WE CAN INCENTIVIZE AN 4078 02:45:12,501 --> 02:45:14,436 INDIVIDUAL'S EFFORT TOWARD GOOD 4079 02:45:14,436 --> 02:45:15,738 DATA SHARING AND YOU'LL HEAR 4080 02:45:15,738 --> 02:45:17,940 MORE ABOUT THAT IN COMING MONTHS 4081 02:45:17,940 --> 02:45:21,777 IF YOU FOLLOW NEIs X ACCOUNT, 4082 02:45:21,777 --> 02:45:23,011 I'M SURE. 4083 02:45:23,011 --> 02:45:24,880 SO JUST CONCLUDING THOUGHTS. 4084 02:45:24,880 --> 02:45:27,616 WITH ALL THESE ADVANCES, BOTH IN 4085 02:45:27,616 --> 02:45:30,719 THE TECHNOLOGY AND IN AI SPACE, 4086 02:45:30,719 --> 02:45:33,522 THIS COULD REALLY TRANSFORM 4087 02:45:33,522 --> 02:45:34,623 HEALTH. 4088 02:45:34,623 --> 02:45:37,392 I OFTEN FIELD WEIRD OVERSELLING 4089 02:45:37,392 --> 02:45:39,728 IT, OR I FEEL LIKE I'M 4090 02:45:39,728 --> 02:45:41,263 OVERSELLING IT AND BUT I DON'T 4091 02:45:41,263 --> 02:45:42,631 THINK I'M OVERSELLING IT AT ALL 4092 02:45:42,631 --> 02:45:43,866 BUT SITTING HERE THE LAST 2 DAYS 4093 02:45:43,866 --> 02:45:44,833 AND HEARING ABOUT THE WORK 4094 02:45:44,833 --> 02:45:46,235 THAT'S DONE AND FUTURE 4095 02:45:46,235 --> 02:45:47,770 INHOIVATIONS THIS, IS AN 4096 02:45:47,770 --> 02:45:48,570 OPPORTUNITY TO TRANSFORM HEALTH 4097 02:45:48,570 --> 02:45:51,173 EMPLOY BUT WE NEED DATA SHARING, 4098 02:45:51,173 --> 02:45:52,775 WE NEED COLLABORATION, WE FLEED 4099 02:45:52,775 --> 02:45:54,409 TO BUILD COMMUNITIES OF 4100 02:45:54,409 --> 02:45:55,811 STANDARDS BELLING GROUPS AND WE 4101 02:45:55,811 --> 02:46:00,883 NEED TO GET ONBOARD AND BUILD 4102 02:46:00,883 --> 02:46:01,316 THAT COOPERATION. 4103 02:46:01,316 --> 02:46:03,685 MY YOB IS TO TRY TO WORK WITH 4104 02:46:03,685 --> 02:46:04,953 THE STANDARDS AND 4105 02:46:04,953 --> 02:46:05,687 INTEROPERABILITY PIECE. 4106 02:46:05,687 --> 02:46:07,222 IT TAKES A VILLAGE. 4107 02:46:07,222 --> 02:46:08,290 I HAVE A VILLAGE. 4108 02:46:08,290 --> 02:46:09,591 I HAVE TECHNOLOGY I CAN 4109 02:46:09,591 --> 02:46:11,226 SHOWCASE, AND I JUST THINK, LIKE 4110 02:46:11,226 --> 02:46:13,562 THIS IS THE FUTURE, THIS IS 4111 02:46:13,562 --> 02:46:15,297 LITTLE--THIS IS AN EXAMPLE OF A 4112 02:46:15,297 --> 02:46:17,366 STATION, YOU WALK UP TO IN A 4113 02:46:17,366 --> 02:46:19,001 GROCERY STORE OR PHARMAC EXPE 4114 02:46:19,001 --> 02:46:20,135 CHECK YOUR HEALTH IN MANY WAY 4115 02:46:20,135 --> 02:46:23,005 ANDS THIS IS DEFINITELY COULD BE 4116 02:46:23,005 --> 02:46:24,807 PART OF THAT IN THE VERY NEAR 4117 02:46:24,807 --> 02:46:25,040 FUTURE. 4118 02:46:25,040 --> 02:46:26,775 SO IF YOU WANT TO FOLLOW THE 4119 02:46:26,775 --> 02:46:29,778 OFFICE OF DATA AND SCIENCE 4120 02:46:29,778 --> 02:46:31,647 HEALTH INFORMATICS, WE DO TRY TO 4121 02:46:31,647 --> 02:46:33,615 POST ABOUT EVENTS SUCH AS THESE 4122 02:46:33,615 --> 02:46:35,450 ON OUR NEWS LETTER. 4123 02:46:35,450 --> 02:46:36,785 YOU CAN YOIN OUR COMMUNITY, 4124 02:46:36,785 --> 02:46:40,055 WE'RE VERY OPEN AND TRANSPARENT, 4125 02:46:40,055 --> 02:46:41,456 WE WANT EVERYONE ONBOARD AND I 4126 02:46:41,456 --> 02:46:43,859 WILL LEAVE IT WITH THAT. 4127 02:46:43,859 --> 02:46:50,566 [ APPLAUSE ] 4128 02:46:50,566 --> 02:46:52,000 >> ALL RIGHT, I WOULD LIKE TO 4129 02:46:52,000 --> 02:46:53,669 THANK THE SPEAKERS FOR STAYINGON 4130 02:46:53,669 --> 02:46:55,838 TIME AND BEING A BIT EARLY SO WE 4131 02:46:55,838 --> 02:46:56,772 CAN HAVE A ROBUST DISCUSSION 4132 02:46:56,772 --> 02:46:58,006 EMPLOY IF YOU CAN MAKE YOUR WAY 4133 02:46:58,006 --> 02:46:58,473 TO THE STAGE. 4134 02:46:58,473 --> 02:47:01,076 WE WILL GET THE SEATS OUT HERE 4135 02:47:01,076 --> 02:47:10,018 AND SOME MICROPHONES. 4136 02:47:10,018 --> 02:47:12,688 AND I'M HOPING THAT ALL OF YOU 4137 02:47:12,688 --> 02:47:15,591 WILL HAVE QUESTIONS AND 4138 02:47:15,591 --> 02:47:15,858 COMMENTS. 4139 02:47:15,858 --> 02:47:17,326 FEEL PREE TO COME TO THE 4140 02:47:17,326 --> 02:47:17,626 MICROPHONES. 4141 02:47:17,626 --> 02:47:18,894 I WAS REFLECTING THAT MANY OF 4142 02:47:18,894 --> 02:47:20,362 YOU ARE USING AI AT SOME LEVEL 4143 02:47:20,362 --> 02:47:24,366 AND SO I'M SURE YOU HAVE SOME 4144 02:47:24,366 --> 02:47:28,670 THOUGHTS AND CONSIDERATIONS TO 4145 02:47:28,670 --> 02:47:31,740 BRING UP HERE. 4146 02:47:31,740 --> 02:47:33,876 OKAY, GREAT. 4147 02:47:33,876 --> 02:47:34,309 >> THANKS. 4148 02:47:34,309 --> 02:47:35,811 GREAT TALK. 4149 02:47:35,811 --> 02:47:40,115 ANY COMMENTS ON HOW EXACTLY THE 4150 02:47:40,115 --> 02:47:42,084 DATA STANDARDIZATION SHOULD BE 4151 02:47:42,084 --> 02:47:42,651 EXECUTED. 4152 02:47:42,651 --> 02:47:44,953 SO LET ME BE SPECIFIC. 4153 02:47:44,953 --> 02:47:47,356 OCT REGARDLESS OF THE WEB SOURCE 4154 02:47:47,356 --> 02:47:49,558 OR WIDE BAND START FROM A CASE 4155 02:47:49,558 --> 02:47:52,394 BASE AND EVERYBODY USING 4156 02:47:52,394 --> 02:47:53,462 DIFFERENT WAYS TO RECONSTRUCT 4157 02:47:53,462 --> 02:47:56,531 IMAGE AND THEN PEOPLE USE 4158 02:47:56,531 --> 02:47:58,734 DIFFERENT WAYS TO ENHANCE THE 4159 02:47:58,734 --> 02:48:01,270 IMPAG, ARE ALL THOSE THINGS PART 4160 02:48:01,270 --> 02:48:02,537 OF THE STANDARDIZATION OR IS 4161 02:48:02,537 --> 02:48:07,109 THAT PART OF THE DISCLOSURE? 4162 02:48:07,109 --> 02:48:16,551 >> I'M FLAD YOU ASKED THAT 4163 02:48:16,551 --> 02:48:20,155 QUESTION BECAUSE--[INAUDIBLE 4164 02:48:20,155 --> 02:48:21,890 ]--I ADDED THIS SLIDE AT THE 4165 02:48:21,890 --> 02:48:23,358 LAST MINUTE AND I COULDN'TAD IT 4166 02:48:23,358 --> 02:48:24,526 SO MY FAULT FOR THAT. 4167 02:48:24,526 --> 02:48:27,195 BUT 1 THING WE WANT TO DO FOR 4168 02:48:27,195 --> 02:48:29,031 STANDARDIZATION IS THAT REASON, 4169 02:48:29,031 --> 02:48:30,999 THE DEVICE MANUFACTURES MEASURE 4170 02:48:30,999 --> 02:48:34,069 THINGS DIFFERENTLY, APPLY 4171 02:48:34,069 --> 02:48:35,037 TECHNIQUES DIFFERENTLY, WE ARE 4172 02:48:35,037 --> 02:48:38,807 ENGAGED WITH A FEW OTHER FOLKS 4173 02:48:38,807 --> 02:48:40,676 ACROSS NIH INCLUDING NIERK BIB, 4174 02:48:40,676 --> 02:48:42,878 AND ADVANCING THE IDEA OF 4175 02:48:42,878 --> 02:48:44,746 PHANTOMS SO IF WE COULD HAVE A 4176 02:48:44,746 --> 02:48:49,184 STANDARD THAT CAN BE APPLIED 4177 02:48:49,184 --> 02:48:50,953 LIKE, CERTIFIED BY SOMEONE SUCH 4178 02:48:50,953 --> 02:48:54,523 AS NIST AND APPLIED ACROSS THE 4179 02:48:54,523 --> 02:48:56,692 MACHINES, THAT WAY YOU KNOW, 4180 02:48:56,692 --> 02:49:01,530 THIS IS REPRESENTATIVE OF A 4181 02:49:01,530 --> 02:49:02,230 NORMALIZED STANDARD. 4182 02:49:02,230 --> 02:49:03,699 NAND JUST TO ADD TO THAT A 4183 02:49:03,699 --> 02:49:07,035 LITTLE BIT, I THINK THE DICOM 4184 02:49:07,035 --> 02:49:08,971 STANDARD IS MEANT FOR THE FINAL 4185 02:49:08,971 --> 02:49:10,739 END PRODUCT IN TERMS OF THE 4186 02:49:10,739 --> 02:49:12,841 B-SCAN IMAGE THAT CLINICIANS USE 4187 02:49:12,841 --> 02:49:14,009 AND VIEW TO MAKE MEDICAL 4188 02:49:14,009 --> 02:49:16,244 DECISIONS AND THAT'S GREAT FOR 4189 02:49:16,244 --> 02:49:17,179 AI ALGORITHMS THAT BUILT ON TOP 4190 02:49:17,179 --> 02:49:19,581 OF THAT BUT TO YOUR POINT WE 4191 02:49:19,581 --> 02:49:23,185 DON'T HAVE A RESEARCH STANDARD 4192 02:49:23,185 --> 02:49:25,921 FOR OCULAR INSTRUMENTS WHERE 4193 02:49:25,921 --> 02:49:27,456 THOSE MORE RAW DATA, LIKE THE 4194 02:49:27,456 --> 02:49:29,992 DATA COMING OFF THE SPECTROMETER 4195 02:49:29,992 --> 02:49:31,426 AND THE INTERMEDIATE PROCESSING 4196 02:49:31,426 --> 02:49:33,595 STEPS ARE NOT ENCODED IN ANY 4197 02:49:33,595 --> 02:49:34,463 STANDARD FORM YET BUT IT WOULD 4198 02:49:34,463 --> 02:49:36,498 BE NICE TO SEE THE RESEARCH 4199 02:49:36,498 --> 02:49:37,866 COMMUNITY COME FORWARD AND BRING 4200 02:49:37,866 --> 02:49:42,637 SOMETHING FORWARD FOR THAT. 4201 02:49:42,637 --> 02:49:42,938 >> GREAT. 4202 02:49:42,938 --> 02:49:44,740 THANK YOU ERCH FOR CONTINUING 4203 02:49:44,740 --> 02:49:47,175 THIS IMPORTANT DISCUSSION, AS I 4204 02:49:47,175 --> 02:49:50,979 CLINICAL RESEARCHER, I RECOGNIZE 4205 02:49:50,979 --> 02:50:01,289 THE IMPORTANCE OF 4206 02:50:06,361 --> 02:50:06,962 INTEROPERABILITY, AND--AND FROM 4207 02:50:06,962 --> 02:50:08,897 WHAT I UNDERSTAND YOU CAN USE 4208 02:50:08,897 --> 02:50:09,464 STANDARD MEASUREMENT TOOLS 4209 02:50:09,464 --> 02:50:13,402 REGARDLESS OF THE MACHINE, HOW 4210 02:50:13,402 --> 02:50:14,836 DID THEY COME TO THE AGREEMENT 4211 02:50:14,836 --> 02:50:16,405 IN TERMS OF HAVING AN IMAGING 4212 02:50:16,405 --> 02:50:17,906 STABBED ARD THAT COULD BE 4213 02:50:17,906 --> 02:50:26,748 MEASURED USING A COMMON TOOL. 4214 02:50:26,748 --> 02:50:35,257 I'LL SAY FROM TALKING ABOUT BUT 4215 02:50:35,257 --> 02:50:38,093 USUALLY THAT THEY NEEDED TO 4216 02:50:38,093 --> 02:50:41,596 REACH CONSENSUS AND IN, LIKE, CT 4217 02:50:41,596 --> 02:50:46,902 SCANS AND MRIs, THERE'S FEWER 4218 02:50:46,902 --> 02:50:48,570 MANUFACTURES, SO THEY DO KIND OF 4219 02:50:48,570 --> 02:50:49,838 HAVE SOME BENEFIT THERE, THEY 4220 02:50:49,838 --> 02:50:52,040 DON'T NEED TO BRING SO MANY 4221 02:50:52,040 --> 02:50:54,676 PEOPLE ONBOARD BUT AS YOU WILL 4222 02:50:54,676 --> 02:50:56,511 SEE TECHNOLOGIES IMPROVE AND 4223 02:50:56,511 --> 02:50:57,679 BECOME MORE STANDARD PRACTICE 4224 02:50:57,679 --> 02:50:59,414 THAT THOSE KINDS OF THINGS WILL 4225 02:50:59,414 --> 02:51:01,149 NEED TO HELP JUST BASED ON 4226 02:51:01,149 --> 02:51:05,554 MARKET INFLUENCE AND THE NEED 4227 02:51:05,554 --> 02:51:07,456 FOR CONNECTEDNESS. 4228 02:51:07,456 --> 02:51:09,224 SO HOPEFULLY, THERE'S BOTH 4229 02:51:09,224 --> 02:51:11,093 INTERNAL AND EXTERNAL PRESSURES 4230 02:51:11,093 --> 02:51:11,293 THERE. 4231 02:51:11,293 --> 02:51:13,395 >> YEAH, I AGREE WITH THAT. 4232 02:51:13,395 --> 02:51:14,996 I THINK HAVING JUST 3 BIG 4233 02:51:14,996 --> 02:51:17,165 COMPANIES TO START OFF WITH 4234 02:51:17,165 --> 02:51:20,068 RADIOLOGY AND A LOT OF 4235 02:51:20,068 --> 02:51:22,270 RADIOLOGISTS HAD A SAY IN HOW 4236 02:51:22,270 --> 02:51:25,407 DATA WAS PRESENT EARLY ON 4237 02:51:25,407 --> 02:51:26,775 WHEREAS FOR OPHTHALMOLOGY MOST 4238 02:51:26,775 --> 02:51:28,410 OF US JUST DIDN'T EACH KNOW HOW 4239 02:51:28,410 --> 02:51:31,213 TO ELECTRIC AT AN OCT SCAN, EACH 4240 02:51:31,213 --> 02:51:32,280 TODAY, MANY CLINICIANS JUST LOOK 4241 02:51:32,280 --> 02:51:34,583 AT THE REPORT AND THOSE 3 4242 02:51:34,583 --> 02:51:36,451 NUMBERS ARE JUST THE 1S SCANNED 4243 02:51:36,451 --> 02:51:38,487 WITH, IS THERE FLUID OR NOT, 4244 02:51:38,487 --> 02:51:39,521 THERE'S NOTHING MORE THAT'S 4245 02:51:39,521 --> 02:51:42,157 DONE, SO THE LEVEL OF 4246 02:51:42,157 --> 02:51:44,426 INTERPRETABILITY IS VERY 4247 02:51:44,426 --> 02:51:45,060 DIFFERENT. 4248 02:51:45,060 --> 02:51:46,862 >> I HAVE A QUESTION SINCE WE 4249 02:51:46,862 --> 02:51:49,531 HAVE SO MANY OCT EXPERTS IN THE 4250 02:51:49,531 --> 02:51:50,732 AUDIENCE BUT WHEN YOU GET THE 4251 02:51:50,732 --> 02:51:52,667 RAW DATA BACK FROM THE OCT 4252 02:51:52,667 --> 02:51:54,836 SYSTEM, LIKE HOW SIMILAR IS THAT 4253 02:51:54,836 --> 02:51:57,405 BETWEEN DIFFERENT MACHINES? 4254 02:51:57,405 --> 02:51:59,040 DO WE KNOW THAT AND IS THERE 4255 02:51:59,040 --> 02:52:04,679 LIKE A SOURCE THAT WE BEING --CD 4256 02:52:04,679 --> 02:52:06,348 START AND EVERYTHING IS MORE 4257 02:52:06,348 --> 02:52:06,581 SIMILAR. 4258 02:52:06,581 --> 02:52:09,985 NI THINK DAVID IS MOVING TO THE 4259 02:52:09,985 --> 02:52:10,152 MIC. 4260 02:52:10,152 --> 02:52:10,652 >> THANK YOU. 4261 02:52:10,652 --> 02:52:14,122 >> WELL I THINK, I WILL POINT 4262 02:52:14,122 --> 02:52:15,624 OUT TO--THAT YOU ACTUALLY IN 4263 02:52:15,624 --> 02:52:16,925 YOUR PRESENTATION HAD A NICE 4264 02:52:16,925 --> 02:52:18,660 SLIDE WHERE YOU COMPARED THE 4265 02:52:18,660 --> 02:52:20,462 ANGLES, THE ANGLE MEASURES AND 4266 02:52:20,462 --> 02:52:21,630 THE CURVEATURE AND SO, I THINK 4267 02:52:21,630 --> 02:52:25,934 WE JUST NEED TO EXPLORE THAT 4268 02:52:25,934 --> 02:52:28,870 MORE AND AGAIN I'M VERY MUCH A 4269 02:52:28,870 --> 02:52:29,738 STORYTELLER AND LET'S SHOW 4270 02:52:29,738 --> 02:52:30,672 PEOPLE, THIS IS ACTUALLY THE 4271 02:52:30,672 --> 02:52:39,414 DIFFERENCE THAT WE SEE. 4272 02:52:39,414 --> 02:52:40,682 >> CHRISTINE [INDISCERNIBLE] I 4273 02:52:40,682 --> 02:52:43,919 WOULD LIKE TO ADVOCATE FOR 4274 02:52:43,919 --> 02:52:44,953 ANATOMICAL STANDARDIZATION AS 4275 02:52:44,953 --> 02:52:46,588 PART OF THE INITIATIVE FOR MACK 4276 02:52:46,588 --> 02:52:48,590 LA RESEARCH, WE HAD A WORK GROUP 4277 02:52:48,590 --> 02:52:50,559 CALLED WHY THE MACULAR AND THERE 4278 02:52:50,559 --> 02:52:52,327 WAS A BIG DISCUSSION ABOUT WHAT 4279 02:52:52,327 --> 02:52:53,595 IS THE MACULAR, AND IT IS 4280 02:52:53,595 --> 02:52:55,697 POSSIBLE TO TRACK BACK THROUGH 4281 02:52:55,697 --> 02:52:56,298 NEUROANATOMY, LITERATE AND YOU 4282 02:52:56,298 --> 02:53:00,268 ARE COME UP WITH A SET OF 4283 02:53:00,268 --> 02:53:02,137 COACHING DEFINITIONS THAT HAVE 4284 02:53:02,137 --> 02:53:05,006 DEFINED NUMBER OF RODS, CONES 4285 02:53:05,006 --> 02:53:06,875 AND RPE CELLS AND WE PUT THIS IN 4286 02:53:06,875 --> 02:53:09,578 A REVIEW THAT CAME OUT A COUPLE 4287 02:53:09,578 --> 02:53:12,347 WEEKS AGO ADVOCATING FOR THE USE 4288 02:53:12,347 --> 02:53:14,182 OF THE MACULAR LUTIA WHICH WAS 4289 02:53:14,182 --> 02:53:18,853 THE FIRST NAME AND SO IF THE 4290 02:53:18,853 --> 02:53:22,924 DATA SCIENCE FOLKS COULD INCLUDE 4291 02:53:22,924 --> 02:53:26,995 PEOPLE WITH INTERESTS IN 4292 02:53:26,995 --> 02:53:28,797 NEUROANATOMY AND 4293 02:53:28,797 --> 02:53:29,931 NEUROPHYSIOLOGY, WE COULD, I 4294 02:53:29,931 --> 02:53:32,234 THINK REACH GOOD 4295 02:53:32,234 --> 02:53:32,834 STANDARDIZATION. 4296 02:53:32,834 --> 02:53:34,669 FORTUNATELY THERE ARE--YOU CAN 4297 02:53:34,669 --> 02:53:36,438 MEASURE 3-MILLIMETER MACK LA 4298 02:53:36,438 --> 02:53:37,639 LUTIA ON BOTH THE SECTIONAL 4299 02:53:37,639 --> 02:53:39,341 ANALYSISERAL SIS AND 4300 02:53:39,341 --> 02:53:40,575 [INDISCERNIBLE]. 4301 02:53:40,575 --> 02:53:42,344 THAT'S GOOD, OKAY, BUT OCT 4302 02:53:42,344 --> 02:53:46,314 BECAUSE OF SIGNAL SOURCES ARE 4303 02:53:46,314 --> 02:53:49,284 SUBCELLULAR, WE NEED SOME 4304 02:53:49,284 --> 02:53:51,286 DEFINED, SOME DEFINITIONS OF THE 4305 02:53:51,286 --> 02:53:53,054 PARTS OF CELLS, ALTER 4306 02:53:53,054 --> 02:53:54,022 STRUCTURES, WHAT ORGANELLES ARE 4307 02:53:54,022 --> 02:53:55,357 INVOLVED SO I THINK THAT WILL BE 4308 02:53:55,357 --> 02:53:58,126 GOOD TO INCLUDE THIS IN THE 4309 02:53:58,126 --> 02:53:58,426 DISCUSSION. 4310 02:53:58,426 --> 02:53:59,394 THANK YOU. 4311 02:53:59,394 --> 02:54:04,633 >> I'LL JUST, TAG ON TO YOUR 4312 02:54:04,633 --> 02:54:04,866 COMMENT. 4313 02:54:04,866 --> 02:54:06,034 SO I ATBREE HUNDRED PERCENT, 4314 02:54:06,034 --> 02:54:08,570 THAT'S SOME OF THE WORK WE'RE 4315 02:54:08,570 --> 02:54:11,273 DOING WITH FANDOMS IS ACTUALLY 4316 02:54:11,273 --> 02:54:13,375 HAVING A NORMALIZED 4317 02:54:13,375 --> 02:54:14,609 REPRESENTATIVE IN THESE MACHINES 4318 02:54:14,609 --> 02:54:15,677 TO MAKE SURE EVERYONE IS 4319 02:54:15,677 --> 02:54:16,778 MEASURING THINGS IN THE SAME 4320 02:54:16,778 --> 02:54:17,846 WAY, 1 OF THE STRUGGLES WITH 4321 02:54:17,846 --> 02:54:22,083 THAT IS TO FIGURE OUT LIKE WHAT 4322 02:54:22,083 --> 02:54:23,485 IS QUOTE-UNQUOTE NORMAL AND DO 4323 02:54:23,485 --> 02:54:27,322 WE NEED DIFFERENT TYPES OF 4324 02:54:27,322 --> 02:54:29,924 NORMAL BASED ON AGE AND GENDER 4325 02:54:29,924 --> 02:54:31,526 AND THINGS LIKE THAT, SO I'M 4326 02:54:31,526 --> 02:54:32,794 VERY INTERESTED IN YOUR PAPER 4327 02:54:32,794 --> 02:54:33,995 BECAUSE IT SOUNDS LIKE WE COULD 4328 02:54:33,995 --> 02:54:38,033 GET SOME OF THOSE NUMBERS, 4329 02:54:38,033 --> 02:54:39,000 RIGHT, THOSE MEASURES? 4330 02:54:39,000 --> 02:54:40,302 >> DAVID IN. 4331 02:54:40,302 --> 02:54:44,439 >> I HAVE SOME COMMENTS ABOUT 4332 02:54:44,439 --> 02:54:46,341 STANDARDIZATION OF SIGNAL. 4333 02:54:46,341 --> 02:54:50,211 I THINK OCTs RELATIVELY SIMPLE 4334 02:54:50,211 --> 02:54:53,081 IN THAT ALTHOUGH THERE ARE MANY 4335 02:54:53,081 --> 02:54:55,283 LONG SCALES AND LINEAR SCALES, 4336 02:54:55,283 --> 02:54:59,120 THERE THEY ARE AT LEAST 4337 02:54:59,120 --> 02:54:59,921 INTERCONVERTIFICATION, EASILY, 4338 02:54:59,921 --> 02:55:04,693 AND YOU COULD STANDARDIZE, LIKE 4339 02:55:04,693 --> 02:55:05,960 THE [INDISCERNIBLE] UNIT IN CT, 4340 02:55:05,960 --> 02:55:09,998 YOU COULD HAVE A STANDARD UNIT 4341 02:55:09,998 --> 02:55:11,700 BUT OCT IN GEOGRAPHY MAY BE 4342 02:55:11,700 --> 02:55:17,572 QUITE DIFFICULT IN THE 4343 02:55:17,572 --> 02:55:19,974 DECORALATION BASED ON AMPLITUDE 4344 02:55:19,974 --> 02:55:24,612 OR COMPLEX AMPLITUDE OR FACE 4345 02:55:24,612 --> 02:55:26,147 VARIANTS REALLY BEHAVE QUITE 4346 02:55:26,147 --> 02:55:28,149 DIFFERENTLY AND THEY SCALE 4347 02:55:28,149 --> 02:55:29,317 DEFICIENTLY WITH SIGNATURES 95 4348 02:55:29,317 --> 02:55:29,651 STRENGTH. 4349 02:55:29,651 --> 02:55:31,419 THEY JUST HAVE VERY DIFFERENT 4350 02:55:31,419 --> 02:55:34,723 PROPERTIES SO UNLESS YOU HAVE 4351 02:55:34,723 --> 02:55:38,693 THE RAW SPECTRAL DATA OR RAW OCT 4352 02:55:38,693 --> 02:55:41,496 DATA, FROM WHICH FLOW SIGNAL IS 4353 02:55:41,496 --> 02:55:43,465 COMPUTED, YOU ALMOST CANNOT 4354 02:55:43,465 --> 02:55:44,299 POSSIBLY INTERCONVERT THEM. 4355 02:55:44,299 --> 02:55:49,804 SO, I'M NOT SURE HOW YOU WOULD 4356 02:55:49,804 --> 02:55:52,340 DEAL WITH THAT. 4357 02:55:52,340 --> 02:55:53,274 MAYBE THESE ALGORITHMS NEED TO 4358 02:55:53,274 --> 02:55:55,477 BE PUCK LICK SO THAT, YOU KNOW 4359 02:55:55,477 --> 02:55:57,245 AT THE SAME IMAGE CAN BE COATED 4360 02:55:57,245 --> 02:56:02,016 IN SEVERAL DIFFERENT WAYS SINCE 4361 02:56:02,016 --> 02:56:03,485 THEY ARE NOW INTERCONVERTIBLE. 4362 02:56:03,485 --> 02:56:05,920 THEY PROBABLY HAVE THE SAME 4363 02:56:05,920 --> 02:56:08,123 THING IN MRI SINCE PULSE 4364 02:56:08,123 --> 02:56:09,424 SEQUENCE GENERATE DIFFERENT DATA 4365 02:56:09,424 --> 02:56:12,861 THAT NOT REALLY, CANNOT BE 4366 02:56:12,861 --> 02:56:13,428 INTERCONVERTIBLE AFTERWARDS 4367 02:56:13,428 --> 02:56:14,929 SOPHISTICATED I DON'T KNOW HOW 4368 02:56:14,929 --> 02:56:16,631 THEY DEAL WITH THAT. 4369 02:56:16,631 --> 02:56:24,239 WE COULD PROBABLY BORROW FROM 4370 02:56:24,239 --> 02:56:24,773 THAT. 4371 02:56:24,773 --> 02:56:26,241 >> YEAH, NO, THANKS. 4372 02:56:26,241 --> 02:56:28,810 THAT IS INSIGHTFUL, RIGHT NOW 4373 02:56:28,810 --> 02:56:30,645 WITHY JUST PROPRIETARY SOFTWARE 4374 02:56:30,645 --> 02:56:32,580 METRICS, THAT'S THE WAY WE DO IT 4375 02:56:32,580 --> 02:56:33,281 FOR CLINICAL TRIALS. 4376 02:56:33,281 --> 02:56:36,885 THERE'S NO OTHER WAY. 4377 02:56:36,885 --> 02:56:40,455 NI HAVE A BIT OF A PET PEEVE 4378 02:56:40,455 --> 02:56:42,424 WITH OCT MANUFACTURES IMAGES 4379 02:56:42,424 --> 02:56:44,159 THAT THEY PRODUCE, BUT A ALWAYS 4380 02:56:44,159 --> 02:56:47,195 PUT A LINEAR SCALE LIKE 4381 02:56:47,195 --> 02:56:48,263 200-MICRONS ANDIME NOT SURE HOW 4382 02:56:48,263 --> 02:56:51,099 YOU DEAL WITH IT BUT THE FACT IS 4383 02:56:51,099 --> 02:56:52,867 THAT EYE SAYS HAVE DIFFERENT 4384 02:56:52,867 --> 02:56:56,070 LENGTH ANDS THAT COULD BE 20, 4385 02:56:56,070 --> 02:56:57,405 MAYBE 30% DIFFERENCES IN THE 4386 02:56:57,405 --> 02:57:01,576 SCALE OF THE IMAGES SO HOW DO WE 4387 02:57:01,576 --> 02:57:02,243 DEAL WITH THAT? 4388 02:57:02,243 --> 02:57:04,345 WHAT DO WE DO WITH INCASULAR 4389 02:57:04,345 --> 02:57:04,612 MEASURES? 4390 02:57:04,612 --> 02:57:06,481 BECAUSE THAT'S WHAT THE SYSTEM 4391 02:57:06,481 --> 02:57:09,751 IS CALIBRATED TO PRODUCE? 4392 02:57:09,751 --> 02:57:11,986 THAT IS A VERY GOOD POINT AND 1 4393 02:57:11,986 --> 02:57:15,023 OF THE DETAILS THAT IS EVEN MORE 4394 02:57:15,023 --> 02:57:17,225 DIFFICULT TO STANDARDIZE UNLESS 4395 02:57:17,225 --> 02:57:19,060 YOU'RE TAKING AXIAL LENS ON 4396 02:57:19,060 --> 02:57:19,994 EVERY PATIENT AND INCORPORATING 4397 02:57:19,994 --> 02:57:28,703 THAT AS PART OF METADATA ALSO, 4398 02:57:28,703 --> 02:57:29,370 THAT IS TRUE. 4399 02:57:29,370 --> 02:57:31,339 >> I JUST WANT TO, BEING ARK 4400 02:57:31,339 --> 02:57:33,374 WARE OF THE DICOM, IS THE 4401 02:57:33,374 --> 02:57:35,143 PRECESS OF THE ORIGINAL DATA WE 4402 02:57:35,143 --> 02:57:38,179 CAPTURE, GOING BA TO WHAT DAVID 4403 02:57:38,179 --> 02:57:40,248 SAID, SO IT'S RELATIVE AT FIRST, 4404 02:57:40,248 --> 02:57:43,685 IT HAS 18 PARTS OF 1 STANDARD, 4405 02:57:43,685 --> 02:57:45,320 THAT NOT EVERYBODY'S FOLLOW 4406 02:57:45,320 --> 02:57:47,055 WITH, MAIORITY ARE NOT, WE TRIED 4407 02:57:47,055 --> 02:57:50,859 FOR 20 YEARS TO BRING DICOM 4408 02:57:50,859 --> 02:57:51,993 STANDARD TO OPHTHALMOLOGY, I'VE 4409 02:57:51,993 --> 02:57:55,396 GIVEN UP 15 YEARS AGO. 4410 02:57:55,396 --> 02:57:57,499 SO I WISH EVERYBODY ELSE GOOD 4411 02:57:57,499 --> 02:57:59,534 LUCK BUT PERHAPS WE SHOULD SAVE 4412 02:57:59,534 --> 02:58:00,935 EVERYTHING IN RAW DATA FORMAT 4413 02:58:00,935 --> 02:58:04,005 AND THEN IT'S MORE EXCHANGEABLE 4414 02:58:04,005 --> 02:58:10,378 BECAUSE IN OCT, YOU HAVE 4415 02:58:10,378 --> 02:58:11,346 VARIATION OF B-SCALE AND WHICH 1 4416 02:58:11,346 --> 02:58:14,749 TO THE NEXT AND WHICH 1 WE 4417 02:58:14,749 --> 02:58:15,016 CHOOSE. 4418 02:58:15,016 --> 02:58:19,320 SOME AVERAGE HUNDRED FRAMES, 4419 02:58:19,320 --> 02:58:21,489 SOME AVERAGE 20 OR 50, SO UNLESS 4420 02:58:21,489 --> 02:58:22,590 YOU COMPARE ALL THOSE UNLESS YOU 4421 02:58:22,590 --> 02:58:30,665 HAVE THE RAW DATA WILL BE QUITE 4422 02:58:30,665 --> 02:58:31,132 CHALLENGING. 4423 02:58:31,132 --> 02:58:32,867 I THINK THERE'S SOMETHING TO BE 4424 02:58:32,867 --> 02:58:38,273 SAID ABOUT USABILITY OF THE DATA 4425 02:58:38,273 --> 02:58:39,173 ALSO WITH PRESENTATION. 4426 02:58:39,173 --> 02:58:40,141 ULTIMATELY THE MOST IMPORTANT 4427 02:58:40,141 --> 02:58:42,810 USER OFF THE DATA IS THE 4428 02:58:42,810 --> 02:58:43,411 OPHTHALMOLOGIST TREATING THE 4429 02:58:43,411 --> 02:58:46,614 PATIENT AND FOR THEM YOU NEED A 4430 02:58:46,614 --> 02:58:47,415 PRESENTABLE FORMAT. 4431 02:58:47,415 --> 02:58:51,085 AND RAW DATA IS EXCEL EPT FOR 4432 02:58:51,085 --> 02:58:51,886 RESEARCH AND ALGORITHM 4433 02:58:51,886 --> 02:58:53,655 DEVELOPMENT AND THAT'S WHAT WE 4434 02:58:53,655 --> 02:58:56,858 NEED, BUT NEEDS TO BE SOMETHING 4435 02:58:56,858 --> 02:58:58,726 SIMPLER AND PROBABLY DICOM IS 4436 02:58:58,726 --> 02:59:01,195 THE EASIEST WAY AND I WOULDN'T 4437 02:59:01,195 --> 02:59:03,598 SAY DICOM IS GIVEN UP BY KERRY'S 4438 02:59:03,598 --> 02:59:06,668 POSITION IS ALL ABOUT DICOM, SO 4439 02:59:06,668 --> 02:59:07,268 WE HAVE HOPE. 4440 02:59:07,268 --> 02:59:09,170 WE HAVE HOPE WITH THE NEI 4441 02:59:09,170 --> 02:59:11,606 BRINGING IT ALL BACK. 4442 02:59:11,606 --> 02:59:11,873 >> YEAH. 4443 02:59:11,873 --> 02:59:14,142 >> AND I'LL JUST MENTION THAT 4444 02:59:14,142 --> 02:59:16,210 SINCE THE BRCA PROJECT CAME UP 4445 02:59:16,210 --> 02:59:17,979 QUITE A FEW TIMES, IN THAT 4446 02:59:17,979 --> 02:59:20,481 PROJECT WE WORKED WITH MANY OF 4447 02:59:20,481 --> 02:59:23,818 THE MANUFACTURES AND INSISTED ON 4448 02:59:23,818 --> 02:59:26,020 THEM CONVERRING THEIR DATA TO 4449 02:59:26,020 --> 02:59:27,789 DICOM AND THEY ALL AGREED. 4450 02:59:27,789 --> 02:59:29,724 SO NOW THEY HAVE THE ABILITY TO 4451 02:59:29,724 --> 02:59:32,760 TURN THEIR DATA FOR BOTH OCT, 4452 02:59:32,760 --> 02:59:37,732 AND OCTA INTO THE PROPER 4453 02:59:37,732 --> 02:59:38,666 STANDARDS COMPLIANT NOW, THE 4454 02:59:38,666 --> 02:59:39,767 FUTURE IS SLOW LE CREEPING 4455 02:59:39,767 --> 02:59:41,869 FORWARD WHERE WE WILL HAVE 4456 02:59:41,869 --> 02:59:43,504 FINALLY HAVE DICOM IN THE FIELD 4457 02:59:43,504 --> 02:59:44,272 OF OPHTHALMOLOGY. 4458 02:59:44,272 --> 02:59:47,075 NAND I WILL JUST TAG THAT DICOM 4459 02:59:47,075 --> 02:59:52,847 WORKING GROUP 9 AND REACTIVATED 4460 02:59:52,847 --> 02:59:53,881 AND INVITE ANYONE WHO HAS 4461 02:59:53,881 --> 02:59:55,283 INTEREST TO YOIN THAT WORK 4462 02:59:55,283 --> 02:59:55,516 EMPLOY. 4463 02:59:55,516 --> 02:59:57,719 >> THANK YOU FOR ALL YOUR 4464 02:59:57,719 --> 02:59:59,487 WONDERFUL PRESENTATIONS I HAVE A 4465 02:59:59,487 --> 03:00:03,958 QUESTION FOR DR. MOHEM, I WAS 4466 03:00:03,958 --> 03:00:05,360 WONDERING THE APPROXIMATE COST 4467 03:00:05,360 --> 03:00:09,964 OF THE OCT DEVICE WAS FOR 4468 03:00:09,964 --> 03:00:10,398 PATIENTS? 4469 03:00:10,398 --> 03:00:12,967 >> SO--HOME OCT IS PROVIDED AS A 4470 03:00:12,967 --> 03:00:13,868 SERVICE, NONAPOPTOTIC AS A 4471 03:00:13,868 --> 03:00:17,438 DEVICE SO THE CONCEPT WOULD BE 4472 03:00:17,438 --> 03:00:18,940 REIMBURSEMENT CODES AS ALWAYS IS 4473 03:00:18,940 --> 03:00:20,541 ASSOCIATE WIDE THE PATIENT, WILL 4474 03:00:20,541 --> 03:00:23,411 SCAN AT HOME, THE MONITORING 4475 03:00:23,411 --> 03:00:24,912 SERVICE, THEY WILL BILL MEDICARE 4476 03:00:24,912 --> 03:00:26,581 EVERY 30 DAYS FOR THE SERVICE 4477 03:00:26,581 --> 03:00:28,883 PROVIDED AND THE PHYSICIAN WHO 4478 03:00:28,883 --> 03:00:30,284 REVIEWS THE DATA WILL BILL 4479 03:00:30,284 --> 03:00:31,719 MEDICARE FOR REVIEW OF THE 4480 03:00:31,719 --> 03:00:32,286 RETURN. 4481 03:00:32,286 --> 03:00:33,221 SO PATIENTS TECHNICALLY SHOULD 4482 03:00:33,221 --> 03:00:35,523 HAVE NO COST IF MEDICARE WAS THE 4483 03:00:35,523 --> 03:00:35,890 SERVICE. 4484 03:00:35,890 --> 03:00:37,425 THEY WILL BE LIABLE FOR ANY 4485 03:00:37,425 --> 03:00:41,462 CO-PAY IF THEY DON'T HAVE 4486 03:00:41,462 --> 03:00:42,363 ADDITIONAL INSURANCE. 4487 03:00:42,363 --> 03:00:43,031 THAT'S THE MODEL. 4488 03:00:43,031 --> 03:00:44,899 IT'S NOT I PURCHASE A DEVICE AND 4489 03:00:44,899 --> 03:00:50,338 YOU KNOW YOU HAVE TO PAY FOR 4490 03:00:50,338 --> 03:00:52,840 THAT. 4491 03:00:52,840 --> 03:00:55,076 >> THANKS. 4492 03:00:55,076 --> 03:00:56,678 >> DR. FUYI MOTO. 4493 03:00:56,678 --> 03:00:57,612 >> MANUFACTURES HAVE CHOSEN 4494 03:00:57,612 --> 03:00:59,380 DIFFERENT METHODS OF DISPLAY TO 4495 03:00:59,380 --> 03:01:00,314 ENHANCE THE VISIBLE, THE 4496 03:01:00,314 --> 03:01:04,318 PERCEPTION THAT THE IMAGE IS 4497 03:01:04,318 --> 03:01:07,422 GOOD, THAT IT HAS CONTINUITY OR 4498 03:01:07,422 --> 03:01:08,156 IMAGING DEPTH, LOG, SQUARE ROOT 4499 03:01:08,156 --> 03:01:10,692 AND SO FORTH AND THEN THIS 4500 03:01:10,692 --> 03:01:12,560 CONCEPT OF AVERAGING OF COURSE 4501 03:01:12,560 --> 03:01:14,429 IMPROVES THE APPEARANCE BUT 4502 03:01:14,429 --> 03:01:15,196 DESTROYS INFORMATION, VARIANTS 4503 03:01:15,196 --> 03:01:18,666 THAT WOULD YOU SEE BETWEEN THE 4504 03:01:18,666 --> 03:01:21,102 IMAGES BECOME CONTINUOUS BUT 4505 03:01:21,102 --> 03:01:21,703 BLURRED, RIGHT? 4506 03:01:21,703 --> 03:01:23,471 SO THE PREVIOUS COMMENT ABOUT 4507 03:01:23,471 --> 03:01:24,539 SAVING THE ORIGINAL DATA IS 4508 03:01:24,539 --> 03:01:27,975 ACTUALLY THE ONLY WAY TO 4509 03:01:27,975 --> 03:01:29,477 RELIABLY RECONSTRUCT EVERYTHING. 4510 03:01:29,477 --> 03:01:34,782 THERE'S TOO MANY STEPS, THAT 4511 03:01:34,782 --> 03:01:35,516 HAVE ADJUSTABLE PARAMETERS. 4512 03:01:35,516 --> 03:01:38,386 THE PROBLEM OF COURSE IS THAT IF 4513 03:01:38,386 --> 03:01:39,987 YOU AVERAGE 16 FRAMES, THEN YOU 4514 03:01:39,987 --> 03:01:42,857 HAVE TO TORE ALL OF THOSE FRAMES 4515 03:01:42,857 --> 03:01:47,228 OR IN OCTA, YOU'RE MULTISCANNING 4516 03:01:47,228 --> 03:01:49,530 THE DATA SETS GET VERY, VERY 4517 03:01:49,530 --> 03:01:53,634 LARGE BUT THAT UNFORTUNATELY IS 4518 03:01:53,634 --> 03:01:55,269 THE WAY TO PRESERVE THE 4519 03:01:55,269 --> 03:01:58,573 INFORMATION, EVERYTHING IS 4520 03:01:58,573 --> 03:02:01,342 DECIMATED NOW, LOG SCALE, 4521 03:02:01,342 --> 03:02:02,844 TYPICALLY 8 BIT, AND A LOT OF 4522 03:02:02,844 --> 03:02:05,847 INFORMATION IS LOST IN THE DATA. 4523 03:02:05,847 --> 03:02:07,014 >> I WAS DO AGREEN CELLS WITH 4524 03:02:07,014 --> 03:02:08,349 THE COMMENT RAISED EARLIER THAT 4525 03:02:08,349 --> 03:02:11,519 PERHAPS THERE NEEDS TO BE 4526 03:02:11,519 --> 03:02:12,053 ANOTHER REPRESENTATIONAL 4527 03:02:12,053 --> 03:02:14,055 STANDARD FOR RESEARCH WHEN IT 4528 03:02:14,055 --> 03:02:15,623 COMES TO STORING THE RAW DATA 4529 03:02:15,623 --> 03:02:17,792 AND THE INTERMEDIATE FORMS OF 4530 03:02:17,792 --> 03:02:18,192 THAT DATA. 4531 03:02:18,192 --> 03:02:21,395 THE FIRST STEP IS, YOU KNOW 4532 03:02:21,395 --> 03:02:25,333 ENCODE ING THAT IN SOME CONSISTT 4533 03:02:25,333 --> 03:02:26,400 FASHION AMONG THE DEVICES AND 4534 03:02:26,400 --> 03:02:28,469 THE SECOND PART WOULD BE HOW TO 4535 03:02:28,469 --> 03:02:34,675 THINK ABOUT IT ACROSS DEVICES. 4536 03:02:34,675 --> 03:02:35,376 >> I TOTALLY APPRECIATE THE 4537 03:02:35,376 --> 03:02:41,149 SERVICE THAT YOU'RE CREATING AT 4538 03:02:41,149 --> 03:02:42,884 NOTALL, BECAUSE MY MOTHER ALSO 4539 03:02:42,884 --> 03:02:46,087 HAS AMD AND SHE GOES EVERY 2 4540 03:02:46,087 --> 03:02:49,724 MONTHS TO THE OPTO PEOPLE AND 4541 03:02:49,724 --> 03:02:51,058 THIS WILL HELP BECAUSE SIT AT 4542 03:02:51,058 --> 03:02:54,929 HOME, SHE CAN BE ENGAGED ALMOST 4543 03:02:54,929 --> 03:02:56,831 DALE COMPETENT SO FORTH. 4544 03:02:56,831 --> 03:02:59,267 SO WHAT IS THE TIMELINE AT THIS 4545 03:02:59,267 --> 03:03:00,902 POINT? 4546 03:03:00,902 --> 03:03:03,204 ARE YOU RECRUITING OTHER 4547 03:03:03,204 --> 03:03:03,471 PATIENTS? 4548 03:03:03,471 --> 03:03:04,472 >> THAT'S A GOOD QUESTION. 4549 03:03:04,472 --> 03:03:05,940 SO WE HAVE MULTIPLE CLINICAL 4550 03:03:05,940 --> 03:03:08,242 TRIALS GOING ON, WE ARE WORKING 4551 03:03:08,242 --> 03:03:11,879 CLOSELY WITH FDA, SO WE 4552 03:03:11,879 --> 03:03:13,781 OBVIOUSLY CANNOT SAY ANYTHING 4553 03:03:13,781 --> 03:03:15,883 YOU KNOW CERTAINTY BUT 4554 03:03:15,883 --> 03:03:20,288 HOPEFULLY, THE DEVICE SHOULD BE 4555 03:03:20,288 --> 03:03:21,055 APPROVED FOR MARKETING SOMETIME 4556 03:03:21,055 --> 03:03:22,924 IN THE NEAR FUTURE BUT OF COURSE 4557 03:03:22,924 --> 03:03:25,026 TELL BE A PROCESS BEFORE IT CAN 4558 03:03:25,026 --> 03:03:26,661 REACH A LARGER POPULATION. 4559 03:03:26,661 --> 03:03:30,431 SO WE ARE DOING OUR BEST. 4560 03:03:30,431 --> 03:03:31,732 THE TEAM IS WORKING DAY IN AND 4561 03:03:31,732 --> 03:03:33,701 DAY OUT TO BRING IT TO AS MANY 4562 03:03:33,701 --> 03:03:34,969 PATIENTS AS POSSIBLE AND FOR 4563 03:03:34,969 --> 03:03:43,578 THOSE WHO NEED IT THE MOST. 4564 03:03:43,578 --> 03:03:44,111 >> THANK YOU. 4565 03:03:44,111 --> 03:03:45,413 >> ALL RIGHT, I THINK WE'RE 4566 03:03:45,413 --> 03:03:46,781 PRETTY MUCH AT TIME UNLESS 4567 03:03:46,781 --> 03:03:48,316 THERE'S ANY OTHER LAST MINUTE 4568 03:03:48,316 --> 03:03:48,583 QUESTIONS. 4569 03:03:48,583 --> 03:03:51,219 I THINK THE SPEAKERS AGAIN FOR 4570 03:03:51,219 --> 03:03:52,286 THE WONDERFUL TALKS AND GREAT 4571 03:03:52,286 --> 03:03:57,024 DISCUSSION THAT WE'VE HAD. 4572 03:03:57,024 --> 03:04:07,235 [ APPLAUSE ] 4573 03:04:19,380 --> 03:04:21,749 >> MY YOB IS BASICALLY TO GIVE 4574 03:04:21,749 --> 03:04:23,818 CLOSING REMARKS HERE AND TRY TO 4575 03:04:23,818 --> 03:04:24,218 SYNTHESIZE THINGS. 4576 03:04:24,218 --> 03:04:25,887 I THINK THIS HAS BEEN AN AMAZING 4577 03:04:25,887 --> 03:04:27,188 2 DAYS OF SCIENCE THAT WE'RE 4578 03:04:27,188 --> 03:04:29,924 HEARING ABOUT, AND YOU KNOW THEY 4579 03:04:29,924 --> 03:04:31,292 ASKED ME TO TRY TO SYNTHESIZE 4580 03:04:31,292 --> 03:04:33,427 THIS AND I WILL DO MY BEST BUT 4581 03:04:33,427 --> 03:04:35,396 JUST TO THE DISCLAIMERS, WE 4582 03:04:35,396 --> 03:04:36,464 CAN'T GET EVERYTHING, BUT WHEN 4583 03:04:36,464 --> 03:04:37,698 WE HAVE SOMETHING THAT'S TOUGH, 4584 03:04:37,698 --> 03:04:40,134 YOU KNOW WHAT I TRY TO DO IS GO 4585 03:04:40,134 --> 03:04:41,936 BACK TO BASICS, YOU KNOW WHICH 4586 03:04:41,936 --> 03:04:43,671 IS OUR MISSION STATEMENT AT THE 4587 03:04:43,671 --> 03:04:45,206 NCEREBELLUMS I TO ELIMINATE 4588 03:04:45,206 --> 03:04:46,474 VISION LOSS AND IMPROVE QUALITY 4589 03:04:46,474 --> 03:04:47,842 OF LIFE THROUGH VISION RESEARCH 4590 03:04:47,842 --> 03:04:52,280 AND YOU KNOW I SEE MY JOB AS 4591 03:04:52,280 --> 03:04:53,214 TRYING TO HELP CREATE AN 4592 03:04:53,214 --> 03:04:54,382 ENVIRONMENT WHERE ALL OF YOU CAN 4593 03:04:54,382 --> 03:04:56,183 THRIVE AND DO THE BEST--DO THE 4594 03:04:56,183 --> 03:04:58,920 BEST RESEARCH TO ADVANCE THAT 4595 03:04:58,920 --> 03:04:59,153 MISSION. 4596 03:04:59,153 --> 03:05:01,022 AND YOU KNOW I THINK IT'S PRETTY 4597 03:05:01,022 --> 03:05:02,223 OVERWHELMING IN A WAY, IF YOU 4598 03:05:02,223 --> 03:05:04,025 STEP BACK, THERE ARE SOME OF THE 4599 03:05:04,025 --> 03:05:05,359 SMARTEST PEOPLE IN THE WORLD IN 4600 03:05:05,359 --> 03:05:07,795 THIS ROOM RIGHT NOW, AND I THINK 4601 03:05:07,795 --> 03:05:09,096 THAT YOU KNOW WAWE REALLY WANT 4602 03:05:09,096 --> 03:05:13,734 TO DO IS TO CREATE A MILIEU 4603 03:05:13,734 --> 03:05:15,002 WHERE THE WHOLE IS GREATER THAN 4604 03:05:15,002 --> 03:05:18,239 THE SUM OF THE PARTS AND WE 4605 03:05:18,239 --> 03:05:19,507 DEFINITELY DON'T WANT A WORLD 4606 03:05:19,507 --> 03:05:20,841 WHERE THE HOLE IS LESS THAN SOME 4607 03:05:20,841 --> 03:05:21,442 OF THE PARTS. 4608 03:05:21,442 --> 03:05:22,944 AND SO, I THINK THAT'S IMPORTANT 4609 03:05:22,944 --> 03:05:26,881 TO KEEP IN MIND. 4610 03:05:26,881 --> 03:05:29,583 I TOOK SOME MENTAL NOTES AS I 4611 03:05:29,583 --> 03:05:30,985 WAS LISTENING HERE XI THOUGHT I 4612 03:05:30,985 --> 03:05:32,320 WOULD SUMMARIZE THE POINTS I 4613 03:05:32,320 --> 03:05:34,088 TOOK AWAY, NUMBER 1, I WANT TO 4614 03:05:34,088 --> 03:05:38,693 START WITH WHAT BROUGHT US HER. 4615 03:05:38,693 --> 03:05:40,828 JIM, DAVID AND ERIC, AMAZING 4616 03:05:40,828 --> 03:05:42,997 WORK AND 1 THING IS THAT THEY'RE 4617 03:05:42,997 --> 03:05:44,865 ALL ENGINEERS WHO GOT INTERESTED 4618 03:05:44,865 --> 03:05:46,067 IN THE VISION SPACE AS ARE MANY 4619 03:05:46,067 --> 03:05:48,903 OF YOU IN THE AUDIENCE, AND YOU 4620 03:05:48,903 --> 03:05:50,871 KNOW I THINK THAT YOU KNOW IN 4621 03:05:50,871 --> 03:05:55,076 THIS FIELD, WE NEED THAT 4622 03:05:55,076 --> 03:05:58,346 METHOLOGICAL EXPERTISE TO 4623 03:05:58,346 --> 03:05:59,380 ADDRESS PROBLEMS. 4624 03:05:59,380 --> 03:06:00,848 THE BEST ENGINEERS AND 4625 03:06:00,848 --> 03:06:03,751 METHODOLOGISTS ARE GOING TO WANT 4626 03:06:03,751 --> 03:06:04,518 TO DEVELOP INNOVATIVE 4627 03:06:04,518 --> 03:06:07,321 METHODOLOGIES NOT TO TAKE OFF 4628 03:06:07,321 --> 03:06:08,289 THE SHELF METHODOLOGIES AND AMRI 4629 03:06:08,289 --> 03:06:09,123 THEM TO THE EYE. 4630 03:06:09,123 --> 03:06:11,192 AND I THINK IT'S INCUMBENT UPON 4631 03:06:11,192 --> 03:06:12,393 US AS A COMMUNITY TO SHOW THAT 4632 03:06:12,393 --> 03:06:15,262 THE EYE IS A REMARKABLE ORGAN 4633 03:06:15,262 --> 03:06:19,000 AND THE VISUAL SYSTEM IS FOR 4634 03:06:19,000 --> 03:06:20,968 DEVELOPING THOSE METHOLOGICAL 4635 03:06:20,968 --> 03:06:22,036 ADVANCES, THAT'S HOW WE WILL 4636 03:06:22,036 --> 03:06:23,437 ATTRACT THE BEST PEOPLE AND 4637 03:06:23,437 --> 03:06:24,739 THAT'S HOW THIS FIELD WILL 4638 03:06:24,739 --> 03:06:24,972 THRIVE. 4639 03:06:24,972 --> 03:06:28,175 SO IF YOU HAVE IDEAS ABOUT HOW 4640 03:06:28,175 --> 03:06:30,211 WE CAN DO THAT BETTER, PLEASE 4641 03:06:30,211 --> 03:06:31,612 SORT OF LET US KNOW. 4642 03:06:31,612 --> 03:06:33,147 NUMBER 2, IS, YOU KNOW WE JUST 4643 03:06:33,147 --> 03:06:36,150 HEARD THIS DISCUSSION ABOUT THE 4644 03:06:36,150 --> 03:06:39,587 BENEFITS OF STANDARDIZATION, YOU 4645 03:06:39,587 --> 03:06:41,155 KNOW, CHRISTINE, AARON, YOU KNOW 4646 03:06:41,155 --> 03:06:44,959 HOW MANY OF YOU TALKED ABOUT 4647 03:06:44,959 --> 03:06:48,396 DIFFERENT ASPECTS OF 4648 03:06:48,396 --> 03:06:49,663 STANDARDIZATION, ANATOMY, 4649 03:06:49,663 --> 03:06:51,399 DIGITAL FORMATS, CLINICAL 4650 03:06:51,399 --> 03:06:52,666 STANDARDS, OTHER SEGMENTATION 4651 03:06:52,666 --> 03:06:55,669 METHODS AND I THINK THAT I LOVE 4652 03:06:55,669 --> 03:06:57,972 THAT, OF COURSE, AND I LOVE THAT 4653 03:06:57,972 --> 03:06:59,707 WHAT WE'RE DOING HERE TO TRY TO 4654 03:06:59,707 --> 03:07:02,309 ACHIEVE THAT. 4655 03:07:02,309 --> 03:07:03,778 YOU KNOW MY OBSERVATION 4656 03:07:03,778 --> 03:07:05,312 WITHSTAND ARD SYSTEM THAT 4657 03:07:05,312 --> 03:07:07,114 EVERYBODY LOVES IT, BUT WHY LOVE 4658 03:07:07,114 --> 03:07:09,450 IT MORE WHEN EVERYBODY FOLLOWS 4659 03:07:09,450 --> 03:07:12,420 MY STANDARD, YOU KNOW, NOT YOUR 4660 03:07:12,420 --> 03:07:12,720 STANDARD. 4661 03:07:12,720 --> 03:07:18,025 AND I THINK THAT TO MAKE THIS 4662 03:07:18,025 --> 03:07:19,560 WORK THEREY GOING TO HAVE TO BE 4663 03:07:19,560 --> 03:07:21,529 GIVE AND TAKE AND WE WILL HAVE 4664 03:07:21,529 --> 03:07:23,164 TO DEVELOP A STANDARD THAT 4665 03:07:23,164 --> 03:07:25,466 EVERYBODY'S HAPPY ENOUGH WITH 4666 03:07:25,466 --> 03:07:26,767 BUT PROBABLY NOBODY'S GOING TO 4667 03:07:26,767 --> 03:07:28,302 BE A HUNDRED% HAPPY AND I WOULD 4668 03:07:28,302 --> 03:07:28,903 CHALLENGE THIS COMMUNITY TO 4669 03:07:28,903 --> 03:07:30,838 THINK ABOUT THAT IN TERMS OF 4670 03:07:30,838 --> 03:07:33,707 DEVELOPING CREW COMMUNITY 4671 03:07:33,707 --> 03:07:33,974 STANDARDS. 4672 03:07:33,974 --> 03:07:37,211 YOU KNOW IN TERMS OF HOW TO DO 4673 03:07:37,211 --> 03:07:39,180 THAT, CINDY TOTH, AND PETE 4674 03:07:39,180 --> 03:07:40,347 CAMPBELL WERE INVOLVED WITH AN 4675 03:07:40,347 --> 03:07:43,851 R. O. P. PROJECT INVOLVING 4676 03:07:43,851 --> 03:07:44,718 STANDARDIZING CLINICAL 4677 03:07:44,718 --> 03:07:45,686 REPRESENTATION AND IT TOOK 4678 03:07:45,686 --> 03:07:47,021 MULTIPLE YEARS BUT IT WORKED IN 4679 03:07:47,021 --> 03:07:49,657 THE END, TALK TO THEM, OR MANY 4680 03:07:49,657 --> 03:07:51,258 OTHER PEOPLE WHO'VE SUFFERED 4681 03:07:51,258 --> 03:07:56,897 THROUGH THIS, BUT IT'S POSSIBLE. 4682 03:07:56,897 --> 03:07:58,766 YOU KNOW ANOTHER ISSUE, I WANT 4683 03:07:58,766 --> 03:08:00,101 TO PIGGYBACK, NUMBER THERE IS I 4684 03:08:00,101 --> 03:08:01,368 WANT TO PIGGYBACK ON SOMETHING 4685 03:08:01,368 --> 03:08:05,940 KERRY BROUGHT UP AND THATIOLE 4686 03:08:05,940 --> 03:08:07,541 AND AMITHA TALKED ABOUT HOW 4687 03:08:07,541 --> 03:08:09,076 ASKED THIS QUESTION ABOUT 4688 03:08:09,076 --> 03:08:10,711 REGARDING HOW THE OCT FIELD 4689 03:08:10,711 --> 03:08:12,413 WOULD BENEFIT FROM 4690 03:08:12,413 --> 03:08:14,648 STANDARDIZATION OF YOU KNOW 4691 03:08:14,648 --> 03:08:15,816 MEASUREMENTS, SEGMENTATION, YOU 4692 03:08:15,816 --> 03:08:16,984 KNOW THE TECHNICAL 4693 03:08:16,984 --> 03:08:18,152 ASSPECTRA PRESENTATIONS, YOU 4694 03:08:18,152 --> 03:08:22,089 KNOW SHARED NORMATIVE DATABASES 4695 03:08:22,089 --> 03:08:24,091 AND JUST TO DOUBLE DOWN ON THIS 4696 03:08:24,091 --> 03:08:25,926 THING KERRY MENTIONED THAT 4697 03:08:25,926 --> 03:08:26,861 THERE'S BEEN AN INITIATIVE THAT 4698 03:08:26,861 --> 03:08:31,799 I BELIEVE CAME OUT OF NIBIB, IT 4699 03:08:31,799 --> 03:08:33,434 WAS REALLY, I HEARD ABOUT IT 4700 03:08:33,434 --> 03:08:34,635 FROM BRUCE AND CANNED WHAT AND 4701 03:08:34,635 --> 03:08:36,737 THEY WERE WORKING WITH THE FDA, 4702 03:08:36,737 --> 03:08:38,672 AND FOLKS LIKE DAN HAMMER AND 4703 03:08:38,672 --> 03:08:41,175 GOT INTERNAL AUDIT VOLVED 4704 03:08:41,175 --> 03:08:43,344 THROUGH KERRY, USING DEVELOPING 4705 03:08:43,344 --> 03:08:44,812 FANDOM TO TRY TO ACHIEVE THIS. 4706 03:08:44,812 --> 03:08:46,380 AND YOU KNOW KERRY IS OUR 4707 03:08:46,380 --> 03:08:46,780 CONTACT FOR THAT. 4708 03:08:46,780 --> 03:08:48,682 IF YOU ARE INTERESTED AND 4709 03:08:48,682 --> 03:08:49,884 SERIOUS ABOUT THAT, PLEASE TALK 4710 03:08:49,884 --> 03:08:51,118 TO KERRY. 4711 03:08:51,118 --> 03:08:52,219 YOU KNOW DAVID, I APPRECIATE 4712 03:08:52,219 --> 03:08:55,089 YOUR THOUGHTS ABOUT OCT XOCT 4713 03:08:55,089 --> 03:09:00,694 ANGIOGRAPHY AND I THINK THAT 4714 03:09:00,694 --> 03:09:03,764 WILL BE, SCIENCE ANALOGY 4715 03:09:03,764 --> 03:09:05,199 DISCOVERY ARE A TEAM SPORT AND 4716 03:09:05,199 --> 03:09:06,567 THAT'S COME ACROSS HERE, IF WE 4717 03:09:06,567 --> 03:09:07,601 WANT TO SOLVE BIG PROBLEMS WE 4718 03:09:07,601 --> 03:09:09,737 WILL HAVE TO DO IT TOGETHER 4719 03:09:09,737 --> 03:09:11,105 THROUGH THINGS LIKE 4720 03:09:11,105 --> 03:09:11,705 STANDARDIZATION, NUMBER 4 IS 4721 03:09:11,705 --> 03:09:13,574 THAT MANY OF YOU TALKED ABOUT 4722 03:09:13,574 --> 03:09:14,909 DATA SHARING. 4723 03:09:14,909 --> 03:09:17,244 I THINK THAT IS AWESOME AND YOU 4724 03:09:17,244 --> 03:09:21,081 KNOW THE REALITY IS THAT, WELL, 4725 03:09:21,081 --> 03:09:22,516 I WILL GIVE YOU MY OPINION IS 4726 03:09:22,516 --> 03:09:25,452 THAT THE REALITY IS THAT OUR 4727 03:09:25,452 --> 03:09:28,756 CURRENT ACADEMIC SYSTEM IS BASED 4728 03:09:28,756 --> 03:09:30,591 ON THE PAPER AS THE CENTER OF 4729 03:09:30,591 --> 03:09:32,326 THE UNIVERSE AND OUR DAT ARE 4730 03:09:32,326 --> 03:09:34,061 SECONDAR TOW THAT PAPER, THEY'RE 4731 03:09:34,061 --> 03:09:36,630 KIND OF A TAG ALONG AND WE KNOW 4732 03:09:36,630 --> 03:09:37,898 THAT DIFFERENT PEOPLE ANALYZING 4733 03:09:37,898 --> 03:09:40,668 THE SAME DATA SET CAN COME UP 4734 03:09:40,668 --> 03:09:41,402 WITH DIFFERENT CONCLUSIONS AND 4735 03:09:41,402 --> 03:09:44,205 YOU KNOW ON TOP OF THAT, YOU 4736 03:09:44,205 --> 03:09:45,005 KNOW CHRISTINE, THEY TALKED 4737 03:09:45,005 --> 03:09:46,974 ABOUT THIS EXAMPLE OF THESE 4738 03:09:46,974 --> 03:09:49,009 WHITE DOTS AND WHAT ARE THEY, 4739 03:09:49,009 --> 03:09:50,544 AND THE REALITIES WE MAY NOT 4740 03:09:50,544 --> 03:09:51,912 KNOW BECAUSE THESE PEOPLE MAY 4741 03:09:51,912 --> 03:09:54,582 NOT HAVE ACCESS TO THAT RAW DATA 4742 03:09:54,582 --> 03:09:56,817 AND SO, THIS HAPPENS, ALL THE 4743 03:09:56,817 --> 03:10:02,590 TIME, AND I THINK THAT KNOWLEDGE 4744 03:10:02,590 --> 03:10:04,491 DISCOVERY WILL BENEFIT IF WE 4745 03:10:04,491 --> 03:10:06,460 HAVE LARGE DATA SETS, MAYBE 4746 03:10:06,460 --> 03:10:08,195 THEY'RE CENTRAL, MAYBE THEY'RE 4747 03:10:08,195 --> 03:10:09,063 FEDERATED DATA SETS WHERE 4748 03:10:09,063 --> 03:10:13,400 COMMUNITIES OF PEOPLE, I THINK 4749 03:10:13,400 --> 03:10:15,736 URSU LA YOU USED THIS PHRASE, 4750 03:10:15,736 --> 03:10:17,004 LIKE MINDED PEOPLE, IN YOUR 4751 03:10:17,004 --> 03:10:18,272 TALK, WHERE THESE LIKE MINDED 4752 03:10:18,272 --> 03:10:20,407 PEOPLE CAN MINE THESE LARGE DATA 4753 03:10:20,407 --> 03:10:21,442 SETS AND ITERATIVELY WORK WITH 4754 03:10:21,442 --> 03:10:22,843 EACH OTHER TO DISCOVER THE 4755 03:10:22,843 --> 03:10:23,077 TRUTH. 4756 03:10:23,077 --> 03:10:24,578 YOU KNOW WE'RE ALL GOING TO FEEL 4757 03:10:24,578 --> 03:10:26,680 DIFFERENT PARTS OF THE ELEPHANT 4758 03:10:26,680 --> 03:10:28,015 WHEN YOU ANALYZE THAT DATA SET 4759 03:10:28,015 --> 03:10:29,283 WHERE YOU WORK TOGETHER AND IF 4760 03:10:29,283 --> 03:10:30,584 YOU HAVE DIFFERENT CONCLUSIONS 4761 03:10:30,584 --> 03:10:31,986 WE'RE NOT RIGHT AND WRONG BUT 4762 03:10:31,986 --> 03:10:33,954 WE'RE WORKING TOGETHER TO 4763 03:10:33,954 --> 03:10:34,788 ITERATIVELY FIGURE OUT WHAT'S 4764 03:10:34,788 --> 03:10:36,757 GOING ON, I THINK THAT WILL 4765 03:10:36,757 --> 03:10:38,726 BENEFIT AND MAYBE WE NEED A NEW 4766 03:10:38,726 --> 03:10:39,927 PARADIGM FOR SCIENCE WHERE DATA 4767 03:10:39,927 --> 03:10:41,695 IS AT THE HUB AND PUBLICATIONS 4768 03:10:41,695 --> 03:10:43,097 COME OUT OF THE SAME DATA SETS 4769 03:10:43,097 --> 03:10:46,567 AND WE TRY TO FIGURE OUT TRUTH 4770 03:10:46,567 --> 03:10:47,801 BASED ON THAT. 4771 03:10:47,801 --> 03:10:48,836 AND I WOULD CHALLENGE THIS 4772 03:10:48,836 --> 03:10:49,737 COMMUNITY TO FIGURE OUT WHAT ARE 4773 03:10:49,737 --> 03:10:52,339 THE RULES OF THE GAME IF WE MOVE 4774 03:10:52,339 --> 03:10:53,040 IN THAT DIRECTION. 4775 03:10:53,040 --> 03:10:56,010 BECAUSE I THINK IT WOULD BE 4776 03:10:56,010 --> 03:10:56,710 GREAT FOR THAT. 4777 03:10:56,710 --> 03:10:58,312 OBVIOUSLY THE ENGINEERING AND 4778 03:10:58,312 --> 03:11:00,748 THE COMPUTER SCIENCE COMMUNITY 4779 03:11:00,748 --> 03:11:01,715 HAVE REALLY INNOVATED IN TERMS 4780 03:11:01,715 --> 03:11:02,783 OF THINKING THAT WAY AND MAYBE 4781 03:11:02,783 --> 03:11:05,219 WE CAN LEARN THINGS FROM THAT. 4782 03:11:05,219 --> 03:11:07,421 NUMBER 5, IS THAT, THIS ISSUE OF 4783 03:11:07,421 --> 03:11:10,257 TRANSLATION OF THE REAL WORLD, 4784 03:11:10,257 --> 03:11:11,692 OF RESEARCH INTO REAL WORLD PROD 4785 03:11:11,692 --> 03:11:12,092 UBIQUITINNATIONS. 4786 03:11:12,092 --> 03:11:13,460 YOU KNOW WE HAD A DISCUSSION 4787 03:11:13,460 --> 03:11:15,396 ABOUT THAT YOU KNOW JIM AND 4788 03:11:15,396 --> 03:11:16,397 DAVID, YOU BROUGHT OUT COMMENTS 4789 03:11:16,397 --> 03:11:18,065 THAT I'VE BEEN THINKING ABOUT 4790 03:11:18,065 --> 03:11:25,606 PRETTY MUCH ALL NIGHT ABOUT THE 4791 03:11:25,606 --> 03:11:26,240 IMPORTANCE OF INVOLVING 4792 03:11:26,240 --> 03:11:26,640 INDUSTRY. 4793 03:11:26,640 --> 03:11:29,777 AS I THINK ABOUT THAT, MAYBE THE 4794 03:11:29,777 --> 03:11:30,844 COMMUNITY WOULD BENEFIT FROM A 4795 03:11:30,844 --> 03:11:32,579 BIT OF GUIDANCE ABOUT HOW TO 4796 03:11:32,579 --> 03:11:35,215 DESIGN STUDIES LIKE WHAT STUDIES 4797 03:11:35,215 --> 03:11:36,950 TO PERFORM HOW TO DESIGN THEM 4798 03:11:36,950 --> 03:11:40,354 AND WHAT END POINTS WOULD 4799 03:11:40,354 --> 03:11:41,755 INDUSTRY BE INTERESTED IN CAN 4800 03:11:41,755 --> 03:11:43,724 HOW WOULD WE YOU KNOW TEMON 4801 03:11:43,724 --> 03:11:44,892 STRAIGHT THAT POTENTIAL TO MAKE 4802 03:11:44,892 --> 03:11:46,493 IMPACT AND IT SHOULD BE 4803 03:11:46,493 --> 03:11:47,594 ATTRACTIVE TO PEOPLE AND MAYBE 4804 03:11:47,594 --> 03:11:50,030 THAT IS AN AREA WHERE NIH CAN BE 4805 03:11:50,030 --> 03:11:51,665 HELPFUL, YOU KNOW FOR EXAMPLE, 4806 03:11:51,665 --> 03:11:54,001 WORKING WITH FDA OR CMS OR WHO 4807 03:11:54,001 --> 03:11:57,638 THE PEOPLE ARE TO COME UP WITH 4808 03:11:57,638 --> 03:11:58,839 GUIDANCE ABOUT YOU KNOW WHAT 4809 03:11:58,839 --> 03:12:00,941 TYPES OF STUDIES WOULD BE NEEDED 4810 03:12:00,941 --> 03:12:02,209 BEFORE YOU DESIGN THEM AND DO 4811 03:12:02,209 --> 03:12:03,844 THEM, NOT AFTER THE FACT WHEN 4812 03:12:03,844 --> 03:12:05,846 YOU SHOW THEM YOUR DATA AND IT'S 4813 03:12:05,846 --> 03:12:06,313 NOT GOOD ENOUGH. 4814 03:12:06,313 --> 03:12:08,048 AND SO JUST IF YOU HAVE IDEAS 4815 03:12:08,048 --> 03:12:09,550 ABOUT THAT, JUST, YOU KNOW 4816 03:12:09,550 --> 03:12:11,085 PLEASE SORT OF LET US KNOW 4817 03:12:11,085 --> 03:12:11,885 BECAUSE I'VE BEEN WORKING 4818 03:12:11,885 --> 03:12:15,956 THROUGH OW WE CAN MAKE EVERYBODY 4819 03:12:15,956 --> 03:12:18,726 MORE EFFICIENT, AND ANOTHER 4820 03:12:18,726 --> 03:12:21,495 ISSUE, NUMBER 6 IS POPULATION 4821 03:12:21,495 --> 03:12:21,729 HEALTH. 4822 03:12:21,729 --> 03:12:23,931 SOME OF YOU TALKED ABOUT IN THE 4823 03:12:23,931 --> 03:12:25,666 END, YOU KNOW, CLEARLY IN THIS 4824 03:12:25,666 --> 03:12:27,267 COUNTRY AND WORLD NOT EVERYBODY 4825 03:12:27,267 --> 03:12:29,770 HAS EQUAL ACCESS TO CARE, AND 4826 03:12:29,770 --> 03:12:32,139 KERRY MENTIONED THIS THING ABOUT 4827 03:12:32,139 --> 03:12:33,207 THE CVS KIOSK AND MAYBE THERE 4828 03:12:33,207 --> 03:12:35,075 WILL BE WAYS TO USE THESE 4829 03:12:35,075 --> 03:12:38,112 TECHNOLOGIES TO INCREASE 4830 03:12:38,112 --> 03:12:39,113 ACCESSIBLE TO CARE AROUND THE 4831 03:12:39,113 --> 03:12:40,714 COUNTRY AND THE WORLD. 4832 03:12:40,714 --> 03:12:41,648 LOVE THOSE IDEAS. 4833 03:12:41,648 --> 03:12:42,850 AND LASTLY, I JUST WANT TO THANK 4834 03:12:42,850 --> 03:12:44,251 ALL THE PEOPLE WHO PUT THIS 4835 03:12:44,251 --> 03:12:44,651 EVENT TOGETHER. 4836 03:12:44,651 --> 03:12:45,919 YOU KNOW WE STARTED OFF BY 4837 03:12:45,919 --> 03:12:48,889 SAYING IT WAS DONE ON SHORT 4838 03:12:48,889 --> 03:12:50,324 NOTICE, BECAUSE OF THE LASKER 4839 03:12:50,324 --> 03:12:52,993 AND THE NATIONAL MEDAL OF 4840 03:12:52,993 --> 03:12:54,027 TECHNOLOGY AWARDS, AND SO THERE 4841 03:12:54,027 --> 03:12:58,599 WERE A LOT OF PEOPLE WHO PLANNED 4842 03:12:58,599 --> 03:13:00,234 THIS, CAPHILL, DAVID, OUR TEAM 4843 03:13:00,234 --> 03:13:01,402 AT THE NCEREBELLUMS I AND THEN 4844 03:13:01,402 --> 03:13:03,504 THE PEOPLE WHO SIT OUTSIDE, 4845 03:13:03,504 --> 03:13:05,906 MICAH, AMY AND A LOT OF PEOPLE, 4846 03:13:05,906 --> 03:13:06,774 THAT REALLY GOT US HERE. 4847 03:13:06,774 --> 03:13:09,476 AND YOU KNOW IT WAS TO THE POINT 4848 03:13:09,476 --> 03:13:10,511 WHERE,--AND THE OTHER THING I 4849 03:13:10,511 --> 03:13:17,618 WANT TO EMPHASIZE IS THAT WHEN 4850 03:13:17,618 --> 03:13:19,620 WE DID THIS, I THINK ALL OF YOU 4851 03:13:19,620 --> 03:13:23,991 NOTICED THAT IN THE BEGINNING 4852 03:13:23,991 --> 03:13:25,058 NOT EVERYTHING WAS PERFECT, YOU 4853 03:13:25,058 --> 03:13:26,727 KNOW WE HAD ISSUES WITH THE 4854 03:13:26,727 --> 03:13:28,495 TABLE BLOCKING THE DISPLAY AND 4855 03:13:28,495 --> 03:13:29,863 THE ECHOES THAT WE DIDN'T 4856 03:13:29,863 --> 03:13:31,665 RECOGNIZE BUT I JUST WANT TO 4857 03:13:31,665 --> 03:13:33,333 GIVE OUT THE TEAM IN THE BACK, 4858 03:13:33,333 --> 03:13:36,603 YOU KNOW FROM CAPITAL 4859 03:13:36,603 --> 03:13:37,805 CONSULTANTS WHO SORT OF 4860 03:13:37,805 --> 03:13:38,839 RECOGNIZED THOSE PROBLEM ANDS 4861 03:13:38,839 --> 03:13:41,642 TRIED TO FIX THEM IN REALTIME, 4862 03:13:41,642 --> 03:13:44,478 YOU KNOW TO THE POINT WHERE LIKE 4863 03:13:44,478 --> 03:13:46,580 DAVE AND CAPHILL WERE MOVING 4864 03:13:46,580 --> 03:13:48,182 CHAIRS AND TABLES TO GET STUFF 4865 03:13:48,182 --> 03:13:49,583 OUT OF THE WAY BECAUSE I THINK 4866 03:13:49,583 --> 03:13:51,251 LIKE IN A WAY, NOT EVERYTHING IS 4867 03:13:51,251 --> 03:13:53,187 LIFE IS PERFECT BUT TIMES WE'RE 4868 03:13:53,187 --> 03:13:55,756 DEFINED BY HOW WE RESPOND TO 4869 03:13:55,756 --> 03:14:01,628 THOSE IMPERFECTIONS, AND I HOPE 4870 03:14:01,628 --> 03:14:03,831 THAT'S A PARADIGM WE WANT AT 4871 03:14:03,831 --> 03:14:04,364 NEI. 4872 03:14:04,364 --> 03:14:05,332 WE'RE TRYING TO SOLVE BIG 4873 03:14:05,332 --> 03:14:06,166 PROBLEMS AND EVERYTHING WE DO 4874 03:14:06,166 --> 03:14:08,368 WILL NOT BE TO EVERY SINGLE 4875 03:14:08,368 --> 03:14:10,571 PERSON'S LIKING BUT I JUST HOPE 4876 03:14:10,571 --> 03:14:11,505 THAT YOU RECOGNIZE THAT WE'RE 4877 03:14:11,505 --> 03:14:14,608 TRYING AND WHAT WE'RE TRYING TO 4878 03:14:14,608 --> 03:14:16,243 DO IS ITERATIVELY FIGURING OUT 4879 03:14:16,243 --> 03:14:17,511 WHAT WE'RE TRYING TO DO AND DO 4880 03:14:17,511 --> 03:14:18,745 BETTER AND JUST DO THE BEST JOB 4881 03:14:18,745 --> 03:14:23,484 FOR ALL OF YOU. 4882 03:14:23,484 --> 03:14:24,785 AND LAST THING I WANT TO SAY IS 4883 03:14:24,785 --> 03:14:26,220 THANKS TO ALL OF YOU FOR 4884 03:14:26,220 --> 03:14:30,257 ATTENDING. 4885 03:14:30,257 --> 03:14:32,693 YOU KNOW THERE'S--I WANT TO 4886 03:14:32,693 --> 03:14:35,963 CONGRATULATE JIM, DAVID AND ERIC 4887 03:14:35,963 --> 03:14:38,832 WHO AREN'T HERE AND ALSO JUST AN 4888 03:14:38,832 --> 03:14:40,634 AMAZING SORT OF, YOU KNOW IT 4889 03:14:40,634 --> 03:14:42,169 HAPPENS EVERY FEW DECADES IN THE 4890 03:14:42,169 --> 03:14:43,837 VISION FIELD AND YOU KNOW THESE 4891 03:14:43,837 --> 03:14:45,205 ARE SORT OF LEGENDARY ARK 4892 03:14:45,205 --> 03:14:48,141 COMPLISHMENTS AND I JUST WANT TO 4893 03:14:48,141 --> 03:14:49,209 CALL THIS OUT. 4894 03:14:49,209 --> 03:14:49,910 AND THEY'RE--I WANT TO 4895 03:14:49,910 --> 03:14:51,311 ACKNOWLEDGE THAT THERE ARE A LOT 4896 03:14:51,311 --> 03:14:52,746 OF OTHER PEOPLE IN THE ROOM WHO 4897 03:14:52,746 --> 03:14:54,481 HAVE DONE AMAZING STUFF, 4898 03:14:54,481 --> 03:14:57,951 TOGETHER, IN SOME CASES WITH 4899 03:14:57,951 --> 03:15:00,053 THESE 3 AND YOU KNOW JOEL'S NAME 4900 03:15:00,053 --> 03:15:02,122 CAME UP QUITE A FEW TIMES IN 4901 03:15:02,122 --> 03:15:04,091 THESE SLIDES AND MANY OTHERS 4902 03:15:04,091 --> 03:15:06,693 HAVE DONE LOOK THE LINES OF 4903 03:15:06,693 --> 03:15:10,464 SCIENCE BEING A TEAM SPORT. 4904 03:15:10,464 --> 03:15:13,066 AND YOU KNOW, CINDY TOTH USED 4905 03:15:13,066 --> 03:15:14,801 THIS PHRASE, OCT IS BEING AN 4906 03:15:14,801 --> 03:15:15,769 INCREDIBLE GIFT TO THE COMMUNITY 4907 03:15:15,769 --> 03:15:20,274 AND I JUST WANT TO CALL THAT 4908 03:15:20,274 --> 03:15:20,440 OUT. 4909 03:15:20,440 --> 03:15:23,010 SO JUST 1 THING I TOOK AWAY FROM 4910 03:15:23,010 --> 03:15:24,444 THIS IS THERE'S AN AMAZING CAST 4911 03:15:24,444 --> 03:15:25,746 BUT I THINK THERE'S A LOT OF 4912 03:15:25,746 --> 03:15:27,981 EVIDENT THAT THE FUTURE IS MORE 4913 03:15:27,981 --> 03:15:28,715 EXCITING THAN THE PAST. 4914 03:15:28,715 --> 03:15:30,784 SO WITH THAT, YOU KNOW I JUST 4915 03:15:30,784 --> 03:15:32,219 HOPE THAT YOU ENJOY THE REST OF 4916 03:15:32,219 --> 03:15:33,887 YOUR STAY HERE IN DC, YOU KNOW 4917 03:15:33,887 --> 03:15:35,622 TRY TO SEE THE CHERRY BLOSSOMS 4918 03:15:35,622 --> 03:15:37,991 IF YOU CAN AND JUST SAFE TRAVELS 4919 03:15:37,991 --> 03:15:40,027 BACK HOME, THANK YOU TO ALL THE 4920 03:15:40,027 --> 03:15:43,931 SPEAKERS. 4921 03:15:43,931 --> 03:15:54,174 [ APPLAUSE ] 4922 03:15:57,210 --> 03:15:58,679 JUST A QUICK FEW ANNOUNCE WANTS 4923 03:15:58,679 --> 03:16:00,681 IF THERE ARE SPEAKERS TRAVELING 4924 03:16:00,681 --> 03:16:02,983 TOA THE AIRPORTS AT THE SOUTH 4925 03:16:02,983 --> 03:16:05,052 SHUTTLES ARE, MEET AT THE SOUTH 4926 03:16:05,052 --> 03:16:06,386 ENTRANCE AT 12:15, THERE MAY BE 4927 03:16:06,386 --> 03:16:08,155 A COUPLE OTHER SPOTS FOR 4928 03:16:08,155 --> 03:16:11,224 NONSPEAKERS WHO ARE HEADING 4929 03:16:11,224 --> 03:16:14,828 THERE AS WELL, NUMBER 2 IF 4930 03:16:14,828 --> 03:16:15,829 ANYBODY LOST A METROSMART CARD 4931 03:16:15,829 --> 03:16:20,801 IT'S OUT IN THE LOBBY WITH 1 OF 4932 03:16:20,801 --> 03:16:22,336 THE STAFF, AND SAVE TRAVELS TO 4933 03:16:22,336 --> 03:16:32,813 EVERYBODY WHO'S GOING A FAR 4934 03:16:33,113 --> 03:27:55,044 DISTANCE. 4935 03:27:55,044 --> 03:28:05,088